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Abstract 
Ola Kamala 
A Comparison of Cultured Human Dermal Fibroblasts Derived from 
Terminal and Vellus Hair Bearing Skin 
Differences in the expression of inhibitors of apoptosis proteins, oestrogen 
receptors, and responses to oestradiol under normal and wound induced 
conditions 
Wounds heal better in skin with terminal hair follicles (large and pigmented) as 
opposed to those with vellus hair follicles (small and unpigmented), while 
dermal fibroblasts from different anatomical regions also exhibit phenotypical 
differences.  Tissue repair requires a tight control of cell proliferation, migration 
and apoptosis, and recent studies have shown the importance of inhibitors of 
apoptosis proteins (IAPs), which are proteins that prevent the process of 
apoptosis via their interaction with caspase molecules in wound healing. 
Oestrogens improve the rate and quality of wound healing, but their 
relationship with IAPs in human skin has not been studied.  Therefore, terminal 
(scalp) and vellus (facial) hair bearing skin from the same donor was compared 
in situ and matching primary cultures of dermal fibroblasts were established 
from terminal (DF(T)) and vellus (DF(V)) hair bearing skin. 
Using immunofluorescent staining, the expression of IAPs and their 
antagonists was compared at different stages of the hair cycle following 
depilation using a murine model and then in terminal and vellus hair bearing 
human skin.  The size and granularity of matching DF(T) and DF(V) cultures 
was compared by FACS analysis and mRNA and protein expression of 
Apollon, cIAP2, NAIP and XIAP and their antagonists DIABLO and Xaf1 
analysed by qRT-PCR and immunocytochemistry in unwounded and 
mechanically wounded fibroblast cultures.  Differences in proliferation, 
migration, viability and caspase 3 activity in the presence of 17β-oestradiol 
and changes in mRNA expression of the oestrogen receptors (GPR30, ERα 
and ERβ) were compared between the two cell types. 
Abstract 
ii 
IAP protein expression was generally found higher during mid anagen of the 
hair cycle in murine skin and hair follicles.  Overall, expression was slightly 
higher in human terminal hair bearing skin compared to corresponding vellus 
hair bearing skin.  IAP protein expression was similar in unwounded DF(T) and 
DF(V) cells with the exception of Apollon which was higher in DF(V) cells.  With 
the exception of XIAP and its direct antagonist Xaf1, mRNA expression was 
higher in DF(V) cells compared to corresponding DF(T) cells.  FACS analysis 
demonstrated that DF(V) cells were more granular than matching DF(T) cells 
and proliferated faster.  17β-oestradiol accelerated migration of DF(T) cells 
only.  Mechanical wounding decreased XIAP mRNA in DF(T) and increased it 
in DF(V) cells, while simultaneously decreasing Xaf1 expression.  In 
unwounded cells, 17β-oestradiol stimulated the expression of XIAP mRNA in 
both DF(T) and DF(V) cells, but in scratched monolayers, while it also 
increased expression in DF(T) cells it decreased it in DF(V) cells.  A XIAP 
inhibitor reduced cell viability in both DF(T) and DF(V) cells, which was 
rescued by 17β-oestradiol in unwounded and mechanically wounded DF(T) 
cells, but only in unwounded DF(V) cells.  17β-oestradiol decreased caspase 
3 activity in the presence of a XIAP inhibitor only in DF(T) cells. 
These results demonstrate significant differences between dermal fibroblasts 
cultured from terminal and vellus hair bearing skin of the same individual. The 
correlation between an increase in XIAP in response to 17β-oestradiol and a 
higher number of viable cells, along with a reduction in caspase 3 activity 
suggests that the protective effect of 17β-oestradiol may be modulated via the 
regulation of XIAP.  Further elucidation of these different signalling pathways 
in dermal fibroblasts from hair bearing skin may lead to improved therapies for 
chronic non-healing wounds, particularly in postmenopausal females. 
Key Words: Wound Healing, Inhibitor of Apoptosis Proteins (IAPs), 
Oestrogen, Hair Follicle 
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ECM  Extra Cellular Matrix 
Eda Ectodysplasin  
Edar Ectodysplasin Receptor 
EGF Epidermal Growth Factor 
ER Oestrogen Receptor 
ERE Oestrogen Response Elements 
FADD  Fas-Associated protein with Death Domain 
FBS Foetal Bovine Serum 
FGF  Fibroblast Growth Factor 
GF Growth Factor 
GPR30/GPER1 G-Protein coupled Receptor 30/ G-Protein Oestrogen Receptor 1 
HtrA2 High temperature recruitment protein A2 
IAP  Inhibitor of Apoptosis Protein 
IBM  IAP Binding Motif 
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IGF Insulin-like Growth Factor 
ILP IAP Like Protein 
IRS  Inner Root Sheath 
Iκβ Inhibitor of κβ  
JNK Jun amino terminal kinase 
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MAPK  Mitogen-Activated Protein Kinase 
MIF Migration Inhibitory Factor 
ML-IAP Melanoma IAP 
MUSE Multi-lineage differentiating Stress Enduring 
NAIP Neuronal Apoptosis Inhibitory Protein 
NFκβ  Nuclear Factor kappa-light-chain-enhancer of activated B cells 
NO Nitric Oxide 
NOD  Nucleotide binding Oligomerisation Domain 
ORS  Outer Root Sheath 
PDGF Platelet Derived Growth Factor 
Pen/Strep Penicillin/Streptomycin 
RING  Really Interesting New Gene 
RIP  Receptor Interacting Protein 
SHG  Secondary Hair Germ 
SMA  Spinal Muscular Atrophy 
Smac  Second Mitochondria-derived Activator of Caspase 
TAK1  Transforming growth factor-β-Activated Kinase 
TGF  Transforming Growth Factor 
TGFβ Transforming Growth Factor β 
TIMP Tissue Inhibitor of MetaloProteases 
TNF Tumour Necrosis Factor 
TNF-R  Tumour Necrosis Factor Receptor 
TRADD TNF Receptor Associated Death Domain 
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TRAIL TNF Related Apoptosis Inducing Ligand  
VEGF Vascular Endothelial Growth Factor 
Xaf1 XIAP Associated Factor 1 
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Reagents and Suppliers: 
Reagent Supplier Code 
17β-oestradiol Sigma E2758 
Antibodies: 
 Apollon 
 cIAP1 
 cIAP2 
 NAIP 
 XIAP 
 DIABLO 
 Xaf1 
 ERα Antibody (HC-20) 
 ERβ Antibody (H-150) 
 Donkey polyclonal Secondary Antibody to Rabbit IgG - H&L (FITC) 
Abcam 
Abcam 
Abcam 
Santa Cruz 
Abcam 
Imgenex 
Imgenex 
Santa Cruz 
Santa Cruz 
Abcam 
Ab19609 
Ab108361 
Ab32059 
Sc-11062 
Ab21278 
Img5753 
Img379 
sc-543 
sc-8974 
Ab98502 
Caspase 3 inhibitor Millipore 235423-1mg 
Caspase-Glo 3/7 Assay Promega G8090 
DMEM (- phenol red) Sigma D5921 
DMEM (+ phenol red) Sigma D6046 
DMSO Sigma D8418 
Donkey Serum Sigma D9663 
Embelin Sigma E1406-10MG 
Fast SYBR® Green Master Mix Life Technologies 4385612 
Fetal Bovine Serum GIBCO 10270106, 41F1213K 
Fetal Bovine Serum, Charcoal Stripped, USDA Approved Regions Invitrogen 12676-011 
ImProm-II™ Reverse Transcription System Promega A3800 
Mitomycin C from Streptomyces caespitosus powder, BioReagent, 
suitable for cell culture (2mg) Sigma M4287-2MG 
PBS Sigma p5493 
Poly-L-Lysine Sigma P8920-500mL 
Primers Sigma - 
RNeasy Mini Kit (50) Qiagen 74104 
SACPIC Staining: 
 Celestine Blue 
 Histoclear 
  
 Indigo Carmine 
 Picric Acid 
 Safrinin O 
 
Sigma 
National-
Diagnostics 
Sigma 
Sigma 
Sigma 
 
206342-25G 
HS-202 
 
I8130-25G 
P6744 
S2255-100G 
Trypan Blue Sigma T6146 
UltraPure™ DNase/RNase-Free Distilled Water – 500ml GIBCO 10977035 
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 Background to Thesis 
1.1 Human Skin 
One of the more complex organs of the human body is the skin (the 
integumentary system) (Kanitakis, 2002) which accounts for around 15% of 
the total weight of an adult. This organ can be divided into two main sections; 
the cutaneous membrane and the skin appendages.   
1.1.1 Function 
The skin has many important roles; it is the first line of defence against 
environmental stress such as microorganisms, UV rays and physical damage.   
Other roles of skin include temperature regulation by means of excreting sweat 
from the body, water balance, a waterproof barrier provided by the thin outer 
layer made up of stratified squamous epithelial cells, biochemical synthesis 
including Vitamin D and melanin.  The skin also contains Merkel cells which 
are receptor cells that relay pressure sensations from the skin surface.  
Compression of these cells causes the release of chemical signals that 
stimulate sensory nerve endings (Lucarz and Brand, 2007).  Another important 
function of the skin is to provide quick immune responses against infection; 
the cells responsible for this are the Langerhans cells (Martini and Ober, 
2006). 
1.1.2 Structure 
The structure of the skin can be categorised into three different layers; they 
are: the epidermis which is the upper layer of the skin, under that the dermis; 
which is separated from the epidermal layer by a dermal-epidermal junction; 
and the inner layer is the hypodermis (Prost-Squarcioni, 2006).  The origins of 
the layers differ, as embryologically the epidermis originates from the 
ectoderm, whilst both the dermis and the hypodermis originate from the 
mesoderm (Kanitakis, 2002).  The skin appendages include the hair follicle, 
sebaceous gland, apocrine glands, multicellular exocrine glands and the nail.  
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Both the cutaneous membrane and the skin appendages making up the 
integumentary system, interact together to provide the functions of the skin. 
  
Figure 1.1: Epidermal and dermal layer of the human skin  
Cytokeratin staining of a facelift skin sample from a 52 year old female patient.  
A clear distinction between the epidermis and dermis can be observed, dashed 
red line. 
1.1.3 Epidermis 
The epidermis is a multi-layered squamous epithelium consisting of five 
cellular layers where the thickness of those layers in humans varies between 
0.05mm in the eyelids to around 1.5mm in the palms of the hand (Martini and 
Ober, 2006). 
The different layers in order from the lower basal lamina are: stratum 
germinativum, stratum spinosum, stratum granulosum, stratum lucidum and 
stratum corneum (Martini and Ober, 2006); generally, there are only four layers 
found, however in thick skin, the stratum lucidum is also seen. 
The epidermis is avascular; therefore for cells to survive, they depend on 
diffusion of nutrients from blood vessels found in the upper dermal layer of the 
skin. By default this separates the cells by their metabolic activity, cells that 
have the highest metabolism are found closest to the basal lamina, and those 
Dermis 
Epidermis 
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with lower metabolism are found further away.  The direction of differentiation 
of keratinocytes proceeds outwardly, where the cells migrate from the basal 
lamina (Fuchs, 1990a, b).  There are four different cell types found in the 
epidermis, these include, keratinocytes, Merkel cells, melanocytes and 
Langerhans cells. The majority and the most abundant of these is the 
keratinocyte, which constitutes 90-95% of the cells of the epidermis.  Different 
types of keratins are produced in the epidermis; keratin markers are used to 
distinguish between the keratin differentiated epidermal layers (Karantza, 
2011; Sun et al., 1983). The remaining 5-10% of the epidermal cells are non-
keratinocyte, this small percentage is made up of mainly melanocytes (>5%), 
Langerhans cells (>2%), and Merkel cells (>6%) (Kanitakis, 2002).  Mast cells 
which are generally found in the dermis can also migrate into the basal layer 
of the epidermis (Harvima et al., 2008; James et al., 2011). 
  
Figure 1.2: The epidermal layer of human skin 
The epidermis is divided into four layers in human skin with an additional layer 
in thick skin such as palm skin; the layers from the innermost upwards are; 1- 
the stratum germinativum, 2- spinosum, 3-  granulosum, and 4- corneum 
(Baba et al., 2005). 
1.1.3.1 Stratum germinativum 
The stratum germinativum is also known as the stratum basale.  Hemi-
desmosomes attach the cells in this layer to the basal lamina which separates 
the dermis from the epidermis.  This layer is very important as it not only 
Epidermis 
Dermis 
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separates, but also increases the strength of the bonds between the epidermis 
and the dermis (Martini and Ober, 2006). 
Cells of the stratum germinativum are highly proliferative in order to maintain 
homeostasis as daughter cells from differentiating stem cells migrate upwards, 
transforming into transit amplifying cells (Barthel et al., 2000). 
Merkel cells, which are specialised cells are also found in the stratum 
germinativum; the speciality of these cells are that they are able to detect 
pressure (Lucarz and Brand, 2007; Nakafusa et al., 2006).  Melanocytes, 
which are pigment producing cells via the production of melanin are also found 
in this layer (Martini and Ober, 2006).  The ratio of melanocytes to 
keratinocytes is 1:36 (Cichorek et al., 2013; De Luca et al., 1988; Fitzpatrick 
and Breathnach, 1963). 
1.1.3.2 Stratum spinosum 
Daughter cells from the cells found in the stratum germinativum are found in 
the stratum spinosum.  There are 8-10 layers of keratinocytes bound together 
by desmosomes that make up the stratum spinosum.  Cells that enter this layer 
from the stratum germinativum continue to divide, increasing the thickness of 
the epidermis.  Keratin 10 is generally found in this layer as opposed to keratin 
14 which is found in the stratum germinativum (Reichelt et al., 2004; Santos 
et al., 2002).  The majority of the cells found in this layer are polyhedral 
keratinocytes, flattened as they migrate up in the epidermis (Arda et al., 2014).  
This layer also contains Langerhans cells, which play a role in the immune 
response system.  Many studies have shown the immunostimulatory effect of 
Langerhans cells in the epidermis is via the stimulation of T cells (Romani et 
al., 2010; Romani et al., 2006).  Another function of this layer is to retain lipids 
to prevent moisture loss via keratinocyte ultrastructure (Martini and Ober, 
2006; Minematsu et al., 2011). 
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1.1.3.3 Stratum granulosum 
In the stratum granulosum, there are approximately three-five layers of 
keratinocytes in human skin.  In this layer of the epidermis, most of the cells 
have stopped dividing.  Their main role is diverted to producing the proteins 
keratin and keratohyalin.  Keratin is a tough, fibrous protein and is the basic 
structural component of skin and nails.  With the development of these keratin 
proteins, the cells become thinner and flatter in appearance whilst their 
membranes become thicker and less permeable.  The second protein 
keratohyalin forms dense cytoplasmic granules; these granules promote 
dehydration of the cell as well as cross linking with keratin (Martini and Ober, 
2006).  Lamellar granules, known also as keratinosomes are secretory 
granules essential for barrier formation (Odland and Holbrook, 1981).  
1.1.3.4 Stratum lucidum 
This layer is only found in the thick layers of human skin such as the fingertips, 
palms and soles.  This layer consists of three to five layers of non-proliferating 
keratinocytes, which are clear and flattened; the keratinocytes are densely 
packed and filled with eleidin, which is an intermediate in thetransformation of 
keratohyalin to keratin (Saladin and Porth, 1998) and thick plasma membranes 
(Martini and Ober, 2006; Tortora and Derrickson, 2008).  The difference 
between the stratum lucidum and the stratum corneum is that stratum lucidum 
has a pale eosinophilic appearance due to the lack of organelles as eleidin 
does not stain well with indistinct boundaries (Saladin and Porth, 1998); and a 
higher lipid content.  The keratinocytes in both of these layers are anucleate 
(Busam, 2010). 
1.1.3.5 Stratum corneum 
This layer forms the upper layer of the epidermis, which is exposed to the 
environment.  In humans the stratum corneum generally has 15-30 layers of 
keratinocytes, which are fully keratinized i.e. the cells are filled with keratin.  
Terminally differentiated cells at the surface of the epidermis are tightly 
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connected, they are shed as groups instead of individual cells (Martini and 
Ober, 2006). 
The duration it takes for the cells to migrate from the inner stratum 
germinativum layer to the outer stratum corneum of the epidermis is generally 
15-30 days depending on the location in the human body and the thickness of 
the skin (Candi et al., 2005).  After the cells have reached the surface, they 
normally remain for a further 2 weeks before they are shed (Martini and Ober, 
2006). 
1.1.4 Dermis 
This layer of the skin is found under the epidermis separated by a thin 
basement membrane zone (Martini and Ober, 2006).  Its thickness ranges 
from 0.2mm found in the eyelids to 4mm on the back of adult humans.  The 
dermis is composed of connective tissue; dermal fibroblasts found in this layer 
are responsible for the production of the extra cellular matrix (ECM), which 
consists predominantly of elastic and collagen fibres.  The proteins elastin and 
fibrillin are produced by fibroblasts, and secreted to form the ECM (Haynes et 
al., 1997; Kajiya et al., 1997); these proteins are important for the formation of 
the elastic fibres and are essential in the production of the connective tissue.  
Microarray analysis of dermal fibroblasts derived from different anatomical 
regions and donors of different ethnicity has demonstrated that they can be 
differentiated from each other via the expression of specific genes (Bryant and 
Nix, 2012; Chang et al., 2002). 
1.1.4.1 Dermal fibroblasts 
The most important cell found in all dermal layers of the skin is the fibroblast; 
the fibroblast is responsible for producing the macromolecules that constitutes 
the ECM (Alberts, 2002).  Fibroblasts are derived from the mesoderm, and on 
occasion, fibroblasts maybe derived from epithelial cells in an epithelial to 
mesenchymal transition, which is an important process in wound healing 
(Kalluri and Weinberg, 2009; Yan et al., 2010).  Fibroblasts are responsible for 
the synthesis of collagens, glycosaminoglycans, reticular and elastic fibres, 
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and glycoproteins, which are all important components of the ECM.  Dermal 
fibroblasts derived from different origins such as keloid, palmar, non-palmar 
and plantar do not show the same characteristics, even when cultured in the 
same culture conditions, such as TGFβ1-RII and αSMA expression, their size 
and granularity and their proliferation rate (Chipev and Simon, 2002).   
Recent studies have identified a type of stem cell among dermal fibroblasts 
(Kuroda et al., 2010; Kuroda et al., 2013), which has been used to try to induce 
differentiation into specific cell types including melanocytes for therapeutic 
purposes (Tsuchiyama et al., 2013); specific isolation techniques have been 
established (Kuroda et al., 2013). Multi-lineage differentiating stress enduring 
(MUSE) cells have been identified in select dermal fibroblast populations 
(Wakao et al., 2011); these cells carry the properties of stress tolerance, 
expression of pluripotent markers, self-renewal and the ability to differentiate 
into the three different cell lineages, i.e. endodermal, mesodermal and 
ectodermal.  As the name suggests, these cells appear under stress including 
long term trypsin incubation, and were isolated from cultures of normal dermal 
fibroblasts, which were stress induced, the remaining live cells were cultured 
in suspension to retain their stem cell properties.  To ensure that these cells 
were the cells of interest, specific markers Nanog, Oct3/4, SSEA-3, PAR4 and 
Sox2 which are transcription factors involved in self renewal, were used for 
identification. 
However, not all fibroblasts have the potential to be MUSE cells, the study 
conducted by Kuroda et al. (2010) showed that from the initial number of 
human skin fibroblasts cultured, only 11.6% of them were MUSE cells.  These 
cells show reduced proliferation especially after 14 days when cultured in 
clusters (cell suspension), however when transferred to an adherent culture, 
they resumed their proliferative properties and were still able to form their 
distinct cluster after multiple “stress cycles” and retain the MUSE cell 
properties. 
These MUSE clusters were transferred onto gelatine coated dishes and after 
7 days, via immunofluorescent staining using specific markers, cells were 
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checked for lineage differentiation; Table 1.1 shows the percentage of cells 
that have differentiated into the different cell lineages using the specific 
markers.  This demonstrates that MUSE cells have stem cell properties and 
could potentially be used to differentiate into other cell types. 
Marker Cell Lineage Percentage cells 
Neurofilamen-M Ectodermal 3.5% 
αSMA Mesodermal 12.2% 
Desmin Mesodermal 14.2% 
Αfetoprotein Endodermal 2.7% 
Cytokeratin 7 Endodermal 5.5% 
Table 1.1: Percentage of MUSE cells differentiating into different cell lineages  
Five different cell markers for the three types of cell lineages, ectodermal, 
mesodermal and endodermal were used to analyse the percentage of MUSE 
enriched dermal fibroblasts differentiating into different cell lineage types 
(Kuroda et al., 2010). 
The dermis can be split into two layers with no distinct boundary as seen 
between the epidermis and dermis; the papillary (upper) layer and the reticular 
(lower) layer (Martini and Ober, 2006).  Their distinction is determined via the 
orientation, distribution and type of collagen found in the two layers; produced 
by fibroblasts found in the region.  The components of the ECM are not uniform 
throughout the dermis, they vary between the papillary and reticular layers 
(Sorrell and Caplan, 2004).  Different types of collagen are produced in the 
dermis; the most common are collagen type I and type III; a list of the collagens 
and where they are found in the dermis is given in Table 1.2.  Production of 
collagen, especially type IV and type VII is influenced by keratinocytes via 
TGFβ2 signalling (Sorrell and Caplan, 2004).  The amount of type I and type 
III collagen found in the dermis is reduced with age (Junqueira et al., 1983; 
Varani et al., 2006).   
The dermis also  contains, blood and lymphatic vessels, nerve fibres, glandular 
units including the sweat glands, hair follicles, sebaceous glands and nail 
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roots.  The histology of the boundary between the epidermis and dermis is 
very distinct, with a wave like structure, where the upward extensions from the 
dermis are the dermal papillae and the downward extensions are from the 
epidermis, interlocking the two structures together, such that the layers do not 
slide free from each other; these are known as the rete ridges.  Depending on 
the location on the human body and the thickness of the skin, the extensions 
from the dermis not only allow grip to be maintained, but will vary so as to allow 
access of blood nutrients  to the outer surface of the skin (Saladin and Porth, 
1998). 
Matrix Component Papillary Dermis Reticular dermis 
Collagens I and III High ratio of type III to I Low ratio of type III to I 
Collagen IV Present in basement membrane Absent  
Collagen VI Present in dermal-epidermal junction (DEJ) Weakly present 
Collagen XII Present  Low to absent 
Collagen XIV Low to absent Present 
Collagen XVI Present in DEJ-region Absent  
Tenascin-C Present in DEJ-region Absent 
Tenascin-X Weak in DEJ-region Present 
Versican Diffuse in DEJ-region, present in matrix fibrils Present in association with elastic fibres 
Decorin Present  Present  
Table 1.2: Distribution of collagen and other ECM compartments in the dermis 
A comparison of the components of the ECM between the papillary dermis 
and reticular dermis adapted from (Sorrell and Caplan, 2004). 
1.1.4.2 Papillary layer – upper dermis 
The papillary layer is an area of loose connective tissue and forms a fifth of 
the total dermal thickness (Saladin and Porth, 1998).  In human skin it is 
approximately 300-400µm in depth, depending on location and age (Sorrell 
and Caplan, 2004).  This layer consists of the capillaries, the lymphatic and 
sensory nerve fibres that supply blood and fluids to the surface of the skin.  
Elastin is concentrated in this layer, with elastic sheets found near the reticular 
layer (Meyer et al., 2000; Starcher et al., 2005).  Collagen fibres are found 
packed as thin bundles, with a diameter of 10µm per bundle (Ventre et al., 
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2009).  In this layer the fibre bundles are generally thin and randomly oriented 
(Sanders et al., 1999).  The main type of collagen found in this layer of the 
dermis is type III collagen (Junqueira et al., 1983). 
Human fibroblasts found in this region of the dermis are known to divide faster 
than fibroblasts cultured from the lower reticular layer of the dermis (Sorrell 
and Caplan, 2004).  Also, an important role that the fibroblasts have is 
communicating with keratinocytes, particularly to form the basement 
membrane of the epidermis.  However, site matched fibroblasts (papillary and 
reticular) interact differently with keratinocytes (Sorrell et al., 1996).  Also, 
myofibroblasts from wound sites appear to interact less efficiently and show 
less support for keratinocyte differentiation and basement membrane 
formation, in comparison to fibroblasts from non-wounded sites (Moulin et al., 
2000; Sorrell and Caplan, 2004).  
Recently, markers have become available to distinguish the two dermal layers 
from each other, this has become important in studying the dermis under 
different conditions, such as during ageing (Janson et al., 2013).  During 
ageing, there is a loss in the epidermal ridges accompanied by a loss in the 
number of fibroblasts in the papillary layer of the dermis.  With the loss of 
fibroblasts, there are changes in the levels of some of the ECM components 
(Janson et al., 2013).  Janson et al. (2013) hypothesised that papillary 
fibroblasts transformed into reticular fibroblasts, and compared the structure 
and characteristics of low and high passage fibroblasts derived from the 
papillary layer with matching patient low passage reticular fibroblasts.  They 
observed that specific markers such as αSMA, reticular calponin 1 (CNN1), 
transglutaminase 2 (TGM2) and cadherin 2 (CDH2) and papillary podoplanin 
(PDPN), netrin 1 (NTN1) and C-C chemokine receptor type 11 (CCRL1) that 
are used to differentiate between the two dermal layers were altered, where 
papillary marker expression was reduced in high passage papillary fibroblasts 
and low passage reticular fibroblasts, whilst the expression of reticular markers 
was increased in high passage papillary fibroblasts.  
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1.1.4.3 Reticular layer – lower dermis 
This layer of the dermis is constructed by a meshwork of dense irregular 
connective tissue where both collagen and elastic fibres are found and 
constitutes four fifths of the dermal thickness (Saladin and Porth, 1998).  The 
collagen fibres found in the reticular layer are an entanglement of densely 
packed collagen bundles of more than 50µm in diameter forming the 
meshwork, and are mostly oriented parallel to the skin surface (Sanders et al., 
1999; Ventre et al., 2009).  The main type of collagen found in the reticular 
layer is type I collagen (Junqueira et al., 1983).  In this layer, the anagen hair 
follicle bulb, the sebaceous glands and the functional units of the sweat glands 
are also located (Alberts et al., 2008).   
Even though human fibroblasts cultured from the reticular layer of the dermis 
grow slower than those cultured from the papillary layer from the same site 
e.g. breast, they contract faster than fibroblasts from the upper papillary layer.  
In addition, they do not have the same properties of cell contact inhibition 
allowing cells to attain a higher density when cultured in a monolayer (Schafer 
et al., 1985; Sorrell et al., 1996) as reviewed by Sorrell and Caplan (2004). 
1.1.5 Hypodermis 
The hypodermis is a subcutaneous layer composed of fatty connective tissue 
and loose connective tissue and has a slightly elastic property.  Generally the 
boundary that separates the dermis from the hypodermis is indistinct, with 
connective tissue from the reticular layer being extensively interwoven with the 
connective tissue in the hypodermis (Martini and Ober, 2006).  The 
predominant cell types found in the hypodermis are adipocytes, although 
fibroblasts and macrophages are also seen.  The role of the hypodermis is to 
provide insulation and also cushioning with added mobility (Bryant and Nix, 
2012).  Recently, a study by Wojciechowicz et al. (2013), demonstrated that 
the adipose layer was created from the cells found in the lower layer (reticular 
layer) of the dermis.  This occurred at the stage of embryonic hair follicle 
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development (in mice), suggesting the importance of hair follicles in dermal 
development. 
1.2 The Hair Follicle 
The hair follicle is considered to be a mini-organ, which is very complex in both 
structure and function.  Hair follicle development initiated by the formation of 
the placode occurs in early skin development; however, regeneration occurs 
throughout life (Chuong et al., 2007; Reynolds et al., 1999).   
There are two main types of hair follicles found in the skin of the human body, 
however, a third type can be distinguished in the foetus (Narisawa et al., 1995); 
in the foetus, lanugo hair follicles are found which are very soft and 
unpigmented and are generally shed just prior to birth.  They are replaced by 
terminal or vellus hair follicles depending on body site.  In humans at puberty, 
with increased levels of sex hormones, vellus hair follicles may transform into 
terminal hair follicles in regions such as the axilla, and in males, on the face 
for example the beard; this takes place over several hair follicle cycles 
(Hamada and Randall, 2006).  The locations of these hair follicles are quite 
distinct in the human body, and also vary between genders.  Vellus hair 
follicles are small, fine and less pigmented, while  terminal hair follicles 
produce large pigmented hairs found on the scalp, eye brows and eye lashes 
(Lai-Cheong and McGrath, 2013).  Although the majority of the skin contains 
either terminal or vellus hair follicles, there are regions which contain no hair 
follicles, these include the lips, the back of the ear, the palms and soles of the 
hand and foot (Wosicka and Cal, 2010). 
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Figure 1.3: Structure of the Hair Follicle 
Cytokeratin staining of a terminal hair follicle from female scalp (age, 52 
years).  The bulb region showing the hair matrix and dermal papilla surrounded 
by the dermal sheath.  The shaft surrounded by the inner and outer root 
sheath. 
1.2.1 Hair follicle function 
The hair follicles have different roles in humans; these include additional 
sensory elements to the skin, temperature regulation and communication.  
Hair follicles are not only important in the production of hair; they are self-
renewing and contain a reservoir of multipotent stem cells that help in the 
regeneration of the epidermis and are also important in wound healing (Millar, 
2002). 
1.2.2 Hair follicle structure 
The entire structure of the hair follicle can be divided into two regions, the 
permanent region, which visibly does not appear to cycle, and the inferior 
region, which with each hair cycle is remodelled (Schneider et al., 2009; Stenn 
and Paus, 2001).  There are many different components that make up the hair 
follicle, these are the hair shaft, inner root sheath, outer root sheath, the bulge 
(stem cell niche) found as part of the outer root sheath (Schneider et al., 2009), 
and located at the insertion  of the arrector pili muscle, under the sebaceous 
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gland (Cotsarelis et al., 1990; Lyle et al., 1998), the companion layer found in 
between the inner outer root sheath, the bulb, which is formed by the 
mesenchymal dermal papilla surrounded by the epithelial hair matrix; the 
entire follicle is then surrounded by the connective tissue or dermal sheath.  
The growing hair follicle is a highly vascularised structure (Wosicka and Cal, 
2010). 
1.2.3 Hair follicle morphology 
The development of the hair follicle is determined by a tightly coordinated 
interaction between the ectoderm and mesoderm (Fuchs, 2007; Schmidt-
Ullrich and Paus, 2005).  The initial formation of the hair follicle involves stem 
cells from different lineages, which are the ectoderm and mesoderm.  
Ectodermal stem cells give rise to epithelial components of the hair follicle 
including the sebaceous and apocrine glands.  Whereas stem cells from the 
mesoderm give rise to the follicular dermal papilla and the connective tissue; 
melanocytes from the neural crest are responsible for the pigmentation of the 
hair (Fuchs, 2008; Fuchs and Horsley, 2008).  Once the hair follicle structure 
is formed, regeneration by initiation of a new hair cycle is achieved by 
signalling between the stem cells found in the bulge and the secondary hair 
germ cells (Toyoshima et al., 2012). 
The hair follicle undergoes cyclic growth during postnatal life.  The hair cycle 
phases are anagen, a phase of active growth, catagen, which is the regressing 
phase, telogen, which is the resting stage of the hair cycle, and finally exogen, 
the hair shedding phase (Hardy, 1992; Milner et al., 2002; Stenn and Paus, 
2001).  In humans the length of each phase varies and also the duration of 
each cycle is different depending on the anatomical location of the body 
(Saitoh et al., 1970).  In human scalp, the hair follicle can remain in anagen 
between two to six years, this is generally the longest period of the cycle.  The 
hair follicle will then regress in the catagen phase which lasts around 2-4 
weeks; this stage is generally the shortest stage of the hair cycle.  The resting 
phase will generally be around 1-4 months before the hair follicle is shed and 
a new anagen phase starts again.  Specific mesenchymal-epithelial 
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interactions control the hair follicle cycle, which involves communication 
between the specialised fibroblasts of the follicular dermal papilla, the 
epithelial keratinocytes of the hair matrix and the stem cells of the bulge 
(Lindner et al., 2000; Stenn et al., 1996).   
1.2.4 Hair follicle cycle 
1.2.4.1 Anagen 
Anagen in the growth phase of the hair cycle (Muller-Rover et al., 2001; Stenn 
et al., 1996; Stenn and Paus, 2001).  It has been widely established that there 
are two main cell types that are important in hair follicle growth; they are the 
dermal papilla and the hair follicle stem cells (Hu et al., 2012; Schneider et al., 
2009; Yi and Fuchs, 2010).  Signalling between the dermal papilla and the hair 
follicle stem cells initiates the formation of the hair follicle, from the hair matrix 
to the dermal sheath.   
1.2.4.2 Catagen 
Catagen is the regression phase and is characterised by the activation of 
apoptosis and the decrease in cell proliferation and melanogenesis.  This 
involves the cessation of cell growth and pigmentation, the dermal papilla 
condenses and is released from the bulb, there is loss of the layered 
differentiation of the lower follicle, remodelling of the extracellular matrix, and 
apoptosis of the inferior hair follicle, causing the dermal papilla to migrate 
towards the bulge region (Stenn and Paus, 2001).   
In this stage the lower parts of the hair follicle regress; the lower part of the 
follicle migrates upward to the level of the arrector pili muscle.  Apoptosis is a 
major process that occurs in this phase of the hair cycle, and needs to be 
tightly regulated (Lindner et al., 1997; Weedon and Strutton, 1981). 
1.2.4.3 Telogen  
Telogen is the resting phase of the hair cycle.  Morphologically, a hair follicle 
is identified to be in telogen when the hair follicle shaft base has a brush club 
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feature formed by cornified cells (Milner et al., 2002; Ryder, 1965).  Structurally 
the hair follicle can be divided into two sections, the upper and lower region of 
the hair follicle, above and below the sebaceous gland.  The epidermal layer 
in the upper region that is a continuation of the skin epidermis has the same 
mitotic activity in the basal layer; however during telogen, the activity in the 
lower region is in a state of relative quiescence (Bullough and Laurence, 1956) 
with little, or only a small amount of DNA and RNA synthesis (Silver and 
Chase, 1970). 
1.2.4.4 Exogen  
The specific timing of when this occurs varies between location and hair follicle 
type (Milner et al., 2002). Studies have shown that this phase of the hair cycle 
is independent of the other distinct phases (Milner et al., 2002; Stenn, 2005).  
Previously, it was thought that the shedding of the old fibre from the follicle  
was due to the new growing fibre dislodging the old (Kligman, 1961).  The 
exact mechanism of how the hair shedding occurs is still unknown (Higgins et 
al., 2009).   
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Figure 1.4: Schematic representation of hair follicle morphogenesis and cycling 
Mouse hair cycle stages from embryonic development through to the continual 
cycle (Foitzik et al., 2009). 
1.3 Wound Healing 
There are four main stages involved in the wound healing process; they are, 
haemostasis, inflammation, proliferation, and remodelling (Wilgus, 2008). 
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Figure 1.5: Phases of the cutaneous wound healing process. 
A flow chart diagram illustrating the phases and events of wound healing.  A) 
At initial wounding, increase in blood cells and platelets at the site of injury, 
with recruitment of immune cells including macrophages.  B) Coagulation 
occurs to close the wound site; however, platelets also act as a scaffolding for 
fibroblasts to migrate onto to produce the necessary ECM components 
required for skin remodelling.  C and D) Later, immune cells are further 
recruited such as neutrophils and macrophages via secretion of cytokines and 
growth factors.  E and F) Myofibroblasts differentiated from fibroblasts cause 
contraction while fibroblasts continue to produce collagen for re-
epithelialisation, building up the new ECM until remodelling is finally finished.  
TGFβ – transforming growth factor β, PDGF – platelet derived growth factor 
(Beanes et al., 2003). 
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1.3.1 Haemostasis phase 
This phase of the wound healing process is the initial step, and involves the 
cessation of blood loss; to ensure that blood pressure is stabilised.  The three 
main process that ensure bleeding stops are: vasoconstriction, platelet 
activation and coagulation (Fischer et al., 2005b). 
The formation of the clot is a temporary solution to the wound repair, protecting 
the wound from the entry of foreign objects in the environment and also 
containing the proteins (such as factor V and VIII and fibronectin for 
coagulation), growth factors (such as platelet derived growth factor (PDGF)) 
and cytokines (such as interleukin1 (IL1)) required in the wound for repair 
(Martin, 1997).  It also has a role in providing the foundation for which 
keratinocytes can migrate to rebuild the epidermis (Scheid et al., 2000). 
Blood will seep into the wound via the damaged blood vessels in the 
surrounding area. Platelets then form blood clots protecting the wound, but 
also act as a mesh to allow cells such as fibroblasts and keratinocytes to 
migrate through.  Once activated platelets degranulate, they release cytokines 
and growth factors important for wound repair.  These growth factors and 
cytokines provide a chemotactic response recruiting inflammatory cells to the 
wound site. 
1.3.2 Inflammatory phase 
There are five important characteristics that indicate that a wound is in the 
inflammatory phase, they are; redness, warmth, swelling, pain and loss of 
function, generally associated with the level of pain or muscle spasms (Wild et 
al., 2010).  The growth factors and cytokines produced by platelets at the 
wound site provide a chemotactic signal that attracts the neutrophils and 
monocytes to the wound site; however, it is not only the chemotactic signals, 
but also molecular changes in the endothelial cells that line the capillaries at 
the wound site that also recruit neutrophils and monocytes (Martin, 1997).  
Neutrophils are the most abundant inflammatory cells in the early stages of 
wound healing (Koh and DiPietro, 2011; Ross and Odland, 1968), with the 
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influx in the number of neutrophils in the wound site monocytes also increase 
and differentiate into mature macrophages (Koh and DiPietro, 2011; Ross and 
Odland, 1968), this generally occurs a few days later (Martin and Leibovich, 
2005).  Neutrophils that enter the wound site mop up the infiltrating bacteria 
and then are disposed of via phagocytosis by macrophages (Martin, 1997; 
Singer and Clark, 1999; Wilgus, 2008).  Even though the immune response in 
wound healing is important, not all factors involved are essentially vital for 
wound regeneration.  It has been demonstrated that neutrophils and 
macrophages contribute to scarring (Wilgus, 2008); however, depletion of 
certain components of the immune response has been shown to disturb the 
wound healing process (Martin and Leibovich, 2005; Simpson and Ross, 
1972).  Certain immune cells such as macrophages are beneficial to wound 
healing depending on the stage of the wound repair (Mirza et al., 2009); 
however excessive neutrophils could be detrimental to wound healing, mainly 
in the re-epithelialisation phase (Wilgus, 2008). 
Different growth factors are released in this stage of wound healing such as 
transforming growth factor β1 (TGFβ1), platelet derived growth factor (PDGF) 
and vascular endothelial growth factor (VEGF); these are important for the 
formation of granulation tissue in preparation for the next stage of the wound 
healing phase (Singer and Clark, 1999).  TGFβ1 is one of the more important 
growth factors that is central to wound healing (El Gazaerly et al., 2013; 
Roberts et al., 1986).  It has a role in inflammation, recruiting inflammatory 
cells to the wound site, in the proliferative phase, by influencing the release of 
collagen into the ECM, and therefore contributing to scar formation (El 
Gazaerly et al., 2013; Roberts et al., 1986).  In a rat study by O'Kane and 
Ferguson (1997), they demonstrated that in a wound healing response there 
are two peaks in TGFβ1 levels.  The first was seen 1 hour post-wounding, 
while the second peak was seen 7 days post wounding.  This could be 
attributed to the different stages of the wound healing process. 
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1.3.3 Proliferative phase 
Also known as granulation tissue formation, this phase is characterised by 
angiogenesis, myofibroblast differentiation and fibroplasias (Amadeu et al., 
2008; Hinz, 2007; Singer and Clark, 1999).  This stage of wound healing can 
be split into stages; they are re-epithelialisation, granular tissue formation, 
neovascularisation and wound contraction. 
1.3.3.1 Re-epithelialisation 
Initially it was thought that the platelets that are first seen at wound sites 
produce the necessary growth factors that would help at later stages of wound 
healing.  However, a study by Szpaderska et al. (2003) in mice demonstrated 
that in the absence of platelets, re-epithelialisation, collagen synthesis and 
angiogenesis still occurred at a normal rate, indicating that even though 
platelets are important for the initial stages of wound healing, they do not 
contribute to the proliferative phase.  In regards to the inflammatory phase, 
macrophages and T cells were increased but no difference was seen in 
neutrophil levels compared to control mice.  This study also looked at the 
levels of VEGF, FGF2, TGFβ1, KGF and EGF and noted that there were no 
significant differences between mice lacking platelet function and controls.  In 
contrast, the increase in neutrophils in the inflammatory response, caused a 
negative impact on wounding in mice; a depletion in neutrophils increased the 
rate of re-epithelialisation (Dovi et al., 2003). 
An important aspect of re-epithelialisation is the ability to produce the cells 
(keratinocytes and fibroblasts) required for the foundation of the wound repair.  
This involves the stem cells located in the skin epidermis, and in some cases 
where hair follicles are present, the stem cells in the bulge of the hair follicle.  
Generally, during wound healing, it was thought that stem cells from the basal 
layer of the epidermis were used to regenerate the damaged epidermis; 
however with new markers that distinguish between the two different stem cell 
niches, it is becoming apparent that stem cells from the hair follicle bulge also 
contribute to epidermal reconstruction during wounding (Ito and Cotsarelis, 
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2008; Ito et al., 2005; Plikus et al., 2012).  It has been shown in mice that 
without the bulge stem cell niche, the skin is capable of wound repair, however, 
this niche allows for a faster rate of epithelialisation (Ito et al., 2005).  Also, 
cells from the bulge do not contribute to the closure of the wound.  
Approximately 25% of re-epithelialised cells in the epidermis where hair 
follicles are found are derived from the bulge (Ito and Cotsarelis, 2008).  
Interestingly, these cells are temporary, in that once they migrate into the 
epidermis, they lose their follicular markers, but express epidermal 
differentiation markers (Ito et al., 2005).  Bulge-derived cells are not long 
lasting, and reduce in number after 20 days of wounding.  The initial 
percentage of bulge-derived cells constitutes 26% of re-epithelialised cells, 
and is reduced to 3.5% after 20 days; whilst non-bulge derived cells persist in 
re-epithelialisation (Ito et al., 2005; Levy et al., 2005).  The contribution of 
bulge stem cells to epidermal regeneration is only wound responsive.  A 
contributing factor with regards to the link between hair follicles and wound 
healing is the stage in which the hair follicle is in during the hair cycle (Ansell 
et al., 2011).  In this mouse study, it was demonstrated that wound healing 
was accelerated (wound area was reduced) when hair follicles were in the 
anagen phase of the hair cycle; there was an increase in angiogenesis and 
accelerated ECM deposition. 
There have been no studies looking at the impact of vellus hair follicles on 
wound healing, many studies are conducted on animal models mainly mice 
which do not possess vellus hair follicles (Driskell et al., 2009).  Due to the size 
of vellus and terminal hair follicles and the location of the bulge relative to the 
epidermis, wound healing responses may differ (Garcia et al., 2011). 
1.3.3.2 Neovascularisation 
Another important stage of the wound healing process is neovascularisation; 
this involves angiogenesis which helps not only in providing oxygen and 
nutrients to the healing tissue, but in the recruitment of immune cells such as 
neutrophils and macrophages to the damaged site.  Its response is dependent 
on the pro-angiogenic factors released from infiltrating macrophages and 
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keratinocytes; these factors include VEGF, FGF and angiopoietin1 (Greaves 
et al., 2013). 
1.3.3.3 Granular tissue formation 
Tissue granulation typically begins around 4-6 days after initial wounding.  It 
is the production of new connective tissue by fibroblasts.  Important signalling 
molecules such as transforming growth factor β1 (TGFβ1) and bone 
morphogenetic proteins (BMPs) are important factors that regulate growth, 
differentiation and matrix synthesis, and are required for wound healing (Jaffe 
et al., 2012).   
An important factor in this process is the ability of fibroblasts to differentiate 
into myofibroblasts which are important in migration and contraction, this is via 
the upregulation of α smooth muscle actin (αSMA) (Hinz, 2007; Hinz et al., 
2007).  One of the main growth factors that stimulates this differentiation is 
TGFβ1 (Midgley et al., 2013).  Myofibroblasts are not only required for 
contraction and migration, but also in cell-to-matrix attachment and 
intracellular adhesion (Hinz, 2007).  There are potentially other factors such 
as the pro-inflammatory cytokine IL6 secreted from macrophages, that also 
contributes to fibroblast differentiation (Gallucci et al., 2006).   
Fibroblasts are also responsible for scar formation, with wounding, fibroblasts 
are activated to release collagen into the wound site to help rebuild the ECM, 
but excess collagen and its irregular distribution can result in scarring (Darby 
and Hewitson, 2007; McDougall et al., 2006). 
During cutaneous wound healing, dermal fibroblasts migrate into the wounded 
area, secreting large amounts of collagenous matrix reforming the dermis, and 
providing ECM scaffolds for keratinocytes (Alberts, 2002).  There are many 
factors that influence dermal fibroblasts to migrate during wound healing; one 
of these factors are hormonal effects.  Oestrogen has been shown to 
significantly increase migration of human dermal fibroblasts cultured from 
female breast skin in vitro (Stevenson et al., 2005).   
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Dermal fibroblasts also produce soluble factors such as keratinocyte growth 
factor 1 (KGF1) a member of the fibroblast growth factor (FGF) family, which 
helps regulate wound repair via keratinocyte proliferation (Sorrell and Caplan, 
2004).  An in vitro study by Moulin et al. (2000) compared the effect of 
myofibroblasts and fibroblasts extracted from breast skin during wound 
healing on keratinocyte re-epithelialisation.  During wound healing, 
myofibroblasts did not interact with keratinocytes to support keratinocyte 
differentiation and basement membrane formation in comparison to normal 
dermal fibroblasts (Moulin et al., 2000).  In a comparison of site matched 
papillary and reticular fibroblasts from breast skin in vitro, the production of 
KGF1 was higher in reticular fibroblasts compared to papillary fibroblasts 
indicating that reticular fibroblasts play a more dominant role in keratinocyte 
differentiation, important in wound healing (Sorrell et al., 2004).   
Collagen synthesis in response to TGFβ1 is not stimulated in patients with 
venous ulcers, this is due to the reduced TGF β type II receptor, affecting 
wound healing.  A study by Hasan et al. (1997) showed that in human in vitro 
studies, the inability of dermal fibroblasts cultured from biopsies taken from 
patients with venous ulcers at the edge of the wound, to respond to TGFβ1 
caused faulty deposition of ECM affecting re-epithelialisation and adversely 
wound healing (Hasan et al., 1997).  In vitro studies have shown that 
fibroblasts respond differently to cytokines depending on the condition in which 
these cells were cultured; the mitogenic potential of fibroblasts cultured from 
diabetic ulcers was reduced when stimulated by different cytokines such as 
IGF1, FGF, EGF and PDGF (Loots et al., 2002).   
1.3.3.4 Wound contraction  
The final stage of the proliferative phase of wound healing is wound 
contraction.  One of the most important elements in this stage is the 
differentiation of dermal fibroblasts into the myofibroblast, which are generated 
early in wound healing and contribute throughout the process.  It is these cells 
that are responsible for contraction due to their smooth muscle property 
(Sorrell and Caplan, 2004).  The combination of both fibroblasts and 
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myofibroblasts improve wound healing with fibroblasts providing traction whilst 
myofibroblasts provide contraction (Li and Wang, 2011).  The myofibroblasts 
later disappear via apoptosis and are replaced by dermal fibroblasts that help 
produce the collagen and build up the ECM (Desmouliere et al., 1995; Sorrell 
and Caplan, 2004).  Excess contraction and ECM deposition leads to scarring, 
therefore it is important to regulate both contraction and collagen synthesis (Li 
and Wang, 2011).  A number of factors can modulate fibroblast contractility; 
tensin, a protein found in the plasma membrane has been shown to modulate 
fibroblast contractibility and affect ECM remodelling in wound healing (Clark 
et al., 2010); particularly the tensin 2 isoform, its knockdown in cultured human 
foreskin fibroblasts inhibited contraction.  Epidermal growth factor (EGF) also 
influences fibroblast contractility (Iwabu et al., 2004).  Stimulation of EGF 
increases the phosphorylation of myosin light chain, a marker for contractile 
force.  Also TGFβ1 secretion correlates with fibroblast contractility (Coleman 
et al., 1998).  These studies used collagen gels to analyse fibroblast 
contraction.  Studies have been conducted in cultured dermal fibroblasts 
derived from female scalp showing that collagen synthesis is increased with 
mechanical wounding and that there is an increase in VEGF and TGFβ1 
secretion (Stevenson et al., 2008b).  There are limited studies directly 
comparing dermal fibroblast migration and collagen synthesis by cells cultured 
from different regions of the same donor. 
1.3.4 Remodelling phase 
This phase of wound healing involves collagen remodelling and angiogenesis 
(Guo and Dipietro, 2010).  This stage of the wound healing process may last 
for up to two years.  Neovascularisation occurs during wound healing to bring 
nutrients and other factors that improve the quality of wound repair.  However, 
once this event has finished, myofibroblasts that are present and the new 
vascular structure need to be removed from the site.  The regression of the 
vascular structure is done via apoptosis, while the myofibroblasts are removed 
by one of three ways; necrosis, migration or apoptosis (Greenhalgh, 1998).  
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Another important feature is the remodelling of the ECM to represent that of 
normal tissue (Campos et al., 2008; Gosain and DiPietro, 2004). 
1.3.5 Contribution of the hair follicle to wound healing 
Wounds heal better in skin bearing terminal hair follicles as opposed to those 
that do not (Jahoda and Reynolds, 2001). This has been hypothesised to be 
not only due to the hair follicle bulge that contains a niche of stem cells 
important for wound healing, but also due to the follicular dermal sheath and 
dermal papilla.  It is thought that the dermal sheath fibroblasts act as 
progenitors for interfollicular dermal fibroblasts, thereby improving wound 
healing (Jahoda and Reynolds, 2001).  Another study showed that in rodents, 
the number of fibroblasts that expressed αSMA from different regions of highly 
dense hair follicle skin, and skin containing intermediate hair follicles and skin 
containing no hair follicles varied in expression between young and old rodents 
(Reynolds et al., 1993).  The expression of αSMA was highest in skin 
containing no hair follicles in young 4 day old rodents, and lowest in highly 
dense terminal hair follicle skin, the opposite results were seen in adult 
rodents.  This has been attributed to hair follicles; with emphasis on the hair 
cycle influencing wound healing; in 4 day old rodents, the hair follicle is in the 
initial morphogenesis stage of the hair cycle, whilst in adults, hair follicles are 
more likely to be in anagen.  In this study, the hair follicle stage was not 
mentioned for both age groups.  Studies on rodents showed that wounds heal 
faster when the hair follicle is in the active growth phase anagen, in 
comparison to when the hair follicle is in the regressive catagen or resting 
telogen phase (Ansell et al., 2011; Jahoda and Reynolds, 2001; Zawacki and 
Jones, 1967).  
Apoptosis is a process that is tightly controlled which in turn controls the 
number of cells present at individual stages of the wound healing process.  It 
has been shown to occur in the early stages of wound healing with 
inflammatory cells (Brown et al., 1997).  During the proliferative phase and 
granulation phase, apoptosis occurs to maintain myofibroblast numbers and 
coordinate the removal of these cells once they are no longer required 
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(Desmouliere et al., 1995).  Therefore, it is an important pathway to investigate 
to further understand how the number of these cells that are important for 
wound healing are maintained and how wound healing is affected. 
1.4 Apoptosis 
Apoptosis is a physiological process of programmed cell death.  It is 
characterised by changes to the cell, both morphologically and biochemically 
including cell shrinkage, nuclear chromatin condensation, DNA fragmentation, 
and proteolysis of caspases (Shi, 2002; Thornberry, 1997).  Apoptosis plays a 
role in many different aspects of cell growth and development.  It occurs in 
response to homeostatic changes, maintaining the number of cell turnover; 
allowing for growth of new cells and the cause of death of old and damaged 
cells.  This specific process also plays a role in the immune defence in humans 
by disposing of dead cells in the organism (Wei et al., 2008).  There are many 
different pathways that are involved in apoptosis, each involving different 
proteins to regulate the process, and each one linking with one another to 
make a more structured and definitive pathway.  The two main pathways of 
apoptosis are the intrinsic and the extrinsic pathways, where the intrinsic 
pathway involves the mitochondria, whilst the extrinsic pathway involves cell 
surface death receptors (Wei et al., 2008). 
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Figure 1.6: Schematic representation of the apoptosis pathway 
The four stages of apoptosis initiation, intracellular response, cell 
fragmentation and phagocytosis, which are highlighted in the diagram 
representing a cell death with different signalling molecules activated in the 
different stages.  The two main apoptotic pathways are illustrated with the 
extrinsic pathway being activated from the cell receptors, and the intrinsic 
pathway involving the mitochondria leading to the common pathway activating 
the caspases, AIF – apoptosis inducing factor, IAP – inhibitor of apoptosis 
protein  (Botchkareva et al., 2006). 
There are four main phases involved in apoptosis; the initiation stage, 
intracellular response, cell fragmentation and eventually phagocytosis 
(Figure 1.6).  The initiation stage of apoptosis involves the detection of different 
stimuli at the cell surface, this may include different apoptotic ligands, or 
changes in growth factor levels; and involves the activation of the extrinsic 
pathway.  Environmental changes can also trigger apoptosis without the use 
of cell surface receptors; these include free radicals, UV radiation, and drugs 
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such as those used in chemotherapy (Buttke and Sandstrom, 1994; Schwall 
et al., 1993; Yamada and Ohyama, 1988).   
The detection of these changes causes an intracellular response, which is the 
second stage of apoptosis, where different proteins that regulate apoptosis 
interact and are released into the cytosol.  An important family of proteins that 
regulate apoptosis are the caspases.  The caspase family members are very 
important in apoptosis and its regulation as caspases modulate the activation 
of transcription factors (Hofmann et al., 1997), which are important in the 
regulation of pro- and anti- apoptotic proteins, which in-turn mediate cell fate.  
Procaspase-8 is able to detect the receptor-ligand complex initiating the 
caspase cascade forcing the cell into cell death (Boldin et al., 1996).  Once the 
cell has reached this stage of apoptosis, the fate of the cell is determined and 
is irreversible; this applies to both the intrinsic and extrinsic pathways of 
apoptosis.    Although caspases have an important role in apoptosis, apoptosis 
may still occur independently of caspase activity via the activation of Apoptosis 
Inducing Factor (AIF) (Susin et al., 1999).  This protein is found in the 
mitochondrial intermembrane space and once released, is translocated into 
the nucleus where it binds to the DNA causing chromatin condensation (Cande 
et al., 2002). 
The third stage of apoptosis is cell fragmentation, where morphological 
changes can be observed, including cell shrinkage, although the plasma 
membrane is still intact.  Chromatin condenses and migrates to the nuclear 
membrane periphery; there is also an increase in mitochondrial activity (Green 
and Reed, 1998).  An important step in this stage is the exposure on the cell 
surface of anionic phospholipids and phosphatidylserine, these are signalling 
molecules that are recognised by phagocytes (Savill, 1997).  At the end of this 
stage, the membrane encapsulates organelles in the cell, resulting in the 
presence of many small vesicles known as apoptotic bodies. 
The final stage of apoptosis is the phagocytosis of the apoptotic body by 
phagocytes; which are capable of recognising the apoptotic bodies due to the 
receptors found on their surface that detect the exposed phosphatidylserine 
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residues and other molecules at the surface of the apoptotic bodies.  Failure 
to recognise the apoptotic cells would lead to the persistence of inflammation, 
eventually assuming necrotic morphology known as secondary necrosis 
(Afford and Randhawa, 2000). 
During wound healing, depending on the type of wound, cells will either 
undergo necrosis or apoptosis.  In chronic wounds where inflammation is 
present at a high level, cells generally go through necrosis.  However, in acute 
wounds where necrosis and inflammation are not continually high, cell number 
decreases either via cells migrating away from the wound site or apoptosis 
(Greenhalgh, 1998). The types of cells that would undergo this process are 
the inflammatory cells once they have completed their roles, and also 
fibroblasts once enough collagen has been deposited.  Studies in mice have 
shown that apoptosis is present at early stages of wound healing in the 
granular tissue where high levels of inflammatory cells are still present, with 
no apoptosis detected in the granular tissue at the wound edge where 
fibroblasts are migrating (Brown et al., 1997; Desmouliere et al., 1997).  
Another study in rats showed that myofibroblasts underwent apoptosis during 
wound closure (Desmouliere et al., 1995).  The importance of apoptosis is 
seen when there is a delay in signalling for the down regulation of the activity 
of both fibroblasts and myofibroblasts beyond a time point, apoptosis is not 
activated leading to excessive collagen synthesis and scar formation 
(Greenhalgh, 1998). 
1.4.1 Intrinsic pathway 
The regulatory point in the intrinsic pathway in which apoptosis occurs is in the 
mitochondria (Festjens et al., 2004; Wong and Puthalakath, 2008).  It is at the 
outer mitochondrial membrane, endoplasmic reticulum and cytoplasmic 
aspect of the nuclear envelope that the pro- and anti- apoptotic proteins reside, 
and contribute to the decision whether the cell should live or die (Krajewski et 
al., 1994; Lithgow et al., 1994; Wong and Puthalakath, 2008).  The intrinsic 
pathway is activated by different stress stimuli which causes alterations in the 
levels of Bcl-2 leading to the release of cytochrome c and AIF from the 
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mitochondrial intramembrane into the cytosol (Daugas et al., 2000).  The 
permeability of the mitochondria to release cytochrome c and AIF are tightly 
regulated by the Bcl-2 super-family (Table 1.3), including both pro- and anti-
apoptotic proteins (Adams and Cory, 1998; Gross et al., 1999; Strasser et al., 
1995).   
Bcl-2 Super-family 
Pro-Apoptotic Anti-Apoptotic 
Bik Bax Bcl-2 
Bad Bak Bcl-XL 
Bim Bok Bcl-w 
Hrk Boo Bcl-1 
Bcl-G Bcl-B Bcl-B 
Noxa Bcl-rambo A1 
Puma Bid Mcl-1 
Bcl-XS  Boo 
Table 1.3: Bcl-2 Family members divided into pro- and anti- apoptotic proteins 
Pro- and anti- apoptotic proteins of the Bcl2 family members, Bcl2 – B cell 
lymphoma 2, Bik – Bcl2 interacting killer, Bad – Bcl2 associated death 
promoter, Bim – Bcl2 like protein 11, Hrk – activator of apoptosis hara-kiri, 
Noxa – Phorbol12myristate13acetate induced protein 1, Puma – p53 
upregulated modulator of apoptosis, Bcl Xs – b cell lymphoma extra small, Bcl 
Xl – b cell lymphoma extra large, Bax – Bcl2 associated X protein, Bak – Bcl2 
homologous antagonist killer, Bok – Bcl2 related ovarian killer, Bid – BH3 
interacting domain death agonist Bcl w – Bcl2 like protein 2, A1 – Bcl2 related 
protein A1, Mcl1 – induced myeloid leukaemia cell differentiation protein Mcl1 
(Mayer and Oberbauer, 2003; van Gurp et al., 2003). 
The most important proteins from the Bcl-2 super-family are Bcl-2 and Bax, 
these proteins inhibit or promote, respectively, the permeability of the 
mitochondrial membrane (Reed, 2006).  AIF has the capability of mediating a 
caspase-independent mitochondrial apoptosis pathway by moving to the 
nucleus and causing chromatin condensation and DNA fragmentation 
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(Daugas et al., 2000).  Cytochrome c binds to apoptotic protease activating 
factor 1 (Apaf1) with the use of energy in the form of dATP to form a protein 
complex named apoptosome, capable of promoting the autoactivation of 
procaspase-9 (Sun et al., 1999). 
1.4.2 Extrinsic pathway 
The extrinsic pathway involves death domain containing receptors found on 
the cell surface, these include Fas and tumour necrosis factor receptor 1 
(TNFR1); these receptors are members of the TNF super-family.  Their 
primary amino acid structure is slightly different,  but they all share the same 
cysteine-rich extracellular subdomain giving rise to a similar tertiary structure 
(Mayer and Oberbauer, 2003).  Once these receptors are activated by 
interacting with a corresponding ligand, they form a multimeric complex (Lavrik 
et al., 2005) generally by the death domain of the adapter molecules such as 
Fas-Associated protein with Death Domain (FADD) and TNF receptor-
associated death domain (TRADD) (Mayer and Oberbauer, 2003).  TRADD is 
able to recruit both TNF Receptor Associated Factor 2 (TRAF2) and Really 
Interesting Protein (RIP) via its amino-terminal region and its death domain 
(Mayer and Oberbauer, 2003). 
These molecules are needed for the formation of the TNFR1 signalling 
complex (Park et al., 2007), without the TNFR1 signalling complex, NFκβ is 
not activated, which is an important transcription factor; however, with the 
suppression of NFκβ, TNFα is able to promote apoptosis via the formation of 
a secondary signalling complex (Varfolomeev et al., 2006).  TRADD, TRAF2 
and RIP are then translocated into the cytosol, where they recruit FADD and 
caspase 8 and 10 forming a death-inducing signalling complex (DISC), which 
has the capability of upregulating the cascade signals that activate capase-8 
(Wilson, 1998).  Once procaspase-8 is activated due to its positioning in the 
DISC (Boatright et al., 2003), caspase 8 is released into the cytosol. 
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Figure 1.7: Schematic representation of the intrinsic and extrinsic apoptosis pathway 
The intrinsic (via mitochondrial pathway) and extrinsic (via death receptors) 
pathway to eventually activate the caspase cascade which leads to cell death. 
BAD – Bcl2 antagonist of cell death, BIM – Bcl2 mediator of cell death, PUMA 
– p53 upregulated modulator of apoptosis, TRADD – TNFR1 associated death 
domain, FADD – Fas associated death domain, FLIP – FLICE inhibitory 
protein, ITCH – itchy E3 ubiquitin protein ligase (Vucic et al., 2011). 
1.4.3 Caspase cascade 
Caspases are cytosolic cysteine containing proteasomes, that, the moment 
they are activated, cause a cascade of events that are irreversible, eventually 
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leading to cell death (Cryns and Yuan, 1998; Thornberry and Lazebnik, 1998).  
There are 14 caspase molecules that have been identified in mammals, 
however, not all the caspase molecules are involved in apoptosis, there are 
some that are involved in skin cell development; a study by Fischer et al. 
(2005a) studied both caspase 3 and caspase 14 in keratinocyte differentiation.  
Increased levels of caspase 14 were seen in mice at embryonic day 14 and 
onwards, a time coinciding with skin development and keratinocyte 
differentiation (Fischer et al., 2005a).  Other caspases have been shown to 
have other roles, for example, caspase 1, -4, -5 and -11 are implicated in 
activation of pro-inflammatory cytokines, interleukin 1 and 18 (Martinon and 
Tschopp, 2004).  There are two types of caspase molecules, they are the 
initiator caspases, which can autoubiquitinate, activating the caspase 
molecule, and the executioner caspases, which are activated by the initiator 
caspases and cleave other caspase molecules activating them (Fadeel and 
Orrenius, 2005). 
 
Figure 1.8: Schematic representation of the caspase cascade 
The initiator caspases (caspase-8 and -9) and the effector caspase (casase-
3).  The initiator caspase can be activated via the intrinsic or extrinsic 
apoptosis pathway.  When the inactive pro-caspases are cleaved, they are 
able to cleave other pro-caspases activating them eventually leading to cell 
death (Holcik and Korneluk, 2001). 
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The active forms of the caspase both from the intrinsic (caspase-9) and 
extrinsic (caspase-8) pathways activate caspase effectors, caspases -3, -6 
and -7 which then leads to apoptosis via the cleavage of proteins (Strasser et 
al., 2000).  For clear catalytic activity to be seen, it is important that caspase-
9 is bound to the Apaf-1 complex through tight interactions between their 
Caspase Recruitment Domain (CARD) (Qin et al., 1999; Rodriguez and 
Lazebnik, 1999).  The method by which the complex is able to catalyse other 
pro-caspase-9 proteins was studied by Malladi et al. (2009).  Two hypotheses 
were identified, either via a displacement model system, or through similar 
catalytic processes to pro-caspase-3 (Malladi et al., 2009).  In this study, it was 
demonstrated that procaspase-9 is not processed like procaspase-3 as a 
normal substrate.  Instead, procaspase-9 is catalysed through its recruitment 
into the Apaf-1 complex and displaced continuing the cycle.  Caspase-2 has 
been shown to become activated by stress stimulated cytokines; suggesting 
that the intrinsic pathway is an amplification of the caspase cascade (Lassus 
et al., 2002).  At the end of the caspase cascade activation phase, caspase-3 
is cleaved which causes DNA fragmentation via a DNA fragmentation factor 
(Mayer and Oberbauer, 2003). 
There have been a number of studies investigating the role of caspases in 
wound healing.  It is known that apoptosis is part of the wound healing process, 
and it would be important and beneficial to understand which caspases are 
involved in this mechanism.  A study by Lee et al. (2009) looked at the levels 
and effects of caspase 8 in the epidermis of mice during a wound healing 
response.  Fluctuation was seen in the epidermis close to the wound site after 
14 days of wounding.  Knockout of caspase 8 correlated with an increased 
level of keratinocyte differentiation and expression of β4 integrin; these 
observations led to the belief that the loss of caspase 8 causes a paracrine 
signalling of interleukin 1α to the stem cells to proliferate (Lee et al., 2009).  
Another study in mice, measured the levels of caspase 3 and -7 via Western 
blotting as these are effector caspases at the end process in the caspase 
cascade (Carter et al., 2009).  In this study, levels of procaspase 3 and cleaved 
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caspase in mice was not altered after wounding; however there was an 
increase in cleaved caspase 7 after wounding. 
1.5 Inhibitors of Apoptosis Proteins (IAPs) 
As the name suggests, inhibitors of apoptosis proteins (IAPs) are proteins that 
have the ability to prevent apoptosis.  These IAPs were identified whilst 
investigating the pathways that might regulate apoptosis (Deveraux and Reed, 
1999; Nachmias et al., 2004; Yang and Li, 2000; Zhang et al., 2004).  The first 
IAP was identified from Cydia pomonella granulosis virus (Crook et al., 1993). 
In 1995, came the discovery of the first IAP in mammals.  In total eight IAPs 
have been identified in humans (Table 1.4); they are neuronal apoptosis 
inhibitory protein (NAIP) 1 and 2, cellular IAP (cIAP)1, cIAP2, X-chromosome 
linked IAP (XIAP), melanoma IAP (ML-IAP), Apollon, Survivin and IAP like 
protein (ILP)2 (Hunter et al., 2007; Salvesen and Duckett, 2002). 
IAP Abbreviations Full Name Tissue Expression Reference  
XIAP/ILP-1/MIHA/BIRC4 X-linked IAP Most human tissue Duckett et al. (1996) 
cIAP1/hIAP1/MIHB/BIRC2 Cellular IAP1 Most human tissue; highly 
expressed in adult thymus, testis, 
ovary 
Rothe et al. (1995) 
cIAP2/hIAP2/MIHC/BIRC3 Cellular IAP2 Most human tissue; highly 
expressed in adult spleen, thymus 
Rothe et al. (1995) 
NAIP/BIRC1 Neuronal apoptosis 
inhibitory protein  
Adult liver, placenta, central 
nervous system 
Roy et al. (1995) 
Apollon/BRUCE/BIRC6 Apollon Golgi complex and the vesicles Hauser et al. (1998) 
ILP2/TS-IAP/BIRC8 IAP-like protein 2 Adult testis Richter et al. (2001) 
ML-IAP/Livin/KIAP/BIRC7 Melanoma IAP Foetal liver, kidney; adult testis, 
thymus 
Vucic et al. (2000) 
Survivin/TIAP/BIRC5 Survivin Foetal liver, kidney, lung, 
gastrointestinal tract; highly 
expressed in tumour 
Ambrosini et al. (1997) 
Table 1.4: Mammalian IAP family members 
The IAPs identified in mammalian tissue adapted from Wei et al. (2008). 
In addition, four IAP antagonists have been identified in humans; XIAP 
associated factor 1 (Xaf1) (Liston et al., 2001), second mitochondria derived 
activator of caspase/ direct IAP binding protein with low pl (Smac/DIABLO) 
(Du et al., 2000), high temperature requirement protein A2 (HtrA2) (Faccio et 
al., 2000) and apoptosis related protein in the TGFβ signalling pathway (Arts) 
(Larisch et al., 2000).  
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IAPs not only interact with caspase proteins inhibiting their activity (Deveraux 
et al., 1998), but they also promote proteasomal degradation by catalysing 
ubiquitination (Qiu and Goldberg, 2005).  IAPs are expressed at different levels 
in cells of the same lineage located in different organs of the human body; it 
has been proposed that the maturation state of the cell affects the expression 
levels of the IAPs (Hasegawa et al., 2003; Vischioni et al., 2006). 
It is important that IAP levels are regulated to maintain the balance of 
homeostasis between cell death and cell survival.  There are different ways in 
which IAPs levels are controlled, one is via transcriptional regulators including 
NF-κβ (Stehlik et al., 1998; Wang et al., 1998), hypoxia inducible factor 1 
(HIF1) (Dong et al., 2001), and via post-translational modification, via the 
degradation of proteasomes (Yang et al., 2000).  The Jun amino terminal 
kinase (JNK) signalling cascade, part of the mitogen activated protein kinase 
(MAPK), a transcription regulator, is activated.  This is via the binding of 
specific IAPs such as XIAP, NAIP and Ml-IAP to the JNK regulator 
transforming growth factor β activated kinase 1 (TAK1).  Binding of IAPs to 
TAK1 allows cells to survive against TNFα and caspase-1 induced 
apoptosis(Figure 1.9).   
Whilst studying different types of IAPs, one study led to the belief that IAP 
expression might be controlled by both cell type-dependant, and organ-
dependant regulatory mechanisms (Vischioni et al., 2006).  This was due to 
an observation made between levels of cIAP1, cIAP2 and XIAP.  Both cIAP1 
and cIAP2 are expressed in cells originating from epithelial and mesenchymal 
origin.  Expression of XIAP was more limited  to certain cell types, and not 
abundantly expressed in the same manner as  cIAP1 and cIAP2 (Vischioni et 
al., 2006).   
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Figure 1.9: IAP and IAP antagonist mechanism of action 
The mechanism of action for the different IAPs and IAP antagonists during 
apoptosis.  Intrinsic or extrinsic stimuli can trigger apoptosis, activation of the 
Fas and TNFR recruits death domains, which activate caspase 8 triggering the 
caspase cascade activating caspase 3 leading to apoptosis.  IAPs can be 
activated or activate transcription factors such as NFκB. IAPs block activation 
of caspase 2, 3, 7 and 9 preventing apoptosis. FasL – Fas ligand, FADD – Fas 
associated protein with death domain, TNF – tumour necrosis factor, TNFR – 
TNF receptor, TRADD, TNFR associated death domain, TRAF – TNFR 
associated factor, Cyto C – Cytochrome C, Apaf1 – apoptotic protease 
activating factor 1, AP1 – activator protein 1, NFκB – nuclear factor kappa light 
chain  enhancer of activated B cells, NIK - NFκB inducing kinase, ASK1 – 
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apoptosis signalling regulating kinase 1, JNK-Phos – cJUN N terminal Kinase 
phosphorylation (Wei et al., 2008). 
1.5.1 BIR domains 
Baculovirus IAP repeat (BIR) domains are found in certain proteins when 
bound inactivate the protein allowing apoptosis to occur, however they also 
play a role in cell development.  The BIR domain itself is structurally distinct, 
with a zinc-finger fold integrated into it (Hinds et al., 1999).  It was shown that 
there were two types of BIR domains (Silke and Vaux, 2001; Verhagen et al., 
2001).  For inhibitors of apoptosis proteins, all forms of IAPs contain the type 
1 BIR domain, however there were some from the family that also contained 
the second type of BIR domain, they are Survivin and Apollon (Takahashi et 
al., 1998; Verhagen et al., 2001). 
The two types of BIR domains are distinguished by the presence or the 
absence of a deep peptide binding groove (Gyrd-Hansen and Meier, 2010).  
Type II BIR domains are more conserved then type I BIR domains (Cao et al., 
2008).  Type I do not contain this groove, whilst BIR type II, which generally 
target proteins that carry an IAP-binding motif (IBM) contain the groove (Cao 
et al., 2008; Gyrd-Hansen and Meier, 2010).  IAPs may contain up to three 
BIR domains; however the function of each individual BIR domain is different 
allowing the IAP to contain specific properties and functions (Duckett et al., 
1996). 
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Figure 1.10: Molecular structure of the eight different mammalian IAPs 
All IAPs have at least one baculovirus IAP repeat (BIR) domain, with some 
containing other features like a really interesting new gene (RING) finger or a 
caspase recruiting domain (CARD), ubiquitin associated domain (UBA), 
ubiquitin conjugase (Ubc), leucine rich repeat (LRR), nucleotide binding and 
oligomerisation domain (NOD); figures represent amino acid length (Beug et 
al., 2012; Wei et al., 2008). 
1.5.2 XIAP 
The XIAP protein structure is characterised by the containment of  three BIR 
domains and a carboxy-terminal really interesting new gene (RING) finger 
domain (Cao et al., 2008).   It has been documented that the BIR domain 1 of 
XIAP protein is capable of dimerisation, activating the NFκβ signalling pathway 
(Lu et al., 2007).  The second and third BIR domains found in XIAP are 
responsible for interacting with the caspase proteins, specifically by blocking 
the active sites of caspase-3, -7, and -9 (Eckelman et al., 2006; Riedl et al., 
2001).  BIR3 specifically binds to capase-9 which is the initiator caspase 
(Shiozaki et al., 2003); the binding requires specific interactions between the 
surface groove found on BIR3 and the residue IAP Binding Motif (IBM) 
molecule found on the amino terminus of the small subunit of pro-caspase-9 
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(Shiozaki et al., 2003; Srinivasula et al., 2001), whilst BIR2 and the linker 
molecule between BIR1 and BIR2 binds to caspase-3 and caspase-7 (Huang 
et al., 2001; Riedl et al., 2001; Salvesen and Duckett, 2002).  The linker 
molecule interacts with the substrate binding groove of the activated caspase 
molecule in a reverse orientation  to the substrate, whilst the BIR2 domain 
interacts with the amino-terminus of the small subunit of the caspase molecule 
once exposed during its activation (Chai et al., 2001; Huang et al., 2001; 
Suzuki et al., 2001b; Varfolomeev et al., 2006). 
However, XIAP is a more potent inhibitor of caspase-9 and caspase-3 then the 
other IAPs (Vince et al., 2007).  Of all the IAPs, only XIAP directly inhibits 
caspase activity (Eckelman and Salvesen, 2006).  Mutant mice lacking XIAP 
did not show phenotypic abnormality, and were not susceptible to apoptosis 
induced by different stimuli (Conze et al., 2005; Harlin et al., 2001; Vince et 
al., 2007).  However, over-expression of XIAP has been shown to increase 
tumour cell survival (Hunter et al., 2007).  XIAP is not only an inhibitor of 
apoptosis via inhibition of caspases, but can also promote pro-survival 
signalling, by activating the NFκβ and JNK pathways (Birkey Reffey et al., 
2001; Hofer-Warbinek et al., 2000; Levkau et al., 2001; Lu et al., 2007; Sanna 
et al., 2002).  It has also been shown in mice, that XIAP expression is gender 
specific, with a higher expression of XIAP in female mice compared to gender 
matched male mice (Siegel et al., 2011).  In this study, to determine that the 
mRNA expression was not due to circulating oestrogen levels, a comparison 
of XIAP mRNA baseline levels were compared between ovariectomised mice 
and those replaced with 17β-oestradiol; baseline XIAP levels were significantly 
higher. 
In some studies it has been shown that XIAP has a protective effect in a 
caspase independent manner.  A study looking at expression of XIAP in 
human umbilical vein endothelial cells (HUVEC) and bovine aortic endothelial 
cells (BAECs) on drug induced apoptosis, where caspase-3 activity was 
increased, showed that even though XIAP was able to inhibit apoptosis, 
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caspase-3 expression was not affected by XIAP (Kim et al., 2008).  Therefore, 
it could be possible that XIAP inhibits apoptosis downstream of caspase 3.  
VEGF is an important growth factor for the production of new vascular 
structures.  Studies have shown that VEGF upregulates the production of XIAP 
in endothelial cells, suggesting its importance in VEGF-dependent cell survival 
(Kim et al., 2008).  To understand the mechanism by which XIAP is 
implemented in cell survival, XIAP levels were monitored via Western blotting 
after treatment of HUVECs with different growth factors, VEGF, basic 
fibroblast growth factor (bFGF) and insulin like growth factor (IGF).  Only 
VEGF caused an increase in XIAP levels (Kim et al., 2008).   
XIAP is specific to certain cell types and is highly expressed in the skin, 
ovaries, uterus, prostate and testis in humans (Vischioni et al., 2006).  
Recently, Fuchs et al. (2013) have shown in an in vivo study that XIAP is 
expressed in the skin and hair follicle of mice and that with XIAP knockout, 
wound healing is compromised.  In this study, it was demonstrated that with 
the knockdown of Arts, a direct antagonist to XIAP, wound repair was 
significantly enhanced with increased re-epithelialisation, and that bulge 
activity in the mouse hair follicle showed an increase in cell proliferation.  To 
determine the exact effect of XIAP, a single knockout of XIAP also disrupted 
wound repair.  To demonstrate the importance of Arts and XIAP in wound 
healing, a double knockout of both Arts and XIAP demonstrated that the 
enhanced re-epithelialisation seen in the Arts knockout mouse was abolished; 
indicating that XIAP plays an important role in wound healing.   
1.5.3 cIAP1 and cIAP2 
Two different cellular IAPs have been identified in mammals: cIAP1 and cIAP2.  
These IAP proteins are similar to each other in structure, function and 
localisation (Cao et al., 2008).  Both types of cIAP proteins (1 and 2) are 
thought to have evolved from the XIAP protein since these three proteins 
contain three BIR domains that have similar subgroups, with the slight 
variation of having the CARD inserted between the BIR domains and the RING 
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finger; the RING finger domain has an additional function as an E3 ubiquitin 
ligase, which is capable of autoubiquitination, where the substrates of this 
activity are Smac/DIABLO, caspase-9 and RIP1 (Ma et al., 2006; Morizane et 
al., 2005). 
cIAP1 was originally identified by its association with TNF-R2 via TRAF1 and 
TRAF2 (Rothe et al., 1995; Uren et al., 1996).  cIAP1 is capable of binding to 
both caspase-7 and caspase-9, however is not able to directly inhibit their 
proteolytic activity (Eckelman and Salvesen, 2006; Tenev et al., 2005).  
Caspase-9 is inhibited by cIAP1 in the nucleus (Tanimoto et al., 2005).  
Studies have shown that cIAP1 can interact with the MAPK pathway by binding 
to the C-RAF protein kinase molecule (Dogan et al., 2008).  cIAP1 contains 
both a BIR domain and a CARD domain, and in between these two structures 
is an ubiquitin-associated domain (Blankenship et al., 2009).   
Studies with cIAP1-/- knockout mice show no phenotypic abnormality and 
appear to have no functional deficiencies in apoptosis initiated by a variety of 
stimuli (Conze et al., 2005; Harlin et al., 2001; Vince et al., 2007).  Even though 
that would suggest that this specific IAP is not important for survival, increased 
levels of cIAP1 have been shown to increase tumour cell survival (Hunter et 
al., 2007).  The main target for IAP antagonists is cIAP1. Low levels of cIAP1, 
lead to NFκβ signalling activation and induces TNFα production; this causes 
apoptosis in tumour cells by activating caspase-8 and affecting TNF-R1 death 
receptor signalling (Vince et al., 2007).  TRAF2 recruits cIAP1 and cIAP2 to 
regulate the suppression of the noncanonical NFκβ pathway (Zarnegar et al., 
2008).  Reduced cellular levels of cIAP2 lowers the ubiquitination of RIP1, 
which converts the RIP1 function from a pro-survival molecule to a pro-
apoptotic adapter protein (Bertrand et al., 2008).  . 
The pattern of expression for both cIAP proteins is generally the same in 
human tissues.  It was shown that cIAP2 is more highly expressed in the basal 
layer of epithelial cells in the skin where proliferating cells reside (Vischioni et 
al., 2006).  When looking specifically at cellular localisation cIAP2 was found 
in the cytoplasm, whilst cIAP1 was found also in the nucleus of many different 
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epithelial cells (Vischioni et al., 2006).  Studies comparing the localisation of 
cIAP1, cIAP2 and XIAP show that cIAP1 is the most abundant IAP of the three 
in many human tissues including  the prostate, testis, ovaries and uterus 
(Vischioni et al., 2006). 
1.5.4 NAIP 
Neuronal Apoptosis Inhibitory Protein (NAIP) was the first IAP member to be 
identified in mammals due to a deletion in infantile spinal muscular atrophy 
(Roy et al., 1995), and is regarded as a potent agent for cell survival, both in 
vitro and in vivo (Christie et al., 2007; Crocker et al., 2001; Davoodi et al., 
2010a; Hutchison et al., 2001; Mikrogianakis et al., 2007).  It is 160kDa in size 
and has three BIR domains found at the amino terminal region; each playing 
a slightly different role in respect to what it binds to.    The second BIR domain, 
BIR2 functions to bind to, and inhibit the actions of caspase-3 and caspase-7 
(Maier et al., 2002); whilst BIR3 binds to and inhibits caspase-9 (Davoodi et 
al., 2004).  NAIP also contains an ATP/GTP binding site and a long carboxy 
terminal region with no known functional domain or motifs (Davoodi et al., 
2010a; Davoodi et al., 2004). 
Another structural feature that is present in the NAIP protein, which sets it 
aside from the other IAPs, is that it contains a nucleotide binding 
oligomerisation domain (NOD) and a leucine rich repeat (LRR).  As with the 
different BIR domains having different roles, these two special features also 
play a role in the overall function of NAIP.  It has been determined that NOD 
acts as an ATP/dATP binding site allowing for the interaction between NAIP 
and caspase-9 to occur, since unlike other IAP members this IAP needs ATP 
to bind to caspase-9 (Davoodi et al., 2004).  NOD is also important in the 
activation of NFκB, The LRR is a regulator for the BIR domains by blocking 
their interactions with the caspases (Davoodi et al., 2010a).   
It has only recently been investigated whether the full length of the NAIP 
protein or the specific BIR3 domain interacts with the caspase-9 apoptosome 
complex.  However, in a recent study by Davoodi et al. (2010a) it was shown 
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that NAIP prevents apoptosis at the point of apoptosome formation and its 
inhibition cannot be stopped by IAP antagonists such as Smac/DIABLO.  NAIP 
also appears to be involved in activation of pro-inflammatory caspase-1 
(Fortier et al., 2005; Molofsky et al., 2006; Ren et al., 2006; Zamboni et al., 
2006).  NAIP can protect neurones from cell death by both caspase-dependent 
and caspase-independent pathways via its BIR3 domain (Mercer et al., 2000).   
NAIP is regulated by the transcription factor Pax2, which directly binds to a 
specific recognition motif in the Naip gene promoter; Mutant mice 
heterozygous for Pax2 reduced the levels of NAIP mRNA expression by 50% 
(Dziarmaga et al., 2006).  The level of NAIP expression is generally low in 
most tissues (Xu et al., 2002); NAIP has been shown to be active in neurones 
(motor, but not sensory) (Liston et al., 1996; Perrelet et al., 2000; Xu et al., 
1997a; Xu et al., 1997b), the granulosa cells of the ovaries in mice (Matsumoto 
et al., 1999) and cell lines including Chinese hamster ovaries (CHO), Henrietta 
Lacks (HeLa) cervical cancer cell line and Rat-1 (Liston et al., 1996) and can 
be found in the human CNS, placenta, liver, spleen, lung and peripheral blood 
leukocytes (Maier et al., 2007).  
1.5.5 Apollon 
This cytosolic protein is one of the largest IAPs containing both the BIR domain 
in the amino terminal region and the ubiquitin-conjugating enzyme domain, 
motif at the carboxy terminal region; also at the C-terminal is a ubiquitin-carrier 
protein motif (Hauser et al., 1998).  It is membrane-associated and contains 
only one BIR domain (Chen et al., 1999a; Hauser et al., 1998).  Apollon can 
inhibit apoptosis induced by the IAP antagonist Smac/DIABLO, by promoting 
the ubiquitination and degradation of the mature form of the antagonist 
Smac/DIABLO (Hao et al., 2004), by specifically binding to the precursor of 
Smac/DIABLO (Qiu and Goldberg, 2005).  Apollon can also bind to pro-
caspase-9 preventing its cleavage (Hao et al., 2004; Qiu and Goldberg, 2005; 
Qiu et al., 2004), and the initiation of the caspase cascade (Srinivasula et al., 
2001; Sung et al., 2007); However it does not inhibit the activity of caspase-3 
(Qiu and Goldberg, 2005).   
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Expression of Apollon has been associated with neural progenitor cells 
indicating that Apollon is important in the proliferation of stem cells and 
neurogenesis (Sippel et al., 2009).  Apollon plays a role in the control of cell 
death in early development; the knockout of Apollon results in defective 
development of the placenta; mouse embryos died in utero due to high levels 
of apoptosis in both the placenta and yolk sac (Ren et al., 2005).  Mutations of 
Apollon leads to the up-regulation of p53, a tumour suppressor causing 
apoptosis in the mitochondria (Ren et al., 2005). High expression of Apollon 
has now been associated with malignancy (Sung et al., 2007).  For example, 
Apollon is upregulated in brain tumour cell lines that are resistant to DNA 
damaging agents (Chen et al., 1999a).   
1.5.6 ILP2 
ILP2 (IAP like protein 2) is a homologue of XIAP.  This protein is only 
expressed in testis in normal human tissue; and detected in lymphoblastoid 
(lymphocyte infected with Epstein-Bar virus) cells (Richter et al., 2001).  ILP2 
has no effect on apoptosis mediated via Fas and TNF; however, it inhibits 
apoptosis with high expression of Bax, or with the co-expression of caspase 9 
with Apaf1. 
1.5.7 ML-IAP 
ML-IAP (Livin) is a 39kDa protein with a single BIR domain and a zinc binding 
RING domain, and like all other IAPs interacts with caspases.  ML-IAP has a 
weak binding affinity with caspase-3, -7 and -9 (Vucic et al., 2005), however, 
it inhibits caspases indirectly by promoting the degradation of Smac/DIABLO 
via its E3 ubiquitin ligase activity (Kasof and Gomes, 2001; Lin et al., 2000; Ma 
et al., 2006).  It also competes with the binding site on Smac/DIABLO, reducing 
XIAP-Smac/DIABLO binding, creating a pool of XIAP which can interact with 
the caspases to prevent apoptosis (Shin et al., 2005; Vucic et al., 2000).  ML-
IAP can be cleaved by caspase molecules; its truncated form has pro-
apoptotic activity (Abd-Elrahman et al., 2009; Nachmias et al., 2003).   
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1.5.8 Survivin 
One of the more studied IAPs is Survivin.  It is the smallest IAP identified (Ryan 
et al., 2009), it has a single BIR domain in the amino-terminal region that is 
crucial for homo dimer formation, and also for protein-protein interactions with 
caspases (Chantalat et al., 2000; Verdecia et al., 2000); it was discovered that 
the BIR found in Survivin has a similar structure to the BIR2 of XIAP (Ambrosini 
et al., 1997; Uren et al., 1998) .   
Survivin interacts in both the intrinsic and extrinsic pathways, counteracting 
different mediators including IL-3, FAS and caspases -3, -7 and -8 (Ambrosini 
et al., 1997; Azuhata et al., 2006; Mahotka et al., 1999; Mirza et al., 2002; 
Suzuki et al., 2000; Tamm et al., 1998; Zaffaroni et al., 2002).   
Another hypothesis that has been suggested for the mechanism of Survivin, 
is that it is able to bind to Smac/DIABLO, displacing already bound IAPs 
allowing them to function by inhibiting apoptosis via the binding of caspases 
(Du et al., 2000; Verhagen et al., 2000).  Survivin expression is high during 
foetal development, however is rarely seen in healthy adult tissue; up-
regulation of Survivin is seen in the majority of cancer cells (Altieri, 2008; Li, 
2003).  Due to the high expression of Survivin in carcinoma cells, Survivin has 
become a protein of interest in developing new therapeutic targets for cancer 
treatment. 
1.6 IAP Antagonists 
1.6.1 Smac/DIABLO 
The Second Mitochondria-derived Activator of Caspases (Smac)/Direct IAp 
Binding with LOw pI (DIABLO) protein (Du et al., 2000; Verhagen et al., 2000) 
is an endogenous antagonist of IAPs (Cossu et al., 2009).  Even though this 
protein is generally found in the mitochondria, during the process of apoptosis 
it migrates into the cytosol (Verhagen and Vaux, 2002).  It is capable of 
activating caspase-3, -7 and -9 by interfering with the IAPs binding to the 
caspases, mainly those that interact with caspase 9 (Du et al., 2000; Shiozaki 
and Shi, 2004; Verhagen et al., 2000; Wu et al., 2000). Smac/DIABLO as well 
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as other IAP antagonists have a conserved N-terminal IBM (Du et al., 2000).  
It is the amino terminal sequence that is important in the binding of 
Smac/DIABLO to the IAP molecules; mutations in this sequence can cause 
the protein to lose its function (Chai et al., 2000). 
Smac/DIABLO is capable of interacting with cIAP1, cIAP2 and XIAP via its E3 
activity, an ubiquitin ligase.  In HeLa cells, Smac/DIABLO was shown to 
decrease the levels of both cIAP1 and cIAP2 by degradation; however it had 
the opposite effect on the levels of XIAP, with a slightly elevated level of 
expression (Yang and Du, 2004).  Smac/DIABLO is capable of antagonising 
the effect of XIAP by binding to the same groove that is used to bind to the 
caspase molecules (Chai et al., 2000; Srinivasula et al., 2001).  The 
degradating effects of Smac/DIABLO on certain IAPs (mainly cIAP1 and 2) is 
as a result of their auto-ubiquitination.  Since Smac/DIABLO has an effect on 
cell survival, it has been of interest as a target protein.  Recently, it has been 
identified that the Hip2 protein (a ubiquitin-conjugating enzyme, involved in cell 
cycle, and the suppression of cell death) interacts with Smac/DIABLO, and 
can also promote proteasomal degradation of mature Smac/DIABLO, 
preventing its interaction with IAPs (Bae et al., 2010).   
1.6.2 Xaf1 
XIAP associated factor (Xaf1) is one of the IAP antagonists that negatively 
regulates the effects of XIAP.  Unlike the IAP antagonist Smac/DIABLO, which 
is a mitochondrial protein, Xaf1 is a nuclear protein which interacts with the 
XIAP-caspase complex, separating them (Liston et al., 2001).  In particular, it 
is the caspase-3 interaction that is antagonised by the over expression of Xaf1 
(Liston et al., 2001).  The structure of this antagonist is that it does not contain 
an amino terminal tetrapeptide motif, suggesting that its interaction is specific, 
unlike the other IAP antagonists (Liu et al., 2000; Tu et al., 2009). 
Whilst comparing Smac/DIABLO and Xaf1 with their interactions with XIAP, it 
was shown that Xaf1 binds preferentially to the BIR2 domain of XIAP, whilst 
Smac/DIABLO binds with higher affinity to the BIR3 domain (Liu et al., 2000).  
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Xaf1 has an additional role, which the other IAP antagonists do not share, in 
that it can also re-localise XIAP from the cytosol to the nucleus (Liston et al., 
2001; Zou et al., 2006).  Due to its association with XIAP, it is also considered 
to be a tumour suppressor; lack of this protein has been associated with many 
different cancer cell lines and human cancers (Byun et al., 2003; Fong et al., 
2000; Lee et al., 2006; Ng et al., 2004). 
The mRNA for Xaf1 is expressed in all normal adult and foetal tissue; whilst in 
different cancer cell lines, the expression is markedly reduced (Fong et al., 
2000).  Over-expression of Xaf1 in colon cancer enhances the activity of 
caspases, in particular caspase 8, via sensitisation of the cells to TNF Related 
Apoptosis Inducing Ligand (TRAIL)-induced-apoptosis (Leaman et al., 2002; 
Micali et al., 2007), an important member of the TNF family causing cell death 
to tumour cells only.  Xaf1 over-expression also plays a role in the down 
regulation of IAPs such as XIAP, Survivin and cIAP2 through enhancement of 
TRAIL effects to trigger tumour regression (Tu et al., 2010).  It’s expression in 
melanoma cells is reduced compared to normal human epidermal melanocyte 
cells (Ng et al., 2004). 
1.6.3 HtrA2/Omi 
High temperature requirement A2 (HtrA2) is an IAP antagonist containing an 
IBM and a serine protease domain; both features are involved in the regulation 
of apoptosis (Hegde et al., 2002; Srinivasula et al., 2003; Suzuki et al., 2004; 
Verhagen et al., 2002; Yang et al., 2003).  This protein, like Smac/DIABLO is 
located in the mitochondria, and is released into the cytosol during apoptosis 
(Hegde et al., 2002; Martins et al., 2002; Suzuki et al., 2001a; van Loo et al., 
2002; Verhagen et al., 2002).  The N-terminus of HtrA2 is cleaved with its 
release from the mitochondria.  HtrA2 interacts with both BIR2 and 3 in XIAP, 
and can interact with cIAP1; it is not capable of interacting with Survivin 
(Suzuki et al., 2001a; van Loo et al., 2002; Verhagen et al., 2002).  
Overexpression of HtrA2 induces cell death in a caspase-independent 
manner, involving the shrinkage of cells without membrane blebbing and 
without the formation of apoptotic bodies (Suzuki et al., 2001a). 
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Figure 1.11: Basic overview of IAP and IAP interactions with caspases 
General basic overview of the different interactions between inhibitors of 
apoptosis proteins (IAPs), IAP antagonists and initiator caspase 9 and effector 
caspases 3 and 7. 
IAPs are regulated to mediate cell homeostasis and in pathology, for example 
cancer, this regulation is disrupted.  IAPs therefore need to be tightly regulated 
to protect cells under stress conditions.  They are also important in wound 
healing, especially in the remodelling phase where cells that are no longer 
required need to be removed from the site and to resume homeostasis; this 
function needs to be tightly controlled (Greenhalgh, 1998).   
Oestrogen has been established to improve wound healing, and provide 
protection in skin (Stevenson and Thornton, 2007)  topical 17β-oestradiol 
treatment has been shown to improve cutaneous wounds by accelerating the 
closure of a wound and wound collagen deposition (Ashcroft et al., 1999).  In 
breast cancer cells, oestrogen has been demonstrated to regulate the levels 
of anti-apoptotic proteins such as Bcl2 (Frasor et al., 2003; Teixeira et al., 
1995).  Another study shows that in breast cancer, 17β-oestradiol activates 
the transcription factor NFκβ, a pro-survival mediator (Biswas et al., 2003; 
Frasor et al., 2009); in MCF7 cells, cIAP2 was a target gene to oestrogen 
receptor, qPCR demonstrated an upregulation of cIAP2 in the presence of 
Xaf1 
Smac/DIABLO 
XIAP 
cIAP1/2 
NAIP 
Apollon 
Caspase 9 
Caspase 3 
Caspase 7 
IAP Antagonist Caspase IAP 
 
 
 
 
Background to Thesis 
 
  
 
52 
 
  
17β-oestradiol and TNFα, blocked by cells incubated with ICI 182, 780; NFκβ 
was shown to be highly up-regulated.  In a study by Stanculescu et al. (2010), 
it was demonstrated that in breast cancer cells, 17β-oestradiol promotes cell 
survival through IAP activation.  17β-oestradiol was shown to increase levels 
of cIAP2 mRNA in combination with TNFα, but not cIAP1 and XIAP; also in 
the absence of cIAP2 via silencing the gene, the protective function of 17β-
oestradiol was not observed.  A different study by Bradford et al. (2010) 
demonstrated that in osteoblasts, oestrogen protect these cells by preventing 
apoptosis.  This has been linked to its effect on caspase activity, in particular 
to inhibit effector caspases 3 and 7 (Bradford et al., 2010).  This interaction 
could be a possible mechanism to protect cells when stressed; with the 
inhibition of effector caspases, apoptosis is prevented. 
1.7 Oestrogen 
Oestrogens are steroid hormones, commonly known as the primary sex 
hormones in females.  In women, oestrogen can be found in three main forms 
circulating in the blood.  A fourth form can be found circulating in the blood 
during pregnancy, which is produced by the liver of the human foetus; 
however, its role is still unclear (Coelingh Bennink et al., 2008; Hagen et al., 
1965).  The different types of oestrogens are: oestrone (E1), 17β-oestradiol 
(E2), oestriol (E3) and oestetrol (E4); they are all C18 steroids, with slight 
differences in the chemical composition and the number of hydroxyl (OH) 
groups found in each type (see Figure 1.12).   
Each variation is important in its function since different levels of these 
hormones are found at different stages of the women’s life (Watson et al., 
2008).  The most predominant oestrogen associated with the female 
reproductive phase is 17β-oestradiol.  During and after menopause, oestone 
is the most significant oestrogen in the blood; whilst oestriol levels are higher 
in women during pregnancy (Watson et al., 2008).  In men, it is mainly 17β-
oestradiol that is converted from testosterone in peripheral tissue (Sherwin et 
al., 2011); levels vary depending on the levels of testosterone and the enzyme 
aromatase which converts testosterone into 17β-oestradiol.   
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Figure 1.12: Structural composition of the different forms of oestrogen 
C18 steroids, all containing one OH group attached to the benzene A ring at 
C3.  A) Oestrone, with a ketone (=O) attached to C17 on the D ring.  B) 17β-
oestradiol, OH group at C17 on the D ring.  Two isoforms exist, 17α-oestradiol 
the OH group sits below the plane of the D ring, altering its 3D structure and 
its affinity for the oestrogen receptors (green dashed box).  C) Oestriol, has a 
second OH group attached to D ring at C16.  D) Oestetrol, has a third OH group 
attached to the D ring at C15.  (Coelingh Bennink et al., 2008) 
Oestrogen is able to act on cells via both the genomic and the non-genomic 
pathways (classical and non-classical).  The genomic pathway involves intra-
cellular receptors located in the nucleus or cytoplasm that act as transcription 
factors (Nilsson et al., 2001); whilst the non-genomic pathways involves a 
membrane bound receptor and secondary messenger signalling events (Silva 
et al., 2010).  Circulating levels of 17β-oestradiol in men are 50-200pmol/L, 
while the levels in females vary depending on the stage of the menstrual cycle.  
During the follicular phase they are 70-500pmol/L, during the preovulatory 
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phase around 400-1500pmol/L, in the luteal phase 70-600pmol/L, and after 
menopause circulating levels are below 130pmol/L (Hornum et al., 1997). 
1.7.1 Oestrogen biosynthesis 
In females of reproductive age, the synthesis of oestrogen occurs principally 
in the ovaries, however other tissues (peripheral sources) such as the liver, 
skin, adipose tissue, adrenal glands and breasts also produce oestrogen, 
which are important sources after menopause (Simpson et al., 2000). 
Oestrogen is the terminal steroid in biosynthesis from cholesterol (see 
Figure 1.13). 
 
Figure 1.13: Flow chart representing the biosynthesis of oestradiol from cholesterol and the 
enzymes involved 
Oestrogen is produced from cholesterol in a number of stages involving 
different enzymes.  DHEA and androstenedione are also secreted by the 
adrenal cortex in humans and some primates to act on peripheral cells (Martin 
et al., 2004; Rose et al., 1997). Cyp11a1 SCC – cholesterol side chain 
cleavage enzyme, HSD – hydroxysteroid dehydrogenase, Cyp7b – 
cytochrome P450 
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Aromatase is the final enzyme involved in the synthesis of oestrogen.  
Oestrogen can be synthesised in extragonadal sites, which allows it to act in 
a paracrine or intracrine manner (Simpson et al., 2000).  The production of 
oestrogen in extragonadal tissue is dependent on circulating C19 precursors, 
DHEA and androstenedione, which are produced by the adrenal cortices of 
both sexes and from circulating testosterone in males.  However, some tissues 
including the skin can synthesis oestrogen from cholesterol (Inoue et al., 
2012).   
1.7.2 Oestrogen action via the genomic pathway 
The genomic pathway, also known as the classical pathway involves 
intracellular receptors that act as transcription factors.  For many years, it was 
thought that there was only one oestrogen receptor that mediates all the 
pharmacological and physiological effects of oestrogen and their antagonists 
(reviewed by Nilsson et al. (2001) and Thornton et al. (2003a)). It was in 1996 
when a second oestrogen receptor was identified in male tissue (Kuiper et al., 
1996; Mosselman et al., 1996); they named the first ERα, and the second ERβ. 
Oestrogen Receptors (ER) α and β belong to a nuclear receptor superfamily 
that include all the steroid receptors and are activated through ligand-receptor 
binding.  They share a high degree of homology with regards to some of their 
functional domains, namely their DNA and ligand binding domains; however 
their N-terminal is more divergent (Hall et al., 2001).  Their cell and tissue 
localisation and expression varies, indicating different functions in different cell 
types (Couse et al., 1997; Monje et al., 2001).  Once a ligand such as 17β-
oestradiol binds to an ER through a ligand-binding domain, it causes a 
conformational change in the receptor releasing the chaperone protein (heat 
shock protein), allowing interaction and binding to a specific DNA sequence 
known as the oestrogen response elements (ERE) and leading to an altered 
rate of transcription of oestrogen related genes (Nilsson et al., 2001).  Ligand 
binding can either cause homo- or hetero-dimerisation of oestrogen receptors, 
depending on cellular expression. 
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Figure 1.14: ERα and ERβ domains 
Schematic representation of the oestrogen receptor α and β domains and their 
homology for each individual domain.  AF – activation function, DBD – DNA 
binding domain, NLS – nuclear localisation site, LBD – ligand binding domain, 
N – amino terminal, C – carboxyl terminal (Garcia-Becerra et al., 2012). 
Through the genomic pathway, there are two different mechanisms of action 
for oestrogen, ligand dependent and independent interaction.  For the ligand 
dependent activation, in the absence of hormones, the receptors are in a state 
of seclusion by a multiprotein inhibitory complex found in the target cells (Hall 
et al., 2001).  When the ligand binds to the receptor, it causes conformational 
changes, which allows it to bind to EREs upstream of the target genes (Hall et 
al., 2001; Walker et al., 1984).  Tissue specific co-factor proteins allow the 
DNA-bound receptor to come into contact with the general transcription 
apparatus (Hall et al., 2001; McKenna et al., 1999).  In ERα, there are two 
domains in which the transcriptional activity is mediated, one is found within 
the N-terminus (A/B domain) which is named activation factor 1 (AF-1), and 
AF-2 which is hormone dependant and is located in the ligand-binding domain 
(Tora et al., 1989).  Like ERα, ERβ also contains AF2, but no AF1 domain is 
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found in human ERβ, however the AF2 domains in the two subtypes function 
differently (Hall et al., 2001). The transcriptional activity of the AFs are 
dependent on the recruitment of co-factors.  Although these AFs function 
synergistically, they are also capable of functioning independently (Hall et al., 
2001). 
ER function can also be modulated by other factors in the absence of 
oestrogen; ERα is activated by epidermal growth factor (EGF) and insulin like 
growth factor 1 (IGF-1), increasing the expression of target genes (Smith, 
1998).  Oestrogen activated ER can also lead to the interaction of the receptor 
with a second DNA-binding transcription factor, generally preventing the 
binding of other transcription factors such as interleukin 6 (IL6), via its 
interaction with a subunit of NFκβ (Galien and Garcia, 1997; O'Lone et al., 
2004; Stein and Yang, 1995).  In breast cancer cells, cells expressing ERα 
show a reduced level of NFκβ activity in comparison with ER negative cells 
(Gionet et al., 2009; Nakshatri et al., 1997). 
1.7.3 Oestrogen action via the non-genomic pathway 
As opposed to the genomic pathway that is relatively slow (hours as opposed 
to minutes (Foradori et al., 2008)), the non-genomic pathway allows 17β-
oestradiol to act rapidly by triggering a variety of secondary messenger 
signalling pathways (Silva et al., 2010) including the activation of adenylate 
cyclase and cAMP and the proto-oncogene Src causing the consequent 
activation of the Erk pathway, including both Erk1 and Erk2 in the Src/Ras/Erk 
cascade (Aronica et al., 1994; Kousteni et al., 2001; Migliaccio et al., 1996; 
Silva et al., 2010).  This pathway is triggered and mediated by membrane 
associated or cytosolic ER (G-protein coupled receptor 30 (GPR30), now 
known as G-protein coupled ER 1 (GPER1) (Cheskis, 2004; Sharma and 
Prossnitz, 2011).   
There are two ways by which the non-genomic pathway can influence gene 
expression.  Phosphorylation of the nuclear ERα via Src/Erk and PI3K 
signalling can activate the receptor in the absence of oestrogen (Kato et al., 
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1995; Silva et al., 2010; Stoica et al., 2000).  Genes that are susceptible to 
oestrogen regulation do not always contain EREs.  Interaction with another 
DNA binding transcription factor such as the activator protein 1 (AP1), binding 
to promoter sequence on target genes (Gaub et al., 1990). 
ERs found on the membrane of the cell are G-protein linked and respond to 
oestrogen ligands (Carmeci et al., 1997; O'Dowd et al., 1998; Owman et al., 
1996; Takada et al., 1997).  Initially it was thought that these receptors are 
only found on the cell membrane, however, immunohistochemistry has 
demonstrated that this receptor could translocate and be found in the 
endoplasmic reticulum and nucleus (Evans et al., 2014; Revankar et al., 2007).  
They were identified in ER negative breast cancer cells, which still responded 
to 17β-oestradiol (Prossnitz et al., 2007).  
Oestrogen has been shown to activate the MAPK signalling pathway.  It has 
been demonstrated that the vascular protecting effects of oestrogen acting via 
ERα are mediated by non-genomic mechanisms through MAPK and Akt 
signalling pathways activating endothelial NO synthase (Chen et al., 1999b; 
Simoncini et al., 2000).  In osteoblasts, oestrogen has a proliferative and anti-
apoptotic effect through the MAPK signalling pathway (Kousteni et al., 2001). 
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Figure 1.15: Oestrogen receptor genomic and non genomic pathway 
Oestrogen receptors (ER) are capable of binding to DNA specific sequences 
either directly or indirectly via other transcription factors.  ERs are capable of 
activating different signalling pathways including MAPK and JAK. cAMP is 
involved in activating oestrogen receptors induced by GPR30. 
E2 - 17β-oestradiol, EGF – epidermal growth factor, PAK1 – Serine/threonine-
protein kinase, PKA – cAMP dependant protein kinase, CARM1 – co-activator 
associated arginine methyltransferase 1, STAT3 – signal transducer and 
activator of transcription 3, SP1 – specificity protein 1, AP1 – activator protein 
1.  Adapted from Tanos et al. (2012) 
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1.7.4 The effect of oestrogens on wound healing 
Studies have shown that ERs are expressed in different cells in human skin 
(Hasselquist et al., 1980) such as adipose cells (Pedersen et al., 1996), 
macrophages (Gulshan et al., 1990), fibroblasts (Thornton et al., 2003b), 
keratinocytes (Thornton et al., 2003b), melanocytes (Jee et al., 1994), and 
endothelial cells (Malet et al., 1991; Venkov et al., 1996).  Many of these cells 
including fibroblasts, keratinocytes and immune cells are all important in 
wound healing, and therefore it would suggest that oestrogen has an effect on 
both normal skin homeostasis and during wound healing.  Ashcroft et al. 
(1997a), investigating the role of 17β-oestradiol in wound healing in both 
humans and mice, showed that 17β-oestradiol substantially improved wound 
healing in aged humans, and in oestrogen depleted mice. 
1.7.4.1 Effects of oestrogen on the inflammatory phase of wound 
healing 
In both males and females in humans (Straub, 2007) and rodents (Kovats, 
2012), oestrogen receptors are expressed in immune cells and their 
progenitors.   
A histological study compared the inflammatory response and granulation 
tissue formation in response to oestradiol in rats ((Taubenhaus and Amromin, 
1949) as reviewed by Calvin (2000)).  Two groups of rats were compared, one 
virtually free of circulating hormones by the surgical removal of the male and 
female gonads and the adrenals, with a group which had intact adrenal glands 
and gonads, neither received any hormone therapy.  The differences observed 
after wounding by subcutaneous implantation (to produce abscesses), were 
that in the animals that had their gonads and adrenals removed, the walls of 
the abscesses were thin with hardly any granulation tissue and fibroblastic 
response; while polymorphonuclear leucocytes were found in abundance, 
suggesting that the progression in healing from the initial inflammatory phase 
was lacking (Taubenhaus and Amromin, 1949) as reviewed by Calvin (2000).  
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More recent studies carried out by Ashcroft et al. (1999), demonstrated that 
application of topical oestrogen on wound sites of both elderly male and female 
patients significantly accelerates wound healing, with a reduced amount of 
neutrophil elastase and increased levels of fibronectin and collagen.  In this 
study, elderly men (age 71.8 ±8.9 and 69.6 ±3.6 placebo and oestrogen) and 
women (age 72.5 ±7.1 and 76.3 ±5.6 placebo and oestrogen) were wounded 
(4mm punch biopsies in the left upper inner arm), and either topically treated 
with placebo or oestrogen for 24 hours.  The wound area was significantly 
reduced in both sexes at similar rates with oestrogen treatment.  There was 
also an increase in total collagen deposition after 7 and 80 days in patients 
treated with oestrogen.  Markers for immune cells CD15 (neutrophils), and 
CD14 (monocytes) were used to compare the number of immune cells positive 
for ERα and ERβ 7 days after wounding in patients treated with either 
oestrogen and placebo.  The results showed that there was a decrease in 
neutrophils and an increase in monocytes when treated with oestrogen for 24 
hours.  The chemotactic response of neutrophils was assessed using a 12 well 
chemotaxis chamber, and was significantly impaired in cells treated with 
oestrogen.   
A later study by Campbell et al. (2010) compared the effect of ERα and ERβ 
specific agonists in ovariectomised mice in relation to inflammatory cells, and 
demonstrated that although signalling through ERα is sufficient to decrease 
inflammation, however alone, does not accelerate wound healing.  With 
ovariectomised mice, treatment with DPN an ERβ antagonist at days -1, 0 and 
+1 of wounding; after 3 days of wounding, wound healing was accelerated.  
Indicating that ERβ has a negative effect on wound healing.  Wound healing 
was delayed in mice that lacked oestrogen, either via ovariectomisation, or 
single knockout of ERα and ERβ.  Interestingly, with ERβ knockout mice, 
treatment with oestrogen did not improve wound healing; however, it 
increased the number of neutrophils.   
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1.7.4.2 Effects of oestrogen on the proliferative phase of wound 
healing 
Migration and proliferation of endothelial cells, fibroblasts and keratinocytes is 
essential in the proliferative phase of wound healing (Bello and Phillips, 2000; 
Park et al., 2011).  Re-epithelialisation is one of the process involved in the 
proliferative phase of wound healing.  Wound healing deteriorates with age, a 
study in male mice, showed that the rate of re-epithelialisation was delayed 
with age; with an increase in inflammatory cells contributing to the delay 
(Ashcroft et al., 1997b). 
In rats, it has been shown that ERβ is responsible for activating tensile strength 
in wound healing in vivo and increased re-epithelialisation of the epidermis 
(tensile strength was calculated by measuring the maximal breaking strength  
at the wound edge by the wound area), whilst ERα was responsible for the 
increase in myofibroblast population (Novotny et al., 2011).  To ensure that 
fibroblast differentiation into myofibroblasts were due to ERα agonists, human 
breast fibroblasts were treated with either ERα agonist PPT, or ERβ agonist 
DPN; after three days, there was an increase in myofibroblast population in 
cells treated with PPT, detected via immunohistochemistry, fibroblasts were 
stained with monoclonal antibody against αSMA to detect presence of 
myofibroblasts. 
A recent study demonstrated that there is a difference in response to treatment 
to 17β-oestradiol in male and female gonadectomised mice (Gilliver et al., 
2010).  This study examined the effect of 17β-oestradiol on re-epithelialisation.  
Castrated males healed faster than ovariectomised female mice, however, 
when males and female mice were administered with oestradiol, wound 
healing was impaired in males and enhanced in females.  This indicates that 
while 17β-oestradiol is beneficial in females, it can have a negative impact on 
males.  Its inhibition was concluded to be via ERα; since in castrated ERβ null 
mice, there was a delay in wound healing and re-epithelialisation, whilst this 
was not seen in castrated ERα null mice (Gilliver et al., 2010). 
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Aging healthy females show a reduced rate of cutaneous wound healing, 
however their quality of scarring is improved, which would suggest that while 
oestrogen is required for wound healing, it has a negative impact on scarring 
(Ashcroft et al., 1997a).  In this study, it was also observed that levels of 
TGFβ1 were reduced, and with an increase in TGFβ1 secretion by fibroblasts 
induced by 17β-oestradiol, wound healing was improved.  In an in vitro study, 
human dermal fibroblasts unwounded monolayer treated with 17β-oestradiol 
caused an increase in the secretion of TGFβ1, however, in mechanically 
wounded cells, secretion of TGFβ1 was reduced (Stevenson et al., 2008a).  
This indicates that fibroblasts are target cells for 17β-oestradiol, but that the 
pathways involved are complex and that 17β-oestradiol could have different 
roles in wound healing responses. 
Interestingly, activation of different ERs has different effects on TGFβ1 
secretion, ERα antagonists in human keratinocyte cell line (NCTC2544) 
stimulated cell proliferation and increased TGFβ1 secretion, however, ERβ 
agonists, increased cell proliferation but did not increase secretion of TGFβ1 
(Merlo et al., 2009).  TGFβ1 was involved in keratinocyte cell migration in a 
scratch wound assay, with TGFβ1 treatment, keratinocyte cell migration was 
increased; this increased migration was also seen when cells were treated 
with 17β-oestradiol.  With TGFβ1 antagonists, migration was inhibited, this 
was also seen with ERα agonist, but not with ERβ agonist (Merlo et al., 2009) 
indicating that ERβ is important in keratinocyte migration.   
1.7.4.3 Effects of oestrogen on matrix formation and remodelling  
Oestrogen has been shown to modulate the remodelling phase of wound 
healing.  Delays in age related wound healing are thought to be due to low 
levels of TGF-β1 in humans (Ashcroft et al., 1997a; Neurohr et al., 2006), a 
decrease in collagen synthesis in humans (Ashcroft and Mills, 2002), and an 
increase in the enzyme elastase in humans (Herrick et al., 1997; Marini et al., 
2010).  Depending on the dose of oestrogen and when it is applied, it may 
have different effects on collagen deposition (Marini et al., 2010; Ramamurthy 
et al., 1999).  During the remodelling phase of wound healing, collagen 
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synthesis detected by hydroxyproline assay, increased with oestrogen 
treatment in both male and female patients (Ashcroft et al., 1999).   
Pirila et al. (2001) showed that in rats, the administration of 17β-oestradiol did 
not affect type I collagen deposition in Sham rats when wounded, however, it 
increased collagen deposition to Sham levels in ovariectomised rats. Ashcroft 
et al. (1997b) demonstrated via immunostaining that collagen deposition was 
reduced with age in male mice, and that when wounded, collagen organisation 
was comparable to normal dermis.   A study by Markiewicz et al. (2013) 
compared collagen mRNA expression, and total collagen from ERα and ERβ 
knockout female mice.  Dermal fibroblasts were cultured and collagen mRNA 
expression determined via qRT-PCR and total collagen by hydroxyproline 
assay.  It was observed in vivo that ERα knockout mouse wounds showed a 
significant increase in collagen production compared to wild type, with a 
significant decrease in collagen with ERβ knockout mice.  However, in vitro, 
this was not detected with dermal fibroblast culture.  Both ERα and ERβ 
knockout mice showed an increase in collagen mRNA expression compared 
to wild type.  Treatment of dermal fibroblasts with 17β-oestradiol increased 
collagen mRNA expression in wild type, ERα and ERβ knockout mice, which 
could indicate that 17β-oestradiol affects collagen production through another 
pathway such as through GPR30; to confirm ERα and ERβ conjunctive 
knockout should be established and dermal fibroblasts treated with 17β-
oestradiol. 
1.7.4.4 Effects of oestrogen on angiogenesis 
Both ERα and ERβ are expressed in blood vessels (both endothelial and 
smooth muscle cells) (Karas et al., 1994; Losordo et al., 1994; Venkov et al., 
1996).  Oestrogens are capable of inducing rapid vasodilation, and modulate 
proliferation via down regulating thrombospondin 1 a negative regulator of 
angiogenesis (Sengupta et al., 2004).  And can also regulate proliferation via 
apoptosis as a protective effect when HUVEC cells are treated with TNFα 
(Spyridopoulos et al., 1997).  Oestrogens increased the synthesis of VEGF in 
mechanically wounded dermal papilla cells cultured from female scalp hair 
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follicles; however decreased levels in mechanically wounded dermal sheath 
cells and had no effect in mechanically wounded dermal fibroblasts 
(Stevenson et al., 2008b).  VEGF is an important factor for angiogenesis and 
for the stimulation of re-epithelisation in wound healing (Stevenson et al., 
2008b).  This could indicate that the importance of dermal fibroblasts in 
influencing angiogenesis is not affected by oestrogens. 
1.8 Aims 
Although improved wound healing in anagen hair bearing skin has been 
attributed to the presence of hair follicle cells, human dermal fibroblasts 
derived from different anatomical regions, scalp, abdomen and breast display 
differences in cell migration and proliferation.  However, a study looking at 
similar anatomical regions bearing terminal and vellus hair follicles have not 
been conducted. 
It is also well established that 17β-oestradiol plays an important role in wound 
healing and has direct effects on both human dermal fibroblasts and hair 
follicle fibroblasts in culture. 
More recently, the family of IAPs, in particular XIAP have been shown to have 
a significant role in wound repair in a murine model.  Furthermore, there 
appear to be gender differences in the regulation of XIAP. 
Therefore, this study will compare the expression of different IAPs and IAP 
antagonists in vivo in mice and in vitro in human dermal fibroblasts. The 
expression of IAPs will be examined in mouse skin following depilation, as 
plucking induces a wound healing response to the hair follicle and orchestrates 
the hair follicles into re-entering anagen of the hair cycle. 
In order to establish whether there are differences in the expression for IAPs 
and their antagonists in human skin, scalp and facial skin biopsies derived 
from the same female donors will be used to culture dermal fibroblasts.  
Immunofluorescent staining will be carried out to establish expression and 
localisation of IAPs and their antagonists in different wounding environments. 
 
 
 
 
Background to Thesis 
 
  
 
66 
 
  
To explore further the differences in the dermal fibroblasts derived from human 
hairy (scalp) and non-hairy (facial) skin in terms of wound healing, 
comparisons in migration, viability and proliferation will be conducted.  Since 
XIAP has been associated with wound healing, mRNA expression of IAPs and 
their antagonists will be carried out under wounding and non-wounding 
conditions. 
Fibroblasts are known to respond to 17β-oestradiol, and studies have shown 
expression of oestrogen receptors, however, a comparison of oestrogen 
receptors between dermal fibroblasts derived from terminal and vellus hair 
bearing skin has never been established. 
The responses of the dermal fibroblasts to 17β-oestradiol in terms of 
migration, proliferation and IAP and their antagonists’ expression will be 
conducted to compare between dermal fibroblasts derived from terminal and 
vellus hair bearing skin. 
A major pathway in which XIAP functions, is through the caspase cascade, 
therefore, caspase activity will be monitored in dermal fibroblasts from terminal 
and vellus hair bearing skin under wounding and non-wounding conditions, in 
the presence of 17β-oestradiol as a cell protector and with embelin, to remove 
XIAP activity. 
Not only will this highlight important differences between dermal fibroblast 
populations from the same person, but will also help to identify the relationship 
between oestrogen and IAPs in human skin, which to date has not been 
established. 
 
  
 
 
 
 
Background to Thesis 
 
  
 
67 
 
  
 
 
  
Chapter 2 
EXPRESSION OF IAPS IN MOUSE AND HUMAN SKIN 
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 Expression of IAPs in Mouse and Human Skin 
2.1 Introduction 
Hair follicles are a good model system to study tissue remodelling in an adult, 
as their lower bulb region is regenerative under normal and different 
physiological conditions (Ito et al., 2007).  By inducing anagen (the growth 
phase), the process of tissue remodelling begins (Paus and Foitzik, 2004).  
Cell proliferation and differentiation during anagen, and apoptosis during 
catagen are tightly controlled. 
2.1.1 Mouse and human models 
Mice and other rodents are often used for studies of hair growth, as well as 
models for wound healing, tissue remodelling and regeneration.  It has been 
demonstrated that mice provide good models to study the hair cycle, since 
synchronised hair follicle cycling can easily be obtained via depilation (Stenn 
et al., 1996; Stenn and Paus, 2001).  However, inducing anagen via depilation 
also causes a wound healing response around the hair follicle (Hsu et al., 
2008; Matsuo et al., 2003).  Inflammatory cells such as T- and B-lymphocytes 
are recruited to the outer root sheath of the hair follicle, and perifollicular 
mesenchyme following depilation to induce anagen (Paus et al., 1998).  The 
hair follicle is forcibly removed from its dermal sheath; apoptosis is activated 
to remove injured cells, which also induces the hair follicles into the anagen or 
the growing phase (Matsuo et al., 2003).  The spontaneous hair cycle is less 
synchronised postnatally in mice; the first anagen wave appears 
approximately 12 days after birth, while the second cycle begins approximately 
28 days after birth (Muller-Rover et al., 2001).  With age, the hair cycle 
becomes less synchronised, therefore, to study the different stages of the hair 
follicle cycle, anagen is generally induced via depilation (Paus et al., 1990).  
However, in humans all hair follicles cycle in an asynchronous manner, 
therefore it is more difficult to study the hair cycle in humans. 
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2.1.2 Expression of IAPs and their antagonists in skin 
In the murine hair follicle, the two most studied members of the IAP family are 
Survivin (Grossman et al., 2001) and XIAP (Fessing et al., 2006; Fuchs et al., 
2013).  Survivin expression in the skin varies depending on the species, in 
rats, a study revealed that Survivin was expressed in the epidermis (Iskandar 
and Al-Joudi, 2006), however, in adult murine skin, the expression of Survivin 
in the epidermis was not found (Grossman et al., 2001).  XIAP mRNA 
expression was analysed in wild type and downless mice (mice with Edar 
knockout, a member of the TNFR superfamily which is highly expressed in the 
mouse hair follicle during the anagen-catagen transition (Fessing et al., 
2006)).  XIAP expression was decreased by 5 fold in downless mice compared 
to wild type.  Using immunofluorescent staining XIAP expression was 
decreased in the outer root sheath and the hair matrix in catagen hair follicles 
in downless mice compared to wild type, however it still remained strongly 
expressed in the dermal papilla (Fessing et al., 2006).  More recently the 
expression of XIAP, using immunfluorescent staining, has been demonstrated 
in the bulge (stem cell region) of telogen hair follicles in the mouse (Fuchs et 
al., 2013). 
Survivin expression has also been identified in human skin and hair follicles 
(Botchkareva et al., 2007); it was located in the cytoplasm of keratinocytes in 
the basal layer of the epidermis, while in the hair follicle, it was located in the 
hair matrix and outer root sheath.  This study also investigated the functional 
importance of Survivin in keratinocyte cell proliferation.  Using 
immunofluorescence the hair follicle was stained with a proliferative marker Ki-
67 and Survivin antibody.  Cells in the outer root sheath expressing Ki-67 also 
expressed Survivin, suggesting that Survivin may contribute to the ability of 
cells to proliferate.  Also with immunohistochemical analysis of catagen hair 
follicles, this study demonstrated that the expression of Survivin in the hair 
matrix decreased during catagen, presumably to allow apoptosis to occur for 
follicle regression. 
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A study by Vischioni et al. (2006) compared the expression of XIAP, cIAP1 
and cIAP2 in different human tissues via immunohistochemistry, including the 
skin and hair follicle.  This study demonstrated that XIAP, cIAP1 and cIAP2 
were all present in human epidermis and dermis, including nerves, sebaceous 
glands, sweat glands and the hair follicle; however, the specific compartments 
of the hair follicle that expressed these proteins were not individually 
assessed.  Furthermore, this study provided no data with regards to whether 
the skin was obtained from male or female donors, nor the specific anatomical 
location from which it was derived. 
In the human hair follicle cycle, IAPs are important in regulating catagen, the 
regression phase (Botchkareva et al., 2006).  Apoptosis in the hair follicle 
signifies catagen, where the hair matrix undergoes apoptosis.  The anagen-
catagen transition can be induced by pro-inflammatory cytokines such as 
TNFα (Hoffmann et al., 1996); and inhibitors of apoptosis proteins are reduced 
(Botchkareva et al., 2006).  During catagen the hair follicle outer root sheath 
also shows high expression of caspase 8 and caspase 3 activation (Peter and 
Krammer, 2003). 
To date, the expression of other members of the IAP family have not been 
identified in murine skin and the hair cycle.  However, a recent study by Fuchs 
et al. (2013) has demonstrated that in murine skin, the expression of XAIP was 
required for wound healing.  While XIAP knockout mice were viable and 
displayed no phenotypical differences, loss of XIAP abolished re-
epithelialisation, and wound repair was markedly delayed compared to wild 
type.  
2.1.3 Importance of the hair follicle in wound healing 
Hair follicles also contribute to wound healing in human skin, it has already 
been established that hairy skin heals better than non-hairy skin (Jahoda and 
Reynolds, 2001; Martinot et al., 1994); and that hair follicle cycling plays a 
major role in improving wound healing (Ito et al., 2005; Levy et al., 2007).  In 
a murine model, improved wound healing has been related to re-
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epithelialisation rather than wound closure, where the presence of anagen hair 
follicles are important for re-epithelialisation (Ansell et al., 2011).   
In mice, the body is covered in terminal hair follicles, whilst in humans, the 
majority of the hair follicles are vellus, with terminal hair follicles found mainly 
in the scalp. The human hair follicle also differs considerably from the murine 
hair follicle, in that in certain regions e.g. scalp, beard and axilla, it is androgen 
dependant (Randall et al., 2000).  In the human scalp approximately 90% of 
the hair follicles are in the anagen phase of the hair cycle, and the ratio of 
terminal to vellus hair follicles is 9:1 (Whiting, 1996).  However, it is not 
possible to know whether a particular hair follicle is in early or late anagen, 
which could last for up to 7 years in the human scalp.  Their asynchronous 
nature also makes it difficult to study the effects of hair cycling in the context 
of wound healing. 
A major difference when comparing human skin from different regions is the 
type of hair follicle present, which can be either vellus or terminal hair follicles.  
However, to date, there have been no studies comparing the expression of 
different IAPs in human skin containing predominantly vellus or terminal hair 
follicles.   
2.1.4 Aim 
Since changes in the expression of Survivin in the murine hair cycle has 
already been established, the expression of cIAP1, cIAP2, XIAP and Apollon, 
(NAIP was not expressed in mouse hair follicles at any stage of the hair cycle 
via qRT-PCR, unpublished data), along with the IAP antagonists DIABLO and 
Xaf1 will be determined in murine skin at day 3, 5, 12, 19 and 21 after 
depilation.  Due to the length of the murine hair cycle, this will include anagen, 
catagen and telogen. 
The first aim of this chapter was to establish whether the immunohistochemical 
expression of IAPs and IAP antagonists in haired mouse skin, is altered 
following depilation, which not only induces a wound healing response to the 
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hair follicle, but initiates the anagen phase and the start of the remodelling 
phase of the hair follicle in a new hair cycle to produce a new hair fibre.   
The second aim of this chapter was to compare the IAP expression of NAIP, 
cIAP2, Apollon and XIAP and their antagonists DIABLO and Xaf1 in human 
skin containing predominantly terminal hair follicles or vellus hair follicles in 
skin derived from the same donor.  ML-IAP and ILP2 are generally associated 
with cancer, and therefore will not be studied.  Hair follicles in the scalp are 
predominantly in anagen and can last between 5-7 years.  These hair follicles 
are not synchronised, some could be in early anagen, whilst others are in late 
anagen; therefore, at different stages of the hair cycle the expression of IAPs 
and their antagonists are difficult to ascertain.  Since human skin cannot be 
depilated to synchronise the hair cycle, the SACPIC staining method was used 
to distinguish whether hair follicles were in the anagen, catagen, or telogen 
phase of the hair cycle. 
Human scalp containing terminal hair follicles, where ~90% of the hair follicles 
are in the anagen phase, was compared with corresponding facial skin of the 
same donor which contain small, fine and unpigmented vellus hair follicles.  A 
comparison of skin from the same donor is ideal to determine whether the 
expression of IAPs in human skin differ between vellus and terminal hair 
bearing skin.   
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2.2 Material and Methods 
2.2.1 Tissue samples 
2.2.1.1 Mouse tissue 
C3H male mice were used for experimental purposes.  To determine the effect 
of depilation on IAP levels, sections obtained from mice at specific time points, 
were collected according to previously published procedures (Paus et al., 
1999) obtained under the project licence available via the Centre for Skin 
Sciences, carried out by Dr Andrei Mardaryev trained and authorised to work 
with animals.  Depilation was performed by the brief application of hot 
wax/rosin mixture to the dorsal skin of mice that were 7 weeks old, and in the 
full anagen stage of the hair cycle.  The hair shafts were plucked using the 
wax/resin mixture to initiate a homogenous anagen wave across the entire 
depilated area; depilation induces an early wounding response and the entry 
of the hair follicle into early anagen.  The time points in which the skin sections 
were obtained were 3-5 days after depilation, 12 days after depilation, 19 days 
after depilation and 21 days after depilation.  The skin samples were mounted 
in OCT media and stored at -80˚C, (see Figure 2.1). 
 
Figure 2.1: Mouse skin isolation 
7 week old C3H mice were raised and a patch on the dorsal skin was depilated 
(area highlighted in dashed red box) and at different days after depilation, DP3, 
5, 12, 19, and 21, mice were sacrificed to obtain the depilated skin section.  
Cut skin samples were folded (marked green dash line) and placed in OCT for 
cryosectioning. 
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2.2.1.2 Human tissue 
Skin samples were obtained from healthy donors with full consent and ethical 
approval after undergoing plastic surgery.  The skin samples were taken from 
female subjects (n=3, age range 50-57 - Table 2.1) following facelift surgery.  
The tissue was placed in transporting medium Dulbecco’s Modified Eagle 
Medium (DMEM) (Sigma), supplemented with 10% foetal bovine serum (FBS) 
(GIBCO), 500Units/mL penicillin and 500µg/mL streptomycin (Pen/Strep) 
(GIBCO), 0.75µg/mL fungizone (GIBCO), glutamax (GIBCO)) and stored at 
4˚C for up to 12 hours.  Skin from each donor was divided into the terminal 
hair bearing scalp region and the non-hairy skin containing vellus hairs of the 
facial skin (Figure 2.2).  This allowed a direct comparison of hairy and non-
hairy skin from the same donor.  Tissues for cryosectioning were frozen within 
24 hours in OCT at -80˚C.  
 
 
Figure 2.2: Terminal and vellus hair bearing skin preparation 
Skin samples from female face lift patients – marked red dashed box were 
isolated from terminal hair bearing [S(T)] and vellus hear bearing skin [S(V)] – 
dashed red line.  Skin samples from both terminal and vellus hair bearing skin 
were then cut into smaller 1cm2 pieces frozen in OCT for cryosectioning.  
 
 
S(T) S(V) 
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Donor ID Gender Age S(T) S(V) 
OK18 Female 56   
OK26 Female 50   
OK27 Female 57   
Table 2.1: Donor sample for cryosectioning for IAP and IAP antagonist immunofluorescent and 
SACPIC staining 
Three donor samples were used for cryosectioning to analyse IAP and IAP 
antagonist localisation and expression and SACPIC staining.  S(T) – terminal 
hair bearing skin, S(V) – vellus hair bearing skin. 
2.2.2 Cryosectioning  
Frozen mouse tissue samples (~1cm x 2cm folded) were secured onto a 
cryostat chuck using OCT media and frozen using QuickFreeze solution/ 
spray.  The cryostat temperature was set to -20˚C.  The tissue sample was 
oriented in the cryostat in order to obtain 8µm longitudinal sections of the 
tissue where the entire hair follicle structure could be seen as well as the 
epidermis.  The tissue sample was maintained at -24˚C during sectioning.  
Correct orientation was checked at the start of the sectioning by staining with 
haematoxylin for 30 seconds and the sections observed through a light 
microscope for definitive features.  All sections were captured on charged 
slides (Poly-L-Lysine coated – Sigma; diluted 1:10 in deionised water) for 
electrostatic coupling, which allows for a more secure attachment of the 
section to the slide to withstand the staining procedure.   All sections were 
stored at -80˚C for further use. 
The human skin was cut to pieces of approximately 1cm2, orientated on the 
cryostat and longitudinal sections (of the hair follicle where available) were cut 
at 7µm.  Sections were cut at -24˚C and stored at -80˚C on Poly-L-Lysine 
coated slides for future use. 
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2.2.3 SACPIC staining of human skin 
All the solutions required for SACPIC staining were prepared before the 
experimental procedure, fresh solutions of ethanol and picric acid were made 
on the day of staining. 
Frozen sections on slides were thawed and fixed by immersing in ice cold 
acetone for 15 minutes.  Sections were rinsed twice in water gently and left to 
dry at room temperature.  Slides were immersed in Celestine blue (Sigma-
Aldrich) stain for 5 minutes then rinsed in tap water.  They were then stained 
in Gill’s haematoxylin (Sigma-Aldrich) for 5 minutes and rinsed in tap water.  
To stain the nucleus blue, the sections were placed in Scott’s tap water for 2 
minutes before rinsing in normal tap water.  Sections were immersed in 
Safranin (Sigma-Aldrich) for 5 minutes before rinsing in tap water.  Once the 
solutions had been washed from the slides, the sections were immersed in 
clean tap water for 1 minute, before placing in 70% ethanol, then 95% ethanol 
consecutively for 1 minute each.  The slides were immediately incubated in a 
solution of absolute picric acid (Sigma-Aldrich) /Ethanol (ratio 1:1) for 3 
minutes.  Without washing, the slides were placed directly in 95%, then 70% 
ethanol for 1 minute, before finally hydrating with tap water for a further minute.  
The sections were stained with picro-indigo carmine (Sigma-Aldrich) for 2 
minutes before rinsing in tap water, and then dehydrated by incubating in 70%, 
then 95%, then absolute alcohol for 5 minutes at each concentration.  Sections 
were cleared in a solution of histoclear (National Diagnostics) /ethanol (ratio 
1:1) for 4 minutes, before immersing in 100% histoclear for an additional 4 
minutes.  Slides were mounted using Histomount onto a coverslip and 
observed under a light microscope. 
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Reagent: Staining Purpose: 
Celestine blue Connective tissue and outer root sheath 
Gill’s haematoxylin Nuclear staining 
Scott’s tap water Clear nuclear staining  
Safranin Non keratinised inner root sheath 
Picric acid/ethanol Keratinised hair fibre and inner root sheath 
Picro-indigo carmine Cells in mitosis, bulge and dermal papilla 
Table 2.2: SACPIC staining reagents 
The purpose of the individual staining reagents for SACPIC staining in the skin 
and hair follicle.  
2.2.4 Immunofluorescence 
Antibody (type): Raised in: Manufacturer: Analysed in: Dilution Ratio: 
NAIP (1˚) R SantaCruz 
(SC11062) 
H, M 1:50 
cIAP1 (1˚) R Abcam 
(Ab108361) 
M 1:100 
cIAP2 (1˚) R Abcam 
(Ab32059) 
H, M 1:1000 
XIAP (1˚) R Abcam 
(Ab21278) 
H, M 1:100 
Apollon (1˚) R Abcam 
(Ab19609) 
H, M 1:100 
Xaf1 (1˚) R Imgenex 
(Img379) 
H, M 1:100 
DIABLO (1˚) R Imgenex 
(Img5753) 
H, M 1:300 
FITC (2˚) D anti R Abcam 
(Ab98502) 
H, M 1:200 
Table 2.3: Antibody dilution ratio used for immunofluorescence staining 
A list of the primary and secondary antibodies used for immunofluorescence 
staining, their dilutions and in which tissue sample they were used. R – Rabbit, 
D – Donkey, H – Human, and M – Mouse. 
Human and mouse tissue sections stored at -80˚C were air dried at room 
temperature for 15 minutes and fixed with ice cold acetone for a further 10 
minutes.  After fixation, the slides were left to dry at room temperature for 20 
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minutes; during this time a circle enclosing the sections was drawn with a PAP 
pen (Dako, UK.) a hydrophobic marker which maintains any solution within the 
confined space created.  The slides were then washed in 1X PBS solution for 
a duration of 3 minutes; this washing process was repeated three times.  The 
sections were blocked using 10% donkey serum (Sigma) in PBS and left at 
room temperature for 20 minutes to block non-specific binding.  Without 
washing, the blocking solution was tapped off and 20µl of the primary antibody 
was added to each individual section; parafilm was cut into roughly 1x0.8cm 
sections and placed over the tissue sections to disperse the antibody solution 
evenly across the entire section.  The concentration of the primary antibody 
used was first determined by a series of small dilution ratios in PBS.  Once the 
primary antibody concentration was determined (Table 2.3), it was added to 
the sections, covered in cut parafilm sections and left overnight at 4˚C in a 
humidified chamber. The negative controls were incubated in PBS instead of 
the primary antibody. 
The parafilm sections were removed and the slides were washed thoroughly 
to remove the primary antibody by immersion in 1x PBS for 5 minutes, 
repeating the process three times.  20µl of the secondary antibody was added 
(see Table 2.3); again sections of parafilm were placed over the tissue section.  
For a second negative control, PBS was added to the section.  The slides were 
incubated for one hour at room temperature to allow binding to occur, followed 
by a washing step in 1x PBS for 5 minutes repeated four times.  Slides were 
mounted with a cover slip using Vectashield with DAPI (VWR) as a mounting 
medium. 
2.2.5 Microscopy 
2.2.5.1 Fluorescent microscopy 
Using the fluorescent microscope (Nikon, Tokyo, Japan), sections either 
stained with SACPIC or fluorescent antibodies were placed onto the 
microscope and using the ACT-2U image analysis software, images were 
captured at different magnifications.   
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Sections stained with SACPIC; two for each IAP and their antagonist for 
matching terminal and vellus hair bearing skin from three different donors, 
using only the light with no filters, images of the skin and hair follicle were 
taken. 
For sections stained with fluorescent antibodies and DAPI, an image of a 
section of interest was taken, and without dislodging the slide, different filters 
were put into place to capture FITC and DAPI.  
2.2.5.2 Confocal microscopy 
Once staining was completed, slides were placed in Zeiss Axioert200M 
microscope and using the Software (LSM510), images at different 
magnification were taken.  Specific sections including the epidermis, dermis 
and hair follicle structures (if present) were taken for analysis.  Two sections 
of each sample were taken for each individual donor, and three donors were 
analysed comparing terminal hair bearing skin to vellus hair bearing skin.  
Setting for the confocal microscope was saved for each objective 
magnification (adjusted eye pin hole and fluorescent gain) and the same 
setting was used for each individual section taken to allow not only for 
localisation within the section, but also for the comparison of fluorescent 
intensity between the different sections to compare between different proteins 
and skin type. A scale of 0-4 was used to identify the intensity of the images, 
with 0 being not expressed, to 4 being extremely highly expressed; all analysis 
was carried out by the same person. 
2.2.6 Statistics 
For the significance between the epidermal thickness between terminal and 
vellus hair bearing skin, an un-paired Students T-test of unequal variance was 
conducted. 
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2.3 Results 
2.3.1 Localisation of IAPs in the mouse skin 
Extensive studies have been carried out on the mouse hair cycle stage to 
identify the specific phases from the structure of the hair follicle (Muller-Rover 
et al., 2001).  Another method to identify the stages of the hair cycle in specific 
breeds of mice was to observe its skin colour.  Skin turns grey at mid anagen, 
and by late anagen the skin of the mouse is black, returning back to grey at 
catagen then pink when hair follicles are in telogen.  This is because in these 
mice, melanocytes are only found in the hair follicle; in telogen, the 
melanocytes are reduced and inactive. 
From the guideline below, sections from day 3 (early anagen), 5 (mid anagen), 
12 (late anagen), 19 (catagen) and 21 (telogen) after depilation were used for 
analysis.  Depilating hair follicles from the skin induced wounding (Xie et al., 
2012); since the hair follicles were in a sense ripped from their natural 
environment causing an inflammatory response associated with wounding 
(Benavides et al., 2009).  Therefore, results obtained from the different stages 
may also reflect changes in IAPs in response to the wound healing response 
of the hair follicle and surrounding dermis. 
 
 
 
 
 
 
Figure 2.3: Hair cycle stages for mouse hair follicles after 
depilation 
Guideline to hair follicle thickness at different stages 
of the hair cycle at different days after depilation.  At 
roughly day 3 after depilation, the hair follicle should 
be in early anagen, at day 5 after depilation, the hair 
follicle should be at mid anagen, at 12 days after 
depilation, the hair follicle should be at late anagen.  
At day 19 after depilation, the hair follicle should 
have gone into the catagen transition, and from day 
21 onwards, the hair follicle is entering telogen.  
Arrows indicate time points which skin was 
harvested (Muller-Rover et al., 2001). 
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2.3.1.1 Apollon (BIRC6) 
Apollon was highly expressed in the epidermis of the mouse skin following 
depilation (Figure 2.4A-F).  Decreasing at day 12 to 19, which corresponds to 
the anagen-catagen transition phase of the hair cycle and increasing again at 
day 21.  A similar pattern of expression was seen throughout the hair cycle in 
the outer root sheath of the hair follicle.  Expression of Apollon in the bulge 
region remained high throughout the hair cycle except at day 19, 
corresponding with catagen, when expression could not be detected.  Low to 
no expression of Apollon was seen in the dermal papilla throughout the hair 
cycle.  Low levels of Apollon was expressed in the fibroblasts in the dermis at 
day 5 and 21 after depilation.  At day 3, 12 and 19 after depilation, Apollon 
was not detected in the cells of the dermis.  Cellular staining of Apollon was 
cytoplasmic.  A summary of the expression of Apollon is given in Table 2.4. 
2.3.1.2 cIAP1 (BIRC2) 
cIAP1 was detected in the epidermis of murine skin throughout the stages of 
the hair cycle (Figure 2.4G-K); its expression was high at day 3 and 5 after 
depilation corresponding with the early stages of anagen.  Expression 
decreased 12 and 19 days after depilation, with expression lowest 21 days 
after depilation.  It was expressed in all the layers of the epidermis.  cIAP1 was 
expressed in the dermal fibroblasts in the dermis surrounding the hair follicle, 
and expression remained high until day 21.  Expression in the outer root 
sheath of the hair follicle gradually decreased; high expression was detected 
3 and 5 days after depilation, with a decreased expression 12 and 19 days 
after depilation; a further decrease of cIAP1 was observed at day 21.  
Expression at the inner root sheath was constant through the hair cycle except 
for day 3 and 21 after depilation where it was not observed.  At day 3 after 
depilation, moderate expression of cIAP1 was seen in the dermal papilla, with 
no expression after 5, 12 or 19 days.  Low levels of expression were detected 
at 21 days after depilation.  cIAP1 staining was located in the cytoplasm of the 
cells.  A summary of the expression of cIAP1 is given in Table 2.4. 
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2.3.1.3 cIAP2 (BIRC3) 
cIAP2 was clearly expressed in the epidermis of murine skin throughout the 
hair cycle stages induced via depilation (Figure 2.4L-P), the expression was 
only detected in the basal layer, except at day 5 after depilation, where all the 
layers of the epidermis were stained.  cIAP2 was not seen in the dermis 
throughout the hair cycle, with the exception of day 5 after depilation, where 
low levels were detected.  It was highly expressed in the outer root sheath of 
the hair follicle throughout the hair cycle.  However, cIAP2 was expressed in 
the inner root sheath only at day 5 after depilation; no expression was detected 
at other stages of the hair cycle.  Expression was detected in the hair matrix 
at day 5 after depilation, at 12 days after depilation the expression of cIAP2 
was located at one side of the matrix in a bilateral disc.  Expression of cIAP2 
19 days after depilation was detected in the dermal sheath surrounding the 
dermal papilla.  cIAP2 was not expressed in the dermal papilla at any stage of 
the hair cycle.  This protein was expressed in the cytoplasm of the cells.  A 
summary of the expression of cIAP2 is given in Table 2.4. 
2.3.1.4 XIAP (BIRC4) 
XIAP was expressed in all layers of the epidermis of the mouse skin 
throughout the hair cycle (Figure 2.4Q-U), its expression was moderate 3 days 
after depilation, increasing 5 days after depilation, at day 12 expression 
decreased, remaining moderate at day 19 and 21 after depilation.  Expression 
of XIAP in the dermis was only detected 5 days after depilation.  Expression 
in the outer root sheath of the hair follicle was high at days 3 and 5, with 
reduced expression at day 12 and 19, its expression increased at day 21.  
Expression was moderate and constant in the inner root sheath at all stages 
of the hair cycle where it was present.  No expression of XIAP was found in 
the dermal papilla throughout the hair cycle until 21 days after depilation when 
low expression was observed.  XIAP was expressed in the cytoplasm of the 
cells.  A summary of the expression of XIAP is given in Table 2.4. 
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Figure 2.4: Expression of IAPs in C3H mice during different stages of the hair cycle induced by 
depilation 
Immunofluorescence data representing the expression of IAPs Apollon, 
cIAP1, cIAP2 and XIAP at different stages of the mouse hair cycle induced by 
depilation. (A-F) Represents immunohistochemical expression of Apollon.  A) 
Early anagen.  B) Mid anagen.  (C + D) Late anagen.  E) Catagen.  F)  Telogen.  
(G-K) Represents expression of cIAP1.  G) Early anagen.  H) Mid anagen.  I) 
Late anagen.  J) Catagen.  (L-P) Represents immunofluorescent expression 
of cIAP2.  L) Early anagen.  M) Mid anagen.  N) Late anagen.  O) Catagen.  
P)  Telogen.  (Q-U) Represents images for expression of XIAP.  Q) Early 
anagen.  R) Mid anagen.  S) Late anagen.  T) Catagen.  U) Telogen.  
Representative image of n=2 sections.  Blue arrow head – epidermis, blue 
arrow – dermal papilla, IRS – inner root sheath, ORS – outer root sheath, HM 
– hair matrix, SHG – secondary hair germ.  Magnification bar 250µm.  
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Apollon  Skin Hair Follicle 
Stage of Hair 
Cycle 
Days after 
Depilation Epidermis Dermis ORS IRS HM DP Bulge SHG 
Early Anagen Day 3 +++ - ++     + ++   
Mid Anagen Day 5 +++ + +++ ++ ++ - +++   
Late Anagen Day 12 ++ - ++ +++ ++ - ++   
Catagen Day 19 +/- - +/- +/- +/- - -   
Telogen Day 21 +++ + ++     + +++ ++ 
          
cIAP1  Skin Hair Follicle 
Stage of Hair 
Cycle 
Days after 
Depilation Epidermis Dermis ORS IRS HM DP Bulge SHG 
Early Anagen Day 3 +++ +++ +++     ++ +++   
Mid Anagen Day 5 +++ +++ +++ +++ ++ -     
Late Anagen Day 12 ++ ++ ++ +++ ++ - +++   
Catagen Day 19 ++ +++ ++ +++ + - +++   
Telogen Day 21 + + +     + ++ ++ 
          
cIAP2  Skin Hair Follicle 
Stage of Hair 
Cycle 
Days after 
Depilation Epidermis Dermis ORS IRS HM DP Bulge SHG 
Early Anagen Day 3 ++ - +++     - +++   
Mid Anagen Day 5 +++ + +++ +++ + - +++   
Late Anagen Day 12 +++ - +++ - ++† - +++   
Catagen Day 19 ++ - +++ - ++‡ - +++   
Telogen Day 21 +++ - +++     - +++ +++ 
                   
XIAP  Skin Hair Follicle 
Stage of Hair 
Cycle 
Days after 
Depilation Epidermis Dermis ORS IRS HM DP Bulge SHG 
Early Anagen Day 3 ++ - ++     - ++   
Mid Anagen Day 5 +++ ++ ++ ++ - -     
Late Anagen Day 12 ++ - + ++ + - +   
Catagen Day 19 ++ - + ++ - - +   
Telogen Day 21 ++ - ++     + ++ +++ 
 
 
  
Table 2.4: Summary table of expression of IAPs in the mouse skin and hair follicle 
IAP expression in the skin and hair follicle of C3H mice at different time points following depilation.  
Day 3 – early anagen, day 5 – mid anagen, day 12 – late anagen, day 19 – catagen, day 21 - 
telogen.  ORS – outer root sheath, IRS – inner root sheath, HM – hair matrix, DP – dermal papilla, 
SHG – secondary hair germ.  Average expression from 2 sections. (blank) not observed, - no 
expression, + low expression, ++ moderate expression, +++ high expression.  †- partial expression 
in a bilateral expression, on one side of the hair matrix, ‡- surrounding the dermal papilla. 
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2.3.2 Localisation of IAP antagonists in the mouse skin 
2.3.2.1 DIABLO 
DIABLO was expressed in all compartments of murine skin and hair follicles 
during the hair follicle cycle (Figure 2.5A-G).  Expression was detected in all 
layers of the epidermis and did not change.  In the dermis, expression was 
moderate and constant throughout the hair cycle.  In the hair follicle 
compartments, DIABLO was expressed in the outer and inner root sheath at 
a moderate level throughout the hair cycle, increasing slightly at day 19, during 
catagen.  Moderate expression was found in the dermal papilla 3 and 5 days 
after depilation, decreasing slightly at day 12 after depilation with a slight 
granular staining appearance.  Expression increased 19 days after depilation, 
reducing at day 21.  Low levels of DIABLO was expressed in the bulge region, 
with a slight increase at day 21 after depilation.  Low expression of DIABLO 
was detected in the hair matrix at day 5 and 12 after depilation, with an 
increase at day 19.  Expression of DIABLO was cytoplasmic in cells.  A 
summary of the expression of DIABLO is given in Table 2.5. 
2.3.2.2 Xaf1 
Xaf1 was expressed in the epidermis and dermis of the mouse skin throughout 
the hair cycle stages induced via depilation (Figure 2.5H-L).  Its expression in 
the epidermis was moderate to high throughout the hair cycle.  Expression of 
XAF1 in the dermis was moderate to high from day 3 to 5 after depilation.  
Expression was not seen at day 12, with a slight increase in Xaf1 expression 
at day 19 and 21 after depilation.  High expression was seen in the outer root 
sheath throughout the hair cycle with the exception of day 12 after depilation, 
where expression decreased.  Moderate to high expression was seen in the 
inner root sheath from day 3 to day 12 following depilation.  Low to no 
expression was seen in the dermal papilla throughout the hair follicle cycle, 
with a slight increase at day 21.  This expression of XAF1 in cells was 
cytoplasmic.  A summary of the expression of Xaf1 is given in Table 2.5. 
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DIABLO Skin Hair Follicle 
Days after 
Depilation Epidermis Dermis ORS IRS HM DP Bulge SHG 
Day 3 ++ ++ ++     ++ +   
Day 5 +++ ++ ++ ++ + ++     
Day 12 +++ ++ ++ ++ + + +   
Day 19 +++ ++ +++ +++ +++ +++ +   
Day 21 +++ ++ ++     ++ ++ ++ 
         
Xaf1 Skin Hair Follicle 
Days after 
Depilation Epidermis Dermis ORS IRS HM DP Bulge SHG 
Day 3 +++ ++ +++     + +++   
Day 5 +++ +++ +++ +++ + - +++   
Day 12 ++ - + ++ + - +   
Day 19 +++ + +++ +++ + + +++   
Day 21 ++ + ++     ++ ++ +++ 
 
Table 2.5: Summary table of expression of IAP antagonists in the mouse skin and hair follicle 
Overview of the IAP antagonists DIABLO and Xaf1 expression in murine skin 
and hair follicles at different time points after depilation.  Day 3 – early anagen, 
day 5 – mid anagen, day 12 – late anagen, day 19 – catagen, day 21 - telogen.  
ORS – outer root sheath, IRS – inner root sheath, HM – hair matrix, DP – 
dermal papilla, SHG – secondary hair germ, Average expression from 2 
sections. (blank) not observed, - no expression, + low expression, ++ 
moderate expression, +++ high expression.  
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2.3.3 Human terminal and vellus hair follicle histology 
The human hair follicle cycle is not synchronised, and for in vivo studies, 
cannot be depilated to get uniformed hair follicle growth.  Most hair follicles in 
the scalp are in anagen, but to clearly determine the stages of the hair cycle 
SACPIC staining was used; this is a useful technique since staining multiple 
components (Table 2.6) on the same section can be achieved to differentiate 
between hair follicle stages (Nixon, 1993).   
Colour: Sections: 
Blue Collagen 
Green Smooth muscle 
Blue/Pink Undifferentiated keratinocytes 
Red Keratinising inner root sheath 
Blue/Grey Pre-keratinising inner root sheath 
Orange/Brown Trichohyalin granules 
Blue Outer root sheath 
Pale Blue Connective tissue sheath 
Yellow Keratinising hair fibre 
Pink Pre-keratinising hair fibres 
Pale Blue Dermal papilla extra cellular matrix 
Blue/Black Dermal papilla cells 
Orange/Yellow Outer borders of brush ends of 
catagen/telogen hair fibre 
Dark Red Stratum corneum  
Dark Blue/Grey Nuclei  
Table 2.6: SACPIC staining key 
Colour representation for SACPIC staining (Nutbrown and Randall, 1996). 
Vellus hair follicles are also distinguished from terminal hair follicles by their 
bulb location in the dermis.  Terminal hair follicle bulbs are located closer and 
into the hypodermis, whilst vellus hair follicles are closer to the epidermis.  The 
size of the hair follicles can also help to differentiate between the two types of 
hair follicles (Garcia et al., 2011), the length of vellus hair shaft are no longer 
than 2mm, whilst in terminal it is longer than 2mm, vellus hair thickness is 
roughly 30µm compared to 60µm in terminal (Garcia et al., 2011)(Figure 2.6).   
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SACPIC staining demonstrated that the hair follicles from the human terminal 
hair bearing scalp skin were in anagen.    There was a slight red staining 
indicating the keratinising inner root sheath.  The yellow indicated the 
keratinising hair fibre.  Blue staining represents the outer root sheath.  The hair 
follicles are surrounded by blue staining indicating the collagen in the dermis.  
The bulb region was distinctive with a clear dermal papilla compartment 
surrounded by the hair matrix, enclosed by the dermal sheath.  The bulb region 
was closer to the hypodermis than the epidermis (Figure 2.6A). 
A representation of a vellus hair follicles from human facial skin appeared to 
be in the catagen/telogen transition due to a brush like appearance at the shaft 
beginning, and the morphology of the bulb region (Figure 2.6C).  The hair fibre 
was stained yellow and the outer root sheath blue, pale blue staining around 
the hair follicle represents the dermal tissue sheath.  The vellus hair follicle 
can be distinguished from the terminal hair follicle from the size and the 
location of the bulb region.  The bulb region of vellus hair follicles does not 
distend beyond the sebaceous gland; the diameter of the hair follicle is also 
smaller (Figure 2.6B).  An epithelial stalk with the dermal papilla at the end 
indicates that the hair follicle was in late catagen/telogen transition.   
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Figure 2.6: SACPIC staining of human skin sections from female scalp containing terminal hair 
and vellus hair follicles 
SACPIC staining to distinguish hair follicle from anagen and telogen stages of 
the hair cycle in terminal and vellus hair bearing skin. A) SACPIC staining from 
a terminal hair bearing skin. B and C) Represent SACPIC staining for vellus 
hair follicles at x20 and x40 objective magnification respectively.  Magnification 
bar 100µm. 
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2.3.4 Epidermal thickness in vellus hair bearing skin is thinner 
compared to matching terminal hair bearing skin 
To determine differences in epidermal thickness between terminal and vellus 
hair bearing skin, thickness was measured from three matching donors by 
calculating pixel length.  For each donor, epidermal thickness was normalised 
against the thickness from terminal hair bearing skin (Figure 2.7).  Epidermal 
thickness from vellus hair bearing skin (~66.85µm) was significantly thinner 
than corresponding terminal hair bearing skin (~82.99µm) (p<0.05), Student 
T-test. 
 
Figure 2.7: Epidermal thickness from vellus hair bearing skin was thinner than matching terminal 
hair bearing skin 
A comparison of epidermal thickness between terminal hair bearing skin – S(T) 
(blue) and vellus hair bearing skin – S(V) (red) from three matching donors 
normalised against the thickness from terminal hair bearing skin.  * p<0.05, 
Student T-test. 
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2.3.5 Localisation of IAPs in the human terminal and vellus hair 
follicle bearing skin 
Expression and localisation of IAPs and their antagonists in terminal and vellus 
hair bearing skin was determined via immunofluorescent staining on three 
matching donor samples (Figure 2.8 and Figure 2.9 respectively) 
2.3.5.1 Apollon (BIRC6) 
Apollon was expressed (Figure 2.8A-E) at moderate to high levels in the 
epidermis of vellus hair bearing skin.  Its expression was seen in all layers of 
the epidermis (Figure 2.8A).  Apollon was also detected in fibroblasts and the 
ECM in the dermal layer of the skin.  A similar level of expression was seen in 
terminal hair bearing skin, in both the epidermis and dermis (Figure 2.8C). 
In the vellus telogen hair follicle, Apollon was not expressed in the dermal 
papilla, but expressed at moderate levels in the outer root sheath 
(Figure 2.8B).   
In the hair follicle compartments, high expression of Apollon was detected in 
the inner and outer root sheath of the terminal hair follicle (Figure 2.8D).  In 
the bulb region of the hair follicle, Apollon was expressed in the hair matrix 
and dermal sheath, with low to moderate levels seen in the dermal papilla 
(Figure 2.8E).  A summary of the expression of Apollon is given in Table 2.7A. 
2.3.5.2 cIAP2 (BIRC3) 
Expression of cIAP2 (Figure 2.8F-J) in the epidermis of vellus hair bearing skin 
(Figure 2.8F) was lower than that in the epidermis of corresponding terminal 
hair bearing skin from the same donor (Figure 2.8I).  Likewise, lower 
expression was also seen in the dermis of vellus hair bearing skin compared 
to corresponding terminal hair bearing skin. 
Vellus hair follicles expressed lower levels of cIAP2 in the inner and outer root 
sheath and there was no expression in the dermal papilla and hair matrix cells 
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of the bulb (Figure 2.8G); there was also no expression of cIAP2 in the 
mesenchymal cells of the dermal sheath in vellus hair follicles.   
In the anagen terminal hair follicle, higher expression of cIAP2 was seen in all 
regions (Figure 2.8I and J) than corresponding vellus hair follicles 
(Figure 2.8G). A summary of the expression of cIAP2 is given in Table 2.7B. 
2.3.5.3 NAIP (BIRC1) 
Similar levels of NAIP expression (Figure 2.8K-O) were seen in the epidermis 
and dermis of both terminal (Figure 2.8K) and vellus (Figure 2.8M) hair bearing 
skin. 
Vellus hair follicles displayed moderate to high levels of expression of NAIP in 
the inner root sheath, the outer root sheath and the dermal sheath.  However, 
there were only low levels of expression in the hair matrix, with no expression 
in the dermal papilla (Figure 2.8L).   
In contrast, the terminal hair follicles displayed little to no expression of NAIP 
in the inner root sheath, with moderate expression in the outer root sheath and 
the dermal sheath (Figure 2.8N).  In the bulb, moderate expression of NAIP 
was seen in the hair matrix with low levels of expression in the dermal papilla 
(Figure 2.8O).  A summary of the expression of NAIP is given in Table 2.7C. 
2.3.5.4 XIAP (BIRC4) 
A similar level of XIAP expression (Figure 2.8P-T) was seen in the epidermis 
and dermis of vellus hair bearing skin (Figure 2.8P) and corresponding 
terminal hair bearing skin (Figure 2.8R). 
In the vellus hair follicle, XIAP was only expressed in low levels in the hair 
matrix and dermal sheath, it was not detected in other compartments of the 
vellus hair follicle (Figure 2.8Q).   
In contrast, in the terminal hair follicle, moderate expression of XIAP was seen 
in the inner and outer root sheath (Figure 2.8S), hair matrix and dermal sheath 
(Figure 2.8T).  A summary of the expression of XIAP is given in Table 2.7D.  
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Figure 2.8: Expression of IAPs in vellus and terminal hair bearing skin, and hair follicle 
compartments. 
Immunofluorescent expression of IAPs in the skin and hair follicle of human 
vellus and terminal hair bearing skin from the same donor.  (A-E) Apollon.  (F-
J) cIAP2.  (K-O) NAIP.  (P-T) XIAP.  (A, F, K, P) IAP expression in vellus hair 
bearing facial skin (S(V)).  B, G, L, Q) IAP expression in vellus hair follicle 
(V(HF)) of vellus hair bearing facial skin.  (C, H, M, R) IAP expression in 
terminal hair bearing scalp skin (S(T)).  (D, I, N, S) IAP expression in the hair 
shaft region of terminal anagen hair follicles (T(HF)) in S(T).  (E, J, O, T) IAP 
expression of the bulb region of T(HF) in S(T). 
DP – dermal papilla, HM – hair matrix, IRS – inner root sheath, ORS – outer 
root sheath, red – IAP protein, blue DAPI – nucleus.  Magnification bar 100µm.  
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A Skin Hair Follicle 
Apollon EK DF ECM IRS ORS HM DP DS 
S(T) +++ ++ +++ ++++ +++ +++ ++ +++ 
S(V) +++ +++ +++   ++  -  ++ 
         
B Skin Hair Follicle 
cIAP2 EK DF ECM IRS ORS HM DP DS 
S(T) ++ ++ ++ ++ ++ ++ + ++ 
S(V) + + +  + +  - -  -  
         
C Skin Hair Follicle 
NAIP EK DF ECM IRS ORS HM DP DS 
S(T) +++ +++ ++++ + ++ ++ + ++ 
S(V) ++ +++ ++++  ++ +++ -/+ -  +++ 
         
D Skin Hair Follicle 
XIAP EK DF ECM IRS ORS HM DP DS 
S(T) ++ + ++ ++ ++ ++   ++ 
S(V) + + ++   -  -  + 
Table 2.7: Summary table of expression of IAPs in skin and hair follicle from vellus and terminal 
hair bearing skin 
Summary of the IAP expression in the skin and hair follicle from vellus and 
terminal hair bearing skin.  A) Apollon.  B) cIAP2.  C) NAIP.  D) XIAP.  S(T) – 
terminal hair bearing skin, S(V) – vellus hair bearing skin, EK – epidermal 
keratinocyte, DF – dermal fibroblast, ECM – extra cellular matrix, IRS – inner 
root sheath, ORS – outer root sheath, HM – hair matrix, DP – dermal papilla, 
DS – dermal sheath.  Three matching patient section from terminal and vellus 
hair bearing skin were stained in duplicates, a value of 0-4 was used for each 
patient and each duplicate, an average was taken then rounded to full integer.  
- no expression, + low expression, ++ moderate expression, +++ high 
expression ++++ very high expression. Red represents expression for one 
donor sample.  
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2.3.6 A comparison of the expression of IAP antagonists in 
human terminal and vellus hair follicle bearing skin 
2.3.6.1 DIABLO 
Expression of DIABLO (Figure 2.9A-E) was high in the epidermis and dermis 
of vellus (Figure 2.9A) and terminal (Figure 2.9C) hair bearing skin from the 
same donor. Whilst expression of DIABLO was cytoplasmic in the epidermis 
of vellus hair bearing skin, it was both cytoplasmic and nuclear in terminal hair 
bearing skin.  DIABLO expression levels were also high in the hair follicles 
(inner root sheath, outer root sheath, dermal papilla, hair matrix and dermal 
sheath) for both vellus (Figure 2.9B) and terminal (Figure 2.9D and E) hair 
follicles.  A summary of the expression of DIABLO is given in Table 2.8A. 
2.3.6.2 Xaf1 
Expression of Xaf1 (Figure 2.9F-J) was moderate in the epidermis and dermis 
of vellus hair bearing skin (Figure 2.9F), with a slightly higher expression in 
corresponding terminal hair bearing skin (Figure 2.9H).  High expression was 
seen in vellus hair follicles in the inner and outer root sheath, with moderate 
levels in the bulb (Figure 2.9G).  Corresponding terminal hair follicles showed 
moderate expression in the inner and outer root sheath, with little or no 
expression in the bulb (Figure 2.9I and J).  A summary of the expression of 
Xaf1 is given in Table 2.8B.  
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A Skin Hair Follicle 
DIABLO EK DF ECM IRS ORS HM DP DS 
S(T) ++++ ++++ ++++ ++++ ++++ ++++ +++ ++++ 
S(V) ++++ +++ +++  ++++ ++++  ++++  ++++  ++++  
         
B Skin Hair Follicle 
Xaf1 EK DF ECM IRS ORS HM DP DS 
S(T) +++ +++ ++ ++ ++ + -/+ + 
S(V) ++ ++ ++  +++ +++   ++  ++  ++ 
 
Table 2.8: Summary table of expression of IAP antagonists in skin and hair follicle from vellus 
and terminal hair bearing skin 
Summary of the IAP antagonist expression in the skin and hair follicle from 
vellus and terminal hair bearing skin.  A) DIABLO.  B) Xaf1.  S(T) – terminal 
hair bearing skin, S(V) – vellus hair bearing skin, EK – epidermal keratinocyte, 
DF – dermal fibroblast, ECM – extra cellular matrix, IRS – inner root sheath, 
ORS – outer root sheath, HM – hair matrix, DP – dermal papilla, DS – dermal 
sheath.  Three matching patient sections from terminal and vellus hair bearing 
skin were stained in duplicate, a value of 0-4 was used for each patient and 
each duplicate, an average was taken then rounded to full integer.  - no 
expression, + low expression, ++ moderate expression, +++ high expression 
++++ very high expression. Red represents expression for one donor sample.  
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2.4 Discussion 
The hair follicle is an excellent model to study adult tissue regeneration.  At 
the beginning of a new hair cycle, the lower portion of the hair follicle is 
remodelled, recapitulating events of late embryogenesis and high levels of 
mitotic activity in the epithelial matrix of the bulb (Commo and Bernard, 1997; 
Hashimoto et al., 2001; Tobin et al., 2003). 
To study the hair cycle, it is important to use a model where the hair cycle is 
synchronised.  The strongest known stimulus to induce the telogen (resting) 
to anagen (growing) switch, and produce synchronicity in growth is via 
depilation (Stenn et al., 1996; Stenn and Paus, 2001).  The hair follicles will 
then all be at the same stage of the hair cycle after depilation, and can be 
followed through the whole cycle from anagen to telogen (Muller-Rover et al., 
2001).  However, depilation also induces a pronounced wound healing 
response of the hair follicle (Matsuo et al., 2003).  Therefore, the mouse not 
only provides an appropriate model to follow changes in the expression of 
different IAPs and their antagonists throughout the hair cycle, since in a mouse 
model, the length of anagen is short (12-17 days) (Muller-Rover et al., 2001), 
but also to determine whether there are any changes in IAP expression 
induced by the wound healing response of the hair follicle following depilation. 
2.4.1 IAP expression in murine skin and the hair follicle cycle 
XIAP, cIAP1 and cIAP2 have been identified in mouse skin, mainly in the 
epidermis and hair follicles (Fessing et al., 2006; Seitz et al., 2000).  However, 
to date, there have been no studies looking at the localisation of these proteins 
in the skin and hair follicle at different stages of the hair cycle.  Depilation 
increases apoptosis in hair follicles and also induces a wound healing 
response to the tissue surrounding the hair follicle (Matsuo et al., 2003; Paus 
et al., 1998).  Immunofluorescent staining has demonstrated that the IAPs 
XIAP, cIAP1, cIAP2 and Apollon are located in the skin and hair follicle of mice 
at all stages of the hair follicle cycle induced by depilation (Figure 2.4 and 
Table 2.4). 
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The expression of Apollon, cIAP1, cIAP2 and XIAP was seen predominantly 
in the epithelial cells of the epidermis and hair follicle (outer root sheath, inner 
root sheath and hair matrix).  All were expressed in the bulge region of the 
outer root sheath, which contains the hair follicle stem cells (Ohyama, 2007).  
All were expressed in the secondary hair germ found only in telogen hair 
follicles (Ito et al., 2004).  This indicates an importance for IAPs in the 
protection of stem cells; which are important in hair follicle regeneration and 
also epidermal regeneration following wounding.  Double immunofluorescent 
staining for stem cells using specific markers such as Sox9 antibodies with 
IAP antibodies would establish whether stem cells express IAPs. 
In contrast, with the exception of cIAP1, there was little expression in the 
dermis or mesenchymal-derived dermal papilla.  cIAP1 was only expressed in 
the dermal papilla 3 days after depilation, corresponding to early anagen and 
then again in telogen at day 21 (Figure 2.4 and Table 2.4).  Since the dermal 
papilla is a constant feature during hair follicle regeneration, it would be 
assumed that the levels of IAPs are highest and constant in the dermal papilla.  
Other inhibitors of apoptosis proteins such as Bcl2 are however found in the 
dermal papilla (Soma and Hibino, 2004).  This indicates that IAPs may not 
have a predominant role in protecting the murine dermal papilla. 
The expression of Apollon in both the epidermis and the hair follicle was 
reduced during the catagen stage of the hair cycle.  Reduction in inhibitors of 
apoptosis proteins such as Bcl2 has been associated with the anagen-catagen 
transition (Botchkareva et al., 2006).  Also the increase in caspase 3 and 8 
activity in the outer root sheath of human hair follicles indicated that the hair 
follicle was in catagen  (Botchkareva et al., 2006).    Therefore, it was not 
surprising that the expression of Apollon decreased during this stage.  Apollon 
has a unique method in preventing apoptosis, in that it degredates DIABLO, 
preventing it from binding to other IAPs (Hao et al., 2004).  This would suggest 
that Apollon has an active role in preventing apoptosis in hair follicles and its 
down regulation may be important in the switch from anagen to catagen.  With 
the reduced Apollon expression at day 19 after depilation, epidermal thickness 
 
 
 
 
Expression of IAPs in Mouse and Human Skin 
 
  
 
103 
 
  
was also reduced, an indication that the hair follicle was in catagen (Muller-
Rover et al., 2001).  Reduced Apollon expression in the epidermis could 
indicate that Apollon may play a role in regulating skin thickness during 
catagen. 
cIAP1 was the only IAP that was consistently expressed at high levels in the 
dermis (cellular and ECM).  In early anagen, expression was mainly cellular 
and some expression was detected in the ECM, however, 5 days after 
depilation until telogen, expression was exclusively cellular.  However, the 
level of expression in the epidermis and dermis was reduced when the hair 
follicle was in telogen, but remained moderate in the bulge and secondary hair 
germ indicating that cIAP2 may have a protective function on hair follicle stem 
cells, which are needed for the regeneration of the hair follicle in anagen 
(Myung and Ito, 2012).  Its low expression in the epidermis and dermis could 
indicate that at this stage of the hair cycle, cIAP1 does not play a role in the 
epidermis.  At 3 days after depilation, expression of cIAP1 was high in the 
epidermis and dermis, and also in the dermal papilla when the hair follicle was 
in early anagen.  At early anagen, the dermal papilla signals to the surrounding 
hair epithelial cells to initiate the growth phase (Chi et al., 2010).  Although it 
is important to protect the dermal papilla at all stages of the hair cycle 
(consistent cells at every hair cycle) (Soma and Hibino, 2004), during catagen 
and telogen, the dermal papilla is quiescent (Botchkarev and Kishimoto, 
2003).  Since cIAP1 expression was not expressed in the dermal papilla in late 
anagen and catagen, its expression could be related to the dermal papilla’s 
quiescent state; regulating dermal papilla function.  Its expression in the 
dermal papilla in early anagen could be in response to depilation and the 
pronounced wound healing response triggered (Matsuo et al., 2003), as a 
backup mechanism to Bcl2.  Apoptosis increases following depilation, due to 
local tissue damage; an increase in cIAP1 in the dermal papilla, could provide 
a mechanism to ensure its protection.  To clarify this, it would be important to 
compare cIAP1 expression in depilated induced early anagen, and naturally 
occurring early anagen in the spontaneous hair cycle.  The first post natal hair 
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cycle would need to be studied, as the first hair follicle cycle is synchronised 
without depilation, with subsequent hair cycles being less synchronised 
(Muller-Rover et al., 2001).  No studies have looked at the effect of wounding 
on cIAP1 levels in skin and hair follicles. 
The expression of cIAP2 was not dissimilar to Apollon in the epidermis and 
dermis (Figure 2.4 and Table 2.4).  However, whilst the expression for Apollon 
in the outer root sheath decreased during catagen, cIAP2 expression 
remained constant throughout the hair cycle.  In the bulge, cIAP2 expression 
was high and constant throughout the hair cycle, which could indicate that 
cIAP2 is important in protecting the stem cell niche, which is tightly regulated 
in hair follicle regeneration (Myung and Ito, 2012).  cIAP2 expression was only 
seen 5 days after depilation in the inner root sheath; during late anagen and 
catagen, expression of cIAP2 was not present.  In late anagen and catagen, 
the inner root sheath undergoes apoptosis (Magerl et al., 2001).  This could 
indicate that the loss of cIAP2 expression regulates apoptosis in the inner root 
sheath.  The lack of expression in the dermal papilla could indicate that this 
IAP does not interact and function to protect the dermal papilla from apoptosis.  
Its expression in the hair matrix in late anagen had a similar pattern of 
expression to Edar (Fessing et al., 2006).  Defects in the gene encoding for 
Edar causes hypohidrotic ectodermal dysplasia which is characterised by a 
defect in the development of skin appendages such as the hair follicle (Azeem 
et al., 2009; Monreal et al., 1999).  Edar has been associated with XIAP 
expression in the catagen hair follicle preventing apoptosis by positively 
regulating XIAP, in Edar deficient mice, there was an early onset and 
accelerated progression of catagen.  It was therefore hypothesised that Edar 
regulates catagen development via XIAP regulation.  Expression of cIAP2 in 
the hair matrix was in a unilateral pattern, similar to that of Edar, which could 
suggest that either Edar also regulates cIAP2 in a similar fashion to XIAP, or 
that cIAP2 controls Edar signalling, which in turn regulates XIAP expression, 
controlling catagen progression.  A double immunostaining would need to be 
carried out to ensure that Edar positive cells also express cIAP2, and whether 
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the knockdown or down regulation of either Edar or cIAP2 has an effect on the 
other.  Another hypothesis suggested by Lavker et al. (2003), was that the 
unilateral expression are segments derived from the hair bulge that have 
migrated to the hair matrix.  Expression of bulge stem cell markers using 
double immunofluorescent staining would establish whether the cells 
expressing cIAP2 in the hair matrix are derived from the bulge stem cell niche.  
These cells are important in the regeneration of the hair follicle, which would 
suggest a role for cIAP2 in hair follicle regeneration. 
The expression of XIAP in the epidermis was similar to Apollon, cIAP1 and 
cIAP2.  It was not expressed in the dermis except at day 5 after depilation 
similar to Apollon and cIAP2 (Figure 2.4 and Table 2.4).  The collaborative 
expression of these IAPs at 5 days after depilation, would indicate that either 
the IAPs were responding to the wound induced by depilation, ensuring that 
only the damaged cells were removed, with a higher expression at this time 
point to ensure no further apoptosis occurs, or that the IAPs regulate this stage 
of the hair cycle, and that the increase in IAP expression triggers the hair 
follicle to enter into catagen.  In a similar experimental design to that of Fessing 
et al. (2006), knockout of specific IAPs in mice could determine the effect these 
IAPs have on hair follicles, and whether the knockout of cIAP2 has an effect 
on the hair cycle especially inducing catagen.  Fuchs et al. (2013) showed that 
in wild type mice, XIAP is expressed at low levels in the bulge region of telogen 
hair follicles.  Similar observations were seen in this study, showing low to 
moderate expression of XIAP in the bulge at all stages of the hair cycle.  The 
study by Fuchs et al. (2013) did not look at the expression of XIAP throughout 
the hair cycle, and no other study has shown the effect of XIAP on hair follicle 
cycling.  However, using similar methods of XIAP knockout, hair follicle cycling 
can be analysed to determine the importance of XIAP. 
2.4.2 IAP antagonist expression in murine skin and the hair 
follicle cycle 
DIABLO is the antagonist to all IAPs, its function either binds directly to IAPs, 
or it prevents the interaction of IAPs with caspases, allowing the caspase 
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cascade to occur (Verhagen et al., 2000).  In contrast, Xaf1 is a direct and 
specific XIAP antagonist (Liston et al., 2001), binding to XIAP preventing its 
interaction with caspases. 
Interestingly, both DIABLO and Xaf1 were expressed in the epidermis 
throughout the hair cycle.  DIABLO was also constantly expressed in the 
dermis, while Xaf1 was highly expressed 5 days after depilation, with no 
expression at day 12 and low expression 19 and 21 days after depilation.  The 
expression of Xaf1 mirrored the expression of XIAP (see Figure 2.4/Table 2.4 
and Figure 2.5/Table 2.5). 
In the rat endometrium, the expression of XIAP was the opposite to that of 
DIABLO during the estrus cycle (Leblanc et al., 2003); suggesting that DIABLO 
regulates XIAP expression; when the expression of DIABLO was high, the 
expression of XIAP was low, and when the expression of DIABLO was 
reduced, the expression of XIAP increased.  The expression of XIAP was 
found at all stages of the estrous cycle (diestrus, proestrus, estrus and 
metestrus), but highest at estrus, while DIABLO expression was constant 
throughout the stages, except for estrus, which was significantly reduced.  The 
administration of 17β-oestradiol to ovariectomised rats reduced DIBALO 
expression, and increased XIAP; suggesting that the regulation of XIAP via 
DIABLO is through 17β-oestradiol.  However, the endogenous level of 
oestrogen peak during proestrus (Staley and Scharfman, 2005), but the 
biggest influence is during estrus which would explain the levels of XIAP and 
DIABLO.  The study by Leblanc et al. (2003) supports that DIABLO regulates 
XIAP levels, however, since in this current study DIABLO expression was 
constant, it would suggest another role for DIABLO especially in the epidermis.  
A study by Murray et al. (2008) demonstrated that caspases may have another 
role aside from apoptosis, in their study, it was shown that caspase 3, 
regulated by caspase 9 was important in the differentiation of muscle cells 
(myoblasts to myotubes).  Keratinocyte proliferation and differentiation is 
tightly controlled in the epidermis (Gandarillas, 2000), therefore since DIABLO 
interacts with caspase 9, it is possible that in the epidermis, DIABLO regulates 
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keratinocyte differentiation throughout the different layers.  In the dermis, 
expression was moderate throughout the hair follicle cycle, a study by Liu et 
al. (2013) compared the expression of DIABLO in fibroblasts derived from 
normal and hypertrophic scars (excessive fibroblast and collagen production); 
DIABLO expression was reduced in hypertrophic scar fibroblasts.  When Liu 
et al. (2013) studied proliferation of hypertrophic scar fibroblasts, they showed 
that over expression of DIABLO reduced proliferation.  Therefore in this study, 
expression of DIABLO in the skin could be to regulate proliferation, since 
DIABLO expression was increased in the inner and outer root sheath, hair 
matrix and dermal papilla during catagen (apoptotic stage).   
Xaf1 expression during catagen reflects that Xaf1 regulates XIAP.  In the outer 
root sheath and inner root sheath where apoptosis is highest at day 19 after 
depilation, Xaf1 expression is high, while XIAP expression is low.  Protection 
of stem cells in the bulge where stem cells reside (Ito et al., 2004) would be 
expected, however, XIAP expression is low, while Xaf1 expression is high.  
This could indicate that XIAP may not be important in hair follicle regeneration 
by protecting the stem cells. 
The effect of hair follicle wounding on IAP and IAP antagonists is hard to 
analyse in this study.  To ensure that the responses observed are solely due 
to hair follicle cycling or wound healing, it would be useful to compare their 
expression in mice undergoing their first natural hair follicle growth wave 
(Muller-Rover et al., 2001; Paus et al., 1999).  
2.4.3 Expression of IAPs in human skin containing terminal or 
vellus hair follicles 
In human scalp skin, 4mm biopsies from 31 Taiwanese donors showed that 
the total number of hair follicles from the scalp biopsies was 21.3, with 20.5 
and 0.8 being terminal and vellus respectively (Ko et al., 2012); the area of the 
scalp is roughly 600cm2 (Schwartz, 2005), therefore the total number of hair 
follicles in the scalp from the study by Ko et al. (2012) would be around roughly 
31,950 hair follicles.  The ratio of anagen to telogen was 91.6:8.4 and the ratio 
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of terminal to vellus was 25.3:1 (Ko et al., 2012).  Similar results were seen in 
Texas donors where a 4mm scalp biopsy (region not mentioned) from 22 
patients showed under normal conditions, the number of total hair follicles from 
the biopsies were 40, where 32.7 were terminal hair follicles in anagen, and 
2.3 of the hair follicles were terminal hair follicles in telogen and 5 hair follicles 
were vellus, therefore the total number of hair follicles in the scalp would be 
around 60,000 hair follicles.  The ratio of terminal to vellus was 7:1 and the 
ratio between anagen to telogen was 93.5:6.3 (Dy and Whiting, 2011; Lee et 
al., 2002; Whiting, 1993, 1996).  In the study by Dy and Whiting (2011), there 
was a slightly higher ratio of terminal to vellus hair follicles in women compared 
to men, where in women the ratio was 11:1 and in men it was 6:1 in normal 
control donors.  In this study, significance between male and female 
terminal:vellus ratio was not analysed. 
In the present study, SACPIC staining was carried out on matching sections 
of skin containing terminal or vellus hair follicles to determine whether hair 
follicles were in the anagen or telogen phase.  In this chapter, longitudinal 
sections were taken to analyse the type of hair follicle and the stage in which 
the hair follicle was in the hair cycle; therefore, limited data could be obtained 
analysing the expression of IAPs and their antagonists in human skin. 
Measurement of epidermal thickness in terminal and corresponding vellus hair 
bearing skin showed a significantly thinner epidermis in vellus hair bearing skin 
compared to matching terminal hair bearing skin (Figure 2.7).  A study by Vogt 
et al. (2007) compared hair follicle properties between terminal and vellus hair 
follicle obtained from scalp (region not specified) and retroauricular regions 
respectively.  Thickness of the epidermis was thinner in vellus hair bearing 
skin compared to terminal hair bearing skin ranging from 64±12µm to 
99±18µm in vellus and 72±16µm to 136±37µm in terminal hair bearing skin.  
Which corresponds with the results obtained in this study, indicating that hair 
follicles are important in epidermal thickness. 
Unfortunately, studying the expression of proteins in human skin at different 
stages of the hair cycle to understand the implications of the hair cycle on IAP 
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expression is difficult, since the human hair cycle is not synchronised (Ebling, 
1987), and impossible to synchronise in human donors unless depilated. 
To date there has only been one study looking at the expression of XIAP, 
cIAP1 and cIAP2 in human skin and the hair follicle (Vischioni et al., 2006) with 
limited data as to which anatomical region the skin samples were taken and 
whether the samples were from male or female donors.  This is the first study 
to compare the expression of NAIP, cIAP2, XIAP and Apollon in human skin 
containing terminal (scalp) and vellus (facial) hair from the same donor. 
All IAPs (NAIP, cIAP2, XIAP and Apollon) were expressed in the epidermis, 
Apollon expression was similar in terminal and vellus hair bearing skin, whilst 
cIAP2, NAIP and XIAP showed higher epidermal expression in terminal hair 
bearing skin than corresponding vellus (Figure 2.8 and Table 2.7).  Expression 
of these IAPs in the human epidermis correlated with those expressed in 
mouse epidermis at anagen. 
The difference in IAP expression between terminal and vellus hair bearing 
epidermal skin could be due to the thickness of the epidermis.  Vellus hair 
bearing epidermis was slightly thinner than terminal hair bearing epidermis 
(Figure 2.7). 
While the expression of the IAPs NAIP, Apollon and XIAP was seen 
throughout the different layers of the epidermis, cIAP2 expression was higher 
in the basal layer of the epidermis.  The basal layer of the epidermis is the only 
layer that is mitotically active, contributing to the formation of the ECM 
separating the epidermis from the dermis, mainly laminin5 by the secretion of 
integrins (α3β1) and laminin (Blanpain and Fuchs, 2006).  Keratinocytes may 
also contribute to the ECM in the dermis via the upregulation and secretion of 
TGFβ1, which increases collagen synthesis and deposition from the 
fibroblasts (Wang et al., 2006).  Also in the basal layer of the epidermis, in the 
rete ridges, stem cells are found (Blanpain and Fuchs, 2006; Lavker and Sun, 
1982).  This could indicate that cIAP2 may be important in protecting 
keratinocytes that are mitotically active and stem cell populations in the 
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epidermis.  Expression of cIAP2 in HeLa cells (cervical cancer cell line) was 
increased during the G2/M stage of the cell cycle (Jin and Lee, 2006).  
Therefore expression of cIAP2 in the basal layer of the epidermis could relate 
to the mitotic stage of the keratinocyte. 
In contrast to murine dermis, the IAPs NAIP, Apollon, cIAP2 and XIAP were 
expressed in the human dermis.  Expression of cIAP2 and XIAP was low, while 
expression of NAIP and Apollon was high.  Since the majority of the cells in 
the dermis are fibroblasts (Dams et al., 2011), which are important for ECM 
formation, NAIP and Apollon may be required for protecting and regulating 
dermal fibroblasts.  No expression of these IAPs were found in the dermis of 
mouse skin at the anagen stage of the hair cycle.  A study by 
Theerakittayakorn and Bunprasert (2011) compared fibroblasts from mouse 
(L929, cell line derived from C3H mice) and human (facial) skin.  
Morphologically, mouse dermal fibroblasts were smaller and proliferated faster 
than human dermal fibroblasts.  Therefore these IAPs might decrease 
fibroblast proliferation, since they are not expressed in murine dermis but are 
expressed in human dermis.  Further studies need to be conducted to 
determine whether this is indeed true by culturing dermal fibroblasts and 
blocking IAPs by using siRNA since individual IAP antagonists are not 
available to study individual IAP effects on proliferation.  
Expression of these IAPs in the dermis was similar between vellus and 
terminal hair bearing skin, with the exception of cIAP2 which had a higher 
expression in the terminal hair bearing skin.  The terminal hair follicles are in 
anagen, however, it is not clear what stage of anagen (early or late) it is, 
therefore it is not possible to know the effect of the hair follicle cycle on 
epidermis thickness. 
Mouse skin was exposed to trauma with regards to depilation, IAP expression 
could have been low in the dermis of mice as a response to hair follicle 
wounding, which did not occur in human skin. Waxing, which was the method 
used to depilate mouse hair follicles (as opposed to plucking) causes an 
increase in immune cells (Ishimatsu-Tsuji et al., 2005; Sloat et al., 2012; Xiao 
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et al., 2012).  cIAP1 was the only IAP that was expressed in the mouse dermis, 
which could be regulated due to the inflammatory response.  
While no expression of NAIP was detected in mouse hair follicles (via PCR – 
data not published), this study showed that NAIP was present in human 
terminal and vellus hair follicles.  This indicates that there are potentially 
different mechanisms in place between different species, reinforcing the 
importance of studying these proteins in humans.  
Expression of the IAPs cIAP2, NAIP and XIAP were moderate in the terminal 
human anagen hair follicle with low expressions in the dermal papilla, while 
Apollon was highly expressed in the hair follicle with moderate expression in 
the dermal papilla.  This is slightly different to mouse hair anagen hair follicles; 
since mouse anagen hair follicles did not express cIAP2, Apollon and XIAP in 
the dermal papilla.  In contrast therefore, these IAPs may contribute to the 
protective state of the dermal papilla during the human hair cycle.  Most 
studies have shown that it is Bcl2 that is highly expressed and contributes to 
dermal papilla protection during catagen in mouse and humans (Botchkareva 
et al., 2006; Lindner et al., 1997; Soma and Hibino, 2004), however, apoptosis 
regulation is complex and other proteins may also contribute to this function. 
This is the first study to compare the expression of IAPs in terminal and vellus 
hair follicles from the same donor.  However, while skin samples from three 
donors were analysed, vellus hair follicle was only obtained from one of these 
donors for immunofluorescent staining, making it difficult to compare the 
results between terminal an vellus hair follicles, also the vellus hair follicles 
were either anagen (for cIAP2 and NAIP staining) or telogen (for Apollon and 
XIAP staining).  The expression of cIAP2, Apollon and XIAP was lower in the 
vellus outer root sheath, dermal papilla and dermal sheath expression 
compared to terminal hair follicles.  A study by Miranda et al. (2010) 
demonstrated that intermediate hair follicles (which are follicles in the transition 
from vellus to terminal) were significantly smaller than terminal hair follicles.  
Therefore expression of IAPs could be due to follicle size.  
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2.4.4 Expression of IAP antagonists in human skin containing 
terminal or vellus hair follicles 
DIABLO was highly expressed in both terminal and vellus hair bearing skin, 
throughout the epidermis, dermis and hair follicle including the dermal papilla 
(Figure 2.9 and Table 2.8).  Its function is to promote apoptosis by binding to 
IAPs and allowing the caspase cascade to occur (Verhagen and Vaux, 2002).  
However, a difference in DIABLO expression between terminal and vellus hair 
bearing skin, is that the expression of DIABLO in vellus hair bearing skin was 
located in the cytoplasm of the keratinocytes, whilst in terminal hair bearing 
skin, it was located in both the cytoplasm and nuclei of keratinocytes.  A study 
by Kim et al. (2006) showed that DIABLO translocated to the nucleus during 
the G2/M arrest resulting in apoptosis. In this study, they demonstrated that 
DIABLO interacts with Survivin at the mitotic spindle promoting apoptosis.  The 
location of DIABLO in the nucleus would suggest that DIABLO is active since 
inactive DIABLO is found in the mitochondria (Adrain et al., 2001).  This would 
suggest that in terminal hair bearing skin DIABLO was more active compared 
to vellus hair bearing skin.  From the staining for the other IAPs, expression 
was not detected in the nucleus.  It would be interesting to observe expression 
of keratinocyte cultures under wounding and non wounding conditions or other 
apoptotic stimuli such as UV, to establish whether IAPs translocate into the 
nucleus under stressed conditions, and whether expression of DIABLO is 
altered in the nucleus.  Its location in the nucleus could indicate that DIABLO 
potentially regulates transcription factors.  AP1 is an important transcription 
factor in the epidermis regulating epidermal differentiation (Eckert et al., 2013).  
To determine whether DIABLO does indeed interact with AP1 or other 
transcription factors, double immunofluorescent staining can be carried out 
using antibodies specific for AP1 and DIBALO in keratinocyte cultures derived 
from terminal and vellus hair bearing skin.  Also ChIP-Seq analysis can be 
carried out in keratinocytes and fibroblasts where DIABLO has been silenced 
using siRNA to see if any gene expressions are affected such as IL1, EGF, 
PDGF, VEGF and TGFβ, which are involved and important in wound healing.  
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To this date, DIABLO has not been associated with other functions other than 
IAP and caspase interaction.   
Xaf1 expression was high in both the epidermis and dermis of the terminal hair 
bearing skin and moderate in vellus hair bearing skin (Figure 2.9 and 
Table 2.8).  The difference in expression could be due to vellus hear bearing 
skin being thinner than corresponding terminal hair bearing skin (Figure 2.7) 
(Vogt et al., 2007). 
Its expression in the epidermis and dermis was higher compared to XIAP 
expression levels (Figure 2.8 and Table 2.7), indicating that Xaf1 may be 
regulating XIAP expression levels (Kempkensteffen et al., 2009). 
Interestingly, Xaf1 was expressed at higher levels in the vellus hair follicle 
compared to the terminal hair follicle.  It is not clear at which stage of anagen 
the hair follicles are at (Ebling, 1987), therefore expression of Xaf1 could 
potentially be due to the stage of the hair cycle, if in late anagen, apoptosis is 
about to occur for the catagen stage.  Therefore expression could increase to 
prevent apoptosis from being inhibited.  This is further evident, since in vellus 
hair follicles, Xaf1 expression was high whereas XIAP expression was low. 
2.5 Conclusion  
Immunofluorescent staining confirmed that in mice, the IAPs cIAP1, cIAP2, 
XIAP and Apollon and their antagonists DIABLO and Xaf1, were present in the 
skin and hair follicle while in humans, NAIP was also expressed.  However, 
immunofluorescent staining is only semi-quantitative, further studies need to 
be conducted to quantitate the changes in the expression of IAPs and their 
antagonists in the hair cycle, particularly during extensive tissue remodelling. 
In mouse skin, the expression of IAPs varied between different stages of the 
hair follicle cycle, indicating that IAPs potentially play a role in regulating the 
hair cycle. 
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Since anagen was induced by depilation, changes in the expression may also 
suggest a role in regulating apoptosis and maintaining cell homeostasis in a 
wound healing response. 
In human skin, the difference in IAP expression between vellus and terminal 
hair follicles could be due to the stage in which the hair follicles are at, but 
could also be influenced by the type of hair follicle (vellus or terminal).  The 
difference in dermal expression may be a reflection of the density of hair 
follicles, since vellus hair bearing skin contains smaller and less hair follicles 
compared to terminal hair bearing skin. 
Ethically, it would be difficult to induce anagen via depilation in human skin to 
study IAPs and their antagonists in tissue regeneration and remodelling.  
Therefore, to study the roles of IAPs in human skin cells, the isolation and 
culture of primary cells is warranted. 
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Chapter 3 
A COMPARISON OF CULTURED HUMAN DERMAL 
FIBROBLASTS DERIVED FROM TERMINAL AND VELLUS 
HAIR BEARING SKIN  
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 A comparison of cultured human dermal fibroblasts 
derived from terminal and vellus hair bearing skin 
3.1 Introduction 
3.1.1 Dermal fibroblasts 
Dermal fibroblasts are derived from the mesoderm (McAnulty, 2007) and are 
the major cell type in the dermis of the skin with an important role in 
constructing the ECM (Alberts, 2002).  Fibroblasts are responsible for the 
synthesis of collagens, glycosaminoglycans, reticular and elastic fibres, and 
glycoproteins, which are all important components of the ECM.  Dermal 
fibroblasts derived from different origins such as keloid scars, palmar, non 
palmar and plantar skin do not show the same plasticity, even when cultured 
under the same culture conditions (Chipev and Simon, 2002). 
Fibroblasts from the same region, but from different layers of the dermis 
(reticular and papillary) also have different properties.  Fibroblasts found in the 
upper papillary region of the dermis divide faster than fibroblasts cultured from 
the lower reticular layer of the dermis (Sorrell and Caplan, 2004).  Different 
markers (Table 3.1) have been identified that distinguish between the two 
different fibroblast populations derived from the papillary and reticular layer 
(Janson et al., 2013).  With aging, the number of fibroblasts present in the 
papillary layer is reduced, this therefore lowers the production of collagen and 
fibrous tissue in the ECM, reducing skin elasticity due to a reduction in elastic 
fibres (Janson et al., 2013; Montagna and Carlisle, 1979).  A study by Mine et 
al. (2008) demonstrated that the dermal fibroblasts derived from the papillary 
layer of the dermis showed up regulation of the secretion of cytokines such as 
KGF, and VEGF in aged skin, with no change in expression with fibroblasts 
derived from the reticular layer. 
Janson et al. (2013) compared the structure and characteristics of low and 
high passage fibroblasts derived from the papillary layer with matching patient 
low passage reticular fibroblasts and observed that specific reticular and 
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papillary markers (Table 3.1) were altered.  Papillary marker expression was 
reduced in high passage (p15-20) papillary fibroblasts to similar levels seen in 
low passage (p3) reticular fibroblasts; while the expression of reticular markers 
was increased in high passage papillary fibroblasts.  They concluded that 
papillary fibroblasts transformed into reticular fibroblasts after a high number 
of passages in culture.   
Therefore, since cultured papillary fibroblasts at high passage differentiate into 
reticular fibroblasts, studies of papillary fibroblasts should be carried out at a 
low passage number to ensure the papillary fibroblasts retain their phenotype. 
Papillary Markers: Reticular Markers: 
Podoplanin (PDPN) Calponin1 (CNN1) 
Netrin1 (NTN1) Transglutaminase2 (TGM2) 
C-C chemokine receptor type 11 (CCRL1) Cadherin2 (CDH2) 
Table 3.1: Papillary and reticular markers 
Papillary and reticular fibroblast markers used to differentiate between the two 
layers (Janson et al., 2013) 
3.1.2 Dermal fibroblasts in wound healing 
The dermal fibroblast has an important role in human skin during wound 
healing (Werner et al., 2007).  The existence of paracrine secretions between 
dermal fibroblasts and epidermal keratinocytes is well established (Nakajima 
et al., 2012; Tandara et al., 2007; Taniguchi et al., 2014).  For example, 
keratinocyte communication with fibroblasts via interleukin 1 (IL1) secretion 
stimulates fibroblasts to secrete growth factors such as KGF, IL6 and 
granulocyte-macrophage colony-stimulating factor (GM-CSF).  These are all 
important in wound healing, and have a positive feedback effect on 
keratinocytes to stimulate epidermal cell proliferation, while inducing 
fibroblasts to secrete collagen (Werner et al., 2007).  The secretion of KGF 
from dermal fibroblasts also stimulates the proliferation of keratinocytes in the 
wound area (Sorrell and Caplan, 2004).  The main role of the dermal fibroblast 
in wound healing is in the proliferative stage where they produce granular 
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tissue to support re-epithelialisation and rebuild the dermis.  Dermal fibroblasts 
also have an important role in wound contraction, by differentiating into 
myofibroblasts, which are characterised by their high expression of α-SMA 
(Alberts, 2002; Hinz, 2007). 
An in vitro study by Moulin et al. (2000) using a skin equivalent model, 
compared the effect of human myofibroblasts and dermal fibroblasts on 
keratinocyte re-epithelialisation.  Wound healing myofibroblasts did not 
interact with keratinocytes to support keratinocyte differentiation and 
basement membrane formation in comparison to undifferentiated dermal 
fibroblasts (Moulin et al., 2000).  In another  in vitro study, a comparison of site 
matched papillary and reticular fibroblasts from breast skin, showed that the 
secretion of KGF1 by reticular fibroblasts was higher than corresponding 
papillary fibroblasts, suggesting that reticular fibroblasts may play a more 
dominant role in keratinocyte differentiation (Sorrell et al., 2004).   
Another important aspect of wound healing is cell migration; fibroblasts need 
to migrate in wounded conditions to aid in repair efficiently.  This is generally 
at the initial stage of wound healing, after platelets have cause clotting, forming 
a scaffold for fibroblasts to migrate (McDougall et al., 2006; Scheid et al., 
2000). 
A supply of stem cells ready to differentiate to replace damaged epithelial cells 
is important in wound healing.  This generally involves the stem cells located 
in the skin epidermis, and in some cases where hair follicles are present, the 
stem cells in the bulge of the hair follicle (Ito and Cotsarelis, 2008; Ito et al., 
2005; Plikus et al., 2012).  It has been shown in mice that without the bulge 
stem cell niche, the skin is capable of wound repair, however, this niche allows 
for a faster rate of epithelialisation (Ito et al., 2005).  The contribution of bulge 
stem cells to epidermal regeneration is only wound responsive.  Wound 
healing is improved in skin where the hair follicle is in the anagen phase of the 
hair cycle (Ansell et al., 2011).   
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It has been established that the hair follicle mesenchyme fibroblasts, the 
dermal sheath, improve wound healing responses (Jahoda and Reynolds, 
2001).  During wound healing, where the outer root sheath contains the stem 
cells that contribute to epidermal regeneration, the dermal sheath plays a 
similar role for the contribution of dermal fibroblasts to the dermis.  
Myofibroblasts are derived from dermal fibroblasts, however, the dermal 
sheath cells already express high levels of α-SMA (Jahoda et al., 1991). 
While the hair follicle clearly plays an important role in wound healing by 
contributing dermal sheath cells to the dermis (Jahoda and Reynolds, 2001), 
the role of the dermal fibroblasts contributing to the maintenance of the hair 
follicle is not clear.  A study by Elliott et al. (1999) compared hair follicle dermal 
papilla size and cortex from male and female facial skin (male beard, female 
vellus hair) and scalp.  Dermal papilla size in female vellus hair follicles was 
significantly smaller than androgen dependant male beard hair follicles.  The 
enlargement of the dermal papilla was due to an increase in the number of 
cells either from cell proliferation, or from cells migrating from the dermal 
sheath (Elliott et al., 1999).  However, there are no studies that have looked at 
the link between the number of fibroblasts in the region around vellus and 
terminal hair follicles, and whether that influences the type of hair follicle in the 
skin. 
There are no studies comparing migration and proliferation, important 
characteristics of wound healing, between fibroblasts derived from hairy skin 
and non hairy skin in humans.  
3.1.3 Aim 
The previous chapter demonstrated that the expression of cIAP2, XIAP and 
NAIP was higher in terminal hair bearing skin compared to corresponding 
vellus hair bearing skin from the same donor. 
The first aim of this chapter was to culture dermal fibroblasts from the papillary 
layer of the dermis of hairy – DF(T) (scalp) and non hairy – DF(V) (facial) skin 
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from the same donor, and compare their morphology and wound healing 
properties such as migration and proliferation in vitro at early passage.  
FACS analysis of papillary dermal fibroblasts cultured from vellus (DF(V)) and 
terminal (DF(T)) hair bearing skin was used to compare cell morphology, a 
scratch wound assay to assess any differences in the rate of migration, and 
cell counting experiments to determine whether there are any differences in 
the rate of proliferation between the two fibroblast populations. 
The second aim was to establish whether there is a difference in the 
expression of the IAPs, XIAP, NAIP, cIAP2 and Apollon, and the IAP 
antagonists DIABLO and Xaf1, between dermal fibroblasts cultured from 
terminal hair bearing skin and vellus hair bearing skin, using 
immunocytochemistry and qRT-PCR.  
To investigate further the role of IAPs and their antagonists in controlling 
apoptosis in a wound healing response, fibroblast monolayers were scratched 
to create a mechanical wound, and changes in the expression of both IAP 
mRNA and protein quantified by qRT-PCR, and immunocytochemistry were 
examined.  
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3.2 Material and Methods 
3.2.1 Cell culture 
A list of donor details (e.g. age, gender and type of cell cultured) for the 
experiments presented in this chapter are listed in Table 3.2. 
Donor ID Age Gender DF(T) DF(V) 
OK14 3, 4 57 Female   
OK15 3, 4 36 Female   
OK17 1, 3 53 Female   
OK18 1, 2, 3, 4 56 Female   
OK21 2 64 Female   
OK22 1 53 Female   
OK24 2 57 Female   
Table 3.2: Details, including internal ID, age, gender and location of which cultured dermal 
fibroblasts were derived. 
Donors used to culture matching dermal fibroblasts from terminal hair bearing 
skin DF(T), or from vellus hair bearing skin (DF(V).  1 - used to FACS analysis, 
2 - used for cell migration, 3 - used for cell proliferation, 4 - used for qRT-PCR 
analysis. 
3.2.1.1 Isolation for primary hair follicle cell culture 
For dermal fibroblast cell culture growth medium, DMEM (Sigma), was 
supplemented with 10% FBS (GIBCO), 100Units/mL, 100µg/mL Penicillin/ 
Streptomycin (GIBCO), 2mM L-Glutamine (GIBCO) and 0.25µg/mL fungizone 
(GIBCO). 
Skin samples were obtained from the scalp and face of healthy females with 
full consent and ethical approval after undergoing facelift surgery.  Matching 
skin samples were obtained from seven female subjects and used for FACS 
analysis (n=3, age range 53-56); cell migration (n=3, age range 56-64); cell 
proliferation (n=4, age range 36-57) and for qRT-PCR analysis (n=3, age 
range 36-57) -Table 3.2.  The tissue was placed in transporting medium 
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(Dulbecco’s Modified Eagle Medium (DMEM) (Sigma), 10% Foetal Bovine 
Serum (FBS) (GIBCO), 500Units/mL / 500µg/mL Penicillin/ streptomycin 
(GIBCO), 0.75µg/mL fungizone (GIBCO), glutamax (GIBCO)) and stored at 
4˚C for up to 12 hours.  Each sample was divided into the terminal hair bearing 
scalp region and the vellus hair bearing facial skin (Figure 3.1).  This allowed 
a direct comparison of dermal fibroblasts cultured from terminal hair bearing 
skin (DF(T)) and vellus hair bearing skin (DF(V)) of the same donor.  Tissue 
for cell culture was used within 24 hours of surgery.  
 
Figure 3.1: Terminal and vellus hair bearing skin separation for dermal fibroblast cell culture 
Skin samples obtained from female face lift patients – marked red dashed box 
were isolated into two sections, terminal hair bearing and vellus hair bearing 
skin – dashed red line.  Skin samples from both terminal and vellus hair 
bearing skin were then cut into smaller 1cm2 pieces.  Samples were placed 
into a 6cm diameter culture dish with medium, the epidermal layer was 
removed using a scalpel and scissors with minimal disruption of the dermis.  
For DF(V) cell culture, cells were placed papillary layer onto the surface of the 
T25 culture flask; for DF(T) cells, once the epidermis was removed, hair 
follicles were plucked and papillary layer of the dermis was placed onto the 
surface of the T25 culture flask.  S(T) – terminal hair bearing skin, S(V) – vellus 
hair bearing skin, T(HF) – terminal hair follicle, V(HF) – vellus hair follicle. 
S(T) S(V) 
Epidermis 
V(HF) 
T(HF) 
Papillary 
dermis 
Reticular 
Dermis 
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Skin obtained from surgery was washed with sterile PBS.  For dermal 
fibroblasts obtained from terminal hair bearing skin (DF(T)), excess fat was 
removed with a thin layer of dermis from the isolated skin section.  The 
epidermis was removed using a sterile blade, leaving the papillary layer and 
reticular layer of the dermis.  Hair shafts still protruding were removed using 
sterile tweezers.  The dermis was divided into smaller pieces of roughly 1cm2.  
The isolated dermal tissue pieces were placed in a T25 culture flask that had 
already been coated with 500µl of FBS and left to air dry in the laminar flow 
cabinet, papillary layer face down onto the surface of the flask.  The flasks 
were scored using the sterile tweezers and the individual small piece dermis 
were placed close to one another; 5-6 pieces were placed in one coated flask.  
The flasks were carefully topped up with 3ml growth medium so as not to 
dislodge the tissue pieces and were incubated at 37˚C and 5% CO2 for 1 week 
without disturbing before the medium was replenished.  After approximately 1-
2 weeks fibroblasts had started to migrate out from the dermal explants in all 
directions (as observed under a phase contrast microscope).  Once the cells 
were established (~4 weeks) and a confluent monolayer of primary dermal 
fibroblasts had grown, the cells were trypsinised, and seeded into a T75 
culture flask for expansion.   
Using the same principle, matching dermal fibroblasts from vellus hair bearing 
skin were cultured from the same biopsies; cells took approximately 3 weeks 
to become confluent before the first passage. 
3.2.1.2 Passaging of cells 
Once cells had reached confluence, they were passaged, and transferred to 
new culture flasks.  In a T75 flask 1.5ml of 0.05% trypsin/EDTA (GIBCO) was 
added to the cells; for T25 flasks, 0.75ml of 0.05% trypsin/EDTA (GIBCO) was 
added.  The fibroblasts were examined under a microscope; the cell 
morphology changed from slightly dendritic in shape to round cells.  Once all 
the cells had shrunk (~1-2 min of adding trypsin), the trypsin solution was 
removed, and the cells incubated at 37˚C for a further 1-2 minutes.  The flask 
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was tapped gently to detach the cells from the surface of the flask and growth 
medium was added to the flask and the cells re-suspended (in T75 flasks, 8mls 
of medium was added; in T25 flasks, 4mls of medium was added).  From the 
cell suspension, a one in four dilution was carried out on the dermal fibroblasts; 
2mls of cell suspension was transferred to a new T75 flask and topped up with 
5ml growth medium; for T25 flasks, 1ml of cell suspension taken and 
transferred to new flask topped up with 2mls of growth medium. 
3.2.1.3 Cell counting 
Once the cells were confluent, the cells were trypsinised and 10µl of cell 
suspension was placed in an improved Neubauer haemocytometer.  The 
number of cells in the corner and middle compartments were counted, and 
only two edges (bottom and left) of each grid were used.  The average number 
of cells were taken and multiplied by 104 to accommodate for the volume of 
the haemocytometer (0.1mm3); this gave the number of cells in 1 ml.  Using 
this information, the number of cells in a confluent flask suspension could be 
calculated. 
3.2.1.4 Freezing cells 
Once cells had reached confluence, and needed to be stored for future use, 
the cells were frozen.  Cells were trypsinised and re-suspended in 10% FBS 
DMEM in a falcon tube and centrifuged at 560RPM for 5 minutes to form a 
pellet.  The supernatant was discarded and the pellet was re-suspended in 
2ml freezing media which consisted of 10% dimethyl sulfoxide (DMSO) in 20% 
FBS DMEM.  The 2ml of cell suspension was divided equally between 2 
labelled cryotubes.  Cryotubes were placed in liquid nitrogen vapour for 1 day, 
and then placed into liquid nitrogen. 
When cells were required, they were removed from the liquid nitrogen and 
immediately thawed in hot water.  One vial of cells was transferred into a T75 
culture flask and topped up with 9ml 10% FBS DMEM.  The cells were left to 
incubate at 37˚C with 5% CO2, with the medium changed after 24hours. 
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3.2.2 FACS analysis for cell morphology 
DF(T) and DF(V) cells were cultured in T75 flasks and left to grow until fully 
confluent. A cell suspension was made with 300,000 dermal fibroblasts in 
300µl PBS.  Cells in each flask were counted and from the total number of 
cells, 300,000 cells were extracted and placed into an Eppendorf tube and 
spun down at 3000g for 4 minutes, before the pellet was made up to 300µl 
using PBS. The cell suspension was transferred into a standard FACS tube 
and placed into a FACS machine (Beckman Coulter).  Using the specific 
software (Summit v.4.3.02.) a spot area was created with the x-axis a forward 
linear scatter, where any light scatter that is in the direction of light beam is 
collected, this indicates the size of the cells analysed; this is against the y-axis 
which is the side scatter, also linear range.  The light scattered from the cell 
that is in any other direction but towards the beam is collected.  This provides 
information on cell complexity, including the amount of cytoplasmic granulation 
and nuclear size.  The voltage and gain for the side scatter is adjusted so cells 
appear in the plot area; the gain for the forward scatter is also adjusted.  The 
threshold is adjusted to remove any dead cells and debris that could affect 
analysis.  A gate is placed around the cell population that needs to be 
analysed.  The samples were run and cells were analysed in terms of size (x-
axis) and complexity (y-axis).  This was carried out for three sets of matching 
dermal fibroblast cell cultures. 
3.2.3 Assessment of cell migration using the scratch wound 
assay 
Matching cultures of dermal fibroblasts (DF(T) and DF(V) cells) were seeded 
at a concentration of 200,000 cells per well in a 6 well plate (Clear Sterile) and 
left to grow to fully confluent (DF(V) – 4 days, DF(T) – 1 week).  The medium 
was changed every 3 days and once cells had reached confluence, they were 
washed with PBS twice, then incubated in serum free, phenol red free DMEM 
for 24 hours. 
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Using the scratch wound device (Figure 3.2A), a scratch with a diameter of 
0.8mm was made down the middle of the well.  The cells were washed twice 
with PBS to remove any dead or detached cells.  2ml of serum free and phenol 
red free medium was added to the cells.  To measure only migration and not 
proliferation, cells were treated in the presence and absence of mitomycin C 
(5µg/ml and 10µg/ml), to ensure cell proliferation was inhibited. 
 
 
Figure 3.2: Scratch wound device and template 
A) This device was used to scratch wounds in 6 well plates to give an even 
thickness scratch without damage to the plates and to give a neat straight 
scratch across the cells.  The rim sits onto the 6 well plate, and the bar is 
0.8mm in diameter at the base. B) Template used to indicate migration points.  
This template was placed under the 6 well plate in which cell migration was 
measured and secured using tape.  Colours were used for reference points. 
A 
B 
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3.2.3.1 Analysing cell migration 
Once the cell monolayers were scratched, a template (Figure 3.2B) was 
placed under the plate. Using a camera (Nikon coolpix4500 – 4x lens 
magnification, Japan) attached to the phase contrast microscope (Ernst Leitz 
Wetzlar GMBH, Germany); images of the scratched cells were taken at x4 
objective magnification (between the two green lines) and x10 objective 
magnification at each template line. 
Using a stage micrometer, images were taken of the 1mm length at both 
objective magnifications, this was to convert pixel length to actual length for 
migration analysis. 
Migration was analysed at different time points, at 0, 2, 4, 6, 24 and 48 hours 
after scratching to analyse at which time point dermal fibroblast migration was 
affected under different experimental conditions.  
3.2.4 Quantitating DF(T) and DF(V) cell proliferation 
Four matching donor DF(T) and DF(V) fibroblast cultures were seeded into 6 
well plates at 10,000 cells per well.  For each individual donor cell type, three 
6 well plates were set up for each experimental condition.  Cells were 
incubated with 5% charcoal stripped FBS in phenol red free medium.  Cells 
were counted at specific time points for 12 days, at 2, 4, 6, 8, 10 and 12 days 
of incubation, medium was changed every 2 days.  Dermal fibroblasts were 
cultured in triplicate wells and cells were counted twice in each individual well. 
3.2.5 Quantitative PCR 
To analyse the expression of different RNA transcripts and how they were 
affected under different experimental conditions, quantitative PCR was carried 
out. 
3.2.5.1 RNA extraction 
DF(T) and DF(V) cells were seeded at 20,000 cells per well in a 6 well plate 
(each experimental condition was done in triplicate wells) and allowed to grow 
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until fully confluent (DF(V) – 1 week, DF(T) – 2 weeks) with growth medium 
change every three days.  Once cells were fully confluent, medium was 
changed to serum free and phenol red free medium and cells were incubated 
for 24hours.  Cells were either scratched or left unwounded, and treated with 
vehicle control (absolute ethanol at 0.001%).  Mechanical wounding was 
achieved by using a 1ml pipette tip and scoring a hash (#) pattern in the wells.  
The cells were washed with PBS to remove any dead or detached cells before 
treatment.   
After a 24hour incubation, cells were trypsinised and collected in 20ml falcon 
tubes by washing the wells containing trypsinised cells with serum free and 
phenol red free medium; cells from triplicate wells were pooled together, then 
centrifuged at 560RPM for 5 minutes. The RNeasy Mini kit (Qiagen) was used 
for RNA extraction.  Cells were lysed using a Buffer RLT (Qiagen kit) solution 
(350µl), then 70% ethanol (350µl) was added to the lysate for binding 
purposes.  700µl of the homogenised cells were transferred to spin columns 
(provided in the kit), and spun down at 8000g for 15 seconds.  The flow through 
was discarded and 500µl of Buffer RPE (Qiagen kit) was added to the spin 
column and spun at 8,000g for 15 seconds; the flow through was discarded 
and this step was repeated twice more, however the solution was spun for 2 
minutes each time.  The spin column was placed in a new collecting tube and 
40µl of RNase free water (Qiagen kit) was added to the spin column and spun 
at 8,000g for 1 minute to elute the RNA.  The RNA was aliquoted in volumes 
of 10µl in 200µl Eppendorf tubes to reduce damage to RNA by constant 
freeze-thawing (~35 µl of RNA was collected from the triplicate wells). 
3.2.5.2 cDNA synthesis 
Once the RNA had been extracted, the quantity of RNA in ng/µl was measured 
using a NanoPhotometer P-330 (Implen).  Reverse transcription was carried 
out to create cDNA, using the ImProm-II™ Reverse Transcription System kit 
(Promega) and protocol.  1µg of RNA was added to 1 µl of random primer 
(Promega kit) and topped up to 5µl with DNase/RNase-Free Distilled Water 
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(Promega kit).  This solution was placed on a preheated 70˚C thermocycler 
(Techne) for 5 minutes.  Immediately, the PCR tubes were placed on ice for at 
least 5 minutes, then to collect all the condensate the tubes were spun for 10 
seconds on a small refrigerated centrifuge (Eppendorf 5415 R).  To each 
reaction 4µl of reaction buffer, 2.5µl of magnesium chloride, 1µl of dNTP mix, 
0.5µl of recombinant RNasin Ribonuclease Inhibitor and 1µl of reverse 
transcriptase enzyme, nuclease free water was added to make up to a 15µl 
solution (all reaction mixture provided from Promega reverse transcription kit); 
this was then added to the 5µl RNA solution making a total of 20µl solution.  
The solution in the PCR tubes were placed in a thermocycler (Techne) 
programmed to heat to 25˚C for 5 minutes for annealing purposes; then to 
increase in temperature to 42˚C for one hour for extension.  The reaction mix 
was inactivated by increasing the temperature to 70˚C for 5 minutes.  The 
cDNA created was stored at -80˚C. 
3.2.5.3 Quantitative real time PCR analysis 
Primer sequences were designed for the IAPs, Apollon, cIAP2, NAIP, XIAP 
and the IAP antagonists DIABLO and Xaf1 
Primer: Forward Sequence: Reverse Sequence: Annealing Temp: 
Apollon CAGCCAACCTTACCTCTCCG GTCCGCAGTCCTACCAACAA 62.2˚C 
cIAP2 GGGCTGTTACCGCTGAGAAT ACGTTGGGCTTTTCAACTGC 62.2˚C 
NAIP AGCTGGAAGTGGAAAGACGG GCTGGATAATGTTCCTCACGC 58.6˚C 
XIAP AGCAATTGGCTTTTTCCCACT CAAGAAAGGTAGCTTGGTGAAGT 62.2˚C 
DIABLO CCAATCCCGACTGCTTCCTT ACAGCCAACTCTTCAGAGCC 62.2˚C 
Xaf1 TGGGTGTAGGATTCTCCAGG GGTTTGCCCAAGGACTACAA 62.2˚C 
GAPDH TATAAATTGAGCCCGCAGCC CGACCAAATCCGTTGACTCC 62.2 and 58.6˚C 
Table 3.3: IAP primers used and their annealing temperature 
Each primer was designed using PrimerBlast and annealing temperature 
optimised via quantitative PCR optimisation 
3.2.5.3.1 Primer annealing temperature optimisation 
The designed primers (Table 3.3) were optimised for their annealing 
temperature.  For each reaction, 5µl of Fast SYBR® Green Master Mix (life 
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Technologies), 0.1µl of forward and 0.1µl of reverse primer, 0.3µl of cDNA and 
4.5µl of UltraPure™ DNase/RNase-Free Distilled Water (GIBCO) were mixed 
together, and analysed at different temperatures ranging from 55˚C to 65˚C.  
The mixture was placed in a 96 well PCR plate (Starlab) and sealed using 
clear flat caps (Starlab), the mixture was quickly vortexed then spun down 
using a plate spinner (Labnet MPS1000) to collect the solution at the bottom 
of the well ensuring no bubbles were present.  The plate was placed into a 
quantitative real time PCR machine (Step One Plus, Applied Biosystems) and 
a designed protocol was run.  The protocol used was to heat to 95˚C for 20 
seconds for initial activation, the first cycle began after the temperature was 
maintained at 95˚C for 3 seconds, then reduced to the temperature ranges for 
optimisation for 30 seconds.  These two steps were repeated for the number 
of cycles that were required (40 cycles).  A melt curve was produced to 
determine whether the product had amplified.  This stage consisted of the 
temperature after the final cycle to increase to 95˚C for 15 seconds, then drop 
to 65˚C for 1 minute then increase back to 95˚C with the reading on the product 
at every increase of 1˚C. 
3.2.5.3.2 Real time PCR 
Once the optimal annealing temperature was established, using the same 
protocol for establishing the optimal annealing temperature for each individual 
primer, the experiment was repeated with the modification of the actual 
annealing temperature (Table 3.3) as opposed to the temperature ranges.  For 
each condition and primer analysis, the reaction was done in triplicate wells.  
For each experimental condition, GAPDH (glyceraldehyde 3-phosphate 
dehydrogenase) a catalyst enzyme in glycolysis used to break down glucose 
for energy, was used as a house keeping gene where levels were unaltered 
at different conditions.  Once the PCR had run, a CT value was generated for 
the reaction.  From the CT values generated, a ΔCT value was generated from 
the house keeping gene (the expression of the gene of interest normalised 
against GAPDH – the change in CT value in comparison to GAPDH); from that 
a ΔΔCT was further generated to ensure that the expression could be 
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obtained.  For consistent purposes, expression was normalised against 
GAPDH. 
3.2.6 Expression of IAPs in dermal fibroblast monolayer culture 
at different wounding conditions via immunofluorescent 
staining 
Matching cultures of DF(T) and DF(V) cells from three different donors were 
seeded into 8 well chamber slides (Millipore) at a density of 3,000 cells per 
well and left to grow until fully confluent (DF(V) – 4 days, DF(T) – 6 days).  
Growth medium was changed every three days.  When cells became fully 
confluent, one well for each IAP and IAP antagonist analysed was scratched 
at one side of the well and left for 24 hours.  After 24 hours, a scratch in another 
well was made using a 20µl pipette tip.  Immediately after scratching, medium 
was removed and cells were left to air dry before fixed using ethanol.  Using 
the same principle of immunofluorescent staining described in section 2.2.4, 
the expression of IAPs and their antagonist was determined in matching DF(T) 
and DF(V) cells non wounded, immediately after wounding (T0) and 24 hours 
later (T24).  Two random images were taken from each well.  Once the images 
were taken, using ImageJ, six random cells were analysed, where their 
fluorescent density was measured (Figure 3.3). 
3.2.7 Statistics 
For all FACS analysis, cells migration assay between two groups and PCR 
data carried out, an un-paired Students T-test of unequal variance was 
conducted, and a one way analysis of variance (ANOVA) on multiple 
comparisons for the same protein for immunofluorescent quantitative analysis 
followed by a Bonferroni test, to determine significance between specific 
groups. 
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Figure 3.3: Schematic representation of wounding method of confluent monolayer in chamber 
slides and image positions 
Confluent DF(T) ad DF(V) monolayers were scratched (white line) at the edge 
of the chamber (this will create the wounding condition after 24 hours).  Cells 
were incubated for 24 hours, and a second scratch was made in another well 
(this will create the wounding condition at time zero). Cells were immediately 
fixed and immunostaining carried out in duplicate.  Random images were 
taken (marked with a red dot).  Each image was analysed using ImageJ, from 
each image, six cells were analysed (green outline).  Unwounded cells, those 
at the point of intersection on the template gridline were analysed, where cells 
were wounded, those at the edge of the wound were analysed. 
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3.3 Results 
3.3.1 DF(V) are smaller and more complex than DF(T) 
To quantitate any differences between DF(T) and DF(V) cells, FACS analysis 
was used to determine the size and cell complexity of the two different dermal 
fibroblast populations (Figure 3.4).  From the dot-plot graph generated, the 
size and complexity of the cells were compared.  Figure 3.4 represents the cell 
morphology for DF(T) and DF(V) cells.  Dermal fibroblasts from three matching 
donors were analysed, generating data for the cell size (x-axis) and the cell 
complexity (y-axis).  When normalising the data against DF(T) cells, DF(V) 
cells are smaller than DF(T) cells (p<0.05), and DF(V) cells are more complex 
in cytoplasm granulation and nuclear size compared to DF(T) cells (p<0.05), 
(Student T-test). 
  
Figure 3.4: Differences in DF(T) and DF(V) cell morphology under FACS analysis 
Cell morphology for DF(T) and DF(V) under FACS analysis.  A) DF(T), B) 
DF(V).  DF(V) were smaller than DF(T) cells from matching donors.  DF(V) 
were more complex in cytoplasm granulation.  Blue – DF(T), red – DF(V). n=3 
donors. 
B A 
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3.3.2 A comparison of the migratory ability of dermal fibroblasts 
derived from terminal and vellus hair bearing skin  
A cell migration assay was carried out on matching cultures of dermal 
fibroblasts (n=3 donors) 24 hours after scratching; all cells were analysed at 
passage 3 (Figure 3.5). 
Figure 3.5A and Figure 3.5B, represent DF(T) cells immediately after 
scratching in the absence and presence of 10µg/ml mitomycin C respectively.  
Figure 3.5C and Figure 3.5D represent DF(T) cell migration 24 hours following 
scratching in the absence and presence of 10µg/ml mitomycin C respectively.  
Cell migration was reduced with treatment of cells with mitomycin C. 
Figure 3.5E and Figure 3.5F, represent DF(V) cells immediately after 
scratching in the absence and presence of 10µg/ml mitomycin C respectively.  
Figure 3.5G and Figure 3.5H represent DF(V) cell migration 24 hours following 
scratching in the absence and presence of 10µg/ml mitomycin C respectively.  
As with DF(T) cells, DF(V) cell migration was reduced with mitomycin C 
treatment. 
With mitomycin C treatment, cell migration was reduced 24 hours after 
scratching in both DF(T) and DF(V) cells, p<0.005 (Figure 3.5I).  No difference 
in cell migration was observed between DF(T) and DF(V) cells in the presence 
or absence of 10µg/ml mitomycin C. 
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Figure 3.5: Dermal fibroblast migration DF(T) and DF(V) in the presence and absence of 
Mitomycin C 
The migration of dermal fibroblasts in a scratch wound assay after 24 hours.  
A and B) Immediate scratching of DF(T) cells in the absence and presence of 
10µg/ml mitomycin C respectively.  C and D) 24 hours after scratching of DF(T) 
cells in the absence and presence of 10µg/ml mitomycin C respectively.  E 
and F) Immediate scratching of DF(V) cells in the absence and presence of 
10µg/ml mitomycin C respectively.  G and H) 24 hours after scratching of 
DF(V) cells in the absence and presence of 10µg/ml mitomycin C respectively.  
I) Comparison of the migration of DF(T) (blue) and DF(V) (red) cells 24 hours 
after scratching, in the presence and absence of Mitomycin C.  n=3, T-Test, ** 
p<0.005.  Magnification bar 100µm. 
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3.3.3 DF(V) proliferate at a faster rate than DF(T)  
To determine whether there were differences between the proliferation of 
dermal fibroblast populations derived from terminal or vellus hair bearing skin, 
matching cultures were established from four different donors; fibroblasts were 
all assayed between passage 3-4 (Figure 3.6).  There were significant 
differences in proliferation between the two dermal fibroblast populations over 
a 12 day period.  By day two, DF(V) cells were proliferating significantly faster 
than DF(T), which was maintained throughout the 12 day period. 
 
 
Figure 3.6: DF(V) grow significantly faster than DF(T) 
Proliferation of matching cultures of DF(T) (Blue) and DF(V) (Red) derived 
from the same donor (n=4 donors) passage (3-4).  Each cell line for each 
individual patient was assessed in triplicate wells for each time point and each 
well was counted in duplicate.  There was a significantly increased rate of 
proliferation by DF(V) compared to DF(T) over a 12 day period.  Each point 
represents mean of 4 donors ± SEM. * p<0.05 (Student t-test). 
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3.3.4 DF(V) express higher levels of NAIP, cIAP2, Apollon and 
DIABLO mRNA than DF(T) 
Quantitative RT-PCR was carried out to compare mRNA expression for IAPs 
and IAP antagonists in matching DF(T) and DF(V) cells from three donors 
(Figure 3.7).  All expressions were normalised against GAPDH. 
Messenger RNA expression for NAIP was ~5x higher in DF(V) cells compared 
to matching DF(T) cells (p<0.0005), while cIAP2 mRNA expression was ~20x 
higher in DF(V) cells compared to corresponding DF(T) cells (p<0.0005).  
mRNA expression for XIAP was similar, while expression of Apollon was ~2.7x 
higher in DF(V) cells compared to matching DF(T) cells (p<0.05) (Figure 3.7A). 
While the expression of DIABLO was ~1.4x higher in DF(V) cells compared to 
matching DF(T) cells (p<0.05) (Figure 3.7B), there was no significant 
difference in the expression of Xaf1 (Figure 3.7C). 
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Figure 3.7: Higher levels of NAIP, cIAP2, Apollon and DIABLO in DF(V) cells compared to DF(T) 
cells under non-wounding conditions. 
A comparison of mRNA expression of IAPs and IAP antagonists between 
matched cultures of DF(T) (blue) and DF(V) (red).  A) Expression of mRNA for 
NAIP, cIAP2, XIAP and Apollon.  (B and C) Expression of mRNA for the IAP 
antagonists DIBALO and Xaf1 respectively.  * p<0.05, *** p<0.0005, (Student 
T-test). n=3 donors in triplicate wells.  
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3.3.5 Changes in mRNA expression of IAPs differ between DF(T) 
and DF(V) cultures following mechanical wounding 
High levels of mRNA expression for XIAP and Apollon were seen in DF(T) 
compared to expression of NAIP and cIAP2; this pattern of expression was 
also seen in cells 24 hours following mechanical wounding.  However, in DF(V) 
cells, expression of cIAP2 and Apollon was higher than XIAP and NAIP.  24 
hours following mechanical wounding in DF(V) cells, Apollon and XIAP mRNA 
expression was higher than NAIP and cIAP2 (Figure 3.8). 
In DF(T) cells (n=3 donors) (Figure 3.8A), mRNA expression of cIAP2 and 
XIAP was reduced 24 hours after the cultured cell monolayers were 
mechanically wounded (p<0.05); but there was no change in the expression 
of NAIP and Apollon mRNA.  In the matching DF(V) cells (Figure 3.8B), cIAP2 
mRNA expression was reduced by a sixth in mechanically wounded cells 
compared to unwounded (p<0.0005), whilst Apollon mRNA expression was 
decreased by a half following mechanical wounding (p<0.05). 
In contrast to DF(T), where there was a decrease in XIAP mRNA expression 
24 hours after scratching, there was an increase in the expression of XIAP in 
DF(V) cells (p<0.05). 
Similar to DF(T), NAIP mRNA expression was not altered 24 hours after 
wounding in DF(V). 
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Figure 3.8: Decreased levels of cIAP2 and XIAP in DF(T) cells with decreased levels of cIAP2 and 
Apollon and increased levels of XIAP in DF(V) following mechanical wounding in vitro 
Confluent monolayers of dermal fibroblasts were mechanically wounded 
(scratched), and the level of IAP mRNA compared between matching DF(T) 
and DF(V) cultures.  A) Represents IAP expression levels in DF(T) before 
(blue) and 24 hour after wounding (hashed blue).  B) Represents IAP 
expression levels in DF(V) before (red) and 24 hour after wounding (hashed 
red).  n=3 donors.  * p<0.05, *** p<0.0005, (Student T-test).  
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3.3.6 IAP antagonist mRNA expression decreases in cultured 
DF(T) and DF(V) after mechanical wounding 
In matching DF(T) and DF(V) cultures, Xaf1 mRNA expression was higher 
compared to DIABLO expression, in unwounded and 24 hours following 
mechanical wounding (Figure 3.9). 
mRNA expression for DIABLO reduced by a half in DF(T) cells following 
mechanical wounding (p<0.005) (Figure 3.9A), whilst in DF(V) cells DIABLO 
mRNA expression was reduced by a quarter after cells were mechanically 
wounded (p<0.05) (Figure 3.9C). 
Xaf1 mRNA expression was not altered following mechanical wounding in 
DF(T) cells (Figure 3.9B), however, in DF(V) cells, expression was reduced by 
about 25% following mechanical wounding (p<0.005) (Figure 3.9D).  
 
 
 
 
 
 
Figure 3.9: Significant decreases for DIABLO in DF(T) and significant decrease in DIABLO and 
Xaf1 in DF(V) cells following mechanical wounding in vitro  
Confluent monolayers of dermal fibroblasts were mechanically wounded 
(scratched), and the level of IAP antagonist mRNA compared between 
matching DF(T) and DF(V) cultures.  (A and B) Represents DIABLO and Xaf1 
mRNA expression levels respectively in DF(T) before (blue) and 24 hour after 
wounding (hashed blue).  (C and D) Represents DIABLO and Xaf1 mRNA 
expression levels respectively in DF(V) before (red) and 24 hour after 
wounding (hashed red).  n=3 donors.  * p<0.05, ** p<0.005, (Student t-test).  
 
 
 
 A comparison of cultured human dermal 
fibroblasts derived from terminal and vellus hair 
bearing skin 
 
  
 
143 
 
  
3.3.7 Protein expression of IAPs in unwounded and mechanically 
wounded DF(T) and DF(V) cultures 
Immunofluorescent staining was carried out in matched DF(T) and DF(V) 
cultures to compare the expression of the IAPs, Apollon, cIAP2, NAIP and 
XIAP protein under different wounding conditions; quantification was via 
ImageJ analysis (Figure 3.10, Figure 3.12, Figure 3.13, and Figure 3.14 
respectively).   
3.3.7.1 Increased level of Apollon expression after immediate 
wounding 
Expression of Apollon was located in the cytoplasm of the dermal fibroblasts 
(Figure 3.10).  The expression of Apollon in unwounded and 24 hours following 
wounding was higher in DF(V) cells compared to matching DF(T) cells (p<0.05 
and p<0.005 respectively) (Figure 3.11A), mirroring mRNA expression 
(Figure 3.7A), which showed that unwounded DF(V) cells expressed 
approximately twice the level of Apollon mRNA than corresponding DF(T). 
By analysing the density of Apollon expression in DF(T) cells using ImageJ 
(Figure 3.10A), expression was significantly increased, (p<0.05) after 
immediate mechanical wounding, and then decreased to a level below the 
expression seen prior to wounding (p<0.0005).  Representative 
photomicrographs for the immunolocalisation of Apollon in unwounded DF(T) 
cultures, immediately, and then 24 hours following mechanical wounding are 
shown in Figure 3.10B, Figure 3.10C and Figure 3.10D respectively.   
Using ImageJ to analyse the density of Apollon in DF(V) cells (Figure 3.10E), 
no change in expression was detected immediately, nor 24 hours following 
mechanical wounding, in contrast to mRNA expression (Figure 3.8B).  
Figure 3.10F, Figure 3.10G and Figure 3.10H represents photomicrographs 
for Apollon in unwounded DF(V) cultures, immediately, and then 24 hours 
following mechanical wounding respectively.   
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Figure 3.10: High expression of Apollon in DF(V) cells compared to DF(T) cells; increased 
expression of Apollon after wounding in DF(T) cells 
Immunofluorescent expression of Apollon in DF(T) and DF(V) monolayers 
under non-wounding and wounding conditions. A) Quantitated results from 
immunofluorescent images using ImageJ for images B-D.  (B, C and D) 
Represent unwounded DF(T) cultures, time zero (T0) after immediately 
wounding, and after 24 hours (T24) respectively.  E) Quantitated results from 
immunofluorescent images using ImageJ for images F-H.  (F, G and H) 
Represent unwounded DF(V) cultures, time zero (T0) after immediately 
wounding, and after 24 hours (T24) respectively.  Green staining – Apollon, 
red staining – DAPI, blue – DF(T), red – DF(V), dashed blue line – wounded 
scratch. Magnification bar 50 µm. n=3 donors, in duplicate wells at two points, 
* p<0.05, *** p<0.0005 (ANOVA-Bonferroni test). 
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Figure 3.11: Expression levels for the IAPs normalised against DF(T) cells 
Expression levels for DF(V) cells for each IAP and wounding condition was 
normalised against matching DF(T) cells.  A) Expression level of Apollon 
protein in unwounded, immediate wounding and 24 hours after wounding.  B) 
Expression level of cIAP2 protein in unwounded, immediate wounding and 24 
hours after wounding.  C) Expression level of NAIP protein in unwounded, 
immediate wounding and 24 hours after wounding.  D)  Expression level of 
XIAP protein in unwounded, immediate wounding and 24 hours after 
wounding.  Red – DF(V), blue – DF(T).  n=3 donors, (Student-T-test), * p<0.05, 
** p<0.005.  
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3.3.7.2 No changes in cIAP2 expression levels when dermal 
fibroblast monolayers were wounded in culture 
Expression of cIAP2 was located in the cytoplasm of the dermal fibroblasts 
(Figure 3.12).  cIAP2 protein expression levels under unwounded and 
mechanically wounded conditions were similar between DF(T) and matching 
DF(V) cultures (Figure 3.11B); while mRNA expression was higher in DF(V) 
cells compared to matching DF(T) cells (Figure 3.7A). 
The expression of cIAP2 in DF(T) cultures did not change when cells were 
mechanically wounded, either at time point 0, or after 24 hours (Figure 3.12A).  
Figure 3.12B, Figure 3.12C and Figure 3.12D represents photomicrographs 
for cIAP2 in unwounded DF(T) cultures, immediately, and 24 hours following 
mechanical wounding respectively.  This was in contrast to mRNA expression, 
when expression was decreased 24 hours following mechanical wounding 
(Figure 3.8A). 
Figure 3.12E represents protein expression of cIAP2 in unwounded, 
immediately, and 24 hours following mechanical wounding in DF(V) cultures.  
In contrast to mRNA expression, which decreased after 24 hours of 
mechanical wounding (Figure 3.8B), no significant changes were seen in 
DF(V) cultures immediately or 24 hours following mechanical wounding.  
Representative photomicrographs for cIAP2 in unwounded DF(V) culture, 
immediately, and 24 hours following mechanical wounding are shown in 
Figure 3.12F, Figure 3.12G and Figure 3.12H respectively.   
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Figure 3.12: No change in cIAP2 expression when wounded 
Immunofluorescent expression of cIAP2 in DF(T) and DF(V) monolayers 
under non-wounding and wounding conditions. A) Quantitated results from 
immunofluorescent images using ImageJ for images B-D.  B, C and D) 
Represent unwounded DF(T) cultures, time zero (T0) after immediately 
wounding, and after 24 hours (T24) respectively.  E) Quantitated results from 
immunofluorescent images using ImageJ for images F-H.  F, G and H) 
Represent unwounded DF(V) cultures, time zero (T0) after immediately 
wounding, and after 24 hours (T24) respectively.  Green staining – cIAP2, red 
staining – DAPI, blue – DF(T), red – DF(V), dashed blue line – wounded 
scratch. Magnification bar 50 µm. n=3 donors, in duplicate wells at two points. 
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3.3.7.3 Expression of NAIP in DF(V) cells decreased after 
mechanical wounding of cultured monolayer 
The localisation of NAIP protein was confirmed just outside the nucleus of 
unwounded DF(T) and matching DF(V) cultures (Figure 3.13) using 
immunofluorescent staining, quantified using ImageJ.   NAIP protein 
expression between DF(T) and DF(V) cells in unwounded and 24 hours 
following mechanical wounding were similar, with lower expression in DF(V) 
monolayers immediately after mechanical wounding, p<0.005, (Figure 3.11C).  
In DF(T) cultures, NAIP protein expression did not significantly change 
immediately, or 24 hours following mechanical wounding (Figure 3.13A); this 
concurs with mRNA expression (Figure 3.8A).  Representative 
photomicrographs for NAIP in unwounded DF(T) culture, immediately and 24 
hours following mechanical wounding are shown in Figure 3.13B, 
Figure 3.13C and Figure 3.13D respectively.   
In matching DF(V) cells, protein expression levels decreased immediately 
after mechanical wounding (p<0.05) and still remained low after 24 hours 
(p<0.05) (Figure 3.13E).  Representative photomicrographs for NAIP in 
unwounded DF(T) cultures, immediately, and 24 hours following mechanical 
wounding are shown in Figure 3.13F, Figure 3.13G and Figure 3.13H 
respectively.   
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Figure 3.13: Decrease in NAIP expression in DF(V) cells after wounding 
Immunofluorescent expression of NAIP in DF(T) and DF(V) cell monolayers 
under non-wounding and wounding conditions. A) Quantitated results from 
immunofluorescent images using ImageJ for images B-D.  (B, C and D) 
Represent unwounded DF(T) cultures, time zero (T0) immediately after 
wounding, and after 24 hours (T24) respectively.  E) Quantitated results from 
immunofluorescent images using ImageJ for images F-H.  (F, G and H) 
Represent unwounded DF(V) cultures, time zero (T0) immediately after 
wounding, and after 24 hours (T24) respectively.  Green staining – NAIP, red 
staining – DAPI, blue – DF(T), red – DF(V), dashed blue line – wounded 
scratch. Magnification bar 50 µm. n=3 donors, * p<0.05 (ANOVA- Bonferroni 
test).  
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3.3.7.4 No changes in XIAP protein expression levels in matching 
DF(T) and DF(V) cells when mechanically wounded 
Localisation of XIAP protein was confirmed in the cytoplasm of DF(T) and 
matching DF(V) cultures (Figure 3.14) using immunofluorescent staining, 
quantified using ImageJ.   Expression of XIAP protein between DF(T) and 
DF(V) cultures was the same in unwounded, immediately and 24 hours 
following mechanical wounding (Figure 3.11D). This reflected mRNA 
expression between matching DF(T) and DF(V) (Figure 3.7A). 
In contrast to mRNA expression of XIAP in DF(T) cultures where expression 
decreased 24 hours following mechanical wounding (Figure 3.8A), protein 
expression levels did not change  immediately, nor 24 hours following 
mechanical wounding (Figure 3.14A).  Representative photomicrographs for 
XIAP in unwounded DF(T) cultures, immediately and 24 hours following 
mechanical wounding are shown in Figure 3.14B, Figure 3.14C and 
Figure 3.14D respectively.   
Similarly with DF(T) cultures, mRNA expression did not concur with protein 
expression (Figure 3.8B); where mRNA expression increased 24 hours 
following mechanical wounding, no change in protein expression was 
observed (Figure 3.14E).  Representative photomicrographs for XIAP in 
unwounded DF(T) culture, immediately and 24 hours following mechanical 
wounding are shown in Figure 3.14F, Figure 3.14G and Figure 3.14H 
respectively.   
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Figure 3.14: No change in XAP expression in DF(T) and DF(V) cells after wounding 
Immunofluorescent expression of XIAP in DF(T) and DF(V) cell monolayers 
under non-wounding and wounding conditions. A) Quantitated results from 
immunofluorescent images using ImageJ for images B-D.  (B, C and D) 
Represent unwounded DF(T) cultures, time zero (T0) after immediately 
wounding, and after 24 hours (T24) respectively.  E) Quantitated results from 
immunofluorescent images using ImageJ for images F-H.  (F, G and H) 
Represent unwounded DF(V) cultures, time zero (T0) after immediately 
wounding, and after 24 hours (T24) respectively.   Green staining – XIAP, red 
staining – DAPI, blue – DF(T), red – DF(V), dashed blue line – wounded 
scratch. Magnification bar 50 µm. n=3 donors.  
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3.3.8 Expression of DIABLO increased immediately after 
mechanical wounding, and returned to basal levels after 24 
hours 
The localisation of DIABLO protein was confirmed in the cytoplasm of DF(T) 
and matching DF(V) cultures with slight nuclear staining in DF(V) cells 
adjacent to the wound edge when immediately wounded, analysed via 
immunofluorescent staining and quantified using ImageJ (Figure 3.15).   
Expression of DIABLO protein between DF(T) and matching DF(V) cells 
showed no difference in unwounded cells, with higher expression in DF(V) 
cells immediately and 24 hours following mechanical wounding (p<0.05) 
(Figure 3.16A).  This data correlates with mRNA expression between DF(T) 
and DF(V) cells (Figure 3.7B). 
In contrast to mRNA expression, which showed a decrease in DIABLO mRNA 
24 hours following mechanical wounding in DF(T) and DF(V) cells (Figure 3.9A 
and Figure 3.9C respectively), protein expression increased immediately after 
mechanical wounding in DF(T) and DF(V) cultures (p<0.05 and p<0.005 
respectively), returning to basal levels 24 hours following mechanical 
wounding (Figure 3.15A and Figure 3.15E respectively).  Representative 
photomicrographs for the expression of DIABLO in DF(T) cultures 
(Figure 3.15B, Figure 3.15C and Figure 3.15D), and DF(V) cultures 
(Figure 3.15F, Figure 3.15G and Figure 3.15H) either unwounded, 
immediately, or 24 hours following mechanical wounding. 
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Figure 3.15: Increased levels of DIABLO in both DF(T) and DF(V) cells after immediate wounding, 
with expression levels returning to non-wounded levels 24hours after wounding 
Immunofluorescent expression of DIABLO in DF(T) and DF(V) cell monolayers 
under non-wounding and wounding conditions. A) Quantitated results from 
immunofluorescent images using ImageJ for images B-D.  (B, C and D) 
Represent unwounded DF(T) cultures, time zero (T0) after immediately 
wounding, and after 24 hours (T24) respectively.  E) Quantitated results from 
immunofluorescent images using ImageJ for images F-H.  (F, G and H) 
Represent unwounded DF(V) cultures, time zero (T0) after immediately 
wounding, and after 24 hours (T24) respectively.  Green staining – DIABLO, 
red staining – DAPI, blue – DF(T), red – DF(V), dashed blue line – wounded 
scratch. Magnification bar 50 µm. n=3 donors, * p<0.05, ** p<0.005 (ANOVA- 
Bonferroni test). 
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Figure 3.16: Expression levels for the IAP antagonist normalised against DF(T) cells 
Expression levels for DF(V) cells for each IAP antagonist and wounding 
condition normalised against matching DF(T) cells.  A) Expression level of 
DIABLO protein in unwounded, immediate wounding and 24 hours after 
wounding.  B) Expression level of Xaf1 protein in unwounded, immediate 
wounding and 24 hours after wounding.  Red – DF(V), blue – DF(T).  n=3 
donors, Student-T test, * p<0.05. 
A 
B 
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3.3.9 Continual decrease in Xaf1 expression after mechanically 
wounding only in DF(V) cultures 
The localisation of Xaf1 protein was confirmed in the cytoplasm of DF(T) and 
matching DF(V) cultures via immunofluorescent staining and quantified using 
ImageJ (Figure 3.17).   
When comparing the expression of Xaf1 protein between DF(T) and DF(V) 
cells under unwounded and mechanically wounded conditions, Xaf1 was 
higher in DF(V) cells immediately after mechanical wounding (p<0.05) 
(Figure 3.16B).  However, no differences were seen in unwounded cells and 
24 hours following mechanical wounding, which concurs with mRNA 
expression (Figure 3.7C) 
Xaf1 protein expression in DF(T) cells did not change following mechanical 
wounding (Figure 3.17A), this correlates with mRNA expression, which 
showed no change in Xaf1 24 hours following mechanical wounding 
(Figure 3.9B).  Representative photomicrographs for Xaf1 protein expression 
in unwounded, immediately, or 24 hours following mechanical wounding are 
given in Figure 3.17B, Figure 3.17C and Figure 3.17D respectively. 
In contrast, protein expression for Xaf1 in matching DF(V) cells decreased 
immediately following mechanical wounding (p<0.05), and continued to further 
decrease 24 hours following mechanical wounding (p<0.005) (Figure 3.17E).  
The decrease in protein levels 24 hours following mechanical wounding 
concurs with mRNA expression (Figure 3.9D).  Representative 
photomicrographs for Xaf1 protein expression in unwounded, immediately and 
24 hours following mechanical wounding are given in Figure 3.17F, 
Figure 3.17G and Figure 3.17H respectively. 
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Figure 3.17: Continual decrease in Xaf1 expression in DF(V) immediately and 24 hours after 
wounding 
Immunofluorescent expression of Xaf1 in DF(T) and DF(V) cell monolayers 
under non-wounding and wounding conditions. A) Quantitated results from 
immunofluorescent images using ImageJ for images B-D.  B, C and D) 
Represent unwounded DF(T) cultures, time zero (T0) after immediately 
wounding, and after 24 hours (T24) respectively.  E) Quantitated results from 
immunofluorescent images using ImageJ for images F-H.  F, G and H) 
Represent unwounded DF(V) cultures, time zero (T0) after immediately 
wounding, and after 24 hours (T24) respectively.  Green staining – Xaf1, red 
staining – DAPI, blue – DF(T), red – DF(V), dashed blue line – wounded 
scratch. Magnification bar 50 µm. n=3 donors, * p<0.05, ** p<0.005 (ANOVA- 
Bonferroni test). 
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3.4 Discussion 
Although previously comparisons have been made between reticular and 
papillary dermal fibroblasts (Sorrell et al., 2004; Sorrell and Caplan, 2004), and 
dermal fibroblasts from different anatomical sites (Stevenson, 2007), this is the 
first study to compare dermal fibroblasts derived from matching terminal and 
vellus hair bearing skin from a similar anatomical region of the same individual. 
3.4.1 Morphology of dermal fibroblasts 
A number of differences were observed between matching cultures of dermal 
fibroblasts derived from terminal hair bearing skin (DF(T)) and vellus hair 
bearing skin (DF(V)) of the same donor.  In the present study, a comparison 
of morphology revealed differences in terms of size and complexity/granularity 
(the number of cytoplasmic granules and membrane size), where DF(V) cells 
were smaller and more granular than matching DF(T) cells (Figure 3.4).  A 
study by Chipev and Simon (2002) demonstrated a difference in cell 
morphology between fibroblasts cultured from different anatomical regions 
such as keloid skin (a scar with overactive fibroblasts causing excessive 
deposition of ECM components), palmar (skin obtained from the palm region), 
plantar (skin from the soles of the feet) and nonplantar skin (the rest of the skin 
region which contains vellus hair follicles).  This group reported that the size 
of palmer fibroblasts were smaller, and that keloid and nonplantar fibroblasts 
were more granular than palmar and plantar fibroblasts.  They suggested that 
the difference in morphology was due to interactions with different signalling 
pathways, in particular to proteins involved in the TGFβ1 signalling pathway.  
When they compared granularity and TGFβ1 receptor II expression between 
the different dermal fibroblasts, there was a correlation between higher 
granularity of cells and higher receptor expression.  Although they did not look 
at the difference between reticular and papillary dermal fibroblasts, a later 
study by Sorrell et al. (2004) showed that structurally in a cell monolayer 
culture, there is a difference in the distribution and layout of the fibroblasts; 
further indicating that fibroblasts from different regions may possess different 
properties that could affect cell characteristics.   
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3.4.2 Migration of dermal fibroblasts 
A study by Stevenson (2007) compared migration of human female dermal 
fibroblasts from three different anatomical regions, scalp, abdomen and breast.  
In a scratch wound assay it was shown that after 48 hours, abdominal and 
scalp dermal fibroblasts had migrated faster than breast dermal fibroblasts.  
However, at the earlier time point of 24 hours, there was no significant 
difference.  Using the same scratch wound assay, scalp dermal fibroblast 
migration was compared to dermal papilla and dermal sheath cell migration; 
no difference was detected in migration 24 hours and 48 hours after scratching.  
In the present study (Figure 3.5), there was no significant difference in the 
migration of DF(T) compared to DF(V) cultures.  This demonstrates that whilst 
potentially fibroblasts from different anatomical regions migrate at different 
rates, fibroblasts from vellus and terminal hair bearing skin from a similar 
anatomical region (face/scalp) from the same donor migrate at a similar rate 
under basal conditions. 
Cell migration in vivo during wound healing will occur in different 3D directions.  
Since the experimental design of this study used a monolayer, the assessment 
of cell migration was in 2D.  There are studies that have compared the 
migration of fibroblasts in 2D and 3D models (Hakkinen et al., 2011; Rhee, 
2009).  Hakkinen et al. (2011) showed that there was a difference in direction 
and velocity of cell migration in 3D models compared to equivalent 2D models.  
This is important as it was hypothesised by McDougall et al. (2006) that 
collagen deposition is parallel to fibroblast migration, and therefore differences 
in DF(T) and DF(V) migration may affect how a scar is formed. 
3.4.3 Dermal fibroblast proliferation 
From the study by Chipev and Simon (2002), which compared the morphology 
of fibroblasts from different anatomical regions, it was observed that fibroblasts 
that had higher granularity expressed higher levels of the TGFβ1 receptor, 
which is important in driving differentiation of dermal fibroblasts into 
myofibroblasts, and is also important in dermal fibroblast proliferation (Jutley 
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et al., 1993; O'Leary et al., 2004).  In the study by Chipev and Simon (2002), 
cells that were more granular showed a lower proliferation rate, as assessed 
by measuring incorporations of 3H-thymidine to measure DNA synthesis.   
The data generated using FACS (Figure 3.4) comparing DF(T) and matching 
DF(V) cells revealed a higher granularity of DF(V) cells compared to 
corresponding DF(T) cells.  This could be important in maintaining the vellus 
hair follicle skin phenotype.  TGFβ1 shortens anagen and induces catagen in 
the hair cycle (Ohnemus et al., 2006).  Therefore, if the more granular vellus 
hair bearing dermal fibroblasts produce more TGFβ1 compared to equivalent 
terminal hair bearing dermal fibroblasts, the anagen phase may be shortened, 
and hair follicles prevented from differentiating into terminal hair follicles, 
keeping them in the vellus state.  This theory is supported by results obtained 
from Stevenson (2007), which showed that dermal fibroblasts derived from 
breast skin secreted TGFβ1 into the culture medium, while dermal fibroblasts 
derived from the scalp, dermal sheath and the dermal papilla did not. 
However, in contrast to the present study, where DF(V) cells showed a higher 
level of granularity, their rate of proliferation was also higher.  Stevenson 
(2007), using 3H-thymidine uptake to measure DNA synthesis, showed that 
dermal fibroblasts cultured in serum free medium derived from breast skin 
proliferated at a higher rate compared to those from abdominal and scalp skin, 
while there was no difference in the rate of proliferation between scalp and 
abdominal dermal fibroblasts.  The breast fibroblasts were derived from 
younger donors (mean age - 29 years), whilst both abdominal and scalp 
fibroblasts were from older donors (mean age - 52 and 49 years respectively), 
which may contribute to the difference in proliferation.  In the present study, 
the mean age of the donors used was 56 years, and each comparison between 
DF(T) and DF(V) cells were cultured from matching donors.  Also, due to the 
duration in which proliferation was measured (12 days), serum needed to be 
added to maintain viability, however in the study by Stevenson (2007), no 
serum was added, which would also influence the proliferation rate.  In the 
same study by Stevenson (2007), dermal fibroblasts derived from breast skin 
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secreted TGFβ1, while in dermal fibroblasts from scalp skin, there was no 
secretion which could be an influential factor in cell proliferation. 
TGFβ1 may not only potentially influence cell proliferation of DF(V) cells, but 
may also influence fibroblast differentiation to myofibroblasts causing more 
scarring with a higher number of fibroblasts in the region expressing α-SMA 
for contraction.  This reflects previous studies stating that skin from hairy 
regions heal better and with less scarring compared to those from non hairy 
regions (Jahoda and Reynolds, 2001; Martinot et al., 1994).  An interesting 
study to verify this claim, would be to compare the secretion of TGFβ1 using 
an ELISA assay and expression of α-SMA either via immunohistochemistry or 
mRNA expression in DF(T) and matching DF(V) cells and look at the potential 
contraction ability using a collagen gel. 
3.4.4 Expression of IAPs in wound healing 
Recently, there has been some interest in the role of IAPs in wound healing.  
Fuchs et al. (2013) in an in vivo study, demonstrated that XIAP was expressed 
in the skin and hair follicles of mice.  Its importance in wound healing was 
demonstrated by gene knockout, which confirmed that in the absence of XIAP 
function, wound healing was compromised.   
In the present study, mRNA expression of XIAP was similar between 
unwounded DF(T) and matching DF(V) cells (Figure 3.7).  However, 24 hours 
following mechanical wounding, expression of XIAP mRNA had decreased in 
DF(T) cells, whilst it had increased in DF(V) cells (Figure 3.8), although further 
analysis of the protein expression between DF(T) and DF(V) cells following 
mechanical wounding did not show a difference in expression (Figure 3.11).  
The study by Fuchs et al. (2013) demonstrated in mice that the hair follicle 
bulge (niche for epidermal stem cells) of telogen hair follicles expressed XIAP, 
and that improved wound healing was attributed to the increase in the hair 
follicle stem cells being protected against apoptosis.  The knockdown of an 
XIAP antagonist (Sept4/Arts) improved wound healing, while with the 
knockdown of XIAP, re-epithelialisation and regeneration of the mouse skin 
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was compromised. The increase of XIAP mRNA in DF(V) cells 24 hours 
following mechanical wounding, suggests that dermal fibroblasts are protected 
against apoptosis within the first 24 hours.  This may be linked to the higher 
rate of cell proliferation in DF(V) compared to DF(T) cells.  The cells were 
incubated in low serum concentrations over a 12 day period, and other studies 
have shown that low serum concentration significantly reduces proliferation 
(Kniss and Burry, 1988; Maltseva et al., 2001). Low serum rendered rat 
astrocytes quiescent (Kniss and Burry, 1988).  While fibroblasts derived from 
rabbit cornea cultured in 10% and 1% FBS for 2 days, showed a decrease in 
cell proliferation in fibroblasts cultured in 1% FBS compared to 10% FBS as 
detected by a BrdU assay (Maltseva et al., 2001).  In contrast, XIAP decreased 
within the first 24 hours in DF(T) cells (Figure 3.8), which could explain why 
they did not proliferate well under low serum concentration.  Cell viability would 
confirm the effect of low serum on DF(T) and DF(V) cell proliferation and 
apoptosis, for example using a TUNEL and BrdU assay to analyse apoptosis 
and proliferation respectively.  The difference between the changes in the 
expression of mRNA and protein may be due to a time difference, the duration 
from which XIAP mRNA is transcribed to protein is not known, therefore either 
more time is needed for protein expression to be modulated, or XIAP mRNA 
is processed immediately after wounding.  This could also be due to the 
necessity of a quick response; mRNA levels are transcribed but not converted 
into proteins until needed.  Therefore, changes in protein and mRNA 
expression need to be analysed at more frequent time intervals.   
Xaf1 is a direct XIAP target, binding to XIAP preventing XIAP from functioning 
(Liston et al., 2001).  Expression of Xaf1 mRNA was the same in DF(T) and 
DF(V) cells.  In mechanically wounded DF(T) cells, mRNA expression 
remained constant, whilst in DF(V) cells, expression decreased (Figure 3.9).  
Similarly, protein Xaf1 expression remained constant in DF(T) under wounded 
conditions, whilst expression decreased in DF(V) cells immediately and 24 
hours following mechanical wounding (Figure 3.17).  Therefore, even though 
protein expression levels of XIAP remained constant after wounding in DF(V) 
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cells, the activity of XIAP is probably enhanced following the reduction in the 
expression of Xaf1.   
In the mouse endothelial cell line (MS1), upregulation of Xaf1 caused a 
decrease in cell proliferation (Qiao et al., 2008).  This may explain the higher 
proliferation rate of DF(V) cells, with reduced expression of Xaf1.  While the 
change in the expression of Xaf1 may be due to the stress of mechanical 
wounding, low serum concentrations over a 12 day period may also subject 
the cells to stress.  To determine whether the expression of Xaf1 is altered 
with stress inducers, DF(T) and DF(V) cells should be compared under 
different conditions such as incubation with TNFα or hydrogen peroxide and 
exposure to UV.  To determine whether changes in the expression of Xaf1 
modulates cell proliferation via its interaction with XIAP, embelin, a XIAP 
inhibitor can be added to DF(T) and DF(V) cell cultures, and mRNA expression 
and protein expression analysed under different wounding conditions.  
Another method which may be used, would be to silence the XIAP gene using 
siRNA and analyse cell proliferation under different conditions. 
NAIP has been shown to have a protective function in neurones in rats against 
ischemia (Xu et al., 1997a).  Messenger RNA expression of NAIP was higher 
in DF(V) cells compared to matching DF(T) cells, however when mechanically 
wounded, expression of NAIP did not change in either DF(T) nor DF(V) cells 
(Figure 3.8).  Protein expression for NAIP in DF(T) cells did not change when 
mechanically wounded, however, protein expression in DF(V) cells was 
reduced immediately following mechanical wounding, and still remained low 
after 24 hours (Figure 3.13).  NAIP does not contain a ring domain, which is 
generally targeted for ubiquitination and degradation of proteins (Cheung et 
al., 2008).  Depending on the amino acids found in the N-terminal, the protein 
can be short lived (30 minutes) or long lived (30 hours) (Lodish et al., 2000).  
To inhibit apoptosis by binding to caspase 9, ATP is required (Davoodi et al., 
2010b), which causes a conformational change to the protein (Davoodi et al., 
2004).  Expression of NAIP protein could decrease and remain low after 24 
hours following mechanical wounding due to NAIP binding to caspase 9 to 
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prevent apoptosis causing a conformational change therefore the antibody 
might not be able to bind to the protein.  Since the levels of NAIP are initially 
low, they might not be important in the initial wound healing response.  
However, this could also be due to the fact that NAIP mRNA is more stable 
and therefore high quantities are not required for a higher rate of protein 
synthesis. 
The expression of Apollon mRNA in both DF(T) and DF(V) was much higher 
than XIAP, NAIP and cIAP2 (Figure 3.7), suggesting that in dermal fibroblasts 
Apollon may have an important role.  A study in mice with a mutant Apollon 
gene reported that the mice died between day 11.5 and 14.5 of embryonic 
development (Hitz et al., 2005).  This was due to the lack of proliferation of 
spongiotrophoblast in placental development, indicating that Apollon is 
important in cell division.  Another study, but in vitro, demonstrated that in the 
endothelial cell line (LoVo), blocking of Apollon, inhibited cell proliferation (He 
et al., 2011).  Messenger RNA and protein expression of Apollon was higher 
in DF(V) cells than corresponding DF(T) cells (Figure 3.7 and Figure 3.10 
respectively); if Apollon does indeed affect cell division and proliferation, it 
could explain the increased rate of proliferation in DF(V) cells compared to 
matching DF(T) cells.  To establish the effect of Apollon on cell proliferation, a 
comparison of the proliferation of DF(T) and DF(V) cells should be carried out 
following gene silencing of Apollon.   
Expression of Apollon mRNA did not change 24 hours following mechanical 
wounding in DF(T) cells, however, it decreased in DF(V) cells (Figure 3.8).  
Protein expression in DF(T) cells increased immediately following mechanical 
wounding, returning to unwounded level of expression after 24 hours, whilst 
no change in protein expression was seen in DF(V) cells (Figure 3.10).  This 
could be due to a specific expression level needed to respond to an inflicted 
wound.  Since the levels of Apollon protein were already higher in unwounded 
DF(V) cells compared to corresponding DF(T) cells, the increase in Apollon 
protein expression immediately following mechanical wounding in DF(T) cells 
brought protein levels to those seen in DF(V) cells.  Which would suggest that 
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in mechanically wounded cells Apollon is needed at a specific level to protect 
DF(T) and DF(V) cells. 
cIAP2 is important in regulating apoptosis in epithelial cells (Roscioli et al., 
2013).  cIAP2 protects cells against damage and apoptosis when stressed, for 
example, in rat liver, cIAP2 expression increased when hepatocytes were 
exposed to bile duct ligation (Schoemaker et al., 2003).  Expression of cIAP2 
mRNA was higher in DF(V) cells compared to matching DF(T) cells 
(Figure 3.7).  When mechanically wounded, mRNA expression decreased in 
both DF(T) and DF(V) cells (Figure 3.8), while protein expression remained 
the same, and was similarly expressed in DF(T) and DF(V) cells (Figure 3.12).   
The reduction of mRNA expression 24 hours after mechanical wounding would 
suggest that this protein was not important in the proliferation and migration of 
dermal fibroblasts following mechanical wounding, at least not immediately. 
There is increasing evidence to suggest that another IAP, Survivin, may 
potentially have another role apart from inhibiting apoptosis (Botchkareva et 
al., 2007; Dallaglio et al., 2012; Dallaglio et al., 2009).  Survivin has been 
associated with cell proliferation in keratinocytes; while over expression of 
Survivin does not modulate keratinocyte proliferation, down regulation of 
Survivin impairs the ability of keratinocytes to proliferate (Thomas et al., 2007).  
Therefore, potentially, changes in the expression of IAP mRNA and proteins 
in dermal fibroblasts could modulate cell proliferation.  Since DF(V) cells 
proliferated faster than corresponding DF(T) cells, and only Apollon protein 
expression was higher in DF(V) cells compared to DF(T) cells in unwounded 
conditions (Figure 3.11), this could indicate a potential role for Apollon in 
dermal fibroblast proliferation.  Silencing the Apollon gene in DF(V) cells and 
analysing DF(V) cell proliferation would establish how much Apollon can 
influence cell proliferation. 
DIABLO is an IAP antagonist (Verhagen et al., 2000), it is mostly associated 
with cIAP1, cIAP2 and XIAP, however it prevents all IAP interactions with 
caspase 9, thereby promoting apoptosis.  Messenger RNA expression of 
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DIABLO was higher in DF(V) cells compared to DF(T) cells (Figure 3.7).  When 
wounded, mRNA expression decreased in both DF(T) and DF(V) cells 
(Figure 3.9), suggesting it is downregulated.  Its protein expression increased 
immediately following mechanical wounding, decreasing to unwounded levels 
after 24 hours in both DF(T) and corresponding DF(V) cells.  The immediate 
increase in DIABLO protein could suggest that it is functioning to regulate other 
IAP expressions, to allow cell death to occur in damaged cells, but is not 
required after 24 hours.  Using a TUNEL assay on wounded cells in correlation 
with DIABLO antibody, will highlight whether cells undergoing apoptosis also 
express DIABLO.  The increase in expression could however indicate that 
DIABLO might not only function to antagonise IAPs, since in situ, DIABLO 
expression was high in the epidermis, dermis and hair follicle of both terminal 
and vellus hair bearing skin (Figure 2.9 and Table 2.8).  Although protein 
expression for DIABLO in unwounded cells was similar between DF(T) and 
DF(V) cells, when wounded, DIABLO was higher in DF(V) cells.  This could 
indicate that DIABLO plays a more crucial role in DF(V) cells in regulating IAP 
expression and preventing apoptosis. 
 DF(V) cells compared to 
DF(T) cells 
Size Smaller and more granular 
Proliferation Higher 
Migration No difference 
 
mRNA expression of: DF(V) cells compared to 
DF(T) cells 
 Effect of wounding cells 
on: 
DF(V) cells compared to 
DF(T) cells 
NAIP Higher  NAIP Higher 
cIAP2 Higher  cIAP2 Higher 
Apollon Higher  Apollon Higher  
XIAP Same  XIAP Higher 
     
DIABLO Higher  DIABLO Higher 
Xaf1 Same  Xaf1 Same 
Table 3.4: Comparison between DF(T) and DF(V) cells 
A comparison between DF(V) and DF(T) cells in size, proliferation and 
migration, and mRNA expression of the IAPs NAIP, cIAP2, Apollon and XIAP, 
their antagonists DIABLO and Xaf1 under wounded and non-wounded 
conditions.  
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3.5 Conclusion 
This chapter demonstrates there are significant differences between dermal 
fibroblasts cultured from the same region of skin that contains either terminal 
(DF(T)) or vellus (DF(V)) hair follicles of the same donor.  Morphologically, 
DF(V) cells are smaller and more complex than DF(T).  While DF(T) and DF(V) 
cells migrate at a similar rate in culture, DF(V) cells proliferate at a faster rate 
than corresponding DF(T) cells. 
The expression of the IAPs NAIP, cIAP2, XIAP and Apollon and the IAP 
antagonists DIABLO and Xaf1 were shown to be present in both DF(T) and 
DF(V) cells at both transcriptional and protein levels. 
At the mRNA level, expression of NAIP, cIAP2, Apollon and DIBALO was 
higher in DF(V) cells compared to DF(T) cells, however, at the protein level, 
only the expression of Apollon was higher in DF(V) cells. 
Mechanical wounding of the cell monolayer increased mRNA expression of 
XIAP in DF(V) cells, but decreased expression in corresponding DF(T) cells.  
Mechanical wounding decreased cIAP2 mRNA expression in both DF(T) and 
DF(V) cells.  The expression of Apollon mRNA was only decreased in DF(V) 
and not DF(T) cells following mechanical wounding.  DIABLO mRNA 
expression decreased in both DF(T) and DF(V) cells, whilst only DF(V) cells 
showed a reduction in Xaf1 mRNA expression following mechanical wounding. 
In contrast, mechanical wounding increased the protein expression of Apollon 
in DF(T) and decreased the protein expression of NAIP in DF(V) cells; there 
was no change in the protein expression of any of the other IAPs in either 
DF(T) nor DF(V) cells.  Protein levels of DIABLO increased immediately 
following mechanical wounding, but returned to unwounded levels 24 hours 
later in both DF(T) and DF(V) cells, while the expression of the specific XIAP 
inhibitor Xaf1 was reduced only in DF(V) cells. 
In summary, this chapter has demonstrated there are significant differences in 
morphology, proliferative potential, IAP expression and changes in IAP 
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expression in a scratch wound assay, in a direct comparison of dermal 
fibroblasts cultured from the same region of skin that contain terminal hair 
follicles (scalp) and vellus hair follicles (facial) of the same donor.  
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Chapter 4 
A COMPARISON OF THE EFFECT OF 17Β-OESTRADIOL 
ON CULTURED HUMAN DERMAL FIBROBLASTS 
DERIVED FROM TERMINAL AND VELLUS HAIR BEARING 
SKIN 
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 A Comparison of the Effect of 17β-Oestradiol on Cultured 
Human Dermal Fibroblasts Derived from Terminal and 
Vellus Hair Bearing Skin 
4.1 Introduction 
As mentioned in the previous chapters, IAPs have been implicated in 
oestrogen responses, in particular XIAP.  There are some studies that have 
linked the regulation of IAPs by 17β-oestradiol.  A study by Leblanc et al. 
(2003) demonstrated that in rat endometrium cells 17β-oestradiol altered XIAP 
and DIABLO levels, XIAP increased while DIABLO expression was reduced.  
Another study by Siegel et al. (2011) showed that XIAP is gender specific, in 
that the levels of XIAP in mice brain tissue was higher in females compared to 
age matched males.  However, in this study, ovariectomised mice, treated with 
17β-oestradiol showed no difference in XIAP levels to ovariectomised mice 
treated with oil.  No other studies have looked at the effect of 17β-oestradiol 
on other IAP levels in skin.  Since there has been some link between treatment 
with 17β-oestradiol and IAP expressions, it would be important to investigate 
if there are any differences in oestrogen receptor expression and how they 
may be affected by 17β-oestradiol between DF(T) and DF(V) cells.  In dermal 
fibroblasts, 17β-oestradiol has been implicated in increasing dermal fibroblast 
proliferation (Son et al., 2005; Stevenson, 2007; Stevenson et al., 2005; 
Stevenson and Thornton, 2007). 
4.1.1 Expression of oestrogen receptors in skin and hair follicles 
Thornton et al. (2003b) demonstrated by immunohistochemistry that ERβ was 
the predominant oestrogen receptor expressed in male and female androgen 
independent scalp skin.  Both ERα and ERβ were expressed in the sebaceous 
glands and in the papillary dermis, with stronger expression of ERβ.  Nuclear 
staining for ERβ was detected in the bulb region of the hair follicle and also in 
the outer root sheath and the bulge region.  Later, Kwon et al. (2004) in a 
comparison of male human androgen dependant and independent scalp using 
PCR and immunofluorescent staining, showed that ERα and ERβ were 
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expressed in the dermal papilla cells in both hair follicle types, with higher 
expression of both ERα and ERβ in the androgen independent hair follicle.  A 
study by Qiao et al. (2012) demonstrated that in human foreskin, both ERα 
and ERβ were expressed, with expression of ERα in the basal levels of the 
epidermis.  Another study by Jang et al. (2010), also demonstrated the 
expression of oestrogen receptor in the cheek skin of women. 
In postmenopausal women, oestrogen levels decrease, skin becomes thinner, 
with reduced collagen content in the dermis and decreased skin elasticity 
(reviewed by Thornton (2013)); while replacement of oestrogen reverses the 
effects.  An immunohistochemical study comparing oestrogen receptor 
expression of young and old donors in both sexes, showed that there was a 
significant decrease in ERβ expression in the epidermis of adults aged over 
70 years (Inoue et al., 2011). 
Topical treatment of human skin with 17β-oestradiol increases collagen 
synthesis, and epidermal keratinocyte proliferation (Son et al., 2005).  While 
type I and III collagen decreases in the dermis of female skin 5 years after 
menopause (by up to 30%) (Affinito et al., 1999); the ratio of type III:type I 
collagen is also reduced.  Topical 17β-oestradiol treatment increases the 
expression of the TGFβ2 receptor, which has been associated with dermal 
fibroblast proliferation and collagen secretion (Son et al., 2005). 
4.1.2 Effect of 17β-oestradiol on wound healing 
Oestrogen has been well established to have a positive effect during wound 
healing by enhancing re-epithelialisation and collagen deposition in both 
human and mouse skin (Ashcroft et al., 1997a; Campbell et al., 2010). 
In the proliferative phase of wound healing, there was a delay in wound re-
epithelialisation with reduced oestrogen (Ashcroft et al., 1997a), this was 
observed by comparing wound healing from pre- and post-menopausal 
women, this effect was reversed with the replacement of oestrogen via 
hormone replacement therapy (HRT).  In aged donors not taking HRT, TGFβ1 
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decreased compared to young donors.  Donors taking HRT, however showed 
an increase in TGFβ1, suggesting that 17β-oestradiol stimulates the 
production of TGFβ1. Due to the increase in TGFβ1 an increase in collagen 
production was seen in women taking hormone replacement compared to 
those deficient in oestrogen (Ashcroft et al., 1997a).  In both male and female 
geriatrics, topical oestrogen increased collagen production, however, there 
was higher collagen deposition in female compared to males (Ashcroft et al., 
1999). 
Cell migration is an important aspect of wound healing.  Two important cell 
types required to migrate in wounds are the dermal fibroblasts and the 
epidermal keratinocytes.  A study by Stevenson et al. (2008b) showed that 
dermal fibroblasts derived from female facelift donors had an increased rate 
of cell migration when incubated with 17β-oestradiol; however, this effect was 
not seen with corresponding dermal sheath and dermal papilla cells.  Further 
studies demonstrated that the increase in dermal fibroblast migration was seen 
with an ERα agonist, but not with an ERβ agonist.  Interestingly dermal 
fibroblast migration in the presence of the ERα agonist was significantly higher 
than with 17β-oestradiol alone, indicating the importance of the ERα in dermal 
fibroblast migration. 
TGFβ1 secretion increased in dermal fibroblasts that were incubated with 17β-
oestradiol (Stevenson et al., 2008a).  When cells were mechanically wounded, 
TGFβ1 secretion also increased, however, when mechanically wounded cells 
were treated with 17β-oestradiol, it inhibited TGFβ1 secretion.  Indicating that 
17β-oestradiol controls collagen synthesis and dermal fibroblast proliferation 
in wounded conditions. 
Another study by (Stevenson, 2007) compared the proliferative rate of dermal 
fibroblasts derived from breast, abdominal and scalp skin using the 3H-
thymidine assay.  In this study, mechanically wounding these cells also 
induced proliferation.  In wounded dermal fibroblast cells, 17β-oestradiol 
increased cell proliferation, while having no effect on unwounded cells. 
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4.1.3 Aim 
The previous chapter demonstrated that dermal fibroblasts from a similar 
anatomical region, derived from skin bearing either terminal (scalp) or vellus 
(facial) hair follicles exhibit different characteristics in terms of proliferation, 
morphology, and expression of IAPs; in particular XIAP.  XIAP is an X-
chromosome linked IAP, its expression is gender specific (Siegel et al., 2011).  
Ovariectomised mice treated with 17β-oestradiol resulted in an increase in 
XIAP levels in the endometrium (Leblanc et al., 2003).  This suggests that IAPs 
potentially can be regulated by 17β-oestradiol, which could be an important 
pathway involved in improved wound healing by 17β-oestradiol. 
Therefore, the first aim of this chapter was to compare the expression of ERα 
and ERβ in situ, in terminal and vellus hair bearing skin using 
immunofluorescent staining.  A study of ERα and ERβ expression and 
localisation has been done in both males and females, showing no difference 
in expression (Thornton et al., 2003a).  However, this is the first study to 
compare the expression of ERα and ERβ, between vellus and terminal hair 
bearing skin of the same donor. 
The previous chapter also highlighted differences in the proliferative capability 
of matching cultures of DF(T) and DF(V) cells.  Therefore, the second aim of 
this chapter was to determine whether DF(T) and DF(V) cells incubated with 
17β-oestradiol exhibit different responses to proliferation and migration in the 
presence of 17β-oestradiol. 
Since immunofluorescent staining is semi-quantitative and there was no 
reliable antibody for GPR30 at the time, the third aim was to quantitate the 
expression of mRNA for oestrogen receptors (ERα, ERβ and GPR30) in 
unwounded and mechanically wounded DF(T) and matching DF(V) cells using 
qRT-PCR.  Since 17β-oestradiol can upregulate the expression of oestrogen 
receptors (Choi, 2007; Mahmoodzadeh et al., 2010), mRNA expression for 
oestrogen receptors was also analysed in unwounded and mechanically 
wounded DF(T) and DF(V) cells incubated in the presence of 17β-oestradiol.  
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4.2 Material and Methods 
4.2.1 Human skin 
Donor skin samples used in this chapter: 
Donor ID Age Gender S(T) S(V) 
OK18 56 Female   
OK26 50 Female   
OK27 57 Female   
Table 4.1: Donor information for skin samples used for immunofluorescent staining 
Matching vellus and terminal hair bearing skin samples from three donors were 
used for immunofluorescent staining, age range (50-57).  S(T) – terminal hair 
bearing skin, S(V) – vellus hair bearing skin. 
Donor ID Age Gender DF(T) DF(V) 
OK14 2, 3 57 Female   
OK15 2, 3 36 Female   
OK17 2 53 Female   
OK18 1, 2, 3 56 Female   
OK21 1 64 Female   
OK24 1 57 Female   
Table 4.2: Donor information for samples used for dermal fibroblast cell culture 
Donors used to culture matching dermal fibroblasts from terminal hair bearing 
skin DF(T), or vellus hair bearing skin (DF(V).  1 - used for cell migration, 2 - 
used for cell proliferation, 3 - used for PCR analysis. 
4.2.2 Cryosectioning 
Using the same method previously described in section 2.2.2, human skin 
sections from facelift patients containing terminal and vellus hair follicles 
(Table 4.1) were cut using a cryostat at 10µm thickness for immunofluorescent 
staining. 
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4.2.3 Immunofluorescent staining of human skin for ERα and ERβ 
Using the same method previously described in section 2.2.4, 
immunofluorescent staining of skin samples for the expression of ERα and 
ERβ (Table 4.3) in matching terminal and vellus hair bearing skin was carried 
out. 
Antibody (type): Raised in: Manufacturer: Analysed in: Dilution Ratio: 
ERα (1˚) R SantaCruz H 1:100 
ERβ (1˚) R SantaCruz H 1:100 
FITC (2˚) D anti R Abcam H 1:200 
Table 4.3: Antibody dilution ratio used for immunofluorescence staining 
A list of the primary and secondary antibodies used for immunofluorescent 
expression, and their dilutions.  R – Rabbit, D – Donkey, H – Human. 
4.2.4 Effect of 17β-oestradiol on dermal fibroblast cell 
proliferation in vitro 
Matching DF(T) and DF(V) cultures from four donors at passage 3-4 
(Table 4.2) were seeded at 10,000 cells per well in 6 well plates in phenol red 
free medium containing either 2% or 5% charcoal striped foetal bovine serum 
(Invitrogen) in the presence or absence of 1nM 17β-oestradiol (Sigma).  
Medium was changed every other day with cells counted every two days over 
a 12 day period; each treatment was done in triplicate wells, and each well 
was counted twice using a haemocytometer. 
Activated carbon removes non-polar materials such as hormones and 
cytokines (Cao et al., 2009), allowing the study of oestrogen on dermal 
fibroblasts without additional hormone influences.  In addition, since phenol 
red may act as a weak oestrogen (Berthois et al., 1986), all experimental 
procedures involving 17β-oestradiol were conducted in phenol red free 
medium, since phenol red increases migration in human scalp dermal 
fibroblast (Stevenson, 2007). 
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4.2.5 The effect of 17β-oestradiol on cultured dermal fibroblast 
migration in a scratch wound assay 
To assess whether 17β-oestradiol had an effect on cell migration, a scratch 
wound assay, which is a well established method for assessing migration was 
carried out (see section3.2.3).  Matching DF(T) and DF(V) cultures from three 
donors (Table 4.2) all at passage three, were seeded in 6 well plates at a 
density of 200,000 cells per well and left to grow until fully confluent (DF(V) – 
4 days, DF(T) – 1 week). Growth medium was changed every three days.  
Once cells became fully confluent, the growth medium was removed, and the 
cells were washed twice with PBS.  2mls of serum free and phenol red free 
medium was added to each well and cells were incubated for a further 24 
hours.  Cells were scratched using the scratch wound device (Figure 3.2A).  
Cells were treated with different concentrations of 17β-oestradiol (1nM, 10nM 
and 100nM) and a vehicle control (0.001% absolute ethanol) in the presence 
of 10µg/ml mitomycin C as previously described (Stevenson et al., 2009).  A 
template was placed under the 6 well plates (Figure 3.2B) and images were 
taken under a phase contrast microscope (Ernst Leitz Wetzlar GMBH, 
Germany) using a camera (Nikon coolpix4500 – 4x lens magnification, Japan) 
at time point zero and after 24 hours of incubation.  Each condition was done 
in triplicate wells. 
4.2.6 qRT-PCR 
Primers were designed for ERα, ERβ and GPR30 using PrimerBlast (NCBI): 
Primer: Forward Sequence: Reverse Sequence: Annealing Temp: 
ERα TGGGCTTACTGACCAACCTG CCTGATCATGGAGGGTCAAA 62.2˚C 
ERβ AGAGTCCCTGGTGTGAAGCAA GACAGCGCAGAAGTGAGCATC 62.2˚C 
GPR30 ATGGATGTGACTTCCCAAGC GAACAGGCCGATCACGTACT 62.2˚C 
GAPDH TATAAATTGAGCCCGCAGCC CGACCAAATCCGTTGACTCC 62.2 and 58.6˚C 
Table 4.4: Primers used and their annealing temperature 
Each primer was designed using PrimerBlast and annealing temperature 
optimised via quantitative PCR optimisation 
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Matching DF(T) and DF(V) cultures from three different donors (Table 4.2) at 
passage 3-4 were seeded into 6 well plates at a density of 200,000 cells per 
well and left to grow until fully confluent (DF(V) – 4 days, DF(T) – 1 week); 
growth medium was changed every three days.  Once cells reached full 
confluence, the medium was removed and the cells were washed with PBS 
twice, before incubating in phenol red and serum free medium for 24 hours.  
Cells were either scratched in a “hash” (#) pattern using a 1ml pipette tip, or 
left unwounded.  Cells were incubated with either 1nM 17β-oestradiol or 
vehicle control (0.001% absolute ethanol) for 24 hours, and then RNA 
extraction and quantitative real time PCR was carried out as described in 
section 3.2.5 using the primers shown in Table 4.4. 
4.2.7 Statistics 
For the cell migration assay to compare effects of different 17β-oestradiol 
concentrations on DF(T) and DF(V) cells, a one way analysis of variance 
(ANOVA) followed by a Dunnett’s  test, to determine significance between 
different concentrations and the control.  For cell proliferation and PCR, an un-
paired Students T-test of unequal variance was conducted between DF(T) and 
DF(V) cells. 
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4.3 Results 
4.3.1 Expression levels and localisation of ERα and ERβ in 
terminal and vellus bearing skin 
Immunofluorescent staining was carried out on matching terminal and hair 
bearing facial/scalp skin from three donors to compare the expression of ERα 
and ERβ (Figure 4.1).   
4.3.1.1 A comparison of the expression of ERα between terminal 
and vellus hair bearing skin from the same donors 
Overall, expression of ERα was lower in vellus hair bearing skin compared to 
terminal hair bearing skin (Figure 4.1A and C respectively), in both the 
epidermis and the dermis.  In the vellus hair bearing skin, epidermal ERα 
expression was cytoplasmic, whilst in terminal hair bearing skin it was both 
cytoplasmic and nuclear.   
The expression of ERα was not seen in the vellus hair follicle (Figure 4.1B).  
In contrast, in terminal hair follicles, ERα was highly expressed in the inner 
and outer root sheath, the dermal sheath, the epithelial cells of the hair matrix, 
with weak expression in the dermal papilla (Figure 4.1D and E). 
A summary of the expression of ERα in terminal and vellus hair bearing skin 
is given in Table 4.5A. 
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4.3.1.2 A comparison of the expression of ERβ between terminal 
and vellus hair bearing skin from the same donors 
Epidermal expression of ERβ was lower in vellus hair bearing skin compared 
to terminal hair bearing skin (Figure 4.1A and C respectively); whilst in the 
dermis, expression of ERβ was low in both.   
The expression of ERβ was low in the inner and outer root sheath and hair 
matrix, with little expression in the dermal papilla of the terminal hair follicles 
(Figure 4.1D and E).  In comparison, higher expression was seen in vellus hair 
follicle compartments, including the inner and outer root sheath, hair matrix, 
dermal papilla and dermal sheath (Figure 4.1B).  Expression of ERβ was 
cytoplasmic throughout. 
A summary of the expression of ERβ in terminal and vellus hair bearing skin 
is given in Table 4.5A. 
 A Skin Hair Follicle 
ERα EK DF IRS ORS HM DP DS 
S(T) +++ +++ +++ +++ +++ + +++ 
S(V) ++ ++  - -  -  -  -  
        
 B Skin Hair Follicle 
ERβ EK DF IRS ORS HM DP DS 
S(T) +++ + + + + -/+ + 
S(V) ++ +  ++ ++ ++ +  +  
Table 4.5:  Summary table for the expression and localisation of ERα and ERβ in terminal and 
vellus hair bearing skin 
Expression of ERα and ERβ in terminal and vellus hair bearing skin and hair 
follicles.  A) ERα expression in terminal and vellus hair bearing skin.  B)  ERβ 
expression in terminal and vellus hair bearing skin.  ER – oestrogen receptor, 
EK – epidermal keratinocyte, DF – dermal fibroblasts, IRS – inner root sheath, 
ORS – outer root sheath, DP – dermal papilla, DS – dermal sheath, S(T) – 
terminal hair bearing skin, S(V) – vellus hair bearing skin.  + low expression, 
++ moderate expression, +++ high expression, n=3 donors. Red – 1 donor.  
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4.3.2 17β-oestradiol has no effect on DF(T) and DF(V) 
proliferation 
DF(T) and matching DF(V) cells from four different donors were incubated in 
the presence or absence of 1nM 17β-oestradiol in the presence of either 2% 
or 5% charcoal stripped serum for 12 days and counted every other day 
(Figure 4.2).   
In 2% charcoal stripped serum, DF(T) cells showed no increase in the rate of 
proliferation over a 12 day period in the presence or absence of 17β-oestradiol 
(Figure 4.2A).  However, in DF(V) cells, in the absence of 17β-oestradiol cell 
number was significantly higher at day 2 (p<0.0005) and day 4 (p<0.05) only.  
Subsequent days showed no significant difference in cell number compared 
to day 0.  No significant increase in cell number was observed in DF(V) cells 
in the presence of 17β-oestradiol (Figure 4.2A). 
In 5% charcoal stripped serum, DF(T) cells showed no increase in number 
over a 12 day period in the presence or absence of 17β-oestradiol 
(Figure 4.2B).  However, DF(V) cells showed a significant increase in the 
absence of 17β-oestradiol at days 2 (p<0.05), 4 (p<0.005), 6 (p<0.05), 8 
(p<0.05), 10 (p<0.005) and 12 (p<0.05) and in the presence of 17β-oestradiol 
at day 2 (p<0.005), 4 (p<0.005), 6 (p<0.05), 8 (p<0.005), 10 (p<0.005) and 12 
(p<0.05) compared to day 0 (Figure 4.2B).  However the increased number of 
cells was not significantly different in DF(V) cells between cells incubated in 
the presence and absence of 17β-oestradiol. 
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Figure 4.2: 17β-oestradiol has no effect on proliferation of DF(T) and matching DF(V) cells at 2 
and 5% charcoal stripped serum 
Cell counting was used to determine the rate of proliferation over 12 days for 
DF(T) and matching DF(V) cells in the presence and absence of 17β-
oestradiol in either 2% or 5% charcoal stripped serum.  A) 2% charcoal 
stripped serum.  B) 5% charcoal stripped serum.  Dark blue – DF(T) vehicle 
control, light blue – DF(T) 1nM 17β-oestradiol, red – DF(V) vehicle control, 
pink – DF(V) 1nM 17β-oestradiol. n=4 donors, in triplicate wells, each well 
counted twice. */# p<0.05, **/##p<0.005, ***p<0.0005. */# - increase in DF(V) cell 
number in the absence/presence of 17β-oestradiol compared to day 0.  
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4.3.3 17β-oestradiol accelerated migration of DF(T) but not DF(V) 
cultures in a scratch wound assay 
The effect of 17β-oestradiol on migration was compared between matching 
DF(T) and DF(V) cells derived from three different female donors.  Figure 4.3 
gives the quantification of the mean cell migration 24 hours following 
scratching of matching DF(T) and DF(V) cultures derived from three donors.  
A significant increase in dermal fibroblast migration was seen in DF(T) cultures 
in the presence of 1nM 17β-oestradiol (p<0.05), and 100nM 17β-oestradiol 
(p<0.005); with distance migrated almost twice that of the dermal fibroblasts 
incubated with the vehicle control.  In contrast, 17β-oestradiol did not 
significantly increase the migration of matching DF(V) cultures under the same 
conditions. 
 
Figure 4.3:  17β-oestradiol increases migration of DF(T) but not DF(V) cells in a scratch wound 
assay 
Quantitative representation of cell migration after 24 hours was assessed in 
matching DF(T) and DF(V) cultures using a scratch wound assay in the 
presence of 17β-oestradiol at different concentrations (1nM, 10nM and 
100nM) against vehicle control - 0.001% absolute ethanol (VC) all in the 
presence of 10µg/ml Mitomycin C.  Red – DF(V) cells, blue – DF(T) cells.  n=3 
donors in triplicate wells at six different regional points.  * p<0.05, ** p<0.005 
(ANOVA – Dunnett’s test).  
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4.3.4 DF(T) cultures express higher mRNA levels of GPR30 and 
ERα than matching DF(V) cultures 
Quantitative real time PCR was carried out on matching cultures of DF(T) and 
DF(V) derived from three female donors to compare the gene expression of 
the three oestrogen receptors, GPR30, ERα and ERβ in both unwounded and 
mechanically wounded dermal fibroblast cultures (Figure 4.4).   
Expression of GPR30 was approximately three times higher in DF(T) cells 
compared to DF(V), (p<0.05).  When DF(T) monolayers were mechanically 
wounded, mRNA expression of GPR30 was reduced to approximately half the 
level of expression seen in unwounded cells, (p<0.05).  In contrast, no change 
in expression of GPR30 was seen when DF(V) cells were mechanically 
wounded (Figure 4.4). 
The expression of mRNA for ERα was approximately three times higher in 
DF(T) cultures compared to matching DF(V) cultures, (p<0.05).  When DF(T) 
cultures were mechanically wounded, mRNA expression of ERα was reduced 
to about 25% of its expression in unwounded cells, (p<0.005).  In contrast 
there was no change in the expression of ERα in DF(V) cultures 24 hours after 
mechanical wounding (Figure 4.4). 
A similar level of mRNA expression of ERβ was seen in matching cultures of 
DF(T) and DF(V) (Figure 4.4).  However, mRNA expression in both DF(T) and 
DF(V) cultures was significantly reduced 24 hours following mechanical 
wounding, (p<0.05 and p<0.0005 respectively). 
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Figure 4.4: Higher levels of GPR30 and ERα in DF(T) cells compared to matching DF(V) cells, 
mRNA expression decreases in DF(T) cells when wounded 
A comparison of the mRNA expression of GPR30, ERα and ERβ in matching 
DF(T) and DF(V) cultures derived from female donors, (n=3) by qRT-PCR.  
Data was normalised against GAPDH under all conditions.  Blue – DF(T), red 
– DF(V), solid – unwounded cells, hashed – wounded cells.  Student T-test, 
n=3 donors in triplicates, * p<0.05 ** p<0.005, *** p<0.0005. 
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4.3.5 Changes in GPR30, ERα and ERβ mRNA in matched DF(T) 
and DF(V) cultures in the presence of 17β-oestradiol 
following mechanical wounding 
4.3.5.1 Increased mRNA levels of GPR30 in DF(V) cultures 
following mechanical wounding in the presence of 17β-
oestradiol  
17β-oestradiol had no effect on GPR30 mRNA expression of unwounded and 
mechanically wounded DF(T) monolayers (Figure 4.5A).  Although 17β-
oestradiol did not modulate the expression of GPR30 of unwounded donor 
matched DF(V) cultures, expression of GPR30 increased (~100%) when 
DF(V) monolayers were mechanically wounded (p<0.05). 
4.3.5.2 Increased mRNA levels of ERα in matching DF(T) and DF(V) 
cultures following mechanical wounding in the presence of 
17β-oestradiol  
17β-oestradiol had no effect on mRNA expression of ERα of unwounded 
DF(T) cultures (Figure 4.5B).  When DF(T) cells were mechanically wounded, 
17β-oestradiol caused an increase (~50%) in ERα mRNA expression (p<0.05), 
but still only bringing it to a level significantly lower (~56%) than corresponding 
unwounded DF(T) cells. 
In matching unwounded DF(V) cultures, 17β-oestradiol had no effect on ERα 
mRNA levels (Figure 4.5B).  There was an increase (~88%) in ERα mRNA 
levels in DF(V) cultures incubated with 17β-oestradiol following mechanical 
wounding (p<0.05), which was higher (~100%) than ERα expression in 
corresponding unwounded DF(V) cells (p<0.05).  
4.3.5.3 mRNA expression levels of ERβ were higher in wounded 
DF(T) cells in the presence of 17β-oestradiol  
17β-oestradiol had no effect on ERβ mRNA expression in unwounded DF(T) 
cultures (Figure 4.5C).  Expression of ERβ was increased (~133%) in 
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mechanically wounded DF(T) cells incubated with 17β-oestradiol, (p<0.05), 
but still only bringing it to a level significantly lower (~56%) than corresponding 
unwounded DF(T) cells.   
In matching DF(V) cultures, mRNA expression of ERβ was not modulated with 
17β-oestradiol treatment in either unwounded or mechanically wounded DF(V) 
cells.  Therefore, mRNA expression in wounded, 17β-oestradiol treated cells 
was significantly lower (~33%) than corresponding unwounded cells 
(p<0.005). 
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Figure 4.5: A comparison of mRNA expression levels for GPR30, ERα and ERβ in matching DF(T) 
and DF(V) cells in the presence of 17β-oestradiol in unwounded and wounded cells 
A comparison of the mRNA expression of GPR30, ERα and ERβ in matching 
DF(T) and DF(V) cultures derived from female donors treated with 17β-
oestradiol, normalised against GAPDH using qRT-PCR.  A) GPR30 mRNA 
expression in DF(T) and DF(V) cultures.  B) ERα mRNA expression in DF(T) 
and DF(V) cultures.  C) ERβ mRNA expression in DF(T) and DF(V) cultures.  
Dark blue – DF(T) vehicle control, light blue – DF(T) 1nM 17β-oestradiol, red 
– DF(V) vehicle control, pink – DF(V) 17β-oestradiol, solid bar – unwounded 
cells, hashed bar – wounded cells.  n=3 donors in triplicates, Student T-test, 
*/# p<0.05, ** p<0.005, *** p<0.0005. * - between unwounded and wounded 
cells, # - between wounded cells.  
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4.4 Discussion 
Previous studies have investigated the expression of ERα and ERβ in human 
skin and hair follicles of both sexes (Kwon et al., 2004; Thornton et al., 2003a, 
b).  However, this is the first study to compare the expression of ERα and ERβ 
between terminal (scalp) and vellus (facial) hair bearing skin derived from the 
same donor. 
4.4.1 In situ expression of ERα and ERβ in human terminal and 
vellus hair bearing skin 
Expression of ERα in the epidermis and dermis of terminal hair bearing skin 
was slightly higher compared to matching vellus hair bearing skin (Figure 4.1 
and Figure 2.9).  This would suggest that scalp terminal hair bearing skin is 
more responsive and more regulated by 17β-oestradiol compared to 
corresponding facial vellus hair bearing skin from the same donor.  It is 
important to note that the donor age range was 50-57, therefore their skin had 
been potentially sun-exposed for a long duration of time.  Also, no information 
of topical medicinal cream application is known, which could potentially 
influence oestrogen receptor expression.  A study by Rittie et al. (2008) 
compared the mRNA expression of oestrogen receptors ERα, ERβ and 
GPR30 in aged males and females (mean age 75) from three anatomical 
regions (sun protected hip, and photoaged forearm and face skin); the biopsies 
were taken from non matched donors, which could cause variability in data.  
Although mRNA expression for ERα, ERβ and GPR30 at the different 
anatomical regions was different, however it was not clear if expression levels 
varied due to light exposure or anatomical region.  Their study showed a higher 
expression of ERα, ERβ and GPR30 in females in hip skin compared to sun-
exposed forearm skin.  However, mRNA expression for ERα and GPR30 
appeared lower in forearm skin compared to face skin, while no differences 
were seen for ERβ. This pattern of expression was similar between males and 
females.   
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A study by Inoue et al. (2011) demonstrated that in both male and female 
human donors, (age range 10-79), there was no change in the expression of 
ERα with age.  Anti-aging creams could potentially have an effect on oestrogen 
receptor expression.  One ingredient that is used in anti-aging creams is 
epidermal growth factor (EGF).  A study by Stoica et al. (2000) demonstrated 
that in MCF7 cell lines incubated with different concentrations of EGF, there 
was a reduction in ERα expression.  Therefore, if the donors used anti-aging 
creams that contained EGF, it may explain why expression of ERα was 
reduced in vellus hair bearing skin compared to matching terminal hair bearing 
skin. 
A similar expression pattern was seen for ERβ in the epidermis, with low 
expression in the dermis for both vellus and terminal hair bearing skin 
(Figure 4.1 and Figure 2.9).  This could also be attributed to the possible 
topical applications applied.  However, epidermal thickness in vellus hair 
bearing skin was significantly thinner than the epidermis from terminal hair 
bearing skin (Figure 2.7).  Studies have shown that topical and oral application 
of oestrogen in castrated women increased epidermal thickness (Punnonen, 
1971; Rauramo and Punnonen, 1969) (as reviewed by Brincat (2000)).  
Therefore, higher expression of oestrogen receptors (ERα and ERβ) in the 
epidermis of terminal hair bearing skin could be due to epidermal thickness. 
17β-oestradiol in rats has been associated with inhibiting hair growth by 
repressing anagen (Oh and Smart, 1996), and in mice, it accelerated anagen 
development (Ohnemus et al., 2005).  However, in humans, 17β-oestradiol 
has an opposite effect, where anagen is thought to be prolonged 
(Schumacher-Stock, 1981) (as reviewed by Ohnemus et al. (2006)).  Terminal 
hair follicles expressed ERα however, vellus hair follicles did not (Figure 4.1).  
This could indicate that 17β-oestradiol is required for regulating human hair 
follicle cycling, if anagen is shortened and early onset of catagen occurs, it 
could prevent the hair follicle from becoming terminal hair follicles.  In contrast 
to ERα, ERβ expression was lower in terminal hair follicles compared to vellus 
hair follicles.  Even though in humans 17β-oestradiol has been shown to 
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prolong anagen (Schumacher-Stock, 1981), thereby controlling the hair follicle 
cycle, its effect on the hair cycle could be dependent on which receptor 17β-
oestradiol activates.  A study by Conrad et al. (2004) demonstrated using 
organ culture that hair follicle shaft elongation was evident as early as in the 
first day of 17β-oestradiol treatment.  However, the effect of 17β-oestradiol via 
which receptor was not analysed.  Each receptor could possibly control 
different aspects of the hair cycle, whether it is to prolong anagen or to 
decreases catagen and telogen.  Unfortunately the effect of 17β-oestradiol on 
hair cycling is hard to analyse in humans, however, using similar techniques 
to Kondo et al. (1990) and Ohnemus et al. (2005), organ cultures can be used 
to treat hair follicles with either ERα or ERβ agonists and observe whether 
anagen is prolonged or whether hair follicles regress into catagen. 
4.4.2 Effects of 17β-oestradiol on dermal fibroblast proliferation 
A previous study by Stevenson (2007) compared the effect of 17β-oestradiol 
on the proliferation of human dermal fibroblasts derived from different 
anatomical regions using 3H-thymidine uptake.  Although fibroblasts derived 
from breast skin proliferated at a faster rate than those derived from scalp and 
abdominal skin, in the presence of 17β-oestradiol there was no change in the 
rate of proliferation in dermal fibroblasts derived from any of those regions. 
A more recent study by Remoue et al. (2013) demonstrated that fibroblasts 
derived from abdominal skin from a young donor (23 years) (then repeated 
with two other donors of ages 21 and 27, with similar outcomes) treated with 
hormone levels circulating at menopause (with a reduction of 17β-oestradiol – 
see Table 4.6) caused cell proliferation to decrease, imitating aging conditions; 
in comparison to non menopausal hormone levels (with high concentration of 
17β-oestradiol).  This shows that 17β-oestradiol accelerates dermal fibroblast 
proliferation derived from abdominal skin.   
The difference between the study conducted by Remoue et al. (2013) and that 
of Stevenson (2007), was that the age in which samples were obtained from.  
With aging, oestrogen receptor expression could be altered.  The study by 
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Inoue et al. (2011) showed that ERβ expression decreased with age, which 
could influence cell proliferation if 17β-oestradiol acts on dermal fibroblasts 
through ERβ. 
Hormones: Non-menopausal Levels: Menopausal Levels: 
17β-oestradiol (pM) 750 60 
Progesterone (nM) 60 6 
Dehydroepiandrosterone (nM) 20 2 
Growth Hormone (ng/ml) 5 1.5 
IGF1 (ng/ml) 200 100 
Table 4.6: Lower hormone levels in menopausal compared to non menopausal women 
Hormone levels in the body of women who are non menopausal and 
menopausal (Remoue et al., 2013). 
This cell counting study concurs with the 3H-thymidine study by Stevenson 
(2007), and while DF(V) cultures proliferated at a faster rate than 
corresponding DF(T), 17β-oestradiol had no effect on proliferation over a 12 
day period of either DF(T) nor DF(V) cells (Figure 4.2).  The difference 
between this study and the study carried out by Stevenson et al. (2005), is that 
for cell counting over a 12 day period, serum had to be present.  Serum 
concentrations had to be at low levels so DF(T) and DF(V) cells survived, and 
in order to remove any residual hormones, sex hormone binding globulin, and 
albumin binding proteins, charcoal stripped serum was used.  This 
demonstrated that low serum concentration did not influence 17β-oestradiol in 
dermal fibroblast cell proliferation. 
4.4.3 Effects of 17β-oestradiol on dermal fibroblast migration 
Migration of DF(T) and DF(V) cells in the absence of 17β-oestradiol was 
similar (Figure 3.5), however in the presence of 17β-oestradiol, only DF(T) 
cells responded to 17β-oestradiol treatment, by increasing their rate of 
migration (Figure 4.3).  
Expression of ERβ was similar in the dermis between terminal and vellus hair 
bearing skin.  The expression of ERα was higher in the dermis of terminal hair 
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bearing skin compared to matching vellus hair bearing skin.  This could 
indicate that ERα was responsible for the accelerated migration in DF(T) cells, 
therefore further studies were carried out to examine DF(T) and DF(V) 
oestrogen receptor expression and how 17β-oestradiol affects oestrogen 
receptor expression when wounded. 
Stevenson (2007) demonstrated that abdominal and scalp human dermal 
fibroblasts migrated faster than dermal fibroblasts derived from breast skin, 
and that 17β-oestradiol accelerated migration of dermal fibroblasts derived 
from breast, abdominal and scalp skin.  By using specific ERα and ERβ 
agonists, incubation with the specific ERα agonist accelerated the migration of 
abdominal dermal fibroblasts while the ERβ agonist had no effect (Stevenson 
et al., 2009), suggesting that stimulation of dermal fibroblast migration by 17β-
oestradiol is modulated via ERα.  To identify whether this is the case for DF(T) 
cells, ERα and ERβ agonists should be used to see if either are the cause for 
faster acceleration in DF(T) cells.  Silencing different oestrogen receptor gene 
expression using siRNA could also help identify the pathway this involved.  
Also, the study by Stevenson (2007) demonstrated that migration of dermal 
fibroblasts derived from breast skin was significantly accelerated when 
incubated with 17β-oestradiol as early as after 4 hours, suggesting that the 
non-genomic pathway may be involved.  Therefore GPR30 expression is 
important to study in both DF(T) and DF(V) cells. 
4.4.4 Expression levels for oestrogen receptors in dermal 
fibroblasts 
GPR30 is a cell surface receptor, which is required for the fast, non-genomic 
17β-oestradiol signalling (Prossnitz et al., 2007).  Therefore, quick responses 
to wound healing may act via GPR30.  Antibodies for GPR30 at the time of 
studies were not available to confirm protein expression, however, since the 
protein levels of ERα and ERβ correlate with the mRNA levels (Figure 4.1/ 
Table 4.5 and Figure 4.4 respectively), it is likely that GPR30 mRNA 
expression may also reflect the protein levels. 
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GPR30 mRNA expression was higher in DF(T) cells compared to matching 
DF(V) cells, suggesting that DF(T) cells respond more quickly than DF(V) cells 
when stimulated with 17β-oestradiol.  This pattern of expression was also seen 
for ERα, however, expression of ERβ was similar in DF(T) and DF(V) cells. 
A study by Stevenson (2007) demonstrated that in dermal fibroblasts derived 
from breast skin, migration was accelerated with 17β-oestradiol at early time 
points (after 4 and 8 hours).  This would suggest that the activity of 17β-
oestradiol is through GPR30 and the non-genomic pathway, rather than the 
genomic pathway that involves ERα and ERβ.  This could also explain why 
migration in DF(T) cells was more responsive to 17β-oestradiol, since GPR30 
mRNA expression was higher in DF(T) cells compared to matching DF(V) 
cells.  Since there are two potential pathways that could be involved, specific 
oestrogen receptor agonists and antagonists can be used to investigate which 
oestrogen receptor is involved.  Silencing different oestrogen receptor gene 
expression by using siRNA in DF(T) and DF(V) cultures in a scratch wound 
assay and incubating them with 17β-oestradiol would help determine which 
receptor is involved in cell migration. 
The mRNA expression of GPR30 and ERα was higher in DF(T) compared to 
matching DF(V) cells, while ERβ expression was similar between DF(T) and 
DF(V) cells (Figure 4.4).  This coincides with the protein expression found in 
the dermis of terminal and vellus hair bearing skin (Figure 4.1 and Table 4.5).  
Higher expression of GPR30 in DF(T) cells would suggest that DF(T) cells 
react more quickly to 17β-oestradiol, as this involves the fast non-genomic 
pathway (Cheskis, 2004; Sharma and Prossnitz, 2011; Silva et al., 2010).  
DF(T) migration was accelerated with 17β-oestradiol treatment, however, 
migration was assessed after 24 hours, to investigate whether 17β-oestradiol 
has an earlier affect in accelerating cell migration, earlier time points need to 
be analysed, which would help establish if 17β-oestradiol is acting through 
GPR30. 
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Messenger RNA expression of oestrogen receptors was not altered in 
unwounded DF(T) and DF(V) cells when they were incubated with 17β-
oestradiol.  Suggesting that 17β-oestradiol only has an effect on damaged 
cells which could explain why 17β-oestradiol did not affect cell proliferation as 
the cells were not wounded.  To measure and compare proliferation in 
unwounded and mechanically wounded cells in the presence and absence of 
17β-oestradiol, a BrdU assay can be carried out on matching DF(T) and DF(V) 
cells from the same donor.  There have been studies that have shown that 
17β-oestradiol stimulates oestrogen receptor expression to sensitise cells to 
17β-oestradiol (Zhou et al., 2001).  However this study used mouse 
mesenchymal stem cells.  Different species and different cells react differently 
to external stimulus.  Another study by Detti et al. (2008) demonstrated that 
ERβ expression increased in abdominal fibroblasts when treated with 17β-
oestradiol.  The difference between the studies could be due to the anatomical 
region in which the fibroblasts were cultured from.  Another study looking at 
human skin fibroblasts demonstrated that 17β-oestradiol upregulated ERβ as 
opposed to ERα (Haczynski et al., 2004).  However, sample location was not 
indicated and therefore even though the skin samples were obtained from post 
menopausal women, different anatomical regions might influence 17β-
oestradiol response. 
When DF(T) cells were mechanically wounded, expression of all three 
oestrogen receptors decreased after 24 hours, only ERβ expression 
decreased in mechanically wounded DF(V) cells (Figure 4.4).  Decreased 
expression of oestrogen receptor mRNA expression when mechanically 
wounded would suggest that cells need to be desensitised to 17β-oestradiol. 
A study by Pomari et al. (2014) demonstrated that with mechanical wounding 
of dermal fibroblasts, activity of aromatase was reduced.  Aromatase is the 
enzyme required for the conversion of testosterone to oestradiol and 
androstenedione to oestrone, increasing the local concentration of oestrogen.  
In this study by Pomari et al. (2014), the opposite effect was seen in epidermal 
keratinocytes that had been mechanically wounded, having increased 
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aromatase activity.  Therefore it would be interesting to observe the effect of 
keratinocytes on dermal fibroblast population, and whether keratinocytes 
cultured from terminal and vellus hair bearing skin affects unwounded and 
wounded fibroblasts differently.   The study by Pomari et al. (2014), looked at 
non-haired facial skin (mean age 50 years).  When cells were mechanically 
wounded, aromatase activity was reduced therefore local oestradiol 
concentration was reduced.  In the present study when DF(V) cells were 
mechanically wounded, only ERβ expression decreased with expression for 
GPR30 and ERα remaining the same.  This could indicate that DF(V) cells 
when wounded are desensitised to 17β-oestradiol via ERβ.  Also, the ratio of 
ERα: ERβ would be altered.  The effect of 17β-oestradiol on cell transcription 
depends on the dimerization of the oestrogen receptors, either they homo- or 
hetro-dimerise to affect transcription (Li et al., 2004).  Therefore, the impact on 
altering oestrogen receptor expression ratio could affect how 17β-oestradiol 
only accelerates migration in DF(T) but not DF(V) cells. 
Interestingly, when wounded DF(T) cells were treated with 17β-oestradiol, 
ERα and ERβ mRNA expression increased, while in DF(V) cells, GPR30 and 
ERα increased compared to wounded non treated cells.  Since migration was 
accelerated in DF(T) cells but not DF(V) cells, it would be assumed that this 
was via ERβ, as long as it leads to an increase in protein expression.  
Therefore, it would be important to measure protein expression in DF(T) and 
DF(V) cells when treated with 17β-oestradiol and see whether protein 
expression is also altered. 
Expression of mRNA for ERα in both DF(T) and DF(V) cells increased in 
wounded cells treated with 17β-oestradiol, however, expression in DF(V) cells 
increased to higher levels compared to DF(T) cells.  This would suggest that 
17β-oestradiol has an effect on both DF(T) and DF(V) cells but more 
pronounced in DF(V) cells.  There are many other factors that are involved in 
wound healing apart from migration and proliferation, such as collagen 
production and adhesion.  A study by Stevenson et al. (2008a) demonstrated 
that in dermal fibroblasts derived from breast skin showed no difference in total 
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collagen secretion.  However, in postmenopausal women there is a decrease 
in collagen content (Brincat et al., 1987; Thornton, 2002), and that with topical 
application of oestradiol, increased collagen fibres in the skin (Sauerbronn et 
al., 2000; Varila et al., 1995). 
There are many different adhesion molecules that could be analysed such as 
integrins, cadherins and selectins.  A study in mice osteoclasts showed that 
17β-oestradiol reduced adhesion (Saintier et al., 2006), however, fibroblasts 
derived from different anatomical regions may react differently, a study by Shi-
Wen et al. (1994) examined intracellular adhesion molecule 1 (ICAM1) 
expression in fibroblasts when treated with 17β-oestradiol.  Expression did not 
increase in cells treated with 17β-oestradiol alone, however with the addition 
of TNFα, expression of ICAM1 increased.  This could be due to the stress of 
the cells, therefore analysing adhesion molecules in unwounded and 
mechanically wounded condition in the presence and absence of 17β-
oestradiol could help establish whether 17β-oestradiol plays a role in cell 
adhesion.  Blocking different receptors by silencing the genes, or using specific 
oestrogen receptor agonists could help establish which receptor is involved. 
When treated with 17β-
oestradiol: 
DF(V) cells compared to 
DF(T) cells 
Proliferation Higher 
Migration Slower  
 
mRNA expression of: DF(V) cells compared to 
DF(T) cells 
 Effect of wounding cells 
on: 
DF(V) cells compared to 
DF(T) cells 
GPR30 Lower  GPR30 Lower 
ERα Lower  ERα Higher 
ERβ Same  ERβ Same 
 
Effect of 17β-oestradiol 
in unwounded cells on: 
DF(V) cells compared to 
DF(T) cells 
 Effect of 17β-oestradiol 
in wounded cells on: 
DF(V) cells compared to 
DF(T) cells 
GPR30 Lower  GPR30 Same 
ERα Lower  ERα Higher 
ERβ Same  ERβ Lower 
Table 4.7: mRNA expression levels of oestrogen receptors in DF(V) cells compared to matching 
DF(T) under different conditions 
A comparison between DF(V) and DF(T) cells in proliferation and migration, 
and mRNA expression of oestrogen receptors GPR30, ERα, and ERβ under 
wounded and non-wounded conditions in the presence and absence of 17β-
oestradiol. 
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4.5 Conclusion 
This chapter has highlighted differences in the in situ expression of ERα and 
ERβ between terminal and vellus hair bearing skin from the same anatomical 
location of the same donor.  In culture, while 17β-oestradiol did not modulate 
the proliferation of either DF(T) or DF(V), 17β-oestradiol accelerated the 
migration of DF(T) cells in a scratch wound assay. 
Higher mRNA expression of oestrogen receptors GPR30 and ERα in DF(T) 
cells compared to matching DF(V) cells would suggest that DF(T) cells have 
quick responses to 17β-oestradiol (via GPR30), and that they are potentially 
more responsive compared to DF(V) cells.   
Whilst incubation with 17β-oestradiol for 24 hours did not alter mRNA 
expression of any of the oestrogen receptors in unwounded DF(T) and DF(V) 
cells, when wounded, 17β-oestradiol increased the expression of ERα and 
ERβ in DF(T), and increased expression of GPR30 and ERα in DF(V) cells.  
Suggesting that accelerated migration in DF(T) 17β-oestradiol treated cells 
could potentially be via ERβ. 
In summary, this chapter has demonstrated that 17β-oestradiol has different 
effects on matching DF(T) and DF(V) cells.  Oestrogen receptor expression is 
also altered in unwounded and mechanically wounded conditions, indicating 
that 17β-oestradiol acts on DF(T) and DF(V) cells via different receptors to 
produce different responses. 
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Chapter 5 
INHIBITION OF XIAP AND THE EFFECT OF 17Β-
OESTRADIOL ON DF(T) AND DF(V) CELL VIABILITY 
AND IAP EXPRESSION 
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 Inhibition of XIAP and the Effects of 17β-Oestradiol on 
DF(T) and DF(V) Cell Viability and IAP Expression 
5.1 Introduction 
From the previous chapter it was demonstrated that whilst 17β-oestradiol had 
no effect on dermal fibroblast proliferation, it accelerated DF(T) cell migration.  
Also the expression of oestrogen receptors was different between the two cell 
types suggesting that 17β-oestradiol has specific roles in each cell type.  
Expression of IAPs also vary between DF(T) and DF(V) cells, and a recent 
study by Fuchs et al. (2013) demonstrated the XIAP is essential in wound 
healing.  Another study by Leblanc et al. (2003) demonstrated that in rat 
endometrium cell, 17β-oestradiol increased XIAP expression and decreased 
DIABLO.  Therefore, regulation of IAPs in particular XIAP by oestrogen may 
be important in dermal fibroblasts during wound healing. 
5.1.1 Importance of XIAP and other IAPs in wound healing 
There are limited studies investigating the role of IAPs in wound healing, since 
most IAPs are generally associated with cancer cells.  However, a recent study 
by Fuchs et al. (2013) demonstrated the importance of XIAP in wound healing.  
This study looked at single and double knockout of XIAP and its antagonist 
Sept4/ARTS in a murine model.   In this study it was demonstrated that with 
the knockout of Sept4/ARTS, wound healing was accelerated, 
reepithelialisation was increased and hair follicle formation was seen 18 days 
post wound infliction, which was not seen in wild type mice.  Also, the amount 
of TUNEL positive stem cells was decreased with Sept4/ARTS knockout.  It is 
the protection of these stem cells that allowed the quick regeneration of the 
hair follicles and the epidermis.  In this study, scar size was also compared 
between wild type and Sept4/ARTS knockout mice.  Scar size significantly 
decreased with the absence of the XIAP antagonist.  To further conclude that 
it is the function of XIAP that is essential to wound healing, XIAP knockout 
mice were also analysed.  Wound healing was significantly impaired at day 5, 
7, 9 and 11 compared to wild type.  Also cleaved caspase 3 positive cells were 
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analysed.  With Sept4/ARTS knockout mice, cleaved caspase 3 was 
significantly reduced, whilst with XIAP knockout, cleaved caspase 3 was 
significantly increased to wild type expression.  This indicates the importance 
of XIAP in wound healing. 
Another wound healing study investigating collagen contraction by Kobayashi 
et al. (2005), looked at collagen contraction by human foetal lung fibroblasts.  
It was shown in this in vitro study that while TGFβ1 stimulated collagen 
contraction, it also inhibited the expression of XIAP thereby stimulating 
apoptosis of the foetal lung fibroblast as detected by the TUNEL assay.  This 
shows that there are other mechanisms in place that need to be taken into 
consideration during wound healing.  IAPs are important in wound healing to 
also remove damaged cells and maintain homeostasis, they also remove 
redundant cells such as immune cells and senescent cells (Wang et al., 2009). 
There are no other studies that have demonstrated the importance of IAPs in 
wound healing.  In a murine model, XIAP was demonstrated to be important 
in wound healing.  Therefore, XIAP and other IAPs deserve to be further 
studied to help establish how they can affect wound healing in human skin. 
5.1.2 XIAP antagonist - embelin 
Embelin, is a XIAP inhibitor, it functions by binding to the BIR3 domain 
(Nikolovska-Coleska et al., 2004); mimicking the action of DIABLO mimetics.  
In a recent study, embelin had an effect on proliferation, migration, cell 
apoptosis and XIAP expression of MCF7 cells (Sumalatha et al., 2014); cell 
proliferation and migration were reduced in the presence of embelin.  Using 
the TUNEL assay, a higher number of MCF7 cells were positive for apoptosis 
with embelin treatment.  XIAP mRNA expression was also reduced, following 
incubation with embelin; which indicates that embelin not only binds to XIAP 
to inhibit its function, but can also decrease XIAP transcription (Sumalatha et 
al., 2014).  These results were compared to the effect of tamoxifen on ER 
positive breast cancer cell lines.  Similar responses between embelin and 
tamoxifen were seen for both treatments in blocking cell migration and 
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reducing cell proliferation, suggesting that embelin may act as an anti-
oestrogen (Sumalatha et al., 2014).   
5.1.3 The effect of 17β-oestradiol on apoptosis and expression of 
IAPs 
It has been suggested that oestrogens have a protective function in stressed 
cells (via oxidative stress) involved in skin wound healing in particular 
fibroblasts and keratinocytes by promoting the expression of anti-apoptotic 
proteins such as Bcl2 (Kanda and Watanabe, 2003; Yamaguchi et al., 2012).   
In postmenopausal women, reduced oestrogen levels increase apoptosis in 
cells such as osteoblasts (Bradford et al., 2010).  No studies have looked at 
the rate of apoptosis in human skin after menopause in vivo, nor how a 
decrease in oestrogen levels modulates apoptosis in keratinocytes and 
fibroblasts in vitro.   
There have been limited studies looking at the effect of oestrogen on the Bcl-
2 family and anti-apoptotic proteins in human skin.  In cultured keratinocytes 
17β-oestradiol prevents hydrogen peroxide induced apoptosis by increasing 
the expression of Bcl2 (Kanda and Watanabe, 2003).  Using Western blotting 
and PCR, the expression of Bcl2 increased in human neonatal foreskin 
cultured keratinocytes treated with 17β-oestradiol. 
In Jurkat (human T lymphocyte cell line), cIAP2 levels are under the control of 
NFκB.  Using qRT-PCR, mRNA expression of cIAP2 in Jurkat cells that are 
responsive to NFκB induction by TNFα showed high expression of cIAP2, 
however, with Jurkat cells transfected with a truncated form of IκBα which lack 
the phosphoacceptor and ubiquitin attachment site, NFκB was not activated 
nor was cIAP2 expressed when cells were treated with TNFα (Chu et al., 
1997).  A study on human coronary artery endothelial cells (HCAEC) showed 
that 17β-oestradiol upregulated NFκB activation within 15 minutes of treatment 
(Hamilton et al., 2004). In this study, HCAEC cells were treated with 17β-
oestradiol and ICI 182 780, which is an ERα and ERβ inhibitor, but an agonist 
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to the GPR30 receptor.  Due to 17β-oestradiol’s quick response, it would have 
been assumed that NFκB activation was through GPR30, however with ICI 
182 780, NFκB was not activated, therefore, it was suggested that NFκB 
activation was via ERα, however, this was based on the admission of 
tamoxifen and reloxifen rather than potent oestrogen receptor specific 
agonists.  Another study using rabbit corneal fibroblasts demonstrated that 
17β-oestradiol decreased the phosphorylation of IκBα an inhibitor of NFκB.  
For NFκB to be activated, IκBα needs to be phosphorylated to dissociate from 
NFκB and activate it for translocation into the nucleus (Zhou et al., 2011).  This 
shows that NFκB can be activated or repressed in different cell types in 
response to 17β-oestradiol.  Since NFκB regulates IAP expression, in 
particular cIAP1, cIAP2 and XIAP (Wang et al., 1998; Wei et al., 2008), IAP 
regulation could potentially be through 17β-oestradiol via NFκB activation. 
A study by Stanculescu et al. (2010) has shown that there is a link between 
the protective effects of 17β-oestradiol and IAPs.  This study was conducted 
in MCF7 breast cancer cell lines, where DIABLO mimetics (cmpd3, MV1 and 
BV6) were used to block the effects of all IAPs and siRNA was used to silence 
XIAP, cIAP1 and cIAP2 before cell viability was studied using TNFα as a stress 
inducer for apoptosis.  This study demonstrated that cIAP1 and cIAP2 were 
required for 17β-oestradiol to have a protective effect against TNFα.  When 
cIAP1 and cIAP2 genes were silenced individually, cell viability was not 
restored when 17β-oestradiol was incubated with TNFα treated MCF7 cells.  
However, with the silencing of the XIAP gene, 17β-oestradiol was still able to 
protect cells.  A combination of cIAP1 and cIAP2 silencing further disrupted 
the protective function of 17β-oestradiol.  cIAP2 mRNA was upregulated by 
oestradiol in MCF7 breast cancer cells whilst cIAP1 and XIAP were not.  This 
regulation was observed in cells positive for oestrogen receptors (mainly ERα) 
(Stanculescu et al., 2010). 
A study by Yin et al. (2008) showed using qRT-PCR that in murine uterine 
epithelial cells 17β-oestradiol induced the expression of NAIP via ERα thereby 
protecting uterine epithelial cells from apoptosis.  Furthermore, NAIP was 
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required for the protective effect of oestradiol since knockout of the Naip gene 
resulted in higher levels of apoptotic cells detected by TUNEL even in the 
presence of oestradiol, with a higher level of caspase 3 and caspase 9 
activation (Yin et al., 2008). 
XIAP has been associated with elevated cell proliferation and VEGF 
production in rat Muller cells (glial cells of the retina), since inhibiting XIAP 
using embelin (an XIAP inhibitor) caused a reduction in VEGF secretion, 
indicating that XIAP is important in regulating VEGF secretion (Sun et al., 
2013).  
Due to the recent study by Fuchs et al. (2013), it has been established that 
XIAP is an important IAP in murine wound healing.  This protein is gender 
specific, a study in male and age related female murine brain showed higher 
expression of XIAP in females than in corresponding males, whilst 
ovariectomy did not alter XIAP expression in females (Siegel et al., 2011).  In 
ovariectomised rats, a three day treatment of 17β-oestradiol caused an 
increase in XIAP expression and decrease DIABLO in the endometrium, 
indicating that XIAP is regulated by 17β-oestradiol, this could potentially be via 
the down regulation of DIABLO expression (Leblanc et al., 2003). 
5.1.4 Effects of 17β-oestradiol on caspase activity 
In osteoblasts, the protective effects of oestrogen have been attributed to the 
reduction of caspase 3 and 7 activity, since TNFα induced apoptosis by 
activating caspase 3, and treatment with 17β-oestradiol reduced caspase 3 
activity (Bradford et al., 2010).  The protective function of 17β-oestradiol in 
bovine aortic endothelial cells following TNFα induced apoptosis was 
demonstrated using a cell viability assay (Koga et al., 2004).  In this study, the 
percentage of cells undergoing apoptosis was determined when cells were 
treated with TNFα in the absence and presence of 17β-oestradiol.  17β-
oestradiol caused a reduction in the percentage of cells undergoing apoptosis.  
A study by Li et al. (2011) demonstrated using Western blotting and qRT-PCR, 
that in ovariectomised rats, 17β-oestradiol protects against cell death by 
 
 
 
 Inhibition of XIAP and the Effects of 17β-
Oestradiol on DF(T) and DF(V) Cell Viability and 
IAP Expression 
 
  
 
212 
 
  
preventing cleavage of caspase 3 in the brain.  This is achieved through ERα, 
since when ERα was blocked using the antagonist MPP, the protective effect 
of 17β-oestradiol was lost; this was not seen when an ERβ antagonist was 
used (Li et al., 2011).  To date, there are no studies analysing the effects of 
17β-oestradiol on caspase activity in skin and hair follicles. 
5.1.5 Aim 
The previous chapter, demonstrated that 17β-oestradiol did not affect 
proliferation of DF(T) and DF(V) cells.  However, DF(T) cell migration was 
accelerated in response to 17β-oestradiol while corresponding DF(V) cells did 
not.  Due to the changes of oestrogen receptor mRNA expression in wounded 
DF(T) and DF(V) cells, accelerated migration in DF(T) cells incubated with 
17β-oestradiol could potentially be via ERβ.  Expression of oestrogen 
receptors did not change with 17β-oestradiol treatment in unwounded cells, 
however when mechanically wounded, expression of ERα and ERβ increased 
in DF(T) cells while ERα and GPR30 increased in DF(V) cells. 
The first aim of this chapter was to establish whether 17β-oestradiol has a 
protective effect on cell viability of DF(T) and DF(V) cells when XIAP 
expression is blocked by embelin in both unwounded and mechanically 
wounded DF(T) and DF(V) cells. 
Since caspase 3 is the effector caspase, it is an important caspase to become 
activated when apoptosis occurs, therefore the second aim of this chapter was 
to determine whether caspase 3 activity was increased when XIAP was 
inhibited by embelin and whether the response of 17β-oestradiol can 
counteract changes in caspase 3 activity. 
Finally, to establish whether 17β-oestradiol can regulate the mRNA expression 
of XIAP, NAIP, cIAP2 and Apollon or their antagonists DIABLO and Xaf1 in 
either DF(T) or DF(V) cells, and whether this changes when cells are 
mechanically wounded.  
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5.2 Materials and Methods 
5.2.1 Human tissue samples used 
Donor samples used in this chapter: 
Donor ID Age Gender DF(T) DF(V) 
OK14 1, 3 57 Female   
OK15 1, 3 36 Female   
OK17 1, 2 53 Female   
OK18 2, 3 56 Female   
OK23 2 51 Female   
Table 5.1: Donor information for skin samples used for immunofluorescent staining 
Donor samples used to culture matching dermal fibroblasts from either 
terminal hair bearing skin DF(T), or from vellus hair bearing skin (DF(V).  1 -
cell viability, 2 - ELISA, 3 - PCR analysis. 
5.2.2 Cell viability of matching DF(T) and DF(V) in the presence of 
embelin (XIAP inhibitor) and 17β-oestradiol 
Matching DF(T) and DF(V) cells cultured from three female donors at the same 
passage (P4) were seeded in 24 well plates in growth medium (DMEM with 
15% FBS) at a cell density of 10,000 cells per well and left to grow to 
confluence (DF(V) – ~5 days, DF(T) – ~1 week); with a medium change every 
3 days.  Once fully confluent, cells were washed with PBS twice and incubated 
in serum free and phenol red free DMEM for 24 hours.  Wells were separated 
into groups, for non wounded conditions and wounded conditions; wounded 
wells were scratched using a 10µl pipette tip in a hash (#) pattern.  The growth 
medium was removed, and cells were incubated in serum free, phenol red free 
medium supplemented with either vehicle control (0.1% DMSO), 17β-
oestradiol (10nM), embelin (Sigma) (50µM), and embelin (50µM) and 17β-
oestradiol (10nM) together; unwounded and wounded cells were assessed in 
triplicate wells. 
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After 24 hours, medium was removed carefully so as to minimise dislodging 
cells that might be on the verge of detaching.  Without washing, 100µl of 0.05% 
trypsin/EDTA was added to the wells; once cells started to condense, they 
were placed in an incubator for 5 minutes.  The 24 well plates were then 
disturbed by knocking on the sides to dislodge cells, once all cells were 
dislodged, 200µl of growth medium was added to each well, bringing the total 
volume to 300µl.  15µl of the cell suspension from each individual well was 
added to 15µl of filtered 0.4% trypan blue solution in an Eppendorf.  Using a 
haemocytometer, each cell suspension was counted twice to determine the 
number of viable and non viable cells and cell viability determined under the 
different experimental conditions. 
5.2.3 Caspase 3 activation in matching DF(T) and DF(V) cells 
using ELISA 
Using the Caspase-Glo 3/7 Assay kit (Promega), caspase activity was 
measured in matching cultures of DF(T) and DF(V) derived from three donors 
at the same passage number (P4).  Cells were seeded in 96 well plates at 
5,000 cells per well in growth medium (DMEM with 15% FBS) and left to grow 
until fully confluent (DF(T) – 3 days, DF(V) cells – 4 days).  Cells were washed 
with PBS twice and incubated in serum free and phenol red free DMEM for 
24hours. The cells were either scratched using a 10µl pipette tip in a plus (+) 
pattern or left unwounded.  The medium was removed and duplicate wells 
incubated with either vehicle control (0.4% DMSO), 17β-oestradiol (10nM), 
embelin (50µM), and embelin (50µM) + 17β-oestradiol (10nM) and incubated 
for 24hours.  The caspase 3 assay kit reagent was added at a 1:1 ratio 
(assay:medium) to the cells and the plates were left on a shaker wrapped in 
foil for 1hour. Using a luminescent plate reader (Tecan, infinite M200), 
caspase 3 activity was measured. 
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5.2.4 PCR analysis of IAPs on 17β-oestradiol treated DF(T) and 
DF(V) cells in unwounded and mechanical wounded 
conditions 
Using the same principles in methodology for qRT-PCR described in 
section 3.2.5; matching DF(T) and DF(V) cells (passage 3-4) were cultured in 
6 well plates and when fully confluent washed then incubated in serum free 
and phenol red free medium for 24 hours.  Half the wells were mechanically 
wounded by scratching a hash (#) pattern using a 1ml pipette tip; cells were 
either incubated with vehicle control (absolute ethanol 0.001%) or 17β-
oestradiol (1nM) for 24 hours.  Using the same methodology described in 
section 3.2.5, RNA was extracted and cDNA was synthesised.  Expression of 
IAPs was normalised against GAPDH. 
5.2.5 Statistics 
For the cell viability, caspase 3 activity and qRT-PCR, Student T-test was 
carried out between DF(T) and DF(V) cells. 
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5.3 Results 
5.3.1 Embelin decreased cell viability in matching DF(T) and 
DF(V), which was partially restored in the presence of 17β-
oestradiol 
Cell viability was assessed using the trypan blue exclusion dye on matching 
DF(T) and DF(V) cultures, in the presence of embelin, a potent XIAP inhibitor,  
or 17β-oestradiol, or embelin and 17β-oestradiol together (Figure 5.1). 
In matching DF(T) and DF(V) cultures, cell viability under control conditions 
was around 98% (Figure 5.1A and B respectively).  Mechanical wounding 
caused no change in cell viability in either DF(T) or DF(V) cultures.  Incubation 
with 17β-oestradiol did not alter cell viability of DF(T) and DF(V) cells when 
mechanically wounded or left unwounded (Figure 5.1A and B respectively). 
However, with embelin treatment, cell viability was significantly reduced in 
unwounded DF(T) cultures to 77% (p<0.005), and to 74% (p<0.005) in 
mechanicaly wounded cells (Figure 5.1A).  In corresponding DF(V) cultures, 
embelin decreased cell viability in unwounded and mechanically wounded 
cells to 85% (P<0.0005) and 87% (P<0.05) respectively (Figure 5.1B). 
In DF(T) cultures, the presence of 17β-oestradiol in embelin treated cells 
resulted in a partial, but significant increase in cell viability, with cell viability 
increasing to 88% in unwounded and 87% in mechanically wounded DF(T) 
cultures (p<0.05) (Figure 5.1A).  In matching unwounded DF(V) cultures, 17β-
oestradiol in embelin treated cells resulted in a partial, but significant increase 
in cell viability to 93% (p<0.05) (Figure 5.1B).  In mechanically wounded cells, 
the presence of 17β-oestradiol in embelin treated cells did not significantly 
change cell viability. 
When comparing the effect of embelin on cell viability between matching DF(T) 
and DF(V) cultures, embelin induced a significantly higher reduction in cell 
viability in DF(T) cultures compared to DF(V) cells, in both unwounded 
(p<0.05) and mechanically wounded cells (p<0.05).  
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Figure 5.1: Cell viability was reduced in DF(T) and DF(V) cells when treated with embelin and 
restored with the addition of 17β-oestradiol 
Cell viability in matching DF(T) and DF(V) cells treated with Embelin and 17β-
oestradiol.  A) DF(T) cell viability.  B) DF(V) cell viability. Blue – DF(T) cells, 
red – DF(V) cells, solid bar – unwounded cells, hashed bar – mechanically 
wounded cells.  n=3 donors, in triplicate wells counted in duplicates.  
*/#/+p<0.05, **p<0.005, ***p<0.0005. (Students T-test). * - between vehicle 
control and embelin, # - between 17β-oestradiol and embelin and 17β-
oestradiol together, + - between embelin and embelin and 17β-oestradiol 
together.   
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5.3.2 Embelin does not alter the activity of caspase 3 in 
unwounded and mechanically wounded dermal fibroblasts 
Since the XIAP antagonist embelin decreased viability of DF(T) and DF(V) 
cells and this was partially counteracted by 17β-oestradiol, changes in the 
activity of caspase 3 was measured when unwounded and mechanically 
wounded dermal fibroblasts were incubated in the presence and absence of 
embelin with, or without, 17β-oestradiol (Figure 5.2). 
Neither embelin alone nor 17β-oestradiol alone significantly altered the activity 
of caspase 3 in matching DF(T) and DF(V) cultures, whether they were 
unwounded or mechanically wounded (Figure 5.2A and B respectively). 
The addition of 17β-oestradiol to embelin treated DF(T) cells significantly 
reduced caspase 3 activity compared to embelin treatment alone (p<0.05) in 
both unwounded and mechanically wounded cells (Figure 5.2A).  In contrast, 
in matching DF(V) cultures, 17β-oestradiol did not significantly reduce 
caspase 3 activity in the presence of embelin in either unwounded or 
mechanically wounded cells (Figure 5.2B). 
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Figure 5.2: Embelin causes no change in caspase 3 activity but a reduction when co-treated with 
17β-oestradiol in vitro 
Caspase 3 activity measured by ELISA in matching DF(T) and DF(V) cells 
incubated with vehicle control (DMSO 0.4%), 17β-oestradiol (10nM), embelin 
(50µM), embelin and caspase 3 inhibitor (10 µM), and embelin and 17β-
oestradiol.  A) Caspase 3 activity in DF(T) cells.  B) Caspase 3 activity in DF(V) 
cells.  Blue – DF(T) cells, red – DF(V) cells, solid bar – unwounded cells, 
hashed bar – mechanically wounded cells.  n=3 donors in duplicates. *p<0.05, 
(Students T-test).  
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5.3.3 Does 17β-oestradiol modulate mRNA expression of IAPs 
and IAP antagonists in DF(T) and DF(V) cells following 
mechanical wounding in vitro? 
Figure 5.3 represents qRT-PCR data on IAP mRNA expression in matching 
DF(T) and DF(V) cells in the presence and absence of 17β-oestradiol in both 
unwounded and mechanically wounded cells. 
5.3.3.1 17β-oestradiol increased XIAP mRNA expression in 
unwounded and mechanically wounded DF(T) and 
unwounded DF(V) cells, but decreased expression in 
mechanically wounded DF(V) cells 
17β-oestradiol increased the mRNA expression of XIAP by ~24% in 
unwounded DF(T) cells (p<0.05), but increased XIAP mRNA expression in 
mechanically wounded cells by ~68% (p<0.0005) (Figure 5.3A).  In 
corresponding DF(V) cells, expression of XIAP was increased in the presence 
of 17β-oestradiol in unwounded cells by ~15% (p<0.05).  Whilst, it was 
reduced by ~30%, in wounded cells incubated with 17β-oestradiol (p<0.0005) 
to levels significantly lower (~33%) than the corresponding unwounded cells 
p<0.0005). 
5.3.3.2 17β-oestradiol increased Apollon mRNA expression in 
DF(T) and decreased expression DF(V) in unwounded and 
mechanically wounded cultures 
17β-oestradiol increased the expression of Apollon in both unwounded by 
~60%, and mechanically wounded by ~125% DF(T) cells (p<0.05 and 
p<0.0005 respectively).  In contrast, in corresponding DF(V) cells incubated 
with 17β-oestradiol for 24 hours, mRNA expression of Apollon decreased in 
both unwounded cells by ~57% and wounded cells by ~57% (p<0.05 and 
p<0.005 respectively).  The decrease in expression in mechanically wounded 
cells by 17β-oestradiol, reduced expression to levels significantly lower 
(~50%) than the corresponding unwounded cells, p<0.005 (Figure 5.3B). 
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5.3.3.3 17β-oestradiol increased cIAP2 mRNA expression in 
mechanically wounded DF(T) and decreased expression in 
mechanically wounded DF(V) cultures  
The expression of cIAP2 in unwounded DF(T) cells was not altered in the 
presence of 17β-oestradiol, but in mechanically wounded DF(T) cells, it was 
increased by ~200% (p<0.0005) (Figure 5.3C).  In contrast, 17β-oestradiol 
reduced cIAP2 expression in unwounded DF(V) cells by ~85% (p<0.0005), but 
did not alter the expression in mechanically wounded cells. 
5.3.3.4 17β-oestradiol increased NAIP mRNA expression in 
unwounded and mechanically wounded DF(T) cells, but did 
not alter expression in DF(V) cells 
In unwounded DF(T) cells, NAIP mRNA expression was increased in the 
presence of 17β-oestradiol by ~83% (p<0.0005), while in mechanically 
wounded cells, it was increased by ~433% (p<0.0005), (Figure 5.3C), bringing 
it to a level significantly higher (~191%) than the corresponding unwounded 
cells (p<0.005).  In corresponding DF(V) cells, 17β-oestradiol did not alter 
NAIP expression in either unwounded or mechanically wounded cells.  
However, the level of expression of NAIP in mechanically wounded DF(V) was 
significantly lower (~37%) than that of unwounded cells in the presence of 17β-
oestradiol (p<0.0005). 
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Figure 5.3: Increased expression of IAPs in DF(T) cells with 17β-oestradiol in unwounded and 
mechanically wounded cells in vitro, with decreased expression in DF(V) cells  
IAP transcription expression analysed via qRT-PCR for matching DF(T) and 
DF(V) cells in unwounded and mechanically wounded conditions, in the 
presence and absence of 17β-oestradiol normalised against GAPDH.  A) 
mRNA expression for XIAP.  B) mRNA expression for Apollon.  C) mRNA 
expression for cIAP2.  D) mRNA expression for NAIP.  Dark blue – vehicle 
control DF(T), light blue – 17β-oestradiol treated DF(T), red – vehicle control 
DF(V), pink – 17β-oestradiol treated DF(V), solid bar – unwounded cells, 
hashed bar – wounded cells.  n=3 donors.  Students T-test, * p<0.05, ** 
p<0.005, *** p<0.0005.  
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5.3.3.5 17β-oestradiol increased mRNA expression of DIABLO in 
matching DF(T) and DF(V) under wounded and non-
wounded conditions 
When unwounded DF(T) cultures were incubated with 17β-oestradiol for 24 
hours, expression of DIABLO mRNA increased by ~50%, p<0.05; however, in 
wounded cells, mRNA expression of DIABLO increased by ~500% (p<0.0005) 
to levels significantly higher (~100%) than corresponding unwounded cells 
(p<0.005) (Figure 5.4A).  In corresponding DF(V) cells, 17β-oestradiol 
increased DIABLO expression by ~133% in unwounded cells (p<0.0005), and 
also increased DIABLO mRNA expression by ~300% in mechanically 
wounded cells (p<0.0005) (Figure 5.4A). 
5.3.3.6 17β-oestradiol increased mRNA expression of Xaf1 in 
unwounded and mechanically wounded DF(T) cells and 
decreased expression in mechanically wounded DF(V) cells 
In a similar manner to DIABLO, 17β-oestradiol increased Xaf1 mRNA 
expression in unwounded DF(T) cells by ~70% (p<0.05), and by 266% in 
mechanically wounded cells (p<0.005) to levels significantly higher (89%) than 
the corresponding unwounded cultures (p<0.05) (Figure 5.4B).  In contrast, in 
matching DF(V) cells, while 17β-oestradiol had no effect on Xaf1 mRNA 
expression in unwounded cells, it decreased expression in mechanically 
wounded cells by ~53% (p<0.0005), to levels significantly lower (~72%) than 
corresponding unwounded cells (p<0.005). 
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Figure 5.4: Increased expression of IAP antagonists in DF(T) cells with DIABLO increasing and 
Xaf1 decreasing in DF(V) cells with 17β-oestradiol treatment  
IAP antagonist mRNA transcription expression analysed via qRT-PCR for 
matching DF(T) and DF(V) cells in unwounded and mechanically wounded 
conditions, in the presence and absence of 17β-oestradiol normalised against 
GAPDH.  A) mRNA expression for DIABLO.  B) mRNA expression for Xaf1.  
Dark blue – vehicle control DF(T), light blue – 17β-oestradiol treated DF(T), 
red – vehicle control DF(V), pink – 17β-oestradiol treated DF(V), solid bar – 
unwounded cells, hashed bar – wounded cells.  n=3 donors.  Student T-test, * 
p<0.05, ** p<0.005, *** p<0.0005.  
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5.4 Discussion 
Limited studies have investigated the role of 17β-oestradiol on IAPs.  In MCF7 
cells, 17β-oestradiol was shown to protect cells from TNFα induced apoptosis 
via cIAP1 and cIAP2 (Frasor et al., 2009; Stanculescu et al., 2010).  
Contradicting information with regards to the effect of 17β-oestradiol on the 
expression of NAIP has been reported; Yin et al. (2008) demonstrated that 
NAIP transcript was increased when murine uterine epithelial cells were 
treated with 17β-oestradiol, while Wall et al. (2013) showed that NAIP 
transcript decreased.  In the rat endometrium 17β-oestradiol has been shown 
to increase XIAP expression while simultaneously decreasing the expression 
of DIABLO (Leblanc et al., 2003).  This thesis is the first study to investigate 
the role of XIAP in the viability and caspase 3 activity of DF(T) and matching 
DF(V) cells in the presence and absence of 17β-oestradiol.  It is also the first 
study investigating the effect of 17β-oestradiol on the expression of mRNA 
transcripts for IAPs (XIAP, Apollon, NAIP and cIAP2) and their antagonists 
(DIABLO and Xaf1). 
5.4.1 The effect of inhibiting XIAP function on the viability of 
DF(T) and DF(V) cultures 
In the presence of embelin, an XIAP antagonist, the cell viability of matching 
cultures of DF(T) and DF(V) cells was reduced by approximately 23% and 12% 
respectively in both unwounded and wounded monolayers (Figure 5.1).  
Embelin binds to the BIR3 domain of XIAP preventing apoptosis, in a similar 
way to DIABLO/XIAP binding (Chen et al., 2006; Nikolovska-Coleska et al., 
2004).  XIAP interacts with caspase 9 via its BIR3 domain, while the region 
between BIR1 and BIR2 binds to caspase 3 (Deveraux and Reed, 1999; 
Huang et al., 2001), therefore in the presence of embelin, apoptosis is not 
inhibited by XIAP.  Since the viability of DF(T) and DF(V) cells was reduced 
when treated with embelin, it would suggest that XIAP is important for cell 
survival.   
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Its importance in cell survival appears to be more evident in DF(T) cells 
compared to matching DF(V) cells, with nearly twice as much cell death in 
DF(T) cultures compared to DF(V) cultures.  Since XIAP protein expression in 
both DF(T) and DF(V) cells was similar under unwounded and wounding 
conditions (Figure 3.11 and Figure 3.14), other protective mechanisms may 
be in place in DF(V) cells compared to matching DF(T) cells.  
Stanculescu et al. (2010) demonstrated that in the breast cancer cell line BT-
474, cIAP2 is potentially important in cell survival, since cmpd3 (a DIABLO 
mimetic) reduced cell survival and that mRNA expression for cIAP2 was higher 
than cIAP1 and XIAP levels.  Since cIAP2 mRNA expression was higher in 
DF(V) cells compared to matching DF(T) cells (Figure 3.7), this could suggest 
that cIAP2 is more important in the survival of DF(T) and DF(V) cells with a 
more important role in maintaining cell viability of DF(V) cells compared to 
matching DF(T) cells. 
A study by Ahn et al. (2007) demonstrated that embelin is not only an XIAP 
antagonist, but can also block NFκB activation in human myeloid KBM5 cells.  
Using nuclear extracts, NFκB was measured in cells treated in the absence 
and presence of embelin at different concentrations.  With higher 
concentration, NFκB activity was reduced.  This could affect other gene 
transcription, since IAPs (cIAP1 and cIAP2) are upregulated with NFκB 
activation, IAP expression may also be modulated by embelin.  Therefore, 
qRT-PRC should be conducted on DF(T) and DF(V) cells to investigate the 
effect of embelin on IAP expression through possible NFκB activation.  A gene 
micro array would also establish which genes are up-regulated when cells are 
treated with embelin. 
Incubation of embelin treated DF(T) and DF(V) cells in the presence of 17β-
oestradiol, improved cell viability, which could suggest that 17β-oestradiol 
potentially regulates IAP transcription.  Therefore, qRT-PCR was carried out 
to investigate whether 17β-oestradiol regulates IAP levels in DF(T) and DF(V) 
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cells.  To confirm that 17β-oestradiol protection of DF(T) and DF(V) cells is via 
XIAP, siRNA may be used to block XIAP production. 
In unwounded cultures, 17β-oestradiol had a similar protective effect on DF(T) 
and DF(V) cells (Figure 5.1).  However, following mechanical wounding 17β-
oestradiol offered a higher degree of protection in DF(T) cells compared with 
DF(V) cells.  Since IAP expression is regulated via NFκB and 17β-oestradiol 
activates NFκB, it would be interesting to find out whether 17β-oestradiol 
regulates IAP expression though NFκB activation.  A study by Lewis-Wambi 
and Jordan (2009) demonstrated that 17β-oestradiol could induce or inhibit 
apoptosis in MCF7 cells.  This depended on the cells being deprived of 
oestradiol.  In cells that were long term deprived of oestradiol, treatment with 
17β-oestradiol caused a reduction in NFκB, whilst the opposite effect was 
seen in normal MCF7 cells.  Oestrogen receptor expression in DF(T) cells was 
higher compared to DF(V) cells, therefore 17β-oestradiol may have a different 
effect on NFκB activity in DF(T) and DF(V) cells.  17β-oestradiol may in DF(T) 
cells stimulate NFκB activation therefore causing the increase in IAPs, whilst 
in DF(V) cells, NFκB could be reduced, lowering IAP production.  A study by 
Gionet et al. (2009) demonstrated that expression of ERα in breast cancer cell 
lines MCF7 and LCC1 caused a reduction in NFκB activation. 
Another possible mechanism is that 17β-oestradiol directly inhibits caspase 3 
downstream activity.  17β-oestradiol has been shown to reduce caspase 3 
activity in human osteoblasts when caspase 3 was induced by TNFα (Bradford 
et al., 2010).  In this paper, the mRNA expression for the IAP Survivin was 
down regulated when osteoblasts were treated with 17β-oestradiol, which, if 
caspase 3 activity was reduced, it would have been assumed that IAP levels 
would increase to prevent apoptosis and caspase 3 activation.  However, other 
apoptosis inducers were down regulated with 17β-oestradiol.  This could 
suggest that in the osteoblast cells, Survivin is not functioning as an IAP.  
Either other IAPs are regulated by 17β-oestradiol and should be analysed via 
qRT-PCR, or 17β-oestradiol is modulating caspase 3 activity independently of 
IAPs.  Silencing the IAP genes, or treating cells with DIABLO mimetics would 
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inhibit IAP function.  If caspase 3 activity was reduced by 17β-oestradiol via 
IAP function, blocking of these IAPs should theoretically prevent caspase 3 
reduction.  If caspase 3 activity was still reduced, it would indicate that 17β-
oestradiol blocks caspase 3 via another pathway. 
5.4.2 Effect of Embelin and 17β-oestradiol on caspase 3 activity 
In rat brain, it was observed that 17β-oestradiol blocked the cleavage of 
caspase 3 preventing apoptosis through ERα (Li et al., 2011).  Caspase 3 
activity was measured by staining cleaved caspase 3.  Rats treated with 17β-
oestradiol and exposed to trauma showed a decrease in cleaved caspase 3 
compared to control.  Western blotting demonstrated that ERα expression was 
increased in traumatised brain, with a further increase in those treated with 
17β-oestradiol, whilst no difference was seen in ERβ expression.  In chapter 
4, qRT-PCR demonstrated that although 17β-oestradiol had no effect on 
mRNA expression of oestrogen receptors in unwounded DF(T) and DF(V) 
cells, following mechanical wounding, ERα and ERβ mRNA expression 
increased in DF(T) cells, while GPR30 and ERα mRNA increased in DF(V) 
cells in the presence of 17β-oestradiol (Figure 4.5).  The level of ERα mRNA 
was higher in DF(V) cells treated with 17β-oestradiol after mechanical 
wounding compared to DF(T) cells.  Therefore, it is possible that the 
upregulation of ERα in mechanically wounded DF(T) and DF(V) cells may be 
a mechanism by which caspase 3 activity is inhibited.  Treatment of DF(T) and 
DF(V) cells with ERα or ERβ agonists would help establish via which receptor 
17β-oestradiol may block caspase 3 activity. 
In this study, embelin treatment did not increase the basal level of caspase 3 
activity of either DF(T) or DF(V) cells under unwounded or mechanically 
wounded conditions (Figure 5.2).  With XIAP inhibition, caspase 3 activity 
would be expected to increase, as XIAP cannot bind to caspase 3 preventing 
its activation.  However, it has already been established that the other IAPs, 
cIAP1, cIAP2 and NAIP also interact with caspase 3 preventing its activation 
(Vucic et al., 2000).     
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Another possibility is that caspase 3 activity was measured 24 hours after 
embelin treatment.  A study by Xu et al. (2010) demonstrated that human 
dermal fibroblasts showed increased caspase 3 activity after 12 hours of UVB 
exposure, decreasing progressively after 48 hours.  This shows that caspase 
3 activity might have already increased in embelin treated DF(T) and DF(V) 
cells and returned to basal levels; measuring caspase activity at earlier time 
points would confirm this.  Also, the reduction of cell viability in both DF(T) and 
DF(V) cells when treated with embelin could have occurred at an earlier time 
point.  Therefore, the protective function of 17β-oestradiol may have been 
within the first few hours of embelin exposure. 
A study by Cheng et al. (2010) demonstrated that embelin alone did not 
increase caspase 3 activity in non-small lung cancer cell lines.  However, 
embelin enhanced caspase 3 activation when cell were treated with cisplatin, 
a cancer drug which causes DNA damage leading to cell death (Gonzalez et 
al., 2001).  Levels of XIAP in this cell line was shown to be high, therefore, the 
concentration of embelin (50µM) used to treat the cells might not have been 
high enough to affect caspase 3 activity. 
Previous studies have shown that endonuclease G (an enzyme that cleaves 
DNA) and AIF that are localised in the mitochondrion and translocate to the 
nucleus during apoptotic stress causes chromosomal DNA cleavage 
independently of caspases (Li et al., 2001; Parrish et al., 2001; Seo et al., 
2014).  In human embryonic kidney 293 cells, using co-immunoprecipitation, 
it was shown that cIAP1 but not cIAP2 interacts with the endonuclease G 
enzyme via its BIR3 domain (Seo et al., 2014).  Suggesting that cell viability 
of DF(T) and DF(V) cells could be decreased due to higher levels of 
endonuclease G or AIF in the nucleus.  Cell fractioning to separate nuclear 
contents and immunoprecipitation could help establish whether there are 
higher concentrations of these proteins in embelin treated DF(T) and DF(V) 
cells. 
 
 
 
 Inhibition of XIAP and the Effects of 17β-
Oestradiol on DF(T) and DF(V) Cell Viability and 
IAP Expression 
 
  
 
231 
 
  
Recently it has been suggested that embelin is not only an XIAP antagonist, 
but can also act as an anti-oestrogen (Sumalatha et al., 2014).  This was due 
to the fact that embelin demonstrated a similar function to tamoxifen in 
decreasing cell migration and proliferation and increasing apoptosis in a breast 
cancer cell line.  Another study by Zhou et al. (2000) demonstrated that in 
mammary tissue from monkeys, tamoxifen reduced ERα mRNA expression, 
therefore it would be important to check whether embelin also affects 
oestrogen receptor expression.   
Caspase 3 activity was not affected in unwounded and wounded DF(T) and 
DF(V) cells when incubated with 17β-oestradiol.  This could be due to the time 
point in which caspase 3 activity was measured, or that 17β-oestradiol only 
prevents caspase 3 activity when apoptosis is induced (Figure 5.2).  
mechanically wounding cells did not affect cell viability (Figure 5.1), nor was 
there any significant difference in caspase 3 activity between wounded and 
unwounded DF(T) and DF(V) cells. 
Interestingly, when DF(T) cells were co-incubated with 17β-oestradiol and 
embelin together, the amount of caspase 3 activity decreased in both 
unwounded and mechanically wounded cells, while no significant changes 
were seen in either unwounded or mechanically wounded DF(V) cells 
(Figure 5.2).  This may suggest that 17β-oestradiol may oppose the effect of 
embelin on caspase 3 in DF(T) cells.  A study on non-small lung cancer cell 
lines has shown that a 2 hour pre-treatment of embelin is enough to reduce 
cell numbers after 24 hours (Cheng et al., 2010).  Therefore, the effect of 
embelin may be more rapid in DF(V) cells, and caspase 3 activity affected at 
earlier time points.  After 24 hours, caspase 3 activity might return to normal 
levels in DF(V), therefore any effect of 17β-oestradiol would not be seen.  
Since 17β-oestradiol alone did not reduce caspase 3 activity in unwounded 
and mechanically wounded DF(T) and DF(V) cells, protective effects of 17β-
oestradiol may only be evident when cells are stressed (e.g. via TNFα or UV), 
suggesting why caspase 3 activity was not affected with 17β-oestradiol alone. 
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Although the pathway by which 17β-oestradiol is acting is unknown, oestrogen 
receptor expression in DF(T) and DF(V) was altered in the presence of 17β-
oestradiol following mechanical wounding (Figure 4.5).  Since XIAP was 
important for cell survival (Figure 5.1), blocking XIAP could increase cell 
stress, which could potentially affect oestrogen receptor expression.  To 
determine which oestrogen receptor is involved protecting against a reduction 
in cell viability and/or reducing caspase 3 activity in DF(T) cells, the use of 
specific oestrogen receptor agonists or antagonists or silencing the oestrogen 
receptor genes using siRNA would establish whether 17β-oestradiol protects 
cells independently of oestrogen receptors, or via oestrogen receptors, and if 
so, which one(s).   
5.4.3 The effect of 17β-oestradiol on IAP mRNA expression 
To determine whether 17β-oestradiol has a direct effect on IAP expression in 
vitro, the expression of mRNA for XIAP, Apollon, cIAP2 and NAIP was 
analysed in unwounded and mechanically wounded cell cultures in both the 
presence and absence of 17β-oestradiol. 
In DF(T) cells, XIAP mRNA expression in unwounded and mechanically 
wounded cells increased in the presence of 17β-oestradiol, and while 17β-
oestradiol increased XIAP mRNA in unwounded DF(V) cells, in mechanically 
wounded DF(V) cells, 17β-oestradiol decreased XIAP expression (Figure 5.3).  
This could be the reason why 17β-oestradiol co-treatment with embelin on 
caspase 3 activity was selective to DF(T) cells.  Since 17β-oestradiol 
stimulated an increase in XIAP mRNA expression, a subsequent increase in 
XIAP protein may counteract the effect of embelin and decrease caspase 3 
activity (Figure 5.2).  This trend was seen in DF(T) and DF(V) cells, where both 
unwounded and wounded DF(T) caspase 3 activity was reduced, and only in 
unwounded DF(V) cells caspase 3 activity was reduced. 
No studies have been conducted to investigate the effect of 17β-oestradiol on 
Apollon expression.  Opposite effects were seen in DF(T) and DF(V) cells 
incubated with 17β-oestradiol; mRNA Apollon transcript were increased in 
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unwounded and mechanically wounded DF(T) cells, but decreased in 
corresponding DF(V) cells (Figure 5.3).  This would suggest that Apollon is not 
involved in protecting DF(V) cells, but could be involved in protecting DF(T) 
cells, since mechanically wounding and 17β-oestradiol both decease Apollon 
expression in DF(V) cells.  However, Apollon could be important in regulating 
cell number.  With a decrease in Apollon, more cells are likely to undergo 
apoptosis, however, since 17β-oestradiol did not modulate cell proliferation of 
either DF(T) or DF(V) cells (Figure 4.2), this suggests that Apollon is not 
involved in proliferation. 
17β-oestradiol had no effect on cIAP2 mRNA expression in unwounded DF(T) 
cells, but increased cIAP2 expression in wounded DF(T) cells.  While in DF(V) 
cells, 17β-oestradiol decreased cIAP2 mRNA expression in unwounded cells, 
and had no effect in wounded DF(V) cells (Figure 5.3).  Expression of cIAP2 
was higher in DF(V) cells compared to matching DF(T) cells.  This suggests 
that cIAP2 has a more dominant function in DF(V) cells, compared to DF(T).  
17β-oestradiol has been shown to protect MCF7 cells from TNFα induced 
apoptosis via cIAP2 (Frasor et al., 2009; Stanculescu et al., 2010).  Since 
mRNA expression of cIAP2 was higher in DF(V) cells, it could suggest the 
reason why the cell viability of DF(V) cells was not reduced as much as 
corresponding DF(T) cells when incubated with embelin. 
The expression of NAIP mRNA expression was increased in unwounded and 
mechanically wounded DF(T) cells in the presence of 17β-oestradiol, while 
expression remained unchanged in corresponding unwounded and 
mechanically wounded DF(V) cells (Figure 5.3).  A study by Yin et al. (2008) 
demonstrated by qRT-PCR that in  the uterine epithelial cells of 
ovariectomised mice, 17β-oestradiol induced the expression of NAIP 
transcript, and that active caspase 3 and caspase 9 were abolished in the 
presence of 17β-oestradiol in vivo.  This supports the data obtained with DF(T) 
cells.  The opposite effect of 17β-oestradiol seen in DF(V) cells is supported 
by a study by Wall et al. (2013), demonstrating that 17β-oestradiol treatment 
in vivo, caused an increase in apoptosis in ovariectomised mouse uterine 
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epithelial cells, detected by a TUNEL assay, and that NAIP mRNA transcript 
were decreased as quantitated by qRT-PCR.  The increase in NAIP mRNA 
transcript in DF(T) but not DF(V) cells in the presence of 17β-oestradiol could 
be attributed to the difference in oestrogen receptor expression. Expression of 
GPR30 was higher in DF(T) cells compared to matching DF(V) cells in both 
unwounded and mechanically wounded cells, in the presence and absence of 
17β-oestradiol (Figure 4.4).  However, to confirm the increase of NAIP mRNA 
transcript in DF(T) cells was due to GPR30, the gene can be silenced, and the 
effect of 17β-oestradiol on NAIP mRNA expression can be assessed. 
DIABLO is an IAP antagonist (Cossu et al., 2009; Verhagen et al., 2001; 
Verhagen et al., 2000), and is important in regulating IAP levels.  In DF(T) and 
matching DF(V) cells, expression of DIABLO mRNA increased in the presence 
of 17β-oestradiol (Figure 5.4).  The increase in DIABLO mRNA expression 
when DF(T) and DF(V) cells were incubated with 17β-oestradiol, could be due 
to the up regulation in IAP expression in DF(T) cells, therefore the increase 
would be to maintain IAPs at a specific level, while in DF(V) cells, DIABLO 
could be the cause for the reduction in IAP expression, since IAP expression 
in higher in DF(V) cells compared to matching DF(T) cells.  After 24 hours 
following mechanical wounding, no change in the protein expression of 
DIABLO was seen (Figure 3.15) however, higher expression was found in 
DF(V) cells compared to DF(T) (Figure 3.16).  Mechanical wounding caused 
a decrease in mRNA expression in both DF(T) and DF(V) cells, which could 
suggest that apoptosis needs to occur to get rid of any damaged cells, but also 
to regulate the amount of protein.  After immediate wounding, DIABLO protein 
expression significantly increased, for DIABLO to return to unwounded levels, 
mRNA expression might need to decrease.  Increased expression of DIABLO 
mRNA with 17β-oestradiol could also indicate that DIABLO has other functions 
when activated by 17β-oestradiol.  The fact that in unwounded and 
mechanically wounded DF(V) cells, DIABLO expression increased but the 
majority of IAP levels either remained the same or decreased, would have 
suggested that in DF(V) cells 17β-oestradiol may induce apoptosis.  However, 
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initial expression of IAP transcript was high in DF(V) cells, and cell viability 
was not affected with 17β-oestradiol alone. 
A study by Yao et al. (2007) looked at the effect of 17β-oestradiol on the IAP 
antagonist DIABLO protein in neuronal cell cultures, and showed that when 
neuronal cells were stressed by β-Amyloid which increased DIBALO 
expression, 17β-oestradiol brought DIABLO protein levels back to normal 
levels found in the mitochondria and cytoplasm.  When cells are undergoing 
apoptosis, expression of DIABLO is increased in the cytosol and decreased in 
the mitochondria (Yao et al., 2007).  Since the location of DIABLO is important 
for its function, it would be important to analyse where in the cell DIABLO is 
expressed, whether it is in the nucleus and active or in the cytoplasm.  To 
demonstrate this, a mitochondria/cytosol fractioning kit may be used to 
separate proteins that are found in the mitochondria and cytoplasm.  DF(T) 
and DF(V) cells would be incubated in the presence or absence of 17β-
oestradiol, then fractioned.  Western blotting of the two separate regions would 
establish the localisation of DIABLO.  Also using double immunoprecipitate, it 
would be possible to confirm whether DIABLO is bound to any IAPs.  A study 
by Leblanc et al. (2003) also demonstrated that in rat uterine endometrial cells, 
17β-oestradiol regulated the expression levels for DIABLO which regulated 
XIAP expression.  However, in their study, incubation with 17β-oestradiol 
caused DIABLO expression to decrease.  This indicates that different species 
and different cells express and regulate IAPs differently.  To ensure that 
DIABLO is binding to IAPs and functioning as an IAP antagonist, co-
immunoprecipitation can be carried out on DIABLO and stained against IAPs 
and vice versa to make sure that DIABLO has bound to IAPs preventing their 
function. 
Xaf1 is a direct XIAP antagonist (Liston et al., 2001), there have been no 
previous studies that have looked at the effect of 17β-oestradiol on the 
expression of Xaf1.  Changes in mRNA expression of Xaf1 mirrored the 
expression of XIAP when cells were incubated with 17β-oestradiol in both 
DF(T) and DF(V) cells (Figure 5.3 and Figure 5.4).  Since Xaf1 is a direct 
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inhibitor of XIAP, and XIAP inhibits apoptosis.  However, it could suggest that 
in DF(T) and DF(V) cells Xaf1 mRNA expression is required to ensure that 
XIAP levels are maintained.  A study by Xia et al. (2006) using mice fibroblasts 
derived from a XIAP knockout animal, showed that Xaf1 still sensitised these 
cells to TNFα, suggesting there is another mechanism for Xaf1 to promote 
apoptosis independently of XIAP.  This could suggest that in DF(T) and DF(V) 
cells XIAP and Xaf1 have different roles that are mediated by 17β-oestradiol, 
this could be through ERβ, since ERβ is up regulated in DF(T) and down 
regulated in DF(V) cells when mechanically wounded and in the presence of 
17β-oestradiol. 
Effect of 17β-oestradiol 
in unwounded cells on: 
DF(V) cells compared to 
DF(T) cells 
 Effect of 17β-oestradiol 
in wounded cells on: 
DF(V) cells compared to 
DF(T) cells 
NAIP Higher  NAIP Same 
cIAP2 Higher  cIAP2 Higher 
Apollon Lower  Apollon Lower 
XIAP Same  XIAP Lower 
     
DIABLO Higher  DIABLO Same 
Xaf1 Same  Xaf1 Lower 
Table 5.2: Expression levels of IAP and IAP antagonist mRNA in DF(V) cell compared to DF(T) 
when treated with 17β-oestradiol 
A comparison between DF(V) and DF(T) cells in mRNA expression of the IAPs 
NAIP, cIAP2, Apollon and XIAP, their antagonists DIABLO and Xaf1 in DF(V) 
cells in comparison to DF(T) cells in unwounded and mechanically wounded 
cells in the presence of 17β-oestradiol. 
5.5 Conclusion 
In this chapter, it was demonstrated that embelin an XIAP antagonist reduces 
cell viability in both unwounded and wounded DF(T) and DF(V) cells derived 
from the same donor.  Furthermore, embelin was more effective at reducing 
cell viability in DF(T) cells compared to DF(V) cells.  This would suggest that 
XIAP function is important in maintaining cell viability particularly in DF(T) 
cultures.  17β-oestradiol increased cell viability when incubated with 
unwounded and mechanically wounded DF(T) cells treated with embelin, while 
it only increased viability in corresponding unwounded DF(V) cells. 
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Interestingly, caspase 3 activity was not increased in either unwounded or 
mechanically wounded DF(T) and DF(V) cells treated with embelin.  17β-
oestradiol reduced caspase 3 activity in DF(T) cells incubated with embelin, 
while this effect was not seen in DF(V) cells.   
Incubation with 17β-oestradiol up regulated mRNA expression of XIAP, 
Apollon and NAIP in both unwounded and mechanically wounded DF(T) cells, 
but only the up regulation of cIAP2 in mechanically wounded cells.  However, 
in mechanically wounded DF(V) cells, 17β-oestradiol reduced the mRNA 
expression of XIAP and Apollon; but unwounded DF(V) cells, it increased the 
expression of XIAP and decreased the expression of cIAP2.  17β-oestradiol 
had no effect on NAIP expression in both unwounded and mechanically 
wounded DF(V) cells.  Since 17β-oestradiol had different effects on DF(T) and 
DF(V) cells in terms of IAP expression, it would suggest that 17β-oestradiol 
protects DF(T) cells through the up regulation of IAPs.  However, since IAPs 
were mainly reduced in DF(V) cells, with the exception of XIAP, 17β-oestradiol 
may protect cells through XIAP expression alone. 
Incubation with 17β-oestradiol up regulated mRNA expression of DIABLO in 
unwounded and mechanically wounded DF(T) and DF(V) cells.  It also 
increased Xaf1 expression in unwounded and mechanically wounded DF(T) 
cells, while in DF(V) cells, 17β-oestradiol had no effect on Xaf1 mRNA 
expression in unwounded cells, but decreased expression in mechanically 
wounded cells.  Since Xaf1 binds to XIAP to prevent XIAP function, it could be 
assumed that in DF(V) cells, XIAP is an important IAP, since the decrease in 
Xaf1 mRNA transcript could mean that there are less Xaf1 to bind to XIAP. 
Therefore, IAPs transcript appear to be differentially regulated by 17β-
oestradiol in both unwounded and mechanically wounded DF(T) and DF(V) 
cells, which may explain their differences in terms of caspase 3 activity and 
protection against a reduction in cell viability.  Taken together, this data 
suggests that 17β-oestradiol may have a role in protecting dermal fibroblasts 
against apoptosis when IAP function is compromised.  
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 Discussion and Conclusion 
6.1 Summary of Discussion  
IAPs are proteins that inhibit apoptosis, there are eight mammalian IAPs that 
have been identified (Wei et al., 2008).  IAPs function by binding to caspases, 
preventing them from being cleaved and subsequently activating the caspase 
cascade, which eventually leads to apoptosis (Deveraux and Reed, 1999; 
Deveraux et al., 1998).  DIABLO is a general IAP antagonist (Verhagen et al., 
2000) that binds either directly to IAPs or interferes with caspase 9 binding, 
while Xaf1 is a direct XIAP antagonist (Liston et al., 2001).  Subsequently, 
there have been other IAP antagonists identified, Sept4/ARTS like Xaf1, 
targets XIAP (Gottfried et al., 2004; Larisch et al., 2000) while Omi/HtrA2 acts 
in a similar way to DIABLO and cleaves various IAPs, including cIAP1, cIAP2 
and XIAP (Verhagen et al., 2002; Yang et al., 2003).  Expression of human 
IAPs appears to be cell and tissue specific (Vischioni et al., 2006).  The control 
of apoptosis is essential in wound healing and tissue regeneration, but the role 
of IAPs, particularly in human skin has not been investigated.  An improved 
rate and quality of wound healing in haired human skin has long been 
acknowledged (Jahoda and Reynolds, 2001). Although this has been 
attributed to the hair follicle stem cells, “non-haired” human skin also contains 
hair follicles, although these produce small, fine and unpigmented vellus hairs. 
In studies of human skin, there is much variation between donors. Therefore, 
this study has used matching skin biopsies of human skin containing terminal 
or vellus hair follicles from the same donor.  
Oestrogens are also important in regulating wound healing in the skin 
(Ashcroft et al., 1997a; Ashcroft et al., 1999).  In the skin and hair follicles, 
oestrogen receptors have been identified in both humans and mouse 
(Campbell et al., 2010; Kwon et al., 2004; Markiewicz et al., 2013; Merlo et al., 
2009; Moverare et al., 2002; Ohnemus et al., 2005; Thornton et al., 2003a, b).  
A more predominant expression of ERβ in human skin and hair follicles would 
suggest that in wound healing, 17β-oestradiol improves wound healing via 
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ERβ (Campbell et al., 2010).  The re-establishment of 17β-oestradiol in post 
menopausal female donors via topical application improved wound healing 
(Ashcroft et al., 1999).  It has been established that the anagen phase of the 
hair cycle promotes wound re-epithelialisation in humans (Ansell et al., 2011); 
and that 17β-oestradiol regulates the hair follicle cycle (Chanda et al., 2000), 
therefore 17β-oestradiol could improve wound healing in hairy skin via its role 
in the hair follicle cycle, which in turn, regulates wound healing. 
The hair cycle is an excellent model to study regeneration and tissue 
remodelling, due to the lower region of the hair follicle undergoing cycles of 
apoptosis, regeneration and remodelling recapitulating the events of late 
embryogenesis (Commo and Bernard, 1997; Hashimoto et al., 2001; Tobin et 
al., 2003).  In a murine model, it is easier to study the individual hair follicle 
cycle stages since anagen can easily be induced compared to humans.   
In this study, it has been established that the expression of IAPs (XIAP, 
Apollon, cIAP1 and cIAP2) differed in various compartments of the skin and 
hair follicle at distinct stages of the hair cycle (Figure 2.4 and Table 2.4).  
Interestingly, the expression of these IAPs was found in the dermis at day 5 
after depilation (early to mid anagen).  The expression could be due to the 
effect of depilation on the skin and hair follicle, since depilation causes a 
wound healing response in the skin and hair follicle (Matsuo et al., 2003).  
However, since it has already been established that wound healing is 
improved in skin containing terminal hair follicles (Ansell et al., 2011), the 
improved wound healing response could be due to the expression of these 
IAPs during this stage of the hair cycle.  These IAPs were also found in stem 
cell niches in the skin and hair follicle, which would indicate their importance 
in protecting cells that are required for regeneration especially during wound 
healing (Ito et al., 2005; Levy et al., 2007; Plikus et al., 2012).  Therefore, these 
IAPs might not only be important in regulating the hair follicle cycle, but are 
also important in contributing to a wound healing response.  It was important 
to establish whether these IAPs were also expressed in human skin and 
potentially regulate a wound healing response.  One study by Fuchs et al. 
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(2013) demonstrated the importance of XIAP in murine wounds.  The inhibition 
of XIAP via gene knockout delayed wound re-epithelialisation, which 
suggested the importance of IAPs in particular XIAP in wound healing. 
To date, this is the first study to compare the expression of IAPs and their 
antagonists in human skin derived from terminal (scalp) and vellus (facial) hair 
bearing skin of the same individual.  Since studies have demonstrated the 
importance of terminal hair follicles in wound healing (Ansell et al., 2011; Ito 
and Cotsarelis, 2008; Jahoda and Reynolds, 2001), and that wounds heal 
better in hairy region compared to “non hairy” regions (Jahoda and Reynolds, 
2001; Martinot et al., 1994), it was important to establish whether this was due 
to difference in IAP expression. 
The majority of hair follicles in the scalp are in the anagen phase of the hair 
cycle, 90% of hair follicles are terminal hair follicles while the rest are vellus 
hair follicles (Whiting, 1993, 1996).  Expression of IAPs was similar in the 
dermis between terminal and vellus hair bearing skin, with the exception of 
cIAP2 which had a lower expression in vellus hair bearing skin compared to 
matching terminal hair bearing skin, however, expression in the epidermis was 
higher in terminal hair bearing skin compared to matching vellus hair bearing 
skin for cIAP2, NAIP and XIAP.  This could potentially be due to epidermal 
thickness, since the epidermis is thicker in terminal hair bearing skin compared 
to corresponding vellus hair bearing skin (Figure 2.7).  A thicker epidermis 
would suggest that there are more keratinocytes, therefore regulation of cell 
death needs to be tightly controlled.  This could also be the reason why 
terminal hair bearing skin heals better with less scarring compared to non-
hairy skin. 
The main difference in IAP expression between human skin and murine skin 
was seen in the dermis, where expression was lower in murine dermis, 
however, it was difficult to compare between mouse and human skin since it 
was difficult to establish which stage of the hair cycle the terminal hair follicles 
were in when stained with IAP antibodies. In the dermis, the main cells are the 
fibroblasts; in human skin, there are a higher number of fibroblasts in the 
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dermis compared to murine dermis (Dams et al., 2011).  This could explain 
why there was a higher expression of IAPs in human dermis compared to 
mouse dermis.  Also, if the hair follicle contributes to the expression of IAPs in 
the skin, hair follicles in mice grow in trios (Adelson et al., 1997), with smaller 
hair follicles in mice compared to humans (Griffin et al., 2006). 
Interestingly, the expression of DIABLO and Xaf1 in both human (Figure 2.9 
and Table 2.8) and murine skin (Figure 2.5 and Table 2.5) showed high 
expression.  DIABLO (Cossu et al., 2009; Verhagen et al., 2001; Verhagen et 
al., 2000) and Xaf1 (Liston et al., 2001) are IAP antagonists, therefore promote 
apoptosis.  Therefore expression in the skin and hair follicle should 
theoretically be low, however, DIABLO was expressed in abundance, which 
would suggest that DIABLO might have another role aside from inhibiting IAP 
function.  A study by Kim et al. (2006) demonstrated that DIABLO interacting 
with Survivin in the nucleus at the G2/M arrest caused apoptosis.  This study 
was conducted in prostate cancer cells, DIABLO may potentially interact in 
normal cells in a different manner.  Since the interaction was during a specific 
cell cycle stage, DIABLO may interact with IAPs to promote cell cycling. 
Since fibroblasts are important in wound healing and differences were seen in 
the dermis between terminal and vellus hair bearing skin, dermal fibroblasts 
derived from terminal and vellus hair bearing skin were cultured.  There have 
been different studies that have demonstrated that dermal fibroblasts derived 
from different regions have different properties, and that dermal fibroblasts 
from the same region, but derived from either the reticular or papillary layer 
were also different (Chipev and Simon, 2002; Schafer et al., 1985; Sorrell et 
al., 2004; Sorrell and Caplan, 2004).  However, no studies have compared 
different properties related to wound healing between dermal fibroblasts from 
similar regions either containing terminal (scalp – DF(T)) or vellus (facial – 
DF(V)) hair follicles from the same donor.  These differences could contribute 
to why there is a difference in wound healing between hairy and non-hairy 
regions.  Since DF(T) and DF(V) cells have a different morphology, a 
hypothesis from the study conducted by Sorrell and Caplan (2004) suggests 
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that granular and more complex cells could relate to a higher production of 
TGFβ1.  TGFβ1stimulates the production of more collagen and increases cell 
proliferation (Jutley et al., 1993; O'Leary et al., 2004), which may account for 
the differences seen in wound healing responses between hairy and non hairy 
regions.  This could easily be shown by comparing TGFβ1 secretion using 
ELISA between DF(T) and DF(V) cells, also mRNA expression could also be 
analysed for TGFβ1. 
Therefore, from the results seen in this thesis, DF(V) cells are more granular 
than corresponding DF(T) cells (Figure 3.4), suggesting that this could 
contribute to the difference in wound healing responses.  Vellus hairs are fine 
and unpigmented (Vogt et al., 2007), therefore difficult to see and remove 
when culturing dermal fibroblasts.  This therefore could potentially lead to 
dermal papilla and dermal sheath cells being cultured among dermal 
fibroblasts from the papillary layer which could also contribute to the difference 
in morphology.  This would not be apparent from terminal hair bearing skin, 
since hair follicles are removed before culture.  Specific markers that 
differentiate between fibroblasts derived from different regions could be used 
to assess the purity of the cultures.  Morphology should have been analysed 
not only between DF(T) and DF(V) cells, but also between mechanically 
wounded and unwounded cells to establish if cell morphology changes in 
response to wounding.  Whilst there was no difference between DF(T) and 
DF(V) cells in terms of cell migration, DF(V) cells proliferate at a higher rate 
(Figure 3.5 and Figure 3.6 respectively).  The difference in morphology which 
could attribute to the difference in proliferation rate could be influenced by the 
hair follicle.  The hair follicle dermal sheath could send out signalling molecules 
which has caused hair follicle fibroblasts to adapt.  With the presence of hair 
follicles, there are more fibroblasts that could provide different functions such 
as secretion of TGFβ1, and therefore the fibroblasts in the dermis from vellus 
hair bearing skin potentially need to compensate from the smaller and less 
available vellus hair follicle.  Therefore, it would interesting to culture non 
contaminated dermal sheath cells from vellus and terminal hair follicles, and 
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analyse if there are any morphological differences.  This hypothesis, would 
suggest that the hair follicle influences the dermal fibroblast population, 
however, it could be possible that the dermal fibroblast influence the type of 
hair follicles growing in the skin.  A gene micro array would establish which 
genes are upregulated in DF(T) and DF(V) cells, and whether there is a 
difference which could influence hair follicle production. 
In addition to migration and proliferation, both important aspects of wound 
healing (Jaffe et al., 2012), the regulation of apoptosis is also critical in wound 
healing.  This is the first study to compare expression of IAPs and their 
antagonists in human dermal fibroblasts cultured from terminal and vellus hair 
bearing skin of the same donor.  IAP mRNA expression levels in DF(V) cells 
were higher compared to DF(T) cells with the exception of XIAP and its direct 
antagonist Xaf1, which showed similar expression between the two cell types 
(Figure 3.7).  When these cells were mechanically wounded, expression levels 
decreased, with the exception of XIAP in DF(V) cells, which increased 
(Figure 3.8), causing mRNA levels of XIAP to be higher in DF(V) cells 
compared to matching DF(T) cells.  From the study by Fuchs et al. (2013), it 
was demonstrated that XIAP is important in wound healing, in particular wound 
closure.  The increase in XIAP levels in DF(V) cells but not DF(T) cells could 
indicate the importance of XIAPs in wound healing.  Even though expression 
of XIAP in DF(T) cells did not increase, terminal hair follicles are found in the 
skin from which these fibroblasts are derived from, therefore the dermal sheath 
fibroblasts could contribute to wound healing, therefore, the dermal fibroblasts 
response to mechanical wounding could be influenced by their anatomical 
region.  It would be beneficial to examine the expression levels of IAPs in 
dermal sheath cells extracted from terminal and vellus hair follicles, and how 
mechanical wounding may alter IAP expression.  Extracting vellus hair follicles 
for dermal sheath cell culture is difficult to their size and pigmentation, however 
intermediate hair follicles are more likely to be isolated an analysed (Miranda 
et al., 2010). 
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DF(T) and DF(V) cells were incubated with 17β-oestradiol to compare 
responses in terms of migration and proliferation.  In this study it was 
demonstrated that 17β-oestradiol had no effect on dermal fibroblast 
proliferation but accelerated migration for DF(T) cells only (Figure 4.3).  
Migration is important in wound healing to allow fibroblasts to spread across 
the wound site to produce collagen and rebuild the ECM (Bello and Phillips, 
2000; Park et al., 2011).  Since wounds heal better in terminal hair bearing 
skin, the effect of 17β-oestradiol on migration could suggest that DF(T) cells 
are able to migrate to wounded sites quicker, and since potentially TGFβ1 
secretion is regulated wounds heal better with less scarring.  However, to 
understand responses of 17β-oestradiol in DF(T) and DF(V) cells under 
wounded and non wounded conditions, oestrogen receptor expression was 
analysed. 
With mechanical wounding, expression of the oestrogen receptors (ERα, ERβ 
and GPR30) decreased in DF(T) cells, while only ERβ decreased in DF(V) 
cells; so while mRNA expression of ERα and GPR30 was higher in DF(T) cells, 
after wounding, ERα mRNA expression was higher in DF(V) cells (Figure 4.4).  
In the presence of 17β-oestradiol, oestrogen receptor expression did not 
change in unwounded dermal fibroblasts, however, following mechanical 
wounding ERα and ERβ mRNA increased in DF(T) cells while in DF(V) cells 
ERα and GPR30 mRNA increased causing GPR30 expression to be similar 
between DF(T) and DF(V) cells with higher expression of ERα and lower levels 
of ERβ in DF(V) cells compared to DF(T) cells (Figure 4.5).  Changes in 
oestrogen receptor expression would suggest that fibroblast responses to 17β-
oestradiol needs to be tightly regulated.  Since migration in the presence of 
17β-oestradiol was accelerated only in DF(T) cells, this could be related to 
expression of oestrogen receptors.  In mechanically wounded conditions, in 
the presence of 17β-oestradiol, ERβ mRNA expression increased to a higher 
levels than those seen in DF(V) cells, which could suggest that accelerated 
migration is through ERβ.  Previous studies have shown that accelerated 
migration in dermal fibroblast was through ERα, however these studies where 
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conducted in fibroblasts cultured from female abdominal skin (Stevenson et 
al., 2005; Stevenson et al., 2009).  However, to solidify this claim, it would be 
important to assess migration of DF(T) and DF(V) cells in the presence of 
oestrogen receptor agonists or antagonists, or another method by which the 
gene for the different oestrogen receptors are silenced using siRNA. 
As previously mentioned, IAPs are important in wound healing, and a study by 
Leblanc et al. (2003) demonstrated that IAPs and their antagonists in particular 
XIAP and DIABLO respectively are regulated by 17β-oestradiol.  Therefore, in 
this current study, it was demonstrated that 17β-oestradiol did regulate IAP 
levels in both unwounded and mechanically wounded dermal fibroblasts; in 
DF(T) cells, 17β-oestradiol increased mRNA expression of the majority of IAPs 
while in DF(V) cells, IAP expression was mainly reduced (Figure 5.3).  IAP 
expression is regulated by NFκB therefore, changes or differences in NFκB 
activation between DF(T) and DF(V) cells need to be studied since the effect 
of 17β-oestradiol on IAP levels could potentially be through NFκB.   
Expression of IAPs was higher in unwounded and mechanically wounded 
DF(V) cells, however, in the presence of 17β-oestradiol, Apollon and XIAP 
expression was altered to be lower.  This could be due to the importance of 
the dermal fibroblasts in maintaining the hair follicle, in terminal hair bearing 
skin, larger numbers of larger hair follicles need to be maintained, and 
therefore with higher IAP expression, cells important for supporting the growth 
of the hair follicle are regulated.  In vellus hair bearing skin, expression of 
Apollon and XIAP was lower suggesting that these cells are more likely to 
undergo apoptosis.  With a higher proliferation rate and slower migration in 
DF(V) cells compared to DF(T) cells, fibroblasts may congregate in a small 
area instead of spreading out in the wound therefore, fibroblasts need to 
undergo apoptosis to prevent accumulation and excess production of 
collagen. 
Cell viability of both DF(T) and DF(V) cells was reduced in the presence of 
embelin an XIAP inhibitor (Nikolovska-Coleska et al., 2004) (Figure 5.1), 
however, the reduction in cell viability was greater in DF(T) compared to 
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matching DF(V) cells.  This suggests that XIAP is important in maintaining cell 
viability, since cell viability of DF(V) cells was not reduced to the same levels 
seen in DF(T) cells, it would suggest that there are other mechanisms that are 
in place to protect DF(V) cells that might not be present in DF(T) cells, e.g. the 
expression of other IAPs protecting the cells.  The addition of 17β-oestradiol 
to embelin treated cells improved cell viability in unwounded and mechanically 
wounded DF(T) cells, while only in unwounded DF(V) cells.  This correlates 
with mRNA expression of XIAP, in unwounded and mechanically wounded 
DF(T) cells, XIAP mRNA increased with 17β-oestradiol treatment (Figure 5.3), 
however, in DF(V) cells, 17β-oestradiol increased expression in unwounded 
cells but decreased expression in wounded DF(V) cells (Figure 5.3); providing 
evidence that cell protection by 17β-oestradiol is via an increase in XIAP 
expression. 
The ability of IAPs to prevent apoptosis is by interacting with caspases 
preventing their activation.  Caspase 3 is the effector caspase which when 
activated leads to cell death (Strasser et al., 2000).  Caspase 3 activity was 
measured in DF(T) and DF(V) cells in the presence of embelin and 17β-
oestradiol (Figure 5.2).  No significant differences were seen in caspase 3 
activity in dermal fibroblasts treated with embelin, however, with embelin and 
17β-oestradiol treatment, caspase 3 activity was reduced in both unwounded 
and mechanically wounded DF(T) cells.  This could also be related to XIAP 
mRNA expression, since higher levels of XIAP might protect against caspase 
3 activation and in DF(T) cells in the presence of 17β-oestradiol, XIAP mRNA 
expression was higher compared to matching DF(V) cells.  A similar trend was 
seen in unwounded DF(V) cells, also correlating to XIAP mRNA expression.  
It is difficult to assess via which receptor 17β-oestradiol protects dermal 
fibroblasts.  The trend in ERβ expression between mechanically wounded and 
unwounded DF(T) and DF(V) cells, could suggest that 17β-oestradiol acts 
through ERβ.  However, to solidify this claim, further experiments need to be 
carried out using either oestrogen receptor agonists, or blocking oestrogen 
receptor expression by antagonists, or silencing the oestrogen receptor genes 
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using siRNA and seeing the effect it has on caspase 3 activity in DF(T) and 
DF(V) cells. 
There are other IAPs expressed in DF(T) and DF(V) cells which may contribute 
to the differences seen between DF(T) and DF(V) cells.  Apollon mRNA 
expression in DF(T) and DF(V) cells was relatively high (Figure 3.7).  This 
could suggest that this protein is important in dermal fibroblasts.  Expression 
of Apollon mRNA was higher in DF(V) cells compared to matching DF(T) cells.  
Protein expression increased in DF(T) cells immediately following mechanical 
wounding returning to unwounded levels after 24 hours, while it remained 
constant in DF(V) cells (Figure 3.10).  A higher constant expression of Apollon 
between unwounded and mechanically wounded cells could potentially 
suggest that in DF(V) cells Apollon is more important in protecting against cell 
death, since basal levels of Apollon were higher in DF(V) cells (Figure 3.11).  
So whilst Apollon may potentially protect DF(V) cells against embelin, 
expression of Apollon mRNA decreased in the presence of 17β-oestradiol, 
suggesting that 17β-oestradiol did not protect DF(V) cells via Apollon. 
NAIP mRNA expression was the lowest of the IAPs in DF(T) and DF(V) cells 
(Figure 3.7), which would suggest that it might not be important in dermal 
fibroblasts.  Its localisation is specific to just outside the nucleus, its increase 
in expression by 17β-oestradiol suggests that it is important in cell survival in 
DF(T) but not necessarily DF(V) cells since 17β-oestradiol only increased 
NAIP mRNA expression in DF(T) cells not DF(V) cells (Figure 3.8).  NAIP 
requires ATP to bind to caspase 9 (Davoodi et al., 2010b), which causes a 
conformational change (Davoodi et al., 2004).  Expression of NAIP could have 
decreased following mechanical wounding in DF(V) cells and remained low 
due to NAIP being used up and not replenished.  Cell viability should be 
assessed with NAIP gene silencing to see if 17β-oestradiol protects cell 
through NAIP in DF(T) cells, reducing caspase 3 activity since NAIP mRNA 
transcript increased in DF(T) cells in the presence of 17β-oestradiol.  
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6.2 Summary of Conclusion  
In conclusion, this study has demonstrated that IAPs and their antagonists are 
present in both mouse and human skin by immunofluorescent staining.  
Expression of IAPs in the mouse model varied in the skin and hair follicle at 
different stages of the hair cycle.  In human skin, since it was difficult to study 
the expression of IAPs at different stages of the hair cycle, a difference 
between vellus and terminal hair bearing skin was analysed.  The difference 
observed between terminal and vellus hair bearing skin would suggest that 
IAPs are regulated differently, which could contribute to the type of follicle 
maintained and/or the difference in the rate and quality of wound healing.  
Since ethically it would be difficult to induce anagen and study the hair cycle 
in humans, dermal fibroblasts from terminal and vellus hair bearing skin from 
similar anatomical regions from the same donor were cultured and studied. 
From the different experiments comparing DF(T) and DF(V) cells, it was 
concluded that DF(T) and DF(V) cells not only showed different characteristics 
in terms of size and cell complexity, but also in their proliferation rate.  
However, no differences were observed between DF(T) and DF(V) in cell 
migration.  Their responses to mechanical wounding in culture and to 
incubation with 17β-oestradiol was also different.  Whilst both DF(T) and DF(V) 
cells expressed the IAPs NAIP, cIAP2, Apollon and XIAP, and the antagonists 
DIABLO and Xaf1, expression of these mRNA transcripts was higher in DF(V) 
cells compared to DF(T) cells with the exception of XIAP and its direct 
antagonist Xaf1.  The protein expression of IAPs was similar between 
unwounded DF(T) and DF(V) cells with the exception of Apollon, which was 
higher in DF(V) cells.  This could suggest that Apollon has an important role in 
DF(V) cells compared to matching DF(T) cells.   
Protein expression of ERα and ERβ in the skin and hair follicle was different 
between terminal and vellus hair bearing skin.  17β-oestradiol had no effect 
on DF(T) and DF(V) proliferation but accelerated migration in DF(T) cells only. 
Higher mRNA expression of GPR30 and ERα was seen in DF(T) cells 
compared to matching DF(V) cells, whilst expression of ERβ was similar.  This 
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could suggest that DF(T) cells react quicker (via GPR30) to 17β-oestradiol 
compared to DF(V) cells.  Incubation with 17β-oestradiol had no effect on 
oestrogen receptor transcript levels in unwounded DF(T) and DF(V) cells, but 
did modulate oestrogen receptor expression in mechanically wounded cells,  
suggesting that in a wound healing response 17β-oestradiol controls different 
aspects of wound healing in DF(T) and DF(V) cells, such as modulating 
collagen synthesis, and adhesion of cells. 
Embelin, a potent XIAP antagonist reduced cell viability in both DF(T) and 
DF(V) cells, with more cell death seen in DF(T) cells compared to matching 
DF(V) cells.  This suggests that XIAP is important in maintaining cell viability; 
however, its significance is more prominent in DF(T) cells than DF(V) cells, or 
DF(V) cells have other mechanisms in place to protect cells.  17β-oestradiol 
protected both DF(T) and DF(V) cells, however, only in DF(T) cells was 
caspase 3 activity reduced when incubated with 17β-oestradiol and embelin.  
17β-oestradiol regulated IAP and IAP antagonists mRNA expression 
differently between DF(T) and DF(V) cells under unwounded and mechanically 
wounded conditions.  The majority of the IAPs increased in DF(T) cells with 
17β-oestradiol treatment, however, in DF(V) cells, expression ether remained 
the same or decreased with the exception of XIAP in unwounded and DIABLO 
in wounded DF(V) cells, which increased with 17β-oestradiol.  Suggesting that 
17β-oestradiol is able to prevent apoptosis in DF(T) cells and reduce caspase 
3 activity potentially through increased XIAP levels. 
This thesis therefore concludes that DF(T) and DF(V) cells possess different 
characteristics which could explain differences in wound healing responses.  
XIAP is an important IAP in maintaining cell viability, with stronger effects in 
DF(T) cells compared to matching DF(V) cells.  Whilst 17β-oestradiol protects 
DF(T) and DF(V) cells, other mechanisms are possibly in place in DF(V) cells 
which helped protect against embelin.  17β-oestradiol potentially reduced 
caspase 3 activity when in the presence of embelin via increased XIAP 
expression.  Further studies are required to fully understand the roles of these 
individual IAPs and their antagonists in wound healing responses.   
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Figure 6.1: Summary diagram of the effects of 17β-oestradiol and embelin on DF(T) and DF(V) 
cells 
A summary on the effects of wounding (red), 17β-oestradiol (green) and 
embelin (purple) on DF(T) and DF(V) cells in terms of mRNA expression of 
IAPs and their antagonists and oestrogen receptor expression concluded from 
this study (bold lines), and potential interactions (dashed lines). 
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6.3 Further Studies 
From this study, it has been established that human dermal fibroblasts derived 
from similar regions of the skin from the same donor that contain either 
terminal or vellus hair follicles, exhibit different properties in culture.  To further 
understand the differences between DF(T) and DF(V) cells in wound healing 
responses a comparison of αSMA expression in DF(T) and DF(V) cells should 
be conducted.  αSMA is a marker for myofibroblasts which are important in 
contraction and relates to scarring.  Immunofluorescence using antibodies 
against αSMA or qRT-PCR would establish whether there is a difference 
between DF(T) and DF(V) cells since scarring is more observant in non-hairy 
skin compared to hairy skin, therefore to study if there is a differences in 
contraction between the two cell types, would help establish potential 
mechanisms to reduce the effect of scarring.  A collagen contraction assay 
could also be used to determine whether DF(T) or DF(V) cells differ in their 
contractile abilities.  TGFβ1 secretion can also be analysed as this is an 
important growth factor in the production of collagen.  A collagen detection kit 
could establish collagen synthesis in both DF(T) and DF(V) cells and if there 
is a difference between the two cell types.  Using an ELISA assay, TGFβ1 
secretion between DF(T) and DF(V) cells can be determined in response to 
mechanical wounding and 17β-oestradiol.  qRT-PCR will also help establish 
TGFβ1 transcription between DF(T) and DF(V) cells.  qRT-PCR would also 
establish transcription levels for adhesion molecules such as ICAMs.  
Establishing differences in collagen production and how it is regulated in DF(T) 
and DF(V) cells could provide potential therapeutic targets to control collagen 
secretion and reduce scarring. 
17β-oestradiol also modulated DF(T) and DF(V) cells differently in terms of 
migration with no effect on proliferation.  Therefore, to fully understand how 
and which aspects of wound healing is improved by 17β-oestradiol in both 
DF(T) and DF(V) cells, collagen synthesis, contractile properties and adhesion 
of these dermal fibroblasts could be assessed in the presence of 17β-
oestradiol.  By determining which oestrogen receptor is involved could provide 
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therapeutic targets in improving wound healing.  This can be achieved by using 
specific ERα and ERβ agonists or silencing oestrogen receptor genes using 
siRNA.  Whilst oestrogen treatment has positive impact on certain cells in the 
skin by increasing skin elasticity and in bones by protecting against erosion 
and activating osteocytes, and detrimental impact on others (such as breast 
cancer), topical application could help localise treatment to affected areas. 
17β-oestradiol mainly increased IAP mRNA levels (XIAP, NAIP, Apollon and 
cIAP2) and their antagonists (DIABLO and Xaf1) in DF(T) cells and reduced 
them in DF(V) cells.  The main differences between DF(T) and DF(V) cells 
were seen particularly in XIAP and Xaf1 mRNA levels in wounded DF(T) and 
DF(V) cells.  This could be due to NFκB regulation, therefore using cell 
fracture, nuclear contents may be separated from the cytoplasm.  NFκB 
activation can be assessed in DF(T) and DF(V) cells to look at possible links 
between NFκB regulation and IAP expression.  Since IAPs are regulated 
through NFκB activation, differences between DF(T) and DF(V) cells would 
help establish whether that is the cause for differences in IAP levels which 
then can be targeted. 
To determine which genes (in particular those responsible for wound healing) 
are regulated by 17β-oestradiol in DF(T) and DF(V) cells, and whether there 
is a difference between the two, ChIPSeq and gene microarray can be carried 
out on DF(T) and DF(V) cells treated with 17β-oestradiol.  This would help 
establish which genes are important in a wound healing response with minimal 
consequences such as scarring, and therefore allow for gene targeting.  This 
could be via epigenetics, where genes are targeted to become inactive. 
Incubating DF(T) and DF(V) cells with embelin reduced viability, however the 
difference in reduction between DF(T) and DF(V) cells would suggest that 
DF(V) cells have other mechanisms in place that protect cells.  Therefore, to 
determine whether the other IAPs are important in cell viability, DIABLO 
mimetics could be used to block IAP function.  Theoretically, if the difference 
between DF(T) and DF(V) cell viability was due to other IAPs in DF(V) cells 
protecting the cell, cell viability should be reduced equally when incubated with 
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DIABLO mimetics, or if each individual IAPs is silenced using siRNA.  By 
understanding which IAP is involved, it could potentially be targeted and 
upregulated when cell death needs to be controlled.  
The fact that 17β-oestradiol blocked caspase 3 activity in DF(T) cells but not 
DF(V) cells when treated with embelin would suggest that there is another 
mechanism in place in DF(V) cells that didn’t allow caspase 3 activity to be 
affected.  This could potentially be due to XIAP expression and the effect of 
17β-oestradiol on XIAP in DF(T) and DF(V) cells.  To solidify this claim siRNA 
for XIAP may be used on DF(T) and DF(V) cells; since protein expression 
between DF(T) and DF(V) cells was the same, silencing the gene should 
cause no changes in XIAP expression when treated with 17β-oestradiol.  
Therefore the effect of embelin and 17β-oestradiol together should be the 
same between DF(T) and DF(V) cells. 
The IAP Survivin has been associated with not only inhibiting apoptosis, but 
also in promoting cell proliferation.  This IAP is capable of translocating into 
the nucleus which has been associated with its dual function.  XIAP is another 
IAP that can also be found in the nucleus, therefore, it is possible that XIAP 
may have other roles such as promoting proliferation and migration.  An MTT 
assay or a BrdU assay may be used to measure proliferation properties.  The 
effect of silencing the XIAP gene on cell proliferation can be determined by a 
BrdU assay.  This will help determine whether XIAP also possesses other 
functions.   
Embelin has been shown to block NFκB activation, which is important in IAP 
regulation.  Therefore it is important to determine whether embelin is not only 
directly blocking XIAP, but also regulating other IAPs.  Using qRT-PCR on 
DF(T) and DF(V) cells treated with embelin will establish whether embelin 
does indeed regulate other IAP expression.  Embelin was designed to bind to 
XIAP in a similar way in which DIABLO binds to XIAP.  DIABLO can also be 
found in the nucleus, therefore if embelin affects NFκB, DIABLO might also be 
able to regulate NFκB.  Silencing the DIABLO gene and measuring NFκB 
activity via Western blotting might help establish whether DIABLO has another 
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function aside from antagonising IAPs.  The expression of DIABLO in DF(T) 
and DF(V) cells and skin from terminal and vellus hair bearing skin showed 
high expression of DIABLO.  Suggesting again that DIABLO may have another 
role in human skin.  More studies need to be done on the importance of 
DIABLO alone in skin biology.  This could be done on transgenic mice that 
have the DIABLO gene knocked out.  This will show whether DIABLO has any 
phenotypical effects on the skin.  In dermal fibroblast cells, silencing DIABLO 
by siRNA would establish whether this is sufficient enough to reduce cell 
viability.  If cell viability is not affected in DF(T) and DF(V) cells, it would 
suggest that DIABLO has other roles. 
A wound healing response is not confined to one cell, in the skin, keratinocytes 
and endothelial cells are important in wound healing.  Therefore it is important 
to understand the interactions that occurs between different cells, and how 
these cells affect or potentially are affected by DF(T) and DF(V) cells in the 
presence and absence of 17β-oestradiol.  Migration effects can be observed 
after keratinocyte or endothelial cell cultures are treated with conditioned 
medium from DF(T) and DF(V) cells at different time points, up to 48 hours, 
and qRT-PCR carried out on the keratinocytes and/or endothelial cells.  Co-
cultures between the different cell types would establish if DF(T) and DF(V) 
cells have different effects on keratinocytes and endothelial cells in terms of 
migration and proliferation. 
It is important to continue these studies to help establish the mechanisms that 
are involved in DF(T) and DF(V) cells, which could therefore help identify 
therapeutic targets that would improve wound healing responses.  
Understanding the mechanisms and being able to target specific pathways 
which contribute to improved wound healing would be able to be applied to 
patients with chronic non-healing wounds and to help improve scarring effects, 
especially in postmenopausal women. 
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 Appendix 
8.1 Solution Protocol 
8.1.1 Celestine blue 
A 5% aqueous solution of ammonium iron sulphate (500ml) was added to 2.5g of 
Celestine blue.  After boiling for 3 minutes, the solution was allowed to cool, and filtered 
(grade 595 filter paper) before the addition of 70ml glycerol. 
8.1.2 Picric acid/ ethanol 
A saturated alcoholic solution of picric acid (5ml) was mixed with 300 ml absolute ethanol. 
8.1.3 Picro-indigo carmine 
A saturated aqueous solution of picric acid (300ml) was mixed thoroughly with 1g of 
indigo-carmine; this solution was filtered before use. 
8.1.4 Safranin  
6g of Safranin was dissolved in 300ml of a 1:1 ethanol:distilled water solution.  The 
solution was filtered before use. 
8.1.5 Scott’s tap water 
2g of sodium hydrogen carbonate and 20g of magnesium sulphate were dissolved in 1L 
distilled water, filtered and stored at 4˚C until used. 
8.1.6 Gill’s haematoxylin  
Dissolve 16.7ml of ethylene glycerol in 50ml of distilled water.  Add 0.13g of haematoxylin, 
0.013g of sodium iodate, 1.33g of aluminium sulphate and 1.33g of glacial acetic acid.  
Stir for 1 hour at room temperature, filter before use. 
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8.2 Abstracts 
8.2.1 7th World Hair Congress 
Differences in the upregulation of inhibitor of apoptosis proteins (IAPs) in human 
dermal fibroblasts derived from hair-bearing and non hair-bearing skin in a scratch 
wound assay 
O Kamala1, AM Graham2, MJ Thornton1 
1Centre for Skin Sciences, University of Bradford, UK 
2Medical Bioscience, University of Bradford, UK 
 
Observational studies describe rapid donor site healing when scalp skin is used for split-
thickness skin grafting, suggesting that wounds heal better from hair-bearing skin. This 
has mainly been attributed to the hair follicle, but studies also suggest that dermal 
fibroblasts from different regions exhibit phenotypic differences. Recently the role of IAPs, 
a family of antiapoptotic proteins that inhibit the activity of caspase proteins, in wound 
repair has been highlighted.  
Using matched patient skin samples (n=3), we cultured dermal fibroblasts from hair-
bearing scalp skin and adjacent skin that does not contain terminal follicles. In a 
comparison of fibroblasts derived from the same patients, at the same passage number, 
those derived from hair-bearing skin grew at a much slower rate over a 12 day period, 
compared to their adjacent counterparts.  
Using a scratch wound assay we compared the expression of a panel of IAPs (NAIP, c-
IAP2, XIAP and Apollon) and their antagonists (XAF1 and SMAC/DIABLO) immediately 
after scratching and 24 hours later using immunocytochemistry quantitated by ImageJ. 
Fibroblasts from hair-bearing skin demonstrated an increase in the expression of NAIP, 
Apollon and SMAC/DIABLO immediately after scratching; all returned to control levels 
after 24h. In contrast, only an upregulation in the expression of SMAC/DIABLO was 
observed in matching fibroblasts from non hair-bearing skin.  
These results provide further evidence for important phenotypic differences in human 
dermal fibroblasts from skin containing either terminal or vellus hair follicles. An immediate 
upregulation of the expression of IAPs in fibroblasts from hair-bearing skin suggests that 
they have better mechanisms in place for cell survival following wounding, which may 
contribute to the superior wound healing observed in hairy skin. Further studies are 
required to determine if fibroblasts from hair bearing skin significantly contribute to the 
wound healing response, which in turn may lead to improved therapies for chronic non-
healing wounds. 
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8.2.2 Skin and Bone Conference  
Human Dermal Fibroblasts Cultured from Different Anatomical Hair Bearing Skin 
Regions Respond Differently to Wound Healing Stimuli by Altered Expression of 
Oestrogen Receptors and the X-linked Inhibitor of Apoptosis Protein 
O Kamala1, AM Graham2, MJ Thornton1 
1Centre for Skin Sciences, University of Bradford, UK 
2Medical Bioscience, University of Bradford, UK 
Human wounds heal better in skin containing large, pigmented terminal hair follicles e.g. 
scalp. Although this may be attributed to hair follicle stem cells, dermal fibroblasts from 
different anatomical regions exhibit phenotypic differences. Therefore, we compared 
matching fibroblasts derived from terminal and vellus (small, un-pigmented follicles) hair 
bearing skin of the same donor. Tissue repair requires tight control of cell proliferation, 
migration and apoptosis; animal studies have shown inactivation of the X-linked inhibitor 
of apoptosis protein (XIAP) impairs wound healing and processing of XIAP after injury is 
gender-specific and may be influenced by endogenous oestrogen. However, the 
relationship between oestrogen and XIAP in human skin has not been studied. 
Dermal fibroblasts (DF) were cultured from female pre-auricular skin containing (T) 
terminal (scalp) or (V) vellus (facial) hair follicles.  Cell morphology was analysed using 
FACS, and cell viability compared in the presence of 17β-oestradiol and the XIAP inhibitor 
embelin.  Migration following mechanical wounding of cell monolayers was compared in 
the presence of 17β-oestradiol (1-100nM) and changes in mRNA expression of oestrogen 
receptors (GPR30, ERα and ERβ) and XIAP quantitated by qRT-PCR.  
DF(V)s were smaller and more granular than corresponding DF(T)s. The XIAP inhibitor 
reduced cell viability in both, while 17β-oestradiol counteracted this effect. Only DF(T)s 
increased cell migration in response to 17β-oestradiol. The expression of all oestrogen 
receptor mRNA decreased in DF(T)s following mechanical wounding; only ERβ 
expression decreased in DF(V)s. ER expression was not modulated by 17β-oestradiol in 
intact fibroblasts, but 17β-oestradiol increased ERα and ERβ in wounded DF(T)s and 
increased GPR30 and ERα in wounded DF(V)s. The expression of XIAP mRNA was 
increased in intact cultures of both cell types in the presence of 17β-oestradiol; however, 
following wounding while 17β-oestradiol increased XIAP expression in DF(T)s, 17β-
oestradiol decreased XIAP expression in DF(V)s. 
These results demonstrate significant differences between dermal fibroblasts from 
different anatomical regions of the same individuals. Accelerated migration and an 
increase in XIAP expression via ERβ in DF(T)s would support previous animal studies 
showing oestrogen promotes cutaneous wound healing via ERβ. Further elucidation of 
the different signalling pathways may lead to improved therapies for chronic non-healing 
wounds. 
